
<html lang="en"     class="pb-page"  data-request-id="20e4e7be-e385-48e5-8778-8de6ce8d7040"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/jm201528b;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2012.55.issue-5"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Cyclooxygenase-1-Selective Inhibitors Based on the (E)-2′-Des-methyl-sulindac Sulfide Scaffold" /></meta><meta name="dc.Creator" content="Andy J.  Liedtke" /></meta><meta name="dc.Creator" content="Brenda C.  Crews" /></meta><meta name="dc.Creator" content="Cristina M.  Daniel" /></meta><meta name="dc.Creator" content="Anna L.  Blobaum" /></meta><meta name="dc.Creator" content="Philip J.  Kingsley" /></meta><meta name="dc.Creator" content="Kebreab  Ghebreselasie" /></meta><meta name="dc.Creator" content="Lawrence J.  Marnett" /></meta><meta name="dc.Description" content="Prostaglandins (PGs) are powerful lipid mediators in many physiological and pathophysiological responses. They are produced by oxidation of arachidonic acid (AA) by cyclooxygenases (COX-1 and COX-2..." /></meta><meta name="Description" content="Prostaglandins (PGs) are powerful lipid mediators in many physiological and pathophysiological responses. They are produced by oxidation of arachidonic acid (AA) by cyclooxygenases (COX-1 and COX-2..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 14, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm201528b" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm201528b" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm201528b" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm201528b" /></link>
        
    
    

<title>Cyclooxygenase-1-Selective Inhibitors Based on the (E)-2′-Des-methyl-sulindac Sulfide Scaffold | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm201528b" /></meta><meta property="og:title" content="Cyclooxygenase-1-Selective Inhibitors Based on the (E)-2′-Des-methyl-sulindac Sulfide Scaffold" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0001.jpeg" /></meta><meta property="og:description" content="Prostaglandins (PGs) are powerful lipid mediators in many physiological and pathophysiological responses. They are produced by oxidation of arachidonic acid (AA) by cyclooxygenases (COX-1 and COX-2) followed by metabolism of endoperoxide intermediates by terminal PG synthases. PG biosynthesis is inhibited by nonsteroidal anti-inflammatory drugs (NSAIDs). Specific inhibition of COX-2 has been extensively investigated, but relatively few COX-1-selective inhibitors have been described. Recent reports of a possible contribution of COX-1 in analgesia, neuroinflammation, or carcinogenesis suggest that COX-1 is a potential therapeutic target. We designed, synthesized, and evaluated a series of (E)-2′-des-methyl-sulindac sulfide (E-DMSS) analogues for inhibition of COX-1. Several potent and selective inhibitors were discovered, and the most promising compounds were active against COX-1 in intact ovarian carcinoma cells (OVCAR-3). The compounds inhibited tumor cell proliferation but only at concentrations &gt;100-fold higher than the concentrations that inhibit COX-1 activity. E-DMSS analogues may be useful probes of COX-1 biology in vivo and promising leads for COX-1-targeted therapeutic agents." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm201528b"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm201528b">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm201528b&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm201528b&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm201528b&amp;href=/doi/10.1021/jm201528b" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 2287-2300</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm201513c" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm201546m" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Cyclooxygenase-1-Selective Inhibitors Based on the (<i>E</i>)-2′-<i>Des</i>-methyl-sulindac Sulfide Scaffold</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andy+J.++Liedtke">Andy J. Liedtke</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brenda+C.++Crews">Brenda C. Crews</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cristina+M.++Daniel">Cristina M. Daniel</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anna+L.++Blobaum">Anna L. Blobaum</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Philip+J.++Kingsley">Philip J. Kingsley</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kebreab++Ghebreselasie">Kebreab Ghebreselasie</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lawrence+J.++Marnett">Lawrence J. Marnett</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">A. B. Hancock Jr. Memorial Laboratory for Cancer Research, Departments of Biochemistry, Chemistry and Pharmacology, Vanderbilt Institute of Chemical Biology, Center in Molecular Toxicology and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States</span></div><div class="corresp-info"><strong>*</strong>Tel: 615-343-7329. Fax: 615-343-7534. E-mail: <a href="/cdn-cgi/l/email-protection#e38f8291919acd8e82918d869797a395828d878691818a8f97cd868796"><span class="__cf_email__" data-cfemail="b2ded3c0c0cb9cdfd3c0dcd7c6c6f2c4d3dcd6d7c0d0dbdec69cd7d6c7">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm201528b&amp;href=/doi/10.1021%2Fjm201528b" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 2287–2300</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 20, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>11 November 2011</li><li><span class="item_label"><b>Published</b> online</span>14 February 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 March 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm201528b" title="DOI URL">https://doi.org/10.1021/jm201528b</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm201528b"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2783</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">43</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm201528b" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Cyclooxygenase-1-Selective Inhibitors Based on the (E)-2′-Des-methyl-sulindac Sulfide Scaffold&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Andy&quot;,&quot;last_name&quot;:&quot;J. Liedtke&quot;},{&quot;first_name&quot;:&quot;Brenda&quot;,&quot;last_name&quot;:&quot;C. Crews&quot;},{&quot;first_name&quot;:&quot;Cristina&quot;,&quot;last_name&quot;:&quot;M. Daniel&quot;},{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;L. Blobaum&quot;},{&quot;first_name&quot;:&quot;Philip&quot;,&quot;last_name&quot;:&quot;J. Kingsley&quot;},{&quot;first_name&quot;:&quot;Kebreab&quot;,&quot;last_name&quot;:&quot;Ghebreselasie&quot;},{&quot;first_name&quot;:&quot;Lawrence&quot;,&quot;last_name&quot;:&quot;J. Marnett&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;2287-2300&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm201528b&quot;},&quot;abstract&quot;:&quot;Prostaglandins (PGs) are powerful lipid mediators in many physiological and pathophysiological responses. They are produced by oxidation of arachidonic acid (AA) by cyclooxygenases (COX-1 and COX-2) followed by metabolism of endoperoxide intermediates by terminal PG synthases. PG biosynthesis is inhibited by nonsteroidal anti-inflammatory drugs (NSAIDs). Specific inhibition of COX-2 has been extensively investigated, but relatively few COX-1-selective inhibitors have been described. Recent reports of a possible contribution of COX-1 in analgesia, neuroinflammation, or carcinogenesis suggest that COX-1 is a potential therapeutic target. We designed, synthesized, and evaluated a series of (E)-2′-des-methyl-sulindac sulfide (E-DMSS) analogues for inhibition of COX-1. Several potent and selective inhibitors were discovered, and the most promising compounds were active against COX-1 in intact ovarian carcinoma cells (OVCAR-3). The compounds inhibited tumor cell proliferation but only at concentrations &gt;100-fold hi&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201528b&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201528b" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201528b&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201528b" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201528b&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201528b" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm201528b&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201528b&amp;href=/doi/10.1021/jm201528b" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm201528b" /></input><a href="/doi/pdf/10.1021/jm201528b" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm201528b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm201528b%26sid%3Dliteratum%253Aachs%26pmid%3D22263894%26genre%3Darticle%26aulast%3DLiedtke%26date%3D2012%26atitle%3DCyclooxygenase-1-Selective%2BInhibitors%2BBased%2Bon%2Bthe%2B%2528E%2529-2%25E2%2580%25B2-Des-methyl-sulindac%2BSulfide%2BScaffold%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D5%26spage%3D2287%26epage%3D2300%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291840" title="Sulfides">Sulfides</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jmcmar.2012.55.issue-5/production/jmcmar.2012.55.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/medium/jm-2011-01528b_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201528b&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Prostaglandins (PGs) are powerful lipid mediators in many physiological and pathophysiological responses. They are produced by oxidation of arachidonic acid (AA) by cyclooxygenases (COX-1 and COX-2) followed by metabolism of endoperoxide intermediates by terminal PG synthases. PG biosynthesis is inhibited by nonsteroidal anti-inflammatory drugs (NSAIDs). Specific inhibition of COX-2 has been extensively investigated, but relatively few COX-1-selective inhibitors have been described. Recent reports of a possible contribution of COX-1 in analgesia, neuroinflammation, or carcinogenesis suggest that COX-1 is a potential therapeutic target. We designed, synthesized, and evaluated a series of (<i>E</i>)-2′-<i>des</i>-methyl-sulindac sulfide (<i>E</i>-DMSS) analogues for inhibition of COX-1. Several potent and selective inhibitors were discovered, and the most promising compounds were active against COX-1 in intact ovarian carcinoma cells (OVCAR-3). The compounds inhibited tumor cell proliferation but only at concentrations >100-fold higher than the concentrations that inhibit COX-1 activity. <i>E</i>-DMSS analogues may be useful probes of COX-1 biology in vivo and promising leads for COX-1-targeted therapeutic agents.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46816" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46816" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cyclooxygenases (COX-1 and COX-2) catalyze the oxygenation of arachidonic acid (AA) to form prostaglandins and thromboxane, which mediate a range of physiological and pathophysiological responses.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The discovery in 1971 that nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit prostaglandin synthesis in guinea pig lung and human platelets established COX-1 as a molecular target for this ancient class of drugs.<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2-4)</a> The subsequent discovery in 1991 of COX-2, which is induced by cytokines during inflammation, suggested that this form of the enzyme represents the molecular target for the anti-inflammatory effects of NSAIDs.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8">(5-8)</a> The differential expression of COX-1 and COX-2, and in particular the finding that COX-1 is the principal form expressed in the gastrointestinal tract, led to the search for COX-2-selective inhibitors as potential anti-inflammatory agents that might lack the gastrointestinal side effects of traditional NSAIDs.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> A number of highly selective inhibitors were introduced to the market including celecoxib (<b>6</b>), rofecoxib (<b>7</b>), valdecoxib, etoricoxib, and lumiracoxib (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref12 ref13 ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15 ref16 ref17">(12-17)</a> These compounds exhibited reduced gastrointestinal side effects in human testing but did not completely eliminate this liability.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> In addition, long-term placebo-controlled studies revealed cardiovascular side effects that led to the withdrawal of rofecoxib and valdecoxib from the market in the United States and Europe.<a onclick="showRef(event, 'ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22 ref23">(20-23)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/medium/jm-2011-01528b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0003.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Upper row: the structures of sulindac (sulfoxide, <b>1a</b>), its in vivo metabolites (<b>1b</b> and <b>1c</b>), and 2′-<i>des</i>-methyl sulindac sulfide (<b>2</b>) as well as indomethacin (<b>3</b>, nonselective COX-1/-2 inhibitor). Lower row: <i>N</i>-(5-amino-2-pyridinyl)-4-(trifluoromethyl) benzamide (TFAP, <b>4</b>), SC-560 (<b>5</b>) (selective COX-1 inhibitors), celecoxib (<b>6</b>), and rofecoxib (<b>7</b>) (selective COX-2 inhibitors).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201528b&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The “COX-2” hypothesis posited that COX-1 inhibition is responsible for the gastrointestinal toxicity of NSAIDs. However, animal studies suggest that the total extent of COX inhibition is more important than the inhibition of the individual enzymes and that highly selective COX-1 inhibitors do not exhibit gastrointestinal toxicity analogous to highly selective COX-2 inhibitors.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a> COX-1-dependent prostaglandin synthesis has been implicated in many pathophysiological processes including atherosclerosis, endothelial dysfunction, neuroinflammation, preterm labor, pain, and cancer.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> The role of COX-1 in neurodegenerative diseases is of particular interest. Neurodegenerative disorders that exhibit a strong inflammatory component produce prostaglandins (PGs) in neurons and glial cells.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The extent of neurodegeneration is reduced in COX-1 knockout mice or by administration of COX-1-selective inhibitors.<a onclick="showRef(event, 'ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref31">(29-31)</a> Very recent results indicate that COX-1 is a major source of pro-inflammatory PGs in the brains of both LPS-treated mice and mice treated with the Parkinsonism-inducing compound, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Therefore, COX-1-selective inhibitors represent a potentially useful class of drugs that has not been extensively investigated.</div><div class="NLM_p">The COX-1 inhibitors that have been described in the literature fall into two main structural classes.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> One class comprises diarylheterocycles discovered during the COX-2 inhibitor programs that led to the development of <b>6</b> and <b>7</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Noteworthy among this class of inhibitors is SC-560 (<b>5</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), which exhibits COX-1 selectivity greater than 700-fold and which has been extensively used as an in vitro and in vivo probe, for example, for investigating inhibition of PGE<sub>2</sub> synthesis in rat primary spinal cord neurons or in (mouse) models of human ovarian cancer (OVCAR-3).<a onclick="showRef(event, 'ref33 ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35 ref36">(33-36)</a> The other class of COX-1 inhibitors comprises substituted benzamides related to <i>N</i>-(5-amino-2-pyridinyl)-4-(trifluoromethyl)-benzamide (TFAP, <b>4</b>; Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref25 ref37'); return false;" href="javascript:void(0);" class="ref ref25 ref37">(25, 37)</a> This compound exhibits high COX-1 selectivity but has not been used extensively as a probe. TFAP and its analogues have been suggested as candidates for analgesics that do not cause stomach erosions or ulcers.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Other compounds related to resveratrol, a noncompetitive COX inhibitor with anti-inflammatory, cardiovascular protective, and cancer chemopreventive properties, and curcumin, the active component of turmeric that possesses anti-inflammatory and anticancer activity, are reported to exhibit modest COX-1 selectivity. A recent study of 92 stilbene analogues, whose biological activities were assessed with various chemoprevention targets, revealed a handful of nitro- or amino-substituted resveratrol derivatives that inhibit COX-1 with potency roughly comparable to the parent compound but without affecting COX-2.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Finally, valeryl salicylate, a derivative of aspirin, selectively inhibits COX-1 by covalent modification of an active site serine residue.<a onclick="showRef(event, 'ref26 ref38'); return false;" href="javascript:void(0);" class="ref ref26 ref38">(26, 38)</a> Biological effects of valeryl salicylate have been, for example, studied in models of acute inflammation in mice.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><div class="NLM_p">Sulindac (compound <b>1a</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) is an NSAID that exhibits cancer chemopreventive activity in animal models, induces polyp regression in familial polyposis patients, and inhibits polyp recurrence in patients when combined with α-difluoromethylornithine.<a onclick="showRef(event, 'ref40 ref41 ref42 ref43 ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42 ref43 ref44 ref45 ref46">(40-46)</a> Sulindac is a pro-drug that is reduced to the active sulfide metabolite by colonic microflora.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Sulindac sulfide (compound <b>1b</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) is a slow, tight-binding inhibitor of both COX-1 and COX-2. We recently reported that the 2′-<i>des</i>-methyl derivative of <b>1b</b> (compound <b>2</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) does not inhibit COX-2 but selectively inhibits COX-1 (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and Figure S5 in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> The absence of the 2′-methyl group during indene synthesis quantitatively directs the geometry of the introduced benzylidene double bond to (<i>E</i>) rather than (<i>Z</i>), which is formed when the 2′-methyl group is present;<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> compound <b>2</b> is a rapid, reversible inhibitor of COX-1. The novelty of this scaffold prompted us to investigate its potential for the construction of more potent and selective COX-1 inhibitors.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. COX-1 and COX-2 Inhibition by Arylmethylidene Variants of <i>E</i>-DMSS<a class="ref internalNav" href="#tbl1-fn1" aria-label="*">*</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/medium/jm-2011-01528b_0013.gif" alt="" id="fx13" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/medium/jm-2011-01528b_0014.gif" alt="" id="fx14" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>Table *</sup><p class="last">Compounds were screened at 4 μM. A concentration of 5 μM of AA-substrate was employed; n.d., not determined.</p></div><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Mean ± SEM of two (<i>n</i>) experiments.</p></div></div><div></div></div><div class="NLM_p last">In the present manuscript, we describe the synthesis of a series of compounds designed to probe the importance of the various functionalities in <b>2</b> with regard to selective inhibition of COX-1. We find that modification of the benzylidene group leads to improved inhibitors, but alterations in the 5′-fluoro or carboxyl group are less well tolerated. The most active compounds are potent inhibitors of COX-1 in cultured human ovarian cells but are weak inhibitors of the growth of the cells in vitro.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52874" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52874" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The indene template is a widely used pharmacophore that has found many applications in medicinal chemistry, for example, in NSAIDs.<a onclick="showRef(event, 'ref50 ref51 ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref50 ref51 ref52 ref53">(50-53)</a> Recent reports have indicated that the benzylidene-indene acetic acid derivative <b>1b</b> can be structurally re-engineered to improve isoform-specific COX binding inter alia.<a onclick="showRef(event, 'ref43 ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref43 ref54 ref55">(43, 54, 55)</a> In the present study, compound <b>2</b>, the <i>E</i>-2′-<i>des</i>-methyl-sulindac sulfide [(<i>E</i>)-DMSS] analogue of <b>1b</b>, served as the lead scaffold for construction of potential COX-1-selective inhibitors. Modifications were made at the carboxyl, benzylidene, and 5′-position of the indene ring (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). The synthetic scheme followed the general approaches previously described for assembly of sulindac analogues with some modifications (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref53 ref56'); return false;" href="javascript:void(0);" class="ref ref53 ref56">(53, 56)</a> In contrast to the standard procedures, which employ “activated” zinc and expensive α-haloalkanoyl esters, we reacted the indanone precursors, <b>8</b>, with inexpensive ethyl alkanoates at low temperatures using lithium diisopropylamide in tetrahydrofuran.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> This method generated the intermediate alcohols, <b>9</b>, after an acidic quench in a much shorter time (2 h). The quantities of side products detected by HPLC were less than with the lengthy Reformatsky reaction (overnight with Zn<sup>0</sup> catalyst).<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> The applied alkylation reaction tolerated different substituents at the core aromatic annulus (e.g., 6′-F, 6′-OCH<sub>3</sub>) and allowed the introduction of α-unsubstituted (<b>9a</b>,<b>b</b>), monomethylated (<b>9c</b>), or geminal-dimethylated (<b>9d</b>) carboxymethyl moieties at position 1 of the indanone ring. Compounds <b>9a</b>, <b>9c</b>, and <b>9d</b> hold a 6′-F substituent at the 1-hydroxy-2,3-dihydro-1<i>H</i>-inden-1-yl partial structure, whereas <b>9b</b> has a methoxy group at its 6′-position. HPLC analysis of <b>9a</b>, <b>9b</b>, and <b>9d</b>, which contain a single asymmetric carbon, afforded a single peak, whereas compound <b>9c</b>, which has two chiral centers, afforded two substantial peaks due to the presence of diastereomers. Attempts to prepare a cyclopropyl analogue using ethyl cyclopropanecarboxylate as an alkylation reagent failed due to the instability of the intermediate cycloalkyl carbanion.<a onclick="showRef(event, 'ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref59 ref60">(59, 60)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/medium/jm-2011-01528b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0004.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Intended chemical modifications on <b>2</b> and <b>13</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201528b&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/medium/jm-2011-01528b_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Route to Multisubstituted (<i>E</i>)-2′-<i>Des</i>-methyl Sulindac Sulfide Analogues Including Procedures for Ester Cleavage and (Re)Esterification Reactions<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201528b&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) For compound <b>2</b>: ethyl bromoacetate, activated zinc dust, benzene/ether, reflux, 16 h. (b) 2 M LDA, THF, (substituted) ethyl alkanoate, −75 °C, 2 h. (c) TsOH·2H<sub>2</sub>O, CaCl<sub>2</sub>·2H<sub>2</sub>O, toluene, reflux, overnight. (d) 1 N NaOH, MeOH, 65–70 °C. (e) Potassium trimethylsilanoate (90% material), THF, microwave radiation, 90–120 °C, 15 min. (f) Water, 2–4 M HCl. (g) 1 M LiOH, THF, RT, 5–6 h. (h) Alkyl alcohol, H<sub>2</sub>SO<sub>4</sub>, reflux, overnight.</p></p></figure><div class="NLM_p">Dehydration of <b>9a</b> and <b>9b</b> produced a mixure of <i>exo-</i> and <i>endo</i>-olefins for both <b>10a</b> and <b>10b</b> (Table S1 in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).<a onclick="showRef(event, 'ref50 ref57'); return false;" href="javascript:void(0);" class="ref ref50 ref57">(50, 57)</a> Steric hindrance from the exocyclic alkyl chain of the racemic mixture <b>10c</b> favored conversion to the <i>endo</i>-olefin as indicated by HPLC analysis and by comparison to the UV spectrum of <b>10d</b>, which cannot exist in the <i>exo</i>-form (Table S1 in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). Unseparated isomeric mixtures of ethyl esters, <b>10a</b>–<b>c</b>, were employed in the subsequent condensation step. Knoevenagel (aldol) condensation between <b>10a</b>–<b>d</b> and the appropriate aldehydes proceeded under basic conditions to afford a single <i>endo</i>-olefin in all cases. Considerable amounts of byproduct, most likely from the Cannizzaro reaction, could be detected by HPLC, MS, and NMR. Together with the recognized light instability of the <i>E</i>-DMSS analogues (UV-induced isomerization about the exocyclic double bond from <i>E</i> to <i>Z</i>), this complicated the purification process and decreased the isolatable yields for some compounds.<a onclick="showRef(event, 'ref48 ref50 ref61'); return false;" href="javascript:void(0);" class="ref ref48 ref50 ref61">(48, 50, 61)</a> The basic conditions of the condensation led to ester hydrolysis for compounds derived from <b>10a</b> and <b>10b</b>. In addition, the lipophilic nature of the final <i>E</i>-DMSS analogues occasionally allowed their quantitative isolation as pure sodium salts directly from the aqueous-alkaline mother liquor (Table S2 in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). The acids could be esterified with alcohols under acidic conditions and hydrolyzed with LiOH.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Hydrolysis was not observed for compounds derived from <b>10c</b> and <b>10d</b>. The ester products either crystallized from the reaction mixture or were extracted and purified by chromatography. The stereochemistry of the exocyclic double bond of all of the <i>E</i>-DMSS analogues was <i>E</i> as anticipated by the absence of a methyl group at the 2′-position of the indenyl ring (compare <sup>1</sup>H NMR and NOESY spectrum of <b>20b</b> in Figures S2 and S3 in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Detailed experimental conditions and spectral properties of all intermediate and final compounds are provided in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div><div class="NLM_p">Individual compounds were preincubated with purified ovine COX-1 or murine COX-2 for 17 min followed by addition of [1-<sup>14</sup>C]-AA (Figure S4 in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>: experimental timeline). After 3 min, the reaction was quenched, and radioactive products were extracted and quantified as described in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. For initial screening, a single concentration of 4 μM inhibitor was employed, and the concentration of [1-<sup>14</sup>C]-AA was 5 μM. The 4 μM inhibitor concentration was chosen based on the previously determined IC<sub>50</sub> of 1.8 μM for compound <b>2</b>. The AA concentration of 5 μM represents the <i>K</i><sub>m</sub> for COX-1 and COX-2, which enables rapid, reversible, and slow, tight-binding inhibitors to be detected. Compound <b>2</b> was used as a reference for all new <i>E</i>-DMSS analogues.</div><div class="NLM_p">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> lists the percent inhibition of COX for the initial series of arylmethylidene analogues of <b>2</b>.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> We determined the effects of different steric and electronic properties upon COX-1 and COX-2 inactivation. Oxidation of the sulfide (<b>11a</b> and <b>11b</b>) reduces activity as previously reported for sulindac sulfide analogues. Substitution with trifluoromethylsulfide (<b>11c</b>) maintains some COX-1 selectivity, while oxidation of the sulfur again reduces activity (<b>11d</b> and <b>11e</b>). A range of <i>para</i> substituents exhibited modest COX-1 selectivity (<b>11f</b>–<b>m</b>). Substitution of carboxyl at the <i>para</i> position reduced the potency against COX-1 but more substantially reduced inhibition of COX-2. Conversion of the phenyl ring to a naphthyl or aza-naphthyl ring maintained COX-1 selectivity and in some cases increased it (<b>12d</b> and <b>12f</b>). The most potent and selective COX-1 inhibitor in this series was the biphenyl analogue <b>13a</b> (COX-1 IC<sub>50</sub>, 570 nM; COX-2 IC<sub>50</sub>, > 4 μM). Such hydrophobic biphenyl systems are a common structure template seen in other small molecule inhibitors of the AA pathway (e.g., flurbiprofen [NSAID] or MK-866 analogues [microsomal prostaglandin E<sub>2</sub> synthase-1 (mPGES-1) inhibitors]).<a onclick="showRef(event, 'ref60 ref62'); return false;" href="javascript:void(0);" class="ref ref60 ref62">(60, 62)</a> Concentration dependences were determined for the most potent compounds, which led to the determination of IC<sub>50</sub> values for a subset of the inhibitors (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and Figure S5 and Table S4 in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div><div class="NLM_p">To build on the discovery of <b>13a</b>, a series of substituted biphenyls were synthesized by either Knoevenagel condensation or Suzuki–Miyaura coupling of brominated benzylidene precursors with (hetero)aryl boronic acids (e.g., <b>13f</b> and <b>13k</b>; Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and Figure S1 in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Evaluation of this series (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) indicated that multiple substitutions were tolerated, although none dramatically increased either the potency or the selectivity of COX-1 inhibition over compound <b>13a</b>. Interestingly, introduction of a 2-aza substituent into a <i>meta</i>-substituted biphenyl scaffold reversed the selectivity of inhibition, yielding compounds with modest COX-2 selectivity (<b>17a</b>–<b>e</b>; compare Figure S6 in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/medium/jm-2011-01528b_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of New “Biphenyl Derivatives” of 2′-<i>Des</i>-methyl Sulindac Sulfide Using Suzuki–Miyaura Coupling Reactions<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201528b&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sup>+</sup>-carbonate, DME/H<sub>2</sub>0, 90 °C, 14 h. Suzuki–Miyaura couplings were performed on submillimolar scale in a sealed glass tube under argon.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></p></p></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. COX-1 and COX-2 Inhibition by Substituted Biphenylmethylidene Derivatives of <i>E</i>-DMSS<a class="ref internalNav" href="#tbl2-fn1" aria-label="*">*</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/medium/jm-2011-01528b_0015.gif" alt="" id="fx15" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/medium/jm-2011-01528b_0016.gif" alt="" id="fx16" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>Table *</sup><p class="last">Compounds were screened at 4 μM. A concentration of 5 μM of AA-substrate was employed.</p></div><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Mean ± SEM of two (<i>n</i>) experiments.</p></div></div><div></div></div><div class="NLM_p">Neutralization of the carboxylic acid by conversion to an ester or amide in the benzylidene series reduced potency but maintained selectivity for COX-1, except for the biphenyl methylidene analogue <b>16e</b>, which revealed potent anti-COX-1 activity but also increased COX-2 inhibition (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). No significant differences were observed on changing the ester from methyl to isopropyl (<b>16a</b>–<b>c</b>).<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. COX-1 and COX-2 Inhibition by Ester and Amide Derivatives of <i>E</i>-DMSS<a class="ref internalNav" href="#tbl3-fn1" aria-label="*">*</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/medium/jm-2011-01528b_0017.gif" alt="" id="fx17" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/medium/jm-2011-01528b_0018.gif" alt="" id="fx18" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>Table *</sup><p class="last">Compounds were screened at 4 μM. A concentration of 5 μM of AA-substrate was employed.</p></div><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Mean ± SEM of two (<i>n</i>) experiments.</p></div></div><div></div></div><div class="NLM_p">Substitution α- to the carboxyl was explored by synthesis of a series of esters and acids (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). The general route outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> was employed using ethyl esters of the indene acetic acids, <b>10c</b> and <b>10d</b>, as building blocks. It was not possible to make a complete series of monomethyl-substituted analogues because of low yields and the generation of multiple side products (Scheme S1 in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). The only monomethyl analogue prepared was the ethyl ester, <b>18a</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>), which demonstrated reduced COX-1 inhibitory activity (30% inhibition at 4 μM) as compared to the ethyl ester of the unsubstituted biphenyl methylidene compound, <b>16e</b> (COX-1 IC<sub>50</sub>, 1.1 μM) (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>).<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Dimethyl analogues were prepared in high yield with minimal side products. The steric hindrance introduced by α,α-disubstitutions dramatically reduced the ease of hydrolysis to the acids. Thus, a nonaqueous hydrolytic strategy was employed in which THF solutions of individual esters were heated in a microwave with potassium trimethylsilanoate (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> This afforded nearly quantitative conversion of the esters to the acids. The two initially prepared acids, <b>19a</b> and <b>19c</b>, were less active than the unsubstituted free acids, <b>2</b> and <b>13a</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), so no further acids were synthesized. The ethyl esters of the α,α-disubstituted compounds, <b>19b</b> and <b>19d</b>–<b>20b</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) retained COX-1 selectivity but exhibited reduced potency. The most selective inhibitor was the oxazole, <b>19i</b>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. COX-1 and COX-2 Inhibition by α-Substituted <i>E</i>-DMSS Analogues<a class="ref internalNav" href="#tbl4-fn1" aria-label="*">*</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/medium/jm-2011-01528b_0019.gif" alt="" id="fx19" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/medium/jm-2011-01528b_0020.gif" alt="" id="fx20" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>Table *</sup><p class="last">Compounds were screened at 4 μM. A concentration of 5 μM of AA-substrate was employed.</p></div><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Mean ± SEM of two (<i>n</i>) experiments.</p></div></div><div></div></div><div class="NLM_p">A series of substituted alkyl- and arylsulfonimides as carboxylic acid isosteres were synthesized as depicted in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>.<a onclick="showRef(event, 'ref60 ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref60 ref67 ref68">(60, 67, 68)</a> Bioisosteric replacements represent a common approach for the rational modification of lead compounds into safer and more clinically effective agents with similar biological properties to the parent compound. Moderate COX-1 selectivity was observed for compounds <b>21a</b>, <b>21b</b>, and <b>21d</b>–<b>n</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>), but the trifluoromethylsulfonimide, <b>21c</b>, with biphenylmethylidene substituent, was the most potent and selective compared of all of the analogues synthesized in the present study (COX-1 IC<sub>50</sub>, 470 nM; COX-2 IC<sub>50</sub>, 14 μM; compare Figure S6 in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). This meant that it exhibited a more than 4-fold improvement in activity against COX-1 as compared with our early lead and reference compound <b>2</b>. Analogue <b>21c</b> was approximately 30-fold more selective for COX-1 over COX-2.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/medium/jm-2011-01528b_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of Sulfonimide Derivatives of 2′-<i>Des</i>-methyl Sulindac Sulfide<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201528b&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Syntheses were performed on a parallel synthesis apparatus using a straightforward one-pot, two-step CDI carbodiimide coupling reaction (route A).<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Alternatively, the two-step sulfonamide couplings could be accomplished with oxalyl chloride as the carboxylic acid activator, according to a disclosed procedure, as established for compound <b>21c</b> (route B).<a onclick="showRef(event, 'ref65 ref86 ref87'); return false;" href="javascript:void(0);" class="ref ref65 ref86 ref87">(65, 86, 87)</a> Reagents and conditions: (Route A): (a1) CDI/DCM, 0–5 °C, 2 h; (b1) alkyl-/arylsulfonamide, DBU, RT, overnight. (Route B): (a2) oxalyl chloride/DCM, RT, overnight; (b2) alkyl-/arylsulfonamide, 1,2-DCE, pyridine, RT, overnight.</p></p></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. COX-1 and COX-2 Inhibition by Sulfonimide Derivatives of <i>E</i>-DMSS<a class="ref internalNav" href="#tbl5-fn1" aria-label="*">*</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/medium/jm-2011-01528b_0021.gif" alt="" id="fx21" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/medium/jm-2011-01528b_0022.gif" alt="" id="fx22" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>Table *</sup><p class="last">Differently substituted alkyl- and arylsulfonimides (<b>21a</b>–<b>n</b>) were prepared as bioisosteres of <b>2</b> and <b>13a</b>, respectively, to alter acidity or modify lipophilicity without making significant changes to the core structure or affecting p<i>K</i><sub>a</sub> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>; see also the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>). Compounds were screened at 4 μM. A concentration of 5 μM of AA-substrate was employed.</p></div><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">Mean ± SEM of two (<i>n</i>) experiments.</p></div></div><div></div></div><div class="NLM_p">Substitution of methoxy for fluoro at the indene 5′-position in analogues <b>15a</b> and <b>15b</b>, respectively (like in compound <b>3</b>), led to a substantial loss of inhibitory potency for both the phenylmethylsulfide and the biphenyl derivatives (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> and Table S3 in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> The differential was most dramatic for the phenylmethylsulfide derivative, <b>15a</b>, which was a poor COX-1 inhibitor. The 5′-methoxy derivative of the biphenyl, <b>15b</b>, exhibited modest COX-1 inhibitory activity, although the presence of a plateau at higher inhibitor concentrations suggests that inhibition is readily reversible (also see Figures S7 and S8 in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/medium/jm-2011-01528b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0005.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Comparison of the inhibition of ovine COX-1 by <b>15a</b> (black circle), <b>15b</b> (red triangle), and <b>2</b> (blue square).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201528b&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The ability of the various <i>des</i>-methylsulindac sulfide analogues to inhibit COX-1 activity in intact cells was evaluated using the human ovarian cancer cell line, NIH-OVCAR-3.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a> This cell line expresses high levels of COX-1 but no detectable COX-2 as demonstrated by the Western blot in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>a.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Individual compounds were incubated with the cells for 30 min followed by the addition of [1-<sup>14</sup>C]-AA and another 30 min incubation. Compound <b>2</b>, <b>13a</b>, and <b>21c</b> inhibited COX-1-dependent [1-<sup>14</sup>C]-AA oxidation with potencies comparable to that of the known COX-1 inhibitor, SC-560 (compound <b>5</b>).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Minimal inhibition of COX-1 in OVCAR-3 cells was detected with celecoxib (compound <b>6</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>a). When parallel experiments were conducted in the COX-2 expressing human head and neck cancer cell line, 1483, no inhibition of [1-<sup>14</sup>C]-AA oxygenation was observed by <b>2</b> and <b>13a</b>, whereas <b>6</b> potently inhibited oxygenation (IC<sub>50</sub> = 54 nM) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>b).</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/medium/jm-2011-01528b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0006.jpeg" id="GRAPHIC-d347e1324-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) Inhibition of COX-1 in ovarian cancer cells. The OVCAR-3 human ovarian epithelial cancer cell line expresses high levels of catalytically active COX-1 but no COX-2 (see Western blot above).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Whole-cell lysates from the OVCAR-3 human ovarian epithelial cancer cell lines were fractionated on a 10% PAGE and probed with polyclonal antibodies specific for COX-1 and COX-2. The control lane for the COX-1 blot is a standard solution of 0.3 μg/μL purified oCOX-1 in M-PER and Laemmli sample buffer, whereas the control lane for the COX-2 blot is a standard solution of 0.3 μg/μL purified mCOX-2 in M-PER and Laemmli sample buffer. Lower graph: Inhibition of hCOX-1 in OVCAR-3 cells (8 μM <sup>14</sup>C-AA, 30 min at 37 °C) by <i>E</i>-DMSS analogues <b>2</b> (green circle; IC<sub>50</sub>, 116 nM), <b>13a</b> (red triangle; IC<sub>50</sub>, 300 nM), and <b>21c</b> (blue square; IC<sub>50</sub>, 495 nM) in comparison with literature reference compounds <b>5</b> (brown diamond; positive control; IC<sub>50</sub>, 160 nM) and <b>6</b> (○; negative control 16% inhibition at 5 μM). (b) Inhibition of hCOX-2 in HNSCC 1483 cells by <i>E</i>-DMSS analogues <b>2</b> (blue circle, n.i. at 5 μM) and <b>13a</b> (red square, n.i. at 5 μM) in comparison with literature reference compound <b>6</b> (○; positive control; IC<sub>50</sub>, 54 nM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201528b&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Sulindac (compound <b>1a</b>) and sulindac sulfide (compound <b>1b</b>) inhibit the growth of tumor cells in culture, and there has been some controversy about the role of COX inhibition (especially COX-2 inhibition) in this antiproliferative activity.<a onclick="showRef(event, 'ref43 ref70 ref71 ref72 ref73 ref74 ref75'); return false;" href="javascript:void(0);" class="ref ref43 ref70 ref71 ref72 ref73 ref74 ref75">(43, 70-75)</a> Therefore, we evaluated the effect of <b>2</b>, <b>13a</b>, <b>1b</b>, and <b>1a</b> on the viability of OVCAR-3 cells (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> and <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Following a 2 day treatment, comparable EC<sub>50</sub> values for inhibition of cell growth were observed with <b>2</b> (223 μM), <b>13a</b> (132 μM), and <b>1a</b> (210 μM), but no inhibition was observed with <b>1b</b> up to 250 μM. Comparison of Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>a and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> reveals that inhibition of cell growth requires concentrations of <b>2</b> and <b>13a</b> that are more than 100-fold higher than the concentrations required for inhibition of COX-1 activity in the OVCAR-3 cells. Therefore, it appears that the antiproliferative effects of this series of compounds on OVCAR-3 cells grown in culture are independent of their ability to inhibit COX-1 activity. Evaluation of sulindac sulfide and compounds <b>13a</b> and <b>21b</b> in the breast cancer cell line, MDA-MB231, yielded EC<sub>50</sub> values of 209, 141, and 215 μM (Figure S11 in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/medium/jm-2011-01528b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. OVCAR-3 cell growth inhibition by <b>1a</b> (purple triangle, n.i. at 250 μM), <b>1b</b> (blue diamond; EC<sub>50</sub>, 210 μM), <b>2</b> (green circle; EC<sub>50</sub>, 223 μM), and <b>13a</b> (red square; EC<sub>50</sub>, 132 μM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201528b&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56336" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56336" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a> summarizes the structure–activity relationships (SARs) for the series of compounds evaluated in the present study. Increasing the size and hydrophobicity of the aryl group from methylsulfanylbenzylidene to biphenylmethylidene significantly improved the potency and selectivity of COX-1 inhibition, so a number of analogues were made (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). Substitutions on the biphenyl ring (e.g., fluoro, trifluoromethyl) did not increase potency. Introduction of nitrogen into either biphenyl ring to increase hydrophilicity decreased potency, and the presence of multiple nitrogens in one ring reduced it further. Fusing the biphenyl (fluorene) retained potency against COX-1 but introduced a higher activity against COX-2. Alkyl substitution α- to the carboxyl group reduced activity in all cases. Conversion of the carboxylic acid to an ester or amide derivative significantly reduced potency, but introduction of the sulfonimide isostere in place of the carboxylate generated the most potent and selective COX-1 inhibitor in the series. Substitution on the sulfonyl sulfur was tolerated from methyl to substituted aryl. Perhaps the most surprising result was the finding of significantly reduced activity on substitution of a 5′-methoxy for the 5′-fluoro.</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/medium/jm-2011-01528b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. SAR for selective COX-1 inhibition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201528b&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/medium/jm-2011-01528b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Derivatization and COX activity data of lead compound <b>13a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201528b&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The in vitro screen utilized ovine COX-1 and mouse COX-2. Ovine COX-1 is the closest in sequence to human COX-1 among several mammalian species and is commonly used as a surrogate for human COX-1.<a onclick="showRef(event, 'ref77 ref78 ref79'); return false;" href="javascript:void(0);" class="ref ref77 ref78 ref79">(77-79)</a> The human enzyme has proven difficult to routinely express and purify with high activity. To verify the in vitro results, we tested the most active compounds against human COX-1 in cultured human ovarian cancer cells, OVCAR-3, and against human COX-2 in cultured head and neck cancer cells, 1483. All of the compounds inhibited COX-1 in the OVCAR cells to an extent that was comparable to that of the established COX-1 inhibitor, <b>5</b>. None of the compounds inhibited COX-2 in the 1483 cells. In contrast, <b>6</b> potently inhibited COX-2 in the 1483 cells but had no effect on COX-1 in the OVCAR-3 cells. Thus, the lead compounds identified in the in vitro screen were effective inhibitors of human COX-1 in intact cells.</div><div class="NLM_p">There was a dramatic differential in the ability of the lead compounds to inhibit PG synthesis by COX-1 in the OVCAR-3 cells and their ability to reduce proliferation in the same cell type. Whereas complete COX-1 inhibition was observed below 1 μM, none of the <i>E</i>-DMSS analogues reduced proliferation below 50 μM, and the EC<sub>50</sub> values were on the order of 130–220 μM (Figures S9a,b and S10 in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). Thus, it appears that the ability of compound <b>1b</b> and the analogues described herein to inhibit proliferation is independent of their ability to inhibit COX-1. Because these experiments were performed in cell culture, one cannot conclude that COX-1 inhibition would not inhibit tumor growth in vivo.<a onclick="showRef(event, 'ref74 ref80'); return false;" href="javascript:void(0);" class="ref ref74 ref80">(74, 80)</a> Tumor growth and metastasis are complex processes involving multiple steps, such as angiogenesis, motility, invasion etc., which are not components of growth in vitro.<a onclick="showRef(event, 'ref36 ref81'); return false;" href="javascript:void(0);" class="ref ref36 ref81">(36, 81)</a> Indeed, literature compound <b>5</b> inhibits tumor growth in different mouse models of ovarian carcinoma.<a onclick="showRef(event, 'ref35 ref82'); return false;" href="javascript:void(0);" class="ref ref35 ref82">(35, 82)</a> Thus, <i>E</i>-DMSS analogues may have antitumor activity as well.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></div><div class="NLM_p">Compound <b>3</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) is a structurally related COX inhibitor to <b>1b</b> (and <b>2</b>) and was used for modeling of COX-1 inhibitor interactions.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> In <b>3</b>, the <i>p</i>-chlorobenzoyl group at the indole nitrogen can rotate around the connecting σ-bond. This allows the molecule to take up an <i>S-trans-</i>conformation, besides its preferred and lower energy <i>S</i>-<i>cis</i>-conformation, to interact with COX. Whereas the <i>cis</i> conformer of <b>3</b> had been found to bind to both COX forms, the <i>trans</i> conformer was only present in cocrystal complexes with COX-1.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> This <i>trans</i>-conformation of <b>3</b> emulates the molecule geometry of the rigid <i>E</i>-2′-DMSS derivatives described in the present study (see Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).</div><div class="NLM_p">The nearly identical 3D structures of the two COX isoforms constitute a substantial obstacle for the design of selective COX-1 inhibitors.<a onclick="showRef(event, 'ref78 ref83'); return false;" href="javascript:void(0);" class="ref ref78 ref83">(78, 83)</a> This is particularly true because in COX-1, the cavity of the selectivity pocket is less accessible due to the presence of Ile523. The same cavity is more spacious in COX-2, having a Val at the same amino acid position.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> It is assumed that compound <b>2</b> and its analogues described herein exert an atypical binding mode with COX, as the orientation of the <i>p</i>-methylsulfanylphenyliden group is predicted to cause steric clashes when the compounds are modeled into a similar configuration as <b>1b</b> or <b>3</b> in the active site.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Unfortunately, the attempt to cocrystallize one of the more potent <i>E</i>-DMSS analogues (<b>2</b> or <b>13a</b>) together with oCOX-1 has not succeeded thus far.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a></div><div class="NLM_p">There has been a report proposing an optional binding mode of COX-1-selective inhibitors derived from <b>3</b>.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Moreover, a recent docking study on the COX binding of 2-methyl-3-indolylacetic acid derivatives that preferentially inactivate COX-1 suggested that the binding specificity of the reported compounds resulted from individual plasticities of the 3D protein structure close to the binding site (“selective induced fit”).<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> These data further point out the formation of a new lipophilic interaction site by COX-1 structural rearrangements triggered by the ligand that favors a boost in inhibitory activity for accurately fitting compounds. The less flexible COX-2 protein does not allow such conformational changes to take place and thus confines binding affinity.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> This hypothesis could be taken into consideration to rationalize the benefit of the rather bulky and lipophilic biphenyl substituent as part of our optimized COX-1 selective <i>E</i>-DMSS analogues (e.g., <b>13a</b> or <b>21c</b>).</div><div class="NLM_p last">COX-1 has emerged as a potential pharmacological target for the treatment of several clinical conditions, and preclinical and clinical data suggest that selective COX-1 inhibitors may not exhibit significant gastrointestinal and cardiovascular side effects.<a onclick="showRef(event, 'ref24 ref25 ref56'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref56">(24, 25, 56)</a> Thus, the <i>E</i>-DMSS analogues described in the present report may be useful leads for novel COX-1 inhibitors or useful probes for the involvement of COX-1 in physiological or pathophysiological processes. However, some of the inhibitors may have off-target effects that would limit their utility in vivo. For example, compound <b>13a</b> is a potent activator of peroxisome proliferator-activated receptor (PPAR)γ in cell culture.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Interestingly, the SAR for activation of PPARγ indicates that a free carboxyl group is absolutely required for activity. Thus, analogues such as the trifluoromethylsulfonimide, <b>21c</b>, may be more useful as probes for COX-1 inhibition in vivo.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38771" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38771" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> General</h3><div class="NLM_p last">Reagents and solvents were of commercial quality and were used without further purification. All synthesized intermediates and final compounds were structurally characterized using <sup>1</sup>H NMR (optionally <sup>19</sup>F NMR, <sup>13</sup>C NMR) and electrospray ionization mass spectrometry. The purity of the test compounds was determined using HPLC [UV detection at 220 and 254 nm (optionally 288 and 347 nm) along with ELSD detection] and was generally ≥95%, if not denoted otherwise. The general synthetic procedures A–J are specified in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Preparation and Analytical Characterization of Exemplified Test Compounds</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> (<i>E</i>)-2-(5-Fluoro-1-((2-fluorobiphenyl-4-yl)methylene)-1<i>H</i>-inden-3-yl)acetic Acid (<b>13d</b>)</h4><div class="NLM_p last">According to general procedure C, the title compound was obtained from the isomer mixture <b>10a</b> (0.05 g, 0.23 mmol) and 2-fluorobiphenyl-4-carbaldehyde (0.05 g, 0.25 mmol) after heating to 65 °C for 3 h and subsequent stirring at ambient temperature overnight. After acidification of the reaction mixture and repeated extraction with dichloromethane, the organic layers were combined and concentrated in vacuo. The remaining yellow solid material revealed good analytical quality and required no further purification. Yield, 63 mg (74%): C<sub>24</sub>H<sub>16</sub>F<sub>2</sub>O<sub>2</sub>, <i>M</i><sub><i>r</i></sub> = 374.39. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.70 (s, 2H), 7.08 (dtd, <i>J</i> = 1.2/2.4/8.4 Hz, 1H), 7.16–7.19 (m, 2H), 7.41–7.45 (m, 1H), 7.49–7.53 (m, 2H), 7.58–7.67 (m, 6H), 7.84 (dd, <i>J</i> = 5.2/8.0 Hz, 1H). HPLC (method 1) <i>t</i>R: 11.30 min (>99%, UV347). ESI/MS: calcd, 373; found, 373.13 ([M – 1]<sup>+</sup>, 22%), 329.27 ([M – 1]<sup>+</sup>–CO<sub>2</sub>, 100%).</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> (<i>E</i>)-2-(5-Fluoro-1-((4-methyl-2-phenylpyrimidin-5-yl)methylene)-1<i>H</i>-inden-3-yl)acetic Acid (<b>13j</b>)</h4><div class="NLM_p last">According to general procedure C, the title compound was obtained from the isomer mixture <b>10a</b> (0.05 g, 0.23 mmol) and 4-methyl-2-phenylpyrimidine-5-carbaldehyde (0.050 g, 0.25 mmol) after heating to 70 °C for 3 h and subsequent stirring at ambient temperature overnight. The crude product was purified by preparative thin-layer chromatography (SiO<sub>2</sub>, EtOAc/hexane, 0.5% AcOH) to afford 43 mg (51%) of <b>13h</b>: C<sub>23</sub>H<sub>17</sub>FN<sub>2</sub>O<sub>2</sub>, <i>M</i><sub><i>r</i></sub> = 372.40. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.69 (s, 3H), 3.67 (s, 2H), 6.87 (s, 1H), 7.11 (td, <i>J</i> = 2.4/8.4 Hz, 1H), 7.18 (dd, <i>J</i> = 2.4/9.2 Hz, 1H), 7.54–7.56 (m, 3H), 7.75 (s, 1H), 7.98 (dd, <i>J</i> = 5.2/8.4 Hz, 1H), 8.44–8.47 (m, 2H), 8.82 (s, 1H). HPLC (method 1) <i>t</i>R: 10.16 min (97%, UV347). LCMS (ESI) (method 2) <i>t</i>R: 2.95 min (97%, ELSD); <i>m</i>/<i>z</i>: 373.2 [M + 1]<sup>+</sup>.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> (<i>E</i>)-2-(5-Fluoro-1-(4-(6-fluoropyridin-3-yl)benzylidene)-1<i>H</i>-inden-3-yl)acetic Acid (<b>13k</b>)</h4><div class="NLM_p last">According to general procedure E, the title compound was obtained from (<i>E</i>)-2-(1-(4-bromobenzylidene)-5-fluoro-1<i>H</i>-inden-3-yl)acetic acid <b>11i</b> (0.50 g, 0.14 mmol) and 2-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine (0.037 g, 0.17 mmol) after 14 h at 90 °C. The crude product was purified by recrystallization from MeOH/hexanes. Yield, 25 mg (48%), bright yellow solid: C<sub>23</sub>H<sub>15</sub>F<sub>2</sub>NO<sub>2</sub>, <i>M</i><sub><i>r</i></sub> = 375.37. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.69 (s, 2H), 7.07 (td, <i>J</i> = (1.2)2.4/8.8 Hz, 1H), 7.15–7.18 (m, 2H), 7.31 (dd, <i>J</i> = 2.8/8.8 Hz, 1H), 7.69 (s, 1H), 7.79–7.88 (m, 5H), 8.36 (td, <i>J</i> = 2.8/8.2 Hz, 1H), 8.63 (d, <i>J</i> = 2.8 Hz, 1H). <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ: −112.96 (d, 1F, C5′-F), −68.78 (d, 1F, Pyr-F). HPLC (method 1) <i>t</i>R: 9.75 min. LCMS (ESI) (method 2) <i>t</i>R: 2.70 min (≥95%, ELSD); <i>m</i>/<i>z</i>: 376.0 [M + 1]<sup>+</sup>.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Sodium (<i>E</i>)-2-(1-([1,1′-Biphenyl]-4-ylmethylene)-5-methoxy-1<i>H</i>-inden-3-yl)acetate [<b>15b</b>(Na)]</h4><div class="NLM_p last">The title compound was prepared by the aldol condensation reaction specified in general procedure D (step 1) from the isomer mixture <b>10b</b> (0.050 g, 0.22 mmol) and commercially available [1,1′-biphenyl]-4-carbaldehyde (0.043 g, 0.24 mmol). After stirring for 72 h at room temperature, the accumulated product precipitate was filtered and washed first with a little ice-cold methanol and then with diethylether. Compound <b>15b</b> was obtained as a yellow solid (Na-salt) in 37% yield (31.5 mg): C<sub>25</sub>H<sub>19</sub>NaO<sub>3</sub>, <i>M</i><sub><i>r</i></sub> = 390.41. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.23 (s, 2H), 3.79 (s, 3H), 6.74 (dd, <i>J</i> = 2.22/8.22 Hz, 1H), 6.89 (s, 1H), 6.99 (d, <i>J</i> = 2.22 Hz, 1H), 7.34–7.41 (m, 2H), 7.47–7.52 (m, 2H), 7.65 (d, <i>J</i>=8.22 Hz, 1H), 7.73–7.79 (m, 6H).</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> (<i>E</i>)-2-(1-([1,1′-Biphenyl]-4-ylmethylene)-5-methoxy-1<i>H</i>-inden-3-yl)acetic Acid (<b>15b</b>)</h4><div class="NLM_p last">The title compound was prepared according to general procedure D (step 2) using 200 μL of 1.5 N HCl, starting from <b>15b</b>(Na) (0.016 g, 0.041 mmol) in 1 mL of H<sub>2</sub>O. Yield, 13 mg (86%): C<sub>25</sub>H<sub>20</sub>O<sub>3</sub>, <i>M</i><sub><i>r</i></sub> = 368.42. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.64 (s, 2H), 3.80 (s, 3H), 6.81 (dd, <i>J</i> = 2.4/8.2 Hz, 1H), 6.92 (d, <i>J</i> = 2.0 Hz, 1H), 7.05 (s, 1H), 7.39 (tt, <i>J</i> = 0.8/2.0/7.2 Hz, 1H), 7.47–7.51 (m, 3H), 7.72–7.79 (m, 7H). LCMS (ESI) (method 2) <i>t</i>R: 3.14 min (≥95%, ELSD); <i>m</i>/<i>z</i>: 369.2 [M + 1]<sup>+</sup>.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> (<i>E</i>)-Isopropyl 2-(5-fluoro-1-(4-(methylthio)benzylidene)-1<i>H</i>-inden-3-yl)acetate (<b>16c</b>)</h4><div class="NLM_p last">According to general procedure F, (<i>E</i>)-2-(5-fluoro-1-(4-(methylthio)benzylidene)-1<i>H</i>-inden-3-yl)acetic acid <b>2</b> (100 mg, 0.31 mmol) was subjected to reaction with 2-propanol (5 mL) to afford <b>16c</b> as a fluffy yellow solid. Yield, 118 mg (100%). C<sub>22</sub>H<sub>21</sub>FO<sub>2</sub>S, <i>M</i><sub><i>r</i></sub> = 368.46. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 400 MHz: 1.19 (d, <i>J</i> = 6.4 Hz, 6H), 2.52 (s, 3H), 3.72 (s, 2H), 4.94 (sept, <i>J</i> = 6.4 Hz, 1H), 7.05 (td, <i>J</i> = 8.9/2.4 (1.2) Hz, 1H), 7.13–7.15 (m, 2H), 7.35 (d, <i>J</i> = 8.4 Hz, 2H), 7.59–7.64 (m, 3H), 7.83 (dd, <i>J</i> = 8.4/5.2 Hz, 1H). <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ: −113.39 (1F, C5′-F). LCMS (ESI) 3.60 min (>99%, ELSD); <i>m</i>/<i>z</i>: 369.2 [M + 1]<sup>+</sup>.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> (<i>E</i>)-2-(5-Fluoro-1-(4-(methylthio)benzylidene)-1<i>H</i>-inden-3-yl)-2-methylpropanoic Acid (<b>19a</b>)</h4><div class="NLM_p last">Ester cleavage as described in general procedure G_variant2 was performed on <b>19b</b> (15 mg, 0.039 mmol). The crude product was purified by flash chromatography (ethyl acetate/hexane 1:1, 0.5% HOAc, gradient) to produce <b>19a</b>. Yield, 12.5 mg (90%). C<sub>21</sub>H<sub>19</sub>FO<sub>2</sub>S, <i>M</i><sub><i>r</i></sub> = 354.44. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.53 (s, 6H), 2.53 (s, 3H), 6.98 (dd, <i>J</i> = 2.4/10.0 Hz, 1H), 7.02–7.07 (m, 2H), 7.36 (d, <i>J</i> = 8.8 Hz, 2H), 7.60 (s, 1H), 7.66 (d, <i>J</i> = 8.4 Hz, 2H), 7.86 (dd, <i>J</i> = 5.4/8.2 Hz, 1H). <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ: −113.31 (q, 1F, C5′-F). LCMS (ESI) (method 2) <i>t</i>R: 3.12 min (98%, ELSD); <i>m</i>/<i>z</i>: 355.2 [M + 1]<sup>+</sup>.</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> (<i>E</i>)-Ethyl 2-(1-([1,1′-biphenyl]-4-ylmethylene)-5-fluoro-1<i>H</i>-inden-3-yl)-2-methylpropanoate (<b>19d</b>)</h4><div class="NLM_p last">The title compound was prepared by the aldol condensation reaction specified in general procedure D (step 1) from <b>10d</b> (0.10 g, 0.40 mmol) and commercially available [1,1′-biphenyl]-4-carbaldehyde (0.081 g, 0.44 mmol). After stirring for 72 h at room temperature, the accumulated product precipitate was filtered and carefully washed with water. Compound <b>19d</b> was obtained as a yellow solid (ethyl ester) in 98% yield (163 mg): C<sub>28</sub>H<sub>25</sub>FO<sub>2</sub>, <i>M</i><sub><i>r</i></sub> = 412.50. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.07 (t, <i>J</i> = 7.2 Hz, 3H), 1.57 (s, 6H), 4.09 (q, <i>J</i> = 7.2 Hz, 2H), 6.90 (dd, <i>J</i> = 2.4/9.6 Hz, 1H), 7.05–7.10 (m, 2H), 7.40 (tt, <i>J</i> = 7.2 Hz, 1H), 7.50 (t, <i>J</i> = 7.2 Hz, 1H), 7.72–7.76 (m, 3H), 7.81 (s, 4H), 7.91 (dd, <i>J</i> = 5.2/8.4 Hz, 1H). LCMS (ESI) (method 2) <i>t</i>R: 3.89 min (>99%, ELSD); <i>m</i>/<i>z</i>: 413.2 [M + 1]<sup>+</sup>.</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (<i>E</i>)-Ethyl 2-(5-fluoro-1-((6-(4-fluorophenyl)pyridin-2-yl)methylene)-1<i>H</i>-inden-3-yl)-2-methyl-propanoate (<b>20b</b>)</h4><div class="NLM_p last">The title compound was prepared by the aldol condensation reaction specified in general procedure D (step 1) from <b>10d</b> (0.050 g, 0.20 mmol) and commercially available 6-(4-fluorophenyl)picolin-aldehyde (0.045 g, 0.22 mmol). After stirring for 72 h at room temperature, the accumulated product precipitate was filtered and carefully washed with water. The title compound was obtained as a yellow solid (Na salt) in 83% yield (72.5 mg): C<sub>27</sub>H<sub>23</sub>F<sub>2</sub>NO<sub>2</sub>, <i>M</i><sub><i>r</i></sub> = 431.47. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.06 (t, <i>J</i> = 7.2 Hz, 3H), 1.59 (s, 6H), 4.08 (q, <i>J</i> = 7.2 Hz, 2H), 6.91 (dd, <i>J</i> = 2.0/9.6 Hz, 1H), 7.07 (td, <i>J</i> = 2.4/8.8 Hz, 1H), 7.38 (pseudo t, <i>J</i> = 8.8 Hz, 2H), 7.61–7.63 (m, 2H), 7.87–8.00 (m, 3H), 8.07 (s, 1H), 8.20–8.24 (dd, <i>J</i> = 5.6/8.8 Hz, 2H). <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ: −111.98 (s, 1F), −110.74 (s, 1F). LCMS (ESI) (method 2) <i>t</i>R: 3.79 min (>99%, ELSD); <i>m</i>/<i>z</i>: 432.2 [M + 1]<sup>+</sup>.</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (<i>E</i>)-2-(1-([1,1′-Biphenyl]-4-ylmethylene)-5-fluoro-1<i>H</i>-inden-3-yl)-<i>N</i>-((trifluoromethyl)sulfonyl)-acetamide (<b>21c</b>)</h4><div class="NLM_p last">According to general procedure J, (<i>E</i>)-2-(1-([1,1′-biphenyl]-4-ylmethylene)-5-fluoro-1<i>H</i>-inden-3-yl)acetyl chloride (20 mg, 0.053 mmol) was subjected to reaction with trifluoromethanesulfonamide (11.9 mg, 0.080 mmol). The crude product was purified by flash chromatography (SiO<sub>2</sub>, EtOAc + hexane: 1 + 1 (0.5% AcOH, gradient) to afford 13.5 mg (52%) of <b>21c</b> as bright yellow solid. C<sub>25</sub>H<sub>17</sub>F<sub>4</sub>NO<sub>3</sub>S, <i>M</i><sub><i>r</i></sub> = 487.47. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.47 (s, 2H), 7.02 (td, <i>J</i> = 2.4/8.8 Hz, 1H), 7.09 (s, 1H), 7.15 (dd, <i>J</i> = 2.4/9.4 Hz, 1H), 7.39 (tt, <i>J</i> = 1.6/7.2 Hz, 1H), 7.49 (t, <i>J</i> = 7.2 Hz, 2H), 7.59 (s, 1H), 7.74 (dd, <i>J</i> = 1.6/7.2 Hz, 2H), 7.78 (s, 4H), 7.82 (dd, <i>J</i> = 5.2/8.4 Hz, 1H). <sup>19</sup>F NMR (282 MHz, DMSO-<i>d</i><sub>6</sub>) δ: −115.25 (s, 1F, C5′-F), −77.31 (s, 3F, −CF<sub>3</sub>). LCMS (ESI) (method 2) <i>t</i>R: 3.62 min (>99%, UV254, ELSD); <i>m</i>/<i>z</i>: 488.0 [M + 1]<sup>+</sup>.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25"><a href="/doi/suppl/10.1021/jm201528b">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24038" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24038" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Synthetic procedures, routine spectroscopic and spectrometric data, HPLC data, exemplified NMR spectra, and biochemical and biological testing methods. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm201528b/suppl_file/jm201528b_si_001.pdf">jm201528b_si_001.pdf (11.48 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm201528b" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70747" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70747" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lawrence J. Marnett</span> - <span class="hlFld-Affiliation affiliation">A. B. Hancock Jr. Memorial
Laboratory for Cancer Research,
Departments of Biochemistry, Chemistry and Pharmacology, Vanderbilt
Institute of Chemical Biology, Center in Molecular Toxicology and
Vanderbilt-Ingram Cancer Center, Vanderbilt University
School of Medicine, Nashville, Tennessee 37232, United
States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#97fbf6e5e5eeb9faf6e5f9f2e3e3d7e1f6f9f3f2e5f5fefbe3b9f2f3e2"><span class="__cf_email__" data-cfemail="35595447474c1b5854475b5041417543545b515047575c59411b505140">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andy J. Liedtke</span> - <span class="hlFld-Affiliation affiliation">A. B. Hancock Jr. Memorial
Laboratory for Cancer Research,
Departments of Biochemistry, Chemistry and Pharmacology, Vanderbilt
Institute of Chemical Biology, Center in Molecular Toxicology and
Vanderbilt-Ingram Cancer Center, Vanderbilt University
School of Medicine, Nashville, Tennessee 37232, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brenda C. Crews</span> - <span class="hlFld-Affiliation affiliation">A. B. Hancock Jr. Memorial
Laboratory for Cancer Research,
Departments of Biochemistry, Chemistry and Pharmacology, Vanderbilt
Institute of Chemical Biology, Center in Molecular Toxicology and
Vanderbilt-Ingram Cancer Center, Vanderbilt University
School of Medicine, Nashville, Tennessee 37232, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cristina M. Daniel</span> - <span class="hlFld-Affiliation affiliation">A. B. Hancock Jr. Memorial
Laboratory for Cancer Research,
Departments of Biochemistry, Chemistry and Pharmacology, Vanderbilt
Institute of Chemical Biology, Center in Molecular Toxicology and
Vanderbilt-Ingram Cancer Center, Vanderbilt University
School of Medicine, Nashville, Tennessee 37232, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna L. Blobaum</span> - <span class="hlFld-Affiliation affiliation">A. B. Hancock Jr. Memorial
Laboratory for Cancer Research,
Departments of Biochemistry, Chemistry and Pharmacology, Vanderbilt
Institute of Chemical Biology, Center in Molecular Toxicology and
Vanderbilt-Ingram Cancer Center, Vanderbilt University
School of Medicine, Nashville, Tennessee 37232, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philip J. Kingsley</span> - <span class="hlFld-Affiliation affiliation">A. B. Hancock Jr. Memorial
Laboratory for Cancer Research,
Departments of Biochemistry, Chemistry and Pharmacology, Vanderbilt
Institute of Chemical Biology, Center in Molecular Toxicology and
Vanderbilt-Ingram Cancer Center, Vanderbilt University
School of Medicine, Nashville, Tennessee 37232, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kebreab Ghebreselasie</span> - <span class="hlFld-Affiliation affiliation">A. B. Hancock Jr. Memorial
Laboratory for Cancer Research,
Departments of Biochemistry, Chemistry and Pharmacology, Vanderbilt
Institute of Chemical Biology, Center in Molecular Toxicology and
Vanderbilt-Ingram Cancer Center, Vanderbilt University
School of Medicine, Nashville, Tennessee 37232, United
States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d347e2432-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22710" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22710" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the NIH (National Cancer Institute, CA89450, and the National Foundation for Cancer Research). A.J.L. gratefully acknowledges funding from the German Research Foundation (DFG-Forschungsstipendium, GZ: LI2019/1-1, Einzelprojekt). We are grateful to Dr. Donald Stec for assistance with NMR analysis and to Dr. Carol Rouzer for proofreading.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i27" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i27"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i28" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i28"> Abbreviations Used</h2><tr><td class="NLM_term">NSAID</td><td class="NLM_def"><p class="first last">nonsteroidal anti-inflammatory drug</p></td></tr><tr><td class="NLM_term">PPAR</td><td class="NLM_def"><p class="first last">peroxisome proliferator-activated receptor</p></td></tr><tr><td class="NLM_term">COX</td><td class="NLM_def"><p class="first last">cyclooxygenase</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">PG</td><td class="NLM_def"><p class="first last">prostaglandin</p></td></tr><tr><td class="NLM_term">AA</td><td class="NLM_def"><p class="first last">arachidonic acid</p></td></tr><tr><td class="NLM_term">RPMI</td><td class="NLM_def"><p class="first last">Roswell Park Memorial Institute medium</p></td></tr><tr><td class="NLM_term">HBSS</td><td class="NLM_def"><p class="first last">Hank's balanced salt solution</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr><tr><td class="NLM_term">mPGES-1</td><td class="NLM_def"><p class="first last">microsomal prostaglandin E<sub>2</sub> synthase-1</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate-buffered saline</p></td></tr><tr><td class="NLM_term">M-PER</td><td class="NLM_def"><p class="first last">mammalian protein extraction reagent</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73407" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73407" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 87 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Blobaum, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span> </span><span class="NLM_article-title">Structural and Functional Basis of Cyclooxygenase Inhibition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1425</span><span class="NLM_x">–</span> <span class="NLM_lpage">1441</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0613166" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXisFeisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1425-1441&author=A.+L.+Blobaumauthor=L.+J.+Marnett&title=Structural+and+Functional+Basis+of+Cyclooxygenase+Inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Functional Basis of Cyclooxygenase Inhibition</span></div><div class="casAuthors">Blobaum, Anna L.; Marnett, Lawrence J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1425-1441</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This review will focus on the structural and functional basis of the inhibition of cyclooxygenase (COX) enzymes by nonselective and COX-2 selective inhibitors.  It will integrate kinetic, mechanistic, and structural information to illustrate not only the range of mols. with COX inhibitory activity but also the diversity of mechanisms by which they act.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8SMg_SRasDLVg90H21EOLACvtfcHk0liDhckXe7MYUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXisFeisL8%253D&md5=b9de2eafa7d2b510c866245b09fba546</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fjm0613166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0613166%26sid%3Dliteratum%253Aachs%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26atitle%3DStructural%2520and%2520Functional%2520Basis%2520of%2520Cyclooxygenase%2520Inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1425%26epage%3D1441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Vane, J. R.</span><span> </span><span class="NLM_article-title">Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs</span> <span class="citation_source-journal">Nature (London), New Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">231</span><span class="NLM_x">, </span> <span class="NLM_fpage">232</span><span class="NLM_x">–</span> <span class="NLM_lpage">235</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1038%2Fnewbio231232a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=5284360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADyaE3MXltVyjur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=231&publication_year=1971&pages=232-235&author=J.+R.+Vane&title=Inhibition+of+prostaglandin+synthesis+as+a+mechanism+of+action+for+aspirin-like+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs</span></div><div class="casAuthors">Vane, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London), New Biology</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">231</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">232-5</span>CODEN:
                <span class="NLM_cas:coden">NNBYA7</span>;
        ISSN:<span class="NLM_cas:issn">0369-4887</span>.
    </div><div class="casAbstract">Indomethacin (I) aspirin (II), and Na salicylate inhibited the generation of prostaglandin F2α (PGF2α)-like activity by guinea pig lung prepns.  Thus, on a wt. basis, I was 23-times more potent than II as an inhibitor of PGF2α, and on a molar basis 47-times more potent.  Na salicylate was less potent than II as an inhibitor of PGF2α-like activity and there was much more variation in the results.  Similar results were obtained when the activity of the samples were assayed on rat stomach strips in terms of prostaglandin E2 (PGE2).  Hydrocortisone (50 μg/ml) inhibited PGF2α and PGE2-like activity <20%; morphine (50 μg/ml) or mepyramine (50 μg/ml) had no effect.  Some of the therapeutic effects of Na salicylate and II-like drugs may be due to inhibition of the synthesis of prostaglandins.  Incubation of lung homogenates with arachidonic acid for 30 min increased PGF2α-like activity by 220-520 ng/ml and PGE2-like activity by 100-500 ng/ml.  The ID50 values for I was 0.27 μg/ml, whereas that for II was 6.3 μg/ml.  None of the drugs tested decreased the contractions of the assay tissues (rat stomach strips and colons) induced by the prostaglandins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSuOCB-VIpVrVg90H21EOLACvtfcHk0lh_2DCpsy_MiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXltVyjur4%253D&md5=20de9e860c4f6bb6fb8b46530dd8aaa6</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnewbio231232a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnewbio231232a0%26sid%3Dliteratum%253Aachs%26aulast%3DVane%26aufirst%3DJ.%2BR.%26atitle%3DInhibition%2520of%2520prostaglandin%2520synthesis%2520as%2520a%2520mechanism%2520of%2520action%2520for%2520aspirin-like%2520drugs%26jtitle%3DNature%2520%2528London%2529%252C%2520New%2520Biol.%26date%3D1971%26volume%3D231%26spage%3D232%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Smith, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, A. L.</span><span> </span><span class="NLM_article-title">Aspirin selectively inhibits prostaglandin production in human platelets</span> <span class="citation_source-journal">Nature (London), New Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">231</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">237</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1038%2F231294a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=5284361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADyaE3MXkvFOhsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=231&publication_year=1971&pages=235-237&author=J.+B.+Smithauthor=A.+L.+Willis&title=Aspirin+selectively+inhibits+prostaglandin+production+in+human+platelets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Aspirin selectively inhibits prostaglandin production in human platelets</span></div><div class="casAuthors">Smith, J. B.; Willis, A. L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London), New Biology</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">231</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">235-7</span>CODEN:
                <span class="NLM_cas:coden">NNBYA7</span>;
        ISSN:<span class="NLM_cas:issn">0369-4887</span>.
    </div><div class="casAbstract">Aspirin (I) (0.01-10.0 μg/ml) markedly decreased the production of prostaglandins F2α and E2 by 3-14C-labeled 5-hydroxytryptamine creatinine sulfate (5-HT) treated human platelets although it had no effect on the release of 5-HT, β-N-acetyl glucosamidase, or phospholipase A1.  I (0.3 μg/ml) inhibited the production of prostaglandin by 50%.  Indomethacin (II) was ∼10-times more potent than I, whereas Na salicylate was ∼10-times less potent.  Hydrocortisone (100 μg/ml) had no effect.  I (600 mg) inhibited the production of prostaglandins in the platelet in a system in which "the release reaction" induced by thrombin (5 units/ml) was impaired.  II (50 mg) taken by 2 volunteers, and II (100 mg) taken by 1 volunteer inhibited the production of prostaglandins by 51, 64, and 83%, resp., without affecting the release of lysosomal enzymes.  No change in the production of prostaglandins was found in platelets of 1 individual given 60 mg codeine or 2 untreated controls.  The finding that the production of prostaglandins is inhibited by I, while the release of phospholipase A is unaffected, strongly suggests that one action of I on platelets is inhibition of the conversion of arachidonic acid into prostaglandins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreUmLyWeiTCLVg90H21EOLACvtfcHk0lh_2DCpsy_MiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXkvFOhsr0%253D&md5=5aaae4920427d85d276c84d38ccaa3fa</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2F231294a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F231294a0%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DJ.%2BB.%26aulast%3DWillis%26aufirst%3DA.%2BL.%26atitle%3DAspirin%2520selectively%2520inhibits%2520prostaglandin%2520production%2520in%2520human%2520platelets%26jtitle%3DNature%2520%2528London%2529%252C%2520New%2520Biol.%26date%3D1971%26volume%3D231%26spage%3D235%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Ferreira, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moncada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vane, J. R.</span><span> </span><span class="NLM_article-title">Indomethacin and aspirin abolish prostaglandin release from the spleen</span> <span class="citation_source-journal">Nature (London), New Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">231</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1038%2F231237a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=5284362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADyaE3MXkvFOjur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=231&publication_year=1971&pages=237-239&author=S.+H.+Ferreiraauthor=S.+Moncadaauthor=J.+R.+Vane&title=Indomethacin+and+aspirin+abolish+prostaglandin+release+from+the+spleen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Indomethacin and aspirin abolish prostaglandin release from the spleen</span></div><div class="casAuthors">Ferreira, S. H.; Moncada, S.; Vane, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London), New Biology</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">231</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">237-9</span>CODEN:
                <span class="NLM_cas:coden">NNBYA7</span>;
        ISSN:<span class="NLM_cas:issn">0369-4887</span>.
    </div><div class="casAbstract">Adrenaline bitartrate (I) (200 ng/min or 6-10 mg/ml during 3 min) infusion into the perfusion dog spleen increased splenic perfusion pressures, contracted the spleen, and increased prostaglandin output, chiefly prostaglandin E2.  Indomethacin (II) (0.37 μg/ml) infusions into the spleen did not decrease splenic wt. or change the splenic perfusion pressure.  The increase in prostaglandin output induced by I infusion, however, was abolished.  In sep. expts., II (4 μg/ml for 15 min and 750 ng/ml for 15 min) completely abolished prostaglandin output.  In these expts., after the II infusion was stopped, there was a gradual return of prostaglandin output induced by I infusion, which reached at least 60% of the initial output within 1-3 hr and sometimes 100%.  Aspirin was much less effective as an inhibitor of prostaglandin release, i.e., at 15 μg/ml, there was 60% inhibition and at 40 μg/ml (2 expts.), there was 75 and 100% inhibition.  Na salicylate (20 and 40 μg/ml) (2 expts.) and hydrocortisone dihydrogen succinate (2 or 25 μg/ml) did not change the prostaglandin output induced by I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNurGG3-yqlLVg90H21EOLACvtfcHk0lh_2DCpsy_MiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXkvFOjur4%253D&md5=1651bcb0653f9d27358a46b2f96ec76a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2F231237a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F231237a0%26sid%3Dliteratum%253Aachs%26aulast%3DFerreira%26aufirst%3DS.%2BH.%26aulast%3DMoncada%26aufirst%3DS.%26aulast%3DVane%26aufirst%3DJ.%2BR.%26atitle%3DIndomethacin%2520and%2520aspirin%2520abolish%2520prostaglandin%2520release%2520from%2520the%2520spleen%26jtitle%3DNature%2520%2528London%2529%252C%2520New%2520Biol.%26date%3D1971%26volume%3D231%26spage%3D237%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Xie, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chipman, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erikson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, D. L.</span><span> </span><span class="NLM_article-title">Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">2692</span><span class="NLM_x">–</span> <span class="NLM_lpage">2696</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1073%2Fpnas.88.7.2692" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=1849272" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADyaK38XhsVyr" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1991&pages=2692-2696&author=W.+Xieauthor=J.+G.+Chipmanauthor=D.+L.+Robertsonauthor=R.+L.+Eriksonauthor=D.+L.+Simmons&title=Expression+of+a+mitogen-responsive+gene+encoding+prostaglandin+synthase+is+regulated+by+mRNA+splicing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing</span></div><div class="casAuthors">Xie, Weilin; Chipman, Jeffrey G.; Robertson, Donald L.; Erikson, R. L.; Simmons, Daniel L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2692-6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Rous sarcoma virus was shown to induce in chicken embryo fibroblasts (CEF) a 4.1-kb mRNA (designated CEF0147) encoding a 603-amino acid protein.  Anal. of the protein sequence showed that it shared 59% amino acid identity with sheep prostaglandin G/H synthase, the enzyme that catalyzes the rate-limiting steps in the prodn. of prostaglandins.  Significant differences, at both the protein and mRNA levels, existed between the src oncogene product-inducible prostaglandin synthase and the protein isolated and cloned from sheep seminal vesicle, suggesting that the src-inducible prostaglandin synthase may be a new form of the enzyme.  A distinguishing feature of src-inducible prostaglandin synthase mRNA is its low abundance in nonproliferating chicken embryo fibroblasts and its relatively high abundance in src-transformed cells.  Addnl., the majority of the src-inducible prostaglandin synthase RNA present in nonproliferating cells was found to be nonfunctional because of the presence of an unspliced intron that sepd. the signal peptide from the remainder of the protein.  Upon mitogenic stimulation, this intron was removed, resulting in the induction of fully-spliced CEF-147 mRNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX45jEf6RjKbVg90H21EOLACvtfcHk0lh9TghwKzG1iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhsVyr&md5=ac26730b2590e4484249f49f77df868c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.88.7.2692&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.88.7.2692%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DW.%26aulast%3DChipman%26aufirst%3DJ.%2BG.%26aulast%3DRobertson%26aufirst%3DD.%2BL.%26aulast%3DErikson%26aufirst%3DR.%2BL.%26aulast%3DSimmons%26aufirst%3DD.%2BL.%26atitle%3DExpression%2520of%2520a%2520mitogen-responsive%2520gene%2520encoding%2520prostaglandin%2520synthase%2520is%2520regulated%2520by%2520mRNA%2520splicing%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1991%26volume%3D88%26spage%3D2692%26epage%3D2696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Fu, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masferrer, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seibert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Needleman, P.</span><span> </span><span class="NLM_article-title">The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">265</span><span class="NLM_x">, </span> <span class="NLM_fpage">16737</span><span class="NLM_x">–</span> <span class="NLM_lpage">16740</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1990&pages=16737-16740&author=J.+Y.+Fuauthor=J.+L.+Masferrerauthor=K.+Seibertauthor=A.+Razauthor=P.+Needleman&title=The+induction+and+suppression+of+prostaglandin+H2+synthase+%28cyclooxygenase%29+in+human+monocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DJ.%2BY.%26aulast%3DMasferrer%26aufirst%3DJ.%2BL.%26aulast%3DSeibert%26aufirst%3DK.%26aulast%3DRaz%26aufirst%3DA.%26aulast%3DNeedleman%26aufirst%3DP.%26atitle%3DThe%2520induction%2520and%2520suppression%2520of%2520prostaglandin%2520H2%2520synthase%2520%2528cyclooxygenase%2529%2520in%2520human%2520monocytes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1990%26volume%3D265%26spage%3D16737%26epage%3D16740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Kujubu, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varnum, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herschman, H. R.</span><span> </span><span class="NLM_article-title">TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">266</span><span class="NLM_x">, </span> <span class="NLM_fpage">12866</span><span class="NLM_x">–</span> <span class="NLM_lpage">12872</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1016%2FS0021-9258%2818%2998774-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=1712772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADyaK38Xhs1Ontbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1991&pages=12866-12872&author=D.+A.+Kujubuauthor=B.+S.+Fletcherauthor=B.+C.+Varnumauthor=R.+W.+Limauthor=H.+R.+Herschman&title=TIS10%2C+a+phorbol+ester+tumor+promoter-inducible+mRNA+from+Swiss+3T3+cells%2C+encodes+a+novel+prostaglandin+synthase%2Fcyclooxygenase+homologue"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homolog</span></div><div class="casAuthors">Kujubu, Dean A.; Fletcher, Bradley S.; Varnum, Brian C.; Lim, Robert W.; Herschman, Harvey R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">266</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">12866-72</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">TIS10 is a primary response gene whose cDNA was cloned as a result of its rapid, superinducible expression in Swiss 3T3 cells in response to 12-O-tetradecanoylphorbol-13-acetate.  The 5'-untranslated region of the 3.9-kilobase TIS10 message contains only 124 nucleotides, whereas the 3'-untranslated region is almost 2 kilobases in length.  Within this long 3' region, there are multiple repeats of the sequence ATTTA, a sequence often present in rapidly degraded mRNA species.  Primer extension revealed that the SIS10 cDNA begins 16 base pairs downstream of the transcription start site for the TIS10 gene.  The TIS10 cDNA encodes a predicted protein of 604 amino acids.  A computer search identified striking similarities between the predicted TIS10 protein product and the murine, sheep, and human prostaglandin synthase/cyclooxygenase proteins.  The TIS10 protein has many of the same conserved amino acids that are thought to be important for cyclooxygenase function.  TIS10 mRNA is undetectable by Northern anal. in quiescent 3T3 cells.  The TIS10 gene is rapidly and transiently induced by forskolin and serum, as well as by 12-O-tetradecanoylphorbol-13-acetate, in Swiss 3T3 cells.  These agents elicit far more dramatic changes in TIS10 mRNA levels than in cyclooxygenase mRNA levels.  The expression of the TIS10 gene appears to be highly cell type-restricted in cultured cell lines; of 12 cell lines tested under superinducing conditions, only the rodent embryonic Swiss 3T3 and Rat1 cell lines expressed TIS10 gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1PfH0Q-KhvrVg90H21EOLACvtfcHk0lh9TghwKzG1iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xhs1Ontbk%253D&md5=881e17ae78d721bfd5b59233656c820a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2998774-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252998774-0%26sid%3Dliteratum%253Aachs%26aulast%3DKujubu%26aufirst%3DD.%2BA.%26aulast%3DFletcher%26aufirst%3DB.%2BS.%26aulast%3DVarnum%26aufirst%3DB.%2BC.%26aulast%3DLim%26aufirst%3DR.%2BW.%26aulast%3DHerschman%26aufirst%3DH.%2BR.%26atitle%3DTIS10%252C%2520a%2520phorbol%2520ester%2520tumor%2520promoter-inducible%2520mRNA%2520from%2520Swiss%25203T3%2520cells%252C%2520encodes%2520a%2520novel%2520prostaglandin%2520synthase%252Fcyclooxygenase%2520homologue%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1991%26volume%3D266%26spage%3D12866%26epage%3D12872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Patel, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sen, D. J.</span><span> </span><span class="NLM_article-title">COX-1 and COX-2 inhibitors: Current status and future prospects over COX-3 inhibitors</span> <span class="citation_source-journal">Int. J. Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">136</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFegt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=136-145&author=C.+K.+Patelauthor=D.+J.+Sen&title=COX-1+and+COX-2+inhibitors%3A+Current+status+and+future+prospects+over+COX-3+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">COX-1 and COX-2 inhibitors: current status and future prospects over COX-3 inhibitors</span></div><div class="casAuthors">Patel, Chirag K.; Sen, Dhrubo Jyoti</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Drug Development & Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">136-145</span>CODEN:
                <span class="NLM_cas:coden">IJDDA7</span>;
        ISSN:<span class="NLM_cas:issn">0975-9344</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Drug Development & Research</span>)
        </div><div class="casAbstract">A review.  Prostaglandins are formed from arachidonic acid by the action of cyclooxygenase and subsequent downstream synthetases.  Two closely related forms of the cyclooxygenase have been identified which are now known as COX-1 and COX-2.  Both isoenzymes transform arachidonic acid to prostaglandins, but differ in their distribution and their physiol. roles.  Meanwhile, the responsible genes and their regulation have been clarified.  COX-1, the pre-dominantly constitutive form of the enzyme, is expressed throughout the body and performs a no. of homeostatic functions such as maintaining normal gastric mucosa and influencing renal blood flow and platelet aggregation.  In contrast, the inducible form is expressed in response to inflammatory and other physiol. stimuli and growth factors, and is involved in the prodn. of the prostaglandins that mediate pain and support the inflammatory process.  All the classic NSAIDs inhibit both COX-1 and COX-2 at std. anti-inflammatory doses.  Simmons also recently co-discovered COX-3 in 2002 and analyzed this new isoenzyme's relation to acetaminophen (paracetamol), arguably the most widely used analgesic drug in the world.  The clin. ramifications and knowledge of COX isoenzymes are therefore rapidly expanding and could perhaps offer significant hope for future treatments of pain, inflammation and fever.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo02JeZep06cLVg90H21EOLACvtfcHk0lgyozkGqpa2QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFegt74%253D&md5=179457dba85c2f7dee66c4048b881585</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DC.%2BK.%26aulast%3DSen%26aufirst%3DD.%2BJ.%26atitle%3DCOX-1%2520and%2520COX-2%2520inhibitors%253A%2520Current%2520status%2520and%2520future%2520prospects%2520over%2520COX-3%2520inhibitors%26jtitle%3DInt.%2520J.%2520Drug%2520Dev.%2520Res.%26date%3D2009%26volume%3D1%26spage%3D136%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Kawai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kojima, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusunoki, N.</span><span> </span><span class="NLM_article-title">Recent advances in nonsteroidal anti-inflammatory drugs</span> <span class="citation_source-journal">Allergol. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">215</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.2332%2Fallergolint.54.209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtVSjurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2005&pages=209-215&author=S.+Kawaiauthor=F.+Kojimaauthor=N.+Kusunoki&title=Recent+advances+in+nonsteroidal+anti-inflammatory+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in nonsteroidal anti-inflammatory drugs</span></div><div class="casAuthors">Kawai, Shinichi; Kojima, Fumiaki; Kusunoki, Natsuko</div><div class="citationInfo"><span class="NLM_cas:title">Allergology International</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">209-215</span>CODEN:
                <span class="NLM_cas:coden">ALINFR</span>;
        ISSN:<span class="NLM_cas:issn">1323-8930</span>.
    
            (<span class="NLM_cas:orgname">Japanese Society of Allergology</span>)
        </div><div class="casAbstract">A review.  Recent advances in basic and clin. researches of nonsteroidal anti-inflammatory drugs (NSAIDs) are reviewed.  Concerning arachidonic acid cascade, recent studies revealed that not only cyclooxygenase (COX) but also terminal enzymes such as prostaglandin E synthase are very important in the understanding of the pathogenesis of inflammation and mechanisms of action of NSAIDs.  We also found that some conventional NSAIDs and a selective COX-2 inhibitor exert pro-apoptotic effect on synovial fibroblasts and several cancer cells by COX-independent mechanisms.  Clin. indications for use of NSAIDs are broad and include the following: rheumatic diseases; painful and/or febrile conditions; and prevention from thrombotic diseases such as myocardial infarction.  In addn., recently developed selective COX-2 inhibitors have been found to be nearly as effective for the same conditions as conventional NSAIDs except with regard to the prevention of thrombosis.  The incidence of severe gastrointestinal events in patients treated with selective COX-2 inhibitors has been proven to be lower than patients treated with conventional NSAIDs.  However, there was no difference in renal complications between the two groups.  Instead, an increased incidence of myocardial infarction after administration of selective COX-2 inhibitors may occur in patients with risk factors for atherosclerotic or thrombotic complications.  Further basic and clin. studies remain to be investigated in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYpTfs6dG5F7Vg90H21EOLACvtfcHk0lgyozkGqpa2QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtVSjurk%253D&md5=4d8adbb17e2f4b40fc72b47b394417d6</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2332%2Fallergolint.54.209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2332%252Fallergolint.54.209%26sid%3Dliteratum%253Aachs%26aulast%3DKawai%26aufirst%3DS.%26aulast%3DKojima%26aufirst%3DF.%26aulast%3DKusunoki%26aufirst%3DN.%26atitle%3DRecent%2520advances%2520in%2520nonsteroidal%2520anti-inflammatory%2520drugs%26jtitle%3DAllergol.%2520Int.%26date%3D2005%26volume%3D54%26spage%3D209%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Al-Hourani, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mane, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuszynski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baracos, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kniess, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suresh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietzsch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wuest, F.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of 1,5-diaryl-substituted tetrazoles as novel selective cyclooxygenase-2 (COX-2) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1823</span><span class="NLM_x">–</span> <span class="NLM_lpage">1826</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1016%2Fj.bmcl.2011.01.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=21316237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjslKjsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1823-1826&author=B.+J.+Al-Houraniauthor=S.+K.+Sharmaauthor=J.+Y.+Maneauthor=J.+Tuszynskiauthor=V.+Baracosauthor=T.+Kniessauthor=M.+Sureshauthor=J.+Pietzschauthor=F.+Wuest&title=Synthesis+and+evaluation+of+1%2C5-diaryl-substituted+tetrazoles+as+novel+selective+cyclooxygenase-2+%28COX-2%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of 1,5-diaryl-substituted tetrazoles as novel selective cyclooxygenase-2 (COX-2) inhibitors</span></div><div class="casAuthors">Al-Hourani, Baker Jawabrah; Sharma, Sai Kiran; Mane, Jonathan Y.; Tuszynski, Jack; Baracos, Vickie; Kniess, Torsten; Suresh, Mavanur; Pietzsch, Jens; Wuest, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1823-1826</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of 1,5-diaryl-substituted tetrazole derivs. was synthesized via conversion of readily available diaryl amides into the corresponding imidoyl chlorides followed by reaction with sodium azide.  All compds. were evaluated by cyclooxygenase (COX) assays in vitro to det. COX-1 and COX-2 inhibitory potency and selectivity.  The tetrazoles showed IC50 values ranging from 0.42 to 8.1 mM for COX-1 and 2.0 to 200 μM for COX-2.  The most potent compd. (IC50 (COX-2) = 2.0 μM) was further used in mol. modeling docking studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxtjcbzE_jpbVg90H21EOLACvtfcHk0lgAfVV0kxiqTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjslKjsbo%253D&md5=e12b71f9a590e8aaa717e7d7465d1087</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.01.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.01.057%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Hourani%26aufirst%3DB.%2BJ.%26aulast%3DSharma%26aufirst%3DS.%2BK.%26aulast%3DMane%26aufirst%3DJ.%2BY.%26aulast%3DTuszynski%26aufirst%3DJ.%26aulast%3DBaracos%26aufirst%3DV.%26aulast%3DKniess%26aufirst%3DT.%26aulast%3DSuresh%26aufirst%3DM.%26aulast%3DPietzsch%26aufirst%3DJ.%26aulast%3DWuest%26aufirst%3DF.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%25201%252C5-diaryl-substituted%2520tetrazoles%2520as%2520novel%2520selective%2520cyclooxygenase-2%2520%2528COX-2%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D1823%26epage%3D1826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Pairet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churchill, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trummlitz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelhardt, G.</span><span> </span><span class="NLM_article-title">Differential inhibition of cyclooxygenase-1 (COX-1) and −2 (COX-2) by NSAIDS: Consequences on anti-inflammatory activity versus gastric and renal safety</span> <span class="citation_source-journal">Inflammopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1996&pages=61-70&author=M.+Pairetauthor=L.+Churchillauthor=G.+Trummlitzauthor=G.+Engelhardt&title=Differential+inhibition+of+cyclooxygenase-1+%28COX-1%29+and+%E2%88%922+%28COX-2%29+by+NSAIDS%3A+Consequences+on+anti-inflammatory+activity+versus+gastric+and+renal+safety"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPairet%26aufirst%3DM.%26aulast%3DChurchill%26aufirst%3DL.%26aulast%3DTrummlitz%26aufirst%3DG.%26aulast%3DEngelhardt%26aufirst%3DG.%26atitle%3DDifferential%2520inhibition%2520of%2520cyclooxygenase-1%2520%2528COX-1%2529%2520and%2520%25E2%2588%25922%2520%2528COX-2%2529%2520by%2520NSAIDS%253A%2520Consequences%2520on%2520anti-inflammatory%2520activity%2520versus%2520gastric%2520and%2520renal%2520safety%26jtitle%3DInflammopharmacology%26date%3D1996%26volume%3D4%26spage%3D61%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Prasit, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span> </span><span class="NLM_article-title">Selective cyclooxygenase-2 inhibitors</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">220</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1997&pages=211-220&author=P.+Prasitauthor=D.+Riendeau&title=Selective+cyclooxygenase-2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DRiendeau%26aufirst%3DD.%26atitle%3DSelective%2520cyclooxygenase-2%2520inhibitors%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D1997%26volume%3D32%26spage%3D211%26epage%3D220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Talley, J. J.</span><span> </span><span class="NLM_article-title">Selective inhibitors of cyclooxygenase-2 (COX-2)</span> <span class="citation_source-journal">Prog. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1016%2FS0079-6468%2808%2970048-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=10818674" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADyaK1MXjvV2ntbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1999&pages=201-234&author=J.+J.+Talley&title=Selective+inhibitors+of+cyclooxygenase-2+%28COX-2%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibitors of cyclooxygenase-2 (COX-2)</span></div><div class="casAuthors">Talley, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">201-234</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review with 241 refs. on the discovery and screening of selective cyclooxygenase-2 inhibitors.  COX-2 inhibitors offer the hope of relief from arthritic diseases and pain without the complication of gastrointestinal side-effects.  In addn., COX-2 inhibitors may be useful for the treatment or prevention of certain tipes of cancer and Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmEUTyOmU-e7Vg90H21EOLACvtfcHk0ljC8J8RAaf9Qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvV2ntbg%253D&md5=ba0886ac03f8d1295c4c9b37c90c3481</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2808%2970048-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252808%252970048-1%26sid%3Dliteratum%253Aachs%26aulast%3DTalley%26aufirst%3DJ.%2BJ.%26atitle%3DSelective%2520inhibitors%2520of%2520cyclooxygenase-2%2520%2528COX-2%2529%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D1999%26volume%3D36%26spage%3D201%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Talley, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertenshaw, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graneto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koboldt, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masferrer, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogier, D. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweifel, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seibert, K.</span><span> </span><span class="NLM_article-title">4,5-Diaryloxazole inhibitors of cyclooxygenase-2 (COX-2)</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1002%2F%28SICI%291098-1128%28199905%2919%3A3%3C199%3A%3AAID-MED1%3E3.0.CO%3B2-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=10232649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADyaK1MXjtVGhur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=199-208&author=J.+J.+Talleyauthor=S.+R.+Bertenshawauthor=D.+L.+Brownauthor=J.+S.+Carterauthor=M.+J.+Granetoauthor=C.+M.+Koboldtauthor=J.+L.+Masferrerauthor=B.+H.+Normanauthor=D.+J.+Rogierauthor=B.+S.+Zweifelauthor=K.+Seibert&title=4%2C5-Diaryloxazole+inhibitors+of+cyclooxygenase-2+%28COX-2%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">4,5-Diaryloxazole inhibitors of cyclooxygenase-2 (COX-2)</span></div><div class="casAuthors">Talley, John J.; Bertenshaw, Stephen R.; Brown, David L.; Carter, Jeffery S.; Graneto, Mathew J.; Koboldt, Carol M.; Masferrer, Jaime L.; Norman, Bryan H.; Rogier, D. Joseph, Jr.; Zweifel, Ben S.; Seibert, Karen</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">199-208</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A series of methylsulfonyl or sulfonamido substituted 4,5-diaryloxazole were prepd. and evaluated for their ability to inhibit the inducible form of cyclooxygenase (COX-2) in vitro and in vivo.  Several unique substitution patterns were identified that led to potent and selective inhibitors of COX-2.  In general, 2-trifluoromethyl-4,5-diaryloxazoles substituted with a methylsulfonyl or sulfonamido group were particularly potent inhibitors.  One of the more potent compds. with a selectivity for COX-2 of about 800 fold was SC-299 (I).  I, a highly fluorescent mol., may be useful for spectroscopic studies on preferential inhibitor binding to COX-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4CDYxBCLLrLVg90H21EOLACvtfcHk0ljC8J8RAaf9Qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtVGhur4%253D&md5=a6602064867f2791cf6da5d9d5025b5b</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-1128%28199905%2919%3A3%3C199%3A%3AAID-MED1%3E3.0.CO%3B2-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-1128%2528199905%252919%253A3%253C199%253A%253AAID-MED1%253E3.0.CO%253B2-7%26sid%3Dliteratum%253Aachs%26aulast%3DTalley%26aufirst%3DJ.%2BJ.%26aulast%3DBertenshaw%26aufirst%3DS.%2BR.%26aulast%3DBrown%26aufirst%3DD.%2BL.%26aulast%3DCarter%26aufirst%3DJ.%2BS.%26aulast%3DGraneto%26aufirst%3DM.%2BJ.%26aulast%3DKoboldt%26aufirst%3DC.%2BM.%26aulast%3DMasferrer%26aufirst%3DJ.%2BL.%26aulast%3DNorman%26aufirst%3DB.%2BH.%26aulast%3DRogier%26aufirst%3DD.%2BJ.%26aulast%3DZweifel%26aufirst%3DB.%2BS.%26aulast%3DSeibert%26aufirst%3DK.%26atitle%3D4%252C5-Diaryloxazole%2520inhibitors%2520of%2520cyclooxygenase-2%2520%2528COX-2%2529%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D1999%26volume%3D19%26spage%3D199%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Chan, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brideau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charleson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cromlish, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ethier, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford-Hutchinson, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrest, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gresser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kargman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Neill, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouellet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrier, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodger, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagari, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Therien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vickers, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visco, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamboni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span> </span><span class="NLM_article-title">Rofecoxib [Vioxx, MK-0966; 4-(4′-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: A potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">551</span><span class="NLM_x">–</span> <span class="NLM_lpage">560</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=10411562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADyaK1MXkvVKgu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=1999&pages=551-560&author=C.+C.+Chanauthor=S.+Boyceauthor=C.+Brideauauthor=S.+Charlesonauthor=W.+Cromlishauthor=D.+Ethierauthor=J.+Evansauthor=A.+W.+Ford-Hutchinsonauthor=M.+J.+Forrestauthor=J.+Y.+Gauthierauthor=R.+Gordonauthor=M.+Gresserauthor=J.+Guayauthor=S.+Kargmanauthor=B.+Kennedyauthor=Y.+Leblancauthor=S.+Legerauthor=J.+Manciniauthor=G.+P.+O%27Neillauthor=M.+Ouelletauthor=D.+Patrickauthor=M.+D.+Percivalauthor=H.+Perrierauthor=P.+Prasitauthor=I.+Rodgerauthor=P.+Tagariauthor=M.+Therienauthor=P.+Vickersauthor=D.+Viscoauthor=Z.+Wangauthor=J.+Webbauthor=E.+Wongauthor=L.+J.+Xuauthor=R.+N.+Youngauthor=R.+Zamboniauthor=D.+Riendeau&title=Rofecoxib+%5BVioxx%2C+MK-0966%3B+4-%284%E2%80%B2-methylsulfonylphenyl%29-3-phenyl-2-%285H%29-furanone%5D%3A+A+potent+and+orally+active+cyclooxygenase-2+inhibitor.+Pharmacological+and+biochemical+profiles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles</span></div><div class="casAuthors">Chan, C.-C.; Boyce, S.; Brideau, C.; Charleson, S.; Cromlish, W.; Ethier, D.; Evans, J.; Ford-Hutchinson, A. W.; Forrest, M. J.; Gauthier, J. Y.; Gordon, R.; Gresser, M.; Guay, J.; Kargman, S.; Kennedy, B.; Leblanc, Y.; Leger, S.; Mancini, J.; O'Neill, G. P.; Ouellet, M.; Patrick, D.; Percival, M. D.; Perrier, H.; Prasit, P.; Rodger, I.; Tagari, P.; Therien, M.; Vickers, P.; Visco, D.; Wang, Z.; Webb, J.; Wong, E.; Xu, L-J.; Young, R. N.; Zamboni, R.; Riendeau, D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">551-560</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The discoveries that cyclooxygenase (COX)-2 is an inducible form of COX involved in inflammation and that COX-1 is the major isoform responsible for the prodn. of prostaglandins (PGs) in the gastrointestinal tract have provided a rationale for the development of specific COX-2 inhibitors as a new class of anti-inflammatory agents with improved gastrointestinal tolerability.  In the present study, the preclin. pharmacol. and biochem. profiles of rofecoxib [Vioxx, also known as MK-0966, 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone], an orally active COX-2 inhibitor, are described.  Rofecoxib is a potent inhibitor of the COX-2-dependent prodn. of PGE2 in human osteosarcoma cells (IC50 = 26 ± 10 nM) and Chinese hamster ovary cells expressing human COX-2 (IC50 = 18 ± 7 nM) with a 1000-fold selectivity for the inhibition of COX-2 compared with the inhibition of COX-1 activity (IC50 > 50 μM in U937 cells and IC50 > 15 μM in Chinese hamster ovary cells expressing human COX-1).  Rofecoxib is a time-dependent inhibitor of purified human recombinant COX-2 (IC50 = 0.34 μM) but caused inhibition of purified human COX-1 in a non-time-dependent manner that could only be obsd. at a very low substrate concn. (IC50 = 26 μM at 0.1 μM arachidonic acid concn.).  In an in vitro human whole blood assay, rofecoxib selectively inhibited lipopolysaccharide-induced, COX-2-derived PGE2 synthesis with an IC50 value of 0.53 ± 0.02 μM compared with an IC50 value of 18.8 ± 0.9 μM for the inhibition of COX-1-derived thromboxane B2 synthesis after blood coagulation.  Using the ratio of the COX-1 IC50 values over the COX-2 IC50 values in the human whole blood assay, selectivity ratios for the inhibition of COX-2 of 36, 6.6, 2, 3, and 0.4 were obtained for rofecoxib, celecoxib, meloxicam, diclofenac, and indomethacin, resp.  In several in vivo rodent models, rofecoxib is a potent inhibitor of carrageenan-induced paw edema (ID50 = 1.5 mg/kg), carrageenan-induced paw hyperalgesia (ID50 = 1.0 mg/kg), lipopolysaccharide-induced pyresis (ID50 = 0.24 mg/kg), and adjuvant-induced arthritis (ID50 = 0.74 mg/kg/day).  Rofecoxib also has a protective effect on adjuvant-induced destruction of cartilage and bone structures in rats.  In a 51Cr excretion assay for detection of gastrointestinal integrity in either rats or squirrel monkeys, rofecoxib has no effect at doses up to 200 mg/kg/day for 5 days.  Rofecoxib is a novel COX-2 inhibitor with a biochem. and pharmacol. profile clearly distinct from that of current nonsteroidal anti-inflammatory drugs and represents a new therapeutic class of anti-inflammatory agents for the treatment of the symptoms of osteoarthritis and rheumatoid arthritis with improved gastrointestinal tolerability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMiRyINGaokLVg90H21EOLACvtfcHk0lh1NK5UGjPGpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkvVKgu7k%253D&md5=c5ed209578557f65d4d5c5c37eab731e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DC.%2BC.%26aulast%3DBoyce%26aufirst%3DS.%26aulast%3DBrideau%26aufirst%3DC.%26aulast%3DCharleson%26aufirst%3DS.%26aulast%3DCromlish%26aufirst%3DW.%26aulast%3DEthier%26aufirst%3DD.%26aulast%3DEvans%26aufirst%3DJ.%26aulast%3DFord-Hutchinson%26aufirst%3DA.%2BW.%26aulast%3DForrest%26aufirst%3DM.%2BJ.%26aulast%3DGauthier%26aufirst%3DJ.%2BY.%26aulast%3DGordon%26aufirst%3DR.%26aulast%3DGresser%26aufirst%3DM.%26aulast%3DGuay%26aufirst%3DJ.%26aulast%3DKargman%26aufirst%3DS.%26aulast%3DKennedy%26aufirst%3DB.%26aulast%3DLeblanc%26aufirst%3DY.%26aulast%3DLeger%26aufirst%3DS.%26aulast%3DMancini%26aufirst%3DJ.%26aulast%3DO%2527Neill%26aufirst%3DG.%2BP.%26aulast%3DOuellet%26aufirst%3DM.%26aulast%3DPatrick%26aufirst%3DD.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DPerrier%26aufirst%3DH.%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DRodger%26aufirst%3DI.%26aulast%3DTagari%26aufirst%3DP.%26aulast%3DTherien%26aufirst%3DM.%26aulast%3DVickers%26aufirst%3DP.%26aulast%3DVisco%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWebb%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DE.%26aulast%3DXu%26aufirst%3DL.%2BJ.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DZamboni%26aufirst%3DR.%26aulast%3DRiendeau%26aufirst%3DD.%26atitle%3DRofecoxib%2520%255BVioxx%252C%2520MK-0966%253B%25204-%25284%25E2%2580%25B2-methylsulfonylphenyl%2529-3-phenyl-2-%25285H%2529-furanone%255D%253A%2520A%2520potent%2520and%2520orally%2520active%2520cyclooxygenase-2%2520inhibitor.%2520Pharmacological%2520and%2520biochemical%2520profiles%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D290%26spage%3D551%26epage%3D560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Esser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimoto, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haston, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimble, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koehler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peppard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quadros, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quintavalla, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toscano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Duzer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, P. J.</span><span> </span><span class="NLM_article-title">Preclinical pharmacology of lumiracoxib: A novel selective inhibitor of cyclooxygenase-2</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x">, </span> <span class="NLM_fpage">538</span><span class="NLM_x">–</span> <span class="NLM_lpage">550</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1038%2Fsj.bjp.0706078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=15655513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsVOmsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2005&pages=538-550&author=R.+Esserauthor=C.+Berryauthor=Z.+Duauthor=J.+Dawsonauthor=A.+Foxauthor=R.+A.+Fujimotoauthor=W.+Hastonauthor=E.+F.+Kimbleauthor=J.+Koehlerauthor=J.+Peppardauthor=E.+Quadrosauthor=J.+Quintavallaauthor=K.+Toscanoauthor=L.+Urbanauthor=J.+van+Duzerauthor=X.+Zhangauthor=S.+Zhouauthor=P.+J.+Marshall&title=Preclinical+pharmacology+of+lumiracoxib%3A+A+novel+selective+inhibitor+of+cyclooxygenase-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase-2</span></div><div class="casAuthors">Esser, Ronald; Berry, Carol; Du, Zhengming; Dawson, Janet; Fox, Alyson; Fujimoto, Roger A.; Haston, William; Kimble, Earl F.; Koehler, Julie; Peppard, Jane; Quadros, Elizabeth; Quintavalla, Joseph; Toscano, Karen; Urban, Laszlo; van Duzer, John; Zhang, Xiaoli; Zhou, Siyuan; Marshall, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">538-550</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">This manuscript presents the preclin. profile of lumiracoxib, a novel cyclooxygenase-2 (COX-2) selective inhibitor.  Lumiracoxib inhibited purified COX-1 and COX-2 with Ki values of 3 and 0.06 μM, resp.  In cellular assays, lumiracoxib had an IC50 of 0.14 μM in COX-2-expressing dermal fibroblasts, but caused no inhibition of COX-1 at concns. up to 30 μM (HEK 293 cells transfected with human COX-1).  In a human whole blood assay, IC50 values for lumiracoxib were 0.13 μM for COX-2 and 67 μM for COX-1 (COX-1/COX-2 selectivity ratio 515).  Lumiracoxib was rapidly absorbed following oral administration in rats with peak plasma levels being reached between 0.5 and 1 h.  Ex vivo, lumiracoxib inhibited COX-1-derived thromboxane B2 (TxB2) generation with an ID50 of 33 mg kg-1, whereas COX-2-derived prodn. of prostaglandin E2 (PGE2) in the lipopolysaccharide-stimulated rat air pouch was inhibited with an ID50 value of 0.24 mg kg-1.  Efficacy of lumiracoxib in rat models of hyperalgesia, edema, pyresis and arthritis was dose-dependent and similar to diclofenac.  However, consistent with its low COX-1 inhibitory activity, lumiracoxib at a dose of 100 mg kg-1 orally caused no ulcers and was significantly less ulcerogenic than diclofenac (P<0.05).  Lumiracoxib is a highly selective COX-2 inhibitor with anti-inflammatory, analgesic and antipyretic activities comparable with diclofenac, the ref. NSAID, but with much improved gastrointestinal safety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGFkSVhj6hjbVg90H21EOLACvtfcHk0ljPw5KuAwzhUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsVOmsbk%253D&md5=c56dbbee7e3bc394087d2cc450c24d47</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706078%26sid%3Dliteratum%253Aachs%26aulast%3DEsser%26aufirst%3DR.%26aulast%3DBerry%26aufirst%3DC.%26aulast%3DDu%26aufirst%3DZ.%26aulast%3DDawson%26aufirst%3DJ.%26aulast%3DFox%26aufirst%3DA.%26aulast%3DFujimoto%26aufirst%3DR.%2BA.%26aulast%3DHaston%26aufirst%3DW.%26aulast%3DKimble%26aufirst%3DE.%2BF.%26aulast%3DKoehler%26aufirst%3DJ.%26aulast%3DPeppard%26aufirst%3DJ.%26aulast%3DQuadros%26aufirst%3DE.%26aulast%3DQuintavalla%26aufirst%3DJ.%26aulast%3DToscano%26aufirst%3DK.%26aulast%3DUrban%26aufirst%3DL.%26aulast%3Dvan%2BDuzer%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DMarshall%26aufirst%3DP.%2BJ.%26atitle%3DPreclinical%2520pharmacology%2520of%2520lumiracoxib%253A%2520A%2520novel%2520selective%2520inhibitor%2520of%2520cyclooxygenase-2%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D144%26spage%3D538%26epage%3D550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Marnett, L. J.</span><span> </span><span class="NLM_article-title">The COXIB experience: A look in the rearview mirror</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1146%2Fannurev.pharmtox.011008.145638" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=18851701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisV2jsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=265-290&author=L.+J.+Marnett&title=The+COXIB+experience%3A+A+look+in+the+rearview+mirror"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The COXIB experience: a look in the rearview mirror</span></div><div class="casAuthors">Marnett, Lawrence J.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">265-290</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most widely used prescription and nonprescription drugs in the world.  The discovery of cyclooxygenase (COX) as the target of NSAIDs, the subsequent identification of two isoforms of COX (COX-1 and COX-2), and studies of their regulation and sites of expression led to the hypothesis that COX-2 is the mol. target for the anti-inflammatory and analgesic effects of NSAIDs.  A corollary was that COX-2-selective inhibitors (COXIBs) would retain the desirable effects of NSAIDs without some of their liabilities (e.g., gastrointestinal toxicity, which was ascribed to COX-1 inhibition).  The first marketed COXIBs exhibited reduced gastrointestinal side effects relative to traditional NSAIDs and were enormous com. successes.  However, clin. trials testing the hypothesis that COXIBs prevent recurrence of premalignant colon polyps uncovered adverse cardiovascular effects that are mechanism based.  This review provides an overview of the discovery, development, and difficulties of the COXIBs, a perspective on what has been learned, and speculation on the way forward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAJBE0T9Iu_7Vg90H21EOLACvtfcHk0ljPw5KuAwzhUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisV2jsb4%253D&md5=5147f02bf6314c86f1f707609a9d2fa5</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.011008.145638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.011008.145638%26sid%3Dliteratum%253Aachs%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26atitle%3DThe%2520COXIB%2520experience%253A%2520A%2520look%2520in%2520the%2520rearview%2520mirror%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2009%26volume%3D49%26spage%3D265%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Rodriguez, L. A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolosa, L. B.</span><span> </span><span class="NLM_article-title">Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">498</span><span class="NLM_x">–</span> <span class="NLM_lpage">506</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2007&pages=498-506&author=L.+A.+G.+Rodriguezauthor=L.+B.+Tolosa&title=Risk+of+upper+gastrointestinal+complications+among+users+of+traditional+NSAIDs+and+COXIBs+in+the+general+population"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez%26aufirst%3DL.%2BA.%2BG.%26aulast%3DTolosa%26aufirst%3DL.%2BB.%26atitle%3DRisk%2520of%2520upper%2520gastrointestinal%2520complications%2520among%2520users%2520of%2520traditional%2520NSAIDs%2520and%2520COXIBs%2520in%2520the%2520general%2520population%26jtitle%3DGastroenterology%26date%3D2007%26volume%3D132%26spage%3D498%26epage%3D506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Hippisley-Cox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coupland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logan, R.</span><span> </span><span class="NLM_article-title">Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: Population based nested case-control analysis</span> <span class="citation_source-journal">BMJ [Br. Med. J.]</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">331</span><span class="NLM_x">, </span> <span class="NLM_fpage">1310</span><span class="NLM_x">–</span> <span class="NLM_lpage">1312</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1136%2Fbmj.331.7528.1310" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=16322018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD28XivVSmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=2005&pages=1310-1312&author=J.+Hippisley-Coxauthor=C.+Couplandauthor=R.+Logan&title=Risk+of+adverse+gastrointestinal+outcomes+in+patients+taking+cyclo-oxygenase-2+inhibitors+or+conventional+non-steroidal+anti-inflammatory+drugs%3A+Population+based+nested+case-control+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis</span></div><div class="casAuthors">Hippisley-Cox, Julia; Coupland, Carol; Logan, Richard</div><div class="citationInfo"><span class="NLM_cas:title">BMJ [British Medical Journal]</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">331</span>
        (<span class="NLM_cas:issue">7528</span>),
    <span class="NLM_cas:pages">1310-1312</span>CODEN:
                <span class="NLM_cas:coden">BMJBFE</span>;
        ISSN:<span class="NLM_cas:issn">0959-8146</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">To det. the risk of an adverse upper gastrointestinal event in patients taking different cyclo-oxygenase-2 inhibitors compared with non-selective non-steroidal anti-inflammatory drugs.  Nested case-control study.  Three hundred sixty-seven general practices contributing to the UK QRESEARCH database, spread throughout every strategic health authority and each health board in England, Wales, and Scotland.  Patients aged 25 or more with a first ever diagnosis of an adverse upper gastrointestinal event (peptic ulcer or hematemesis) between 1 August 2000 and 31 July 2004 and up to 10 controls per case matched for age, sex, calendar time, and practice.  Unadjusted and adjusted odds ratios for adverse upper gastrointestinal events assocd. with exposure to celecoxib, rofecoxib, ibuprofen, diclofenac, naproxen, other selective and non-selective non-steroidal anti-inflammatory drugs, and aspirin.  The incidence of adverse upper gastrointestinal events was 1.36 per 1000 person years (95% confidence interval 1.34 to 1.39).  We identified 9407 incident cases and 88 867 matched controls.  Increased risks of adverse gastrointestinal events were assocd. with current use of cyclo-oxygenase-2 inhibitors and with conventional non-steroidal anti-inflammatory drugs.  Risks were reduced after adjustment for confounders but remained significantly increased for naproxen (adjusted odds ratio 2.12, 95% confidence interval 1.73 to 2.58), diclofenac (1.96, 1.78 to 2.15), and rofecoxib (1.56, 1.30 to 1.87) but not for current use of celecoxib (1.11, 0.87 to 1.41).  We found clin. important interactions with current use of ulcer healing drugs that removed the increased risks for adverse gastrointestinal events for all groups of non-steroidal anti-inflammatory drugs except diclofenac, which still had an increased odds ratio (1.49, 1.26 to 1.76).  No consistent evidence was found of enhanced safety against gastrointestinal events with any of the new cyclo-oxygenase-2 inhibitors compared with non-selective non-steroidal anti-inflammatory drugs.  The use of ulcer healing drugs reduced the increased risk of adverse gastrointestinal outcomes with all groups of non-steroidal anti-inflammatory drugs, but for diclofenac the increased risk remained significant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvRWAkh6DvRrVg90H21EOLACvtfcHk0lgAKgH2rBCgjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XivVSmsg%253D%253D&md5=9653ecc6041941da8de130a6eb9d498e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1136%2Fbmj.331.7528.1310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.331.7528.1310%26sid%3Dliteratum%253Aachs%26aulast%3DHippisley-Cox%26aufirst%3DJ.%26aulast%3DCoupland%26aufirst%3DC.%26aulast%3DLogan%26aufirst%3DR.%26atitle%3DRisk%2520of%2520adverse%2520gastrointestinal%2520outcomes%2520in%2520patients%2520taking%2520cyclo-oxygenase-2%2520inhibitors%2520or%2520conventional%2520non-steroidal%2520anti-inflammatory%2520drugs%253A%2520Population%2520based%2520nested%2520case-control%2520analysis%26jtitle%3DBMJ%2520%255BBr.%2520Med.%2520J.%255D%26date%3D2005%26volume%3D331%26spage%3D1310%26epage%3D1312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Ott, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nussmeier, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duke, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feneck, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alston, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snabes, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saidman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangano, D. T.</span><span> </span><span class="NLM_article-title">Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery</span> <span class="citation_source-journal">J. Thorac. Cardiovasc. Surg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">1481</span><span class="NLM_x">–</span> <span class="NLM_lpage">1492</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=1481-1492&author=E.+Ottauthor=N.+A.+Nussmeierauthor=P.+C.+Dukeauthor=R.+O.+Feneckauthor=R.+P.+Alstonauthor=M.+C.+Snabesauthor=R.+C.+Hubbardauthor=P.+H.+Hsuauthor=L.+J.+Saidmanauthor=D.+T.+Mangano&title=Efficacy+and+safety+of+the+cyclooxygenase+2+inhibitors+parecoxib+and+valdecoxib+in+patients+undergoing+coronary+artery+bypass+surgery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOtt%26aufirst%3DE.%26aulast%3DNussmeier%26aufirst%3DN.%2BA.%26aulast%3DDuke%26aufirst%3DP.%2BC.%26aulast%3DFeneck%26aufirst%3DR.%2BO.%26aulast%3DAlston%26aufirst%3DR.%2BP.%26aulast%3DSnabes%26aufirst%3DM.%2BC.%26aulast%3DHubbard%26aufirst%3DR.%2BC.%26aulast%3DHsu%26aufirst%3DP.%2BH.%26aulast%3DSaidman%26aufirst%3DL.%2BJ.%26aulast%3DMangano%26aufirst%3DD.%2BT.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520the%2520cyclooxygenase%25202%2520inhibitors%2520parecoxib%2520and%2520valdecoxib%2520in%2520patients%2520undergoing%2520coronary%2520artery%2520bypass%2520surgery%26jtitle%3DJ.%2520Thorac.%2520Cardiovasc.%2520Surg.%26date%3D2003%26volume%3D125%26spage%3D1481%26epage%3D1492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Nussmeier, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whelton, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langford, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoeft, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parlow, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verburg, K. M.</span><span> </span><span class="NLM_article-title">Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x">, </span> <span class="NLM_fpage">1081</span><span class="NLM_x">–</span> <span class="NLM_lpage">1091</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1056%2FNEJMoa050330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=15713945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXit1Kqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2005&pages=1081-1091&author=N.+A.+Nussmeierauthor=A.+A.+Wheltonauthor=M.+T.+Brownauthor=R.+M.+Langfordauthor=A.+Hoeftauthor=J.+L.+Parlowauthor=S.+W.+Boyceauthor=K.+M.+Verburg&title=Complications+of+the+COX-2+inhibitors+parecoxib+and+valdecoxib+after+cardiac+surgery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery</span></div><div class="casAuthors">Nussmeier, Nancy A.; Whelton, Andrew A.; Brown, Mark T.; Langford, Richard M.; Hoeft, Andreas; Parlow, Joel L.; Boyce, Steven W.; Verburg, Kenneth M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1081-1091</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Valdecoxib and its i.v. prodrug parecoxib are used to treat postoperative pain but may involve risk after coronary-artery bypass grafting (CABG).  We conducted a randomized trial to assess the safety of these drugs after CABG.  In this randomized, double-blind study involving 10 days of treatment and 30 days of follow-up, 1671 patients were randomly assigned to receive i.v. parecoxib for at least 3 days, followed by oral valdecoxib through day 10; i.v. placebo followed by oral valdecoxib; or placebo for 10 days.  All patients had access to std. opioid medications.  The primary end point was the frequency of predefined adverse events, including cardiovascular events, renal failure or dysfunction, gastroduodenal ulceration, and wound-healing complications.  As compared with the group given placebo alone, both the group given parecoxib and valdecoxib and the group given placebo and valdecoxib had a higher proportion of patients with at least one confirmed adverse event (7.4 % in each of these two groups vs. 4.0 % in the placebo group; risk ratio for each comparison, 1.9; 95 % confidence interval, 1.1 to 3.2; P = 0.02 for each comparison with the placebo group).  In particular, cardiovascular events (including myocardial infarction, cardiac arrest, stroke, and pulmonary embolism) were more frequent among the patients given parecoxib and valdecoxib than among those given placebo (2.0 % vs. 0.5 %; risk ratio, 3.7; 95 % confidence interval, 1.0 to 13.5; P = 0.03).  The use of parecoxib and valdecoxib after CABG was assocd. with an increased incidence of cardiovascular events, arousing serious concern about the use of these drugs in such circumstances.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplvkMQyXQWoLVg90H21EOLACvtfcHk0lgAKgH2rBCgjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXit1Kqu74%253D&md5=ca20e1d0f91cc56020437883ebd4c6d7</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa050330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa050330%26sid%3Dliteratum%253Aachs%26aulast%3DNussmeier%26aufirst%3DN.%2BA.%26aulast%3DWhelton%26aufirst%3DA.%2BA.%26aulast%3DBrown%26aufirst%3DM.%2BT.%26aulast%3DLangford%26aufirst%3DR.%2BM.%26aulast%3DHoeft%26aufirst%3DA.%26aulast%3DParlow%26aufirst%3DJ.%2BL.%26aulast%3DBoyce%26aufirst%3DS.%2BW.%26aulast%3DVerburg%26aufirst%3DK.%2BM.%26atitle%3DComplications%2520of%2520the%2520COX-2%2520inhibitors%2520parecoxib%2520and%2520valdecoxib%2520after%2520cardiac%2520surgery%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D352%26spage%3D1081%26epage%3D1091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Cannon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtis, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">FitzGerald, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krum, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognese, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reicin, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bombardier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinblatt, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Heijde, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laine, L.</span><span> </span><span class="NLM_article-title">Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the multinational etoricoxib and diclofenac arthritis long-term (MEDAL) programme: A randomized comparison</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x">, </span> <span class="NLM_fpage">1771</span><span class="NLM_x">–</span> <span class="NLM_lpage">1781</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2006&pages=1771-1781&author=C.+P.+Cannonauthor=S.+P.+Curtisauthor=G.+A.+FitzGeraldauthor=H.+Krumauthor=A.+Kaurauthor=J.+A.+Bologneseauthor=A.+S.+Reicinauthor=C.+Bombardierauthor=M.+E.+Weinblattauthor=D.+van+der+Heijdeauthor=E.+Erdmannauthor=L.+Laine&title=Cardiovascular+outcomes+with+etoricoxib+and+diclofenac+in+patients+with+osteoarthritis+and+rheumatoid+arthritis+in+the+multinational+etoricoxib+and+diclofenac+arthritis+long-term+%28MEDAL%29+programme%3A+A+randomized+comparison"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCannon%26aufirst%3DC.%2BP.%26aulast%3DCurtis%26aufirst%3DS.%2BP.%26aulast%3DFitzGerald%26aufirst%3DG.%2BA.%26aulast%3DKrum%26aufirst%3DH.%26aulast%3DKaur%26aufirst%3DA.%26aulast%3DBolognese%26aufirst%3DJ.%2BA.%26aulast%3DReicin%26aufirst%3DA.%2BS.%26aulast%3DBombardier%26aufirst%3DC.%26aulast%3DWeinblatt%26aufirst%3DM.%2BE.%26aulast%3Dvan%2Bder%2BHeijde%26aufirst%3DD.%26aulast%3DErdmann%26aufirst%3DE.%26aulast%3DLaine%26aufirst%3DL.%26atitle%3DCardiovascular%2520outcomes%2520with%2520etoricoxib%2520and%2520diclofenac%2520in%2520patients%2520with%2520osteoarthritis%2520and%2520rheumatoid%2520arthritis%2520in%2520the%2520multinational%2520etoricoxib%2520and%2520diclofenac%2520arthritis%2520long-term%2520%2528MEDAL%2529%2520programme%253A%2520A%2520randomized%2520comparison%26jtitle%3DLancet%26date%3D2006%26volume%3D368%26spage%3D1771%26epage%3D1781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Blobaum, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span> </span><span class="NLM_article-title">NSAID action and the foundations for cardiovascular toxicity</span> <span class="citation_source-journal">Cardiotoxicity Non-Cardiovascular Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">285</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1002%2F9780470660379.ch8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSqs7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=257-285&author=A.+L.+Blobaumauthor=L.+J.+Marnett&title=NSAID+action+and+the+foundations+for+cardiovascular+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">NSAID action and the foundations for cardiovascular toxicity</span></div><div class="casAuthors">Blobaum, Anna L.; Marnett, Lawrence J.</div><div class="citationInfo"><span class="NLM_cas:title">Cardiotoxicity of Non-Cardiovascular Drugs</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">257-285</span>CODEN:
                <span class="NLM_cas:coden">69NEAC</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review on the clin. history of non-steroidal anti-inflammatory drugs (NSAIDs) and COXIBs and the mol. foundations of their cardiovascular toxicity.  Topics discussed include history of NSAIDs, COX and NSAID action, the discovery of COX-2 and the development of COXIBs, COX-2 and arthritis trials, COX-2 and cancer, colon polyp recurrence trials, specific evidence for COX-2 derived PGI2 suppression and cardiovascular toxicity, addnl. mechanisms for cardiovascular events related to COX-2 inhibition, and COXIBs vs. NSAIDs and cardiovascular risk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeq4wqXJPBtrVg90H21EOLACvtfcHk0lj42Bny-tsNhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVSqs7vP&md5=cb66f38061fe4cf6943c08af82cd428d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2F9780470660379.ch8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F9780470660379.ch8%26sid%3Dliteratum%253Aachs%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26atitle%3DNSAID%2520action%2520and%2520the%2520foundations%2520for%2520cardiovascular%2520toxicity%26jtitle%3DCardiotoxicity%2520Non-Cardiovascular%2520Drugs%26date%3D2010%26spage%3D257%26epage%3D285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Wallace, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKnight, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergnolle, N.</span><span> </span><span class="NLM_article-title">NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">706</span><span class="NLM_x">–</span> <span class="NLM_lpage">714</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2000&pages=706-714&author=J.+L.+Wallaceauthor=W.+McKnightauthor=B.+K.+Reuterauthor=N.+Vergnolle&title=NSAID-induced+gastric+damage+in+rats%3A+requirement+for+inhibition+of+both+cyclooxygenase+1+and+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWallace%26aufirst%3DJ.%2BL.%26aulast%3DMcKnight%26aufirst%3DW.%26aulast%3DReuter%26aufirst%3DB.%2BK.%26aulast%3DVergnolle%26aufirst%3DN.%26atitle%3DNSAID-induced%2520gastric%2520damage%2520in%2520rats%253A%2520requirement%2520for%2520inhibition%2520of%2520both%2520cyclooxygenase%25201%2520and%25202%26jtitle%3DGastroenterology%26date%3D2000%26volume%3D119%26spage%3D706%26epage%3D714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Kakuta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tai, A.</span><span> </span><span class="NLM_article-title">Cyclooxygenase-1-Selective Inhibitors Are Attractive Candidates for Analgesics That Do Not Cause Gastric Damage. Design and in Vitro/in Vivo Evaluation of a Benzamide-Type Cyclooxygenase-1 Selective Inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2400</span><span class="NLM_x">–</span> <span class="NLM_lpage">2411</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701191z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2400-2411&author=H.+Kakutaauthor=X.+Zhengauthor=H.+Odaauthor=S.+Haradaauthor=Y.+Sugimotoauthor=K.+Sasakiauthor=A.+Tai&title=Cyclooxygenase-1-Selective+Inhibitors+Are+Attractive+Candidates+for+Analgesics+That+Do+Not+Cause+Gastric+Damage.+Design+and+in+Vitro%2Fin+Vivo+Evaluation+of+a+Benzamide-Type+Cyclooxygenase-1+Selective+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm701191z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701191z%26sid%3Dliteratum%253Aachs%26aulast%3DKakuta%26aufirst%3DH.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DOda%26aufirst%3DH.%26aulast%3DHarada%26aufirst%3DS.%26aulast%3DSugimoto%26aufirst%3DY.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DTai%26aufirst%3DA.%26atitle%3DCyclooxygenase-1-Selective%2520Inhibitors%2520Are%2520Attractive%2520Candidates%2520for%2520Analgesics%2520That%2520Do%2520Not%2520Cause%2520Gastric%2520Damage.%2520Design%2520and%2520in%2520Vitro%252Fin%2520Vivo%2520Evaluation%2520of%2520a%2520Benzamide-Type%2520Cyclooxygenase-1%2520Selective%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2400%26epage%3D2411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Perrone, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scilimati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simone, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitale, P.</span><span> </span><span class="NLM_article-title">Selective COX-1 inhibition: A therapeutic target to be reconsidered</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3769</span><span class="NLM_x">–</span> <span class="NLM_lpage">3805</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.2174%2F092986710793205408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=20858219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGqu7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=3769-3805&author=M.+G.+Perroneauthor=A.+Scilimatiauthor=L.+Simoneauthor=P.+Vitale&title=Selective+COX-1+inhibition%3A+A+therapeutic+target+to+be+reconsidered"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Selective COX-1 inhibition: a therapeutic target to be reconsidered</span></div><div class="casAuthors">Perrone, M. G.; Scilimati, A.; Simone, L.; Vitale, P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">3769-3805</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Since cyclooxygenase (COX) isoenzymes discovery, many papers and reviews have been published to describe the structural bases of COX inhibition, and to debate on the therapeutic and adverse effects of worldwide clin. used nonsteroidal anti-inflammatory drugs (NSAIDs), included COX-2 selective inhibitors (well known as Coxibs).  COX-2 inhibition has been widely investigated, whereas the role of COX-1 in human pathophysiol. is mostly not yet well ascertained.  As time goes on, the cliche that the constitutively expressed isoform COX-1 is only involved in normal physiol. functions, such as platelet aggregation, gastric mucosa protection and renal electrolyte homeostasis is going to be shattered.  Low-dose aspirin, behaving as a preferential inhibitor of platelet COX-1, allowed to enlighten the role exerted by this isoenzyme in many mammalian cell types.  This review would elucidate the most recent findings on selective COX-1 inhibition and their relevance to human pathol. such as cancer, neuro-inflammation, cardioprotection, fever and pain.  It would also focus on the design and development of new highly selective COX-1 inhibitors, useful tools in pharmacol. studies aimed at gaining a deeper insight of the role of COX-1 in human health and disease.  Among the traditional NSAIDs, other then aspirin and indomethacin, only few examples of selective COX-1 inhibitors (SC-560, FR122047, mofezolac, P6 and TFAP) have been so far identified.  This review has also the scope to stimulate the development of novel drugs, which activity is COX-1 mediated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg5V9ocjssTLVg90H21EOLACvtfcHk0lih8uF4oA9Sew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGqu7vI&md5=6cfc06d889d5b2234302d63c309d86b1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2174%2F092986710793205408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710793205408%26sid%3Dliteratum%253Aachs%26aulast%3DPerrone%26aufirst%3DM.%2BG.%26aulast%3DScilimati%26aufirst%3DA.%26aulast%3DSimone%26aufirst%3DL.%26aulast%3DVitale%26aufirst%3DP.%26atitle%3DSelective%2520COX-1%2520inhibition%253A%2520A%2520therapeutic%2520target%2520to%2520be%2520reconsidered%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D3769%26epage%3D3805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Aid, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosetti, F.</span><span> </span><span class="NLM_article-title">Targeting cyclooxygenases-1 and -2 in neuroinflammation: Therapeutic implications</span> <span class="citation_source-journal">Biochimie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2011&pages=46-51&author=S.+Aidauthor=F.+Bosetti&title=Targeting+cyclooxygenases-1+and+-2+in+neuroinflammation%3A+Therapeutic+implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAid%26aufirst%3DS.%26aulast%3DBosetti%26aufirst%3DF.%26atitle%3DTargeting%2520cyclooxygenases-1%2520and%2520-2%2520in%2520neuroinflammation%253A%2520Therapeutic%2520implications%26jtitle%3DBiochimie%26date%3D2011%26volume%3D93%26spage%3D46%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Simmons, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botting, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hla, T.</span><span> </span><span class="NLM_article-title">Cyclooxygenase isozymes: The biology of prostaglandin synthesis and inhibition</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">437</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2004&pages=387-437&author=D.+L.+Simmonsauthor=R.+M.+Bottingauthor=T.+Hla&title=Cyclooxygenase+isozymes%3A+The+biology+of+prostaglandin+synthesis+and+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSimmons%26aufirst%3DD.%2BL.%26aulast%3DBotting%26aufirst%3DR.%2BM.%26aulast%3DHla%26aufirst%3DT.%26atitle%3DCyclooxygenase%2520isozymes%253A%2520The%2520biology%2520of%2520prostaglandin%2520synthesis%2520and%2520inhibition%26jtitle%3DPharmacol.%2520Rev.%26date%3D2004%26volume%3D56%26spage%3D387%26epage%3D437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Teismann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tieu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, D.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, D.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunot, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vila, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson-Lewis, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Przedborski, S.</span><span> </span><span class="NLM_article-title">Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">5473</span><span class="NLM_x">–</span> <span class="NLM_lpage">5478</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=5473-5478&author=P.+Teismannauthor=K.+Tieuauthor=D.-K.+Choiauthor=D.-C.+Wuauthor=A.+Nainiauthor=S.+Hunotauthor=M.+Vilaauthor=V.+Jackson-Lewisauthor=S.+Przedborski&title=Cyclooxygenase-2+is+instrumental+in+Parkinson%27s+disease+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTeismann%26aufirst%3DP.%26aulast%3DTieu%26aufirst%3DK.%26aulast%3DChoi%26aufirst%3DD.-K.%26aulast%3DWu%26aufirst%3DD.-C.%26aulast%3DNaini%26aufirst%3DA.%26aulast%3DHunot%26aufirst%3DS.%26aulast%3DVila%26aufirst%3DM.%26aulast%3DJackson-Lewis%26aufirst%3DV.%26aulast%3DPrzedborski%26aufirst%3DS.%26atitle%3DCyclooxygenase-2%2520is%2520instrumental%2520in%2520Parkinson%2527s%2520disease%2520neurodegeneration%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2003%26volume%3D100%26spage%3D5473%26epage%3D5478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Choi, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosetti, F.</span><span> </span><span class="NLM_article-title">Cyclooxygenase-1 null mice show reduced neuroinflammation in response to β-amyloid</span> <span class="citation_source-journal">Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">234</span><span class="NLM_x">–</span> <span class="NLM_lpage">244</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.18632%2Faging.100021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=20157512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GkurvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=234-244&author=S.-H.+Choiauthor=F.+Bosetti&title=Cyclooxygenase-1+null+mice+show+reduced+neuroinflammation+in+response+to+%CE%B2-amyloid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclooxygenase-1 null mice show reduced neuroinflammation in response to β-amyloid</span></div><div class="casAuthors">Choi, Sang-Ho; Bosetti, Francesca</div><div class="citationInfo"><span class="NLM_cas:title">Aging</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">234-244</span>CODEN:
                <span class="NLM_cas:coden">AGINCN</span>;
        ISSN:<span class="NLM_cas:issn">1945-4589</span>.
    
            (<span class="NLM_cas:orgname">Impact Journals LLC</span>)
        </div><div class="casAbstract">Several independent epidemiol. studies indicate that chronic use of non-steroidal anti-inflammatory drugs can reduce the risk of developing Alzheimer's disease (AD), supporting the inflammatory cascade hypothesis.  Although the first clin. trial with indomethacin, a preferential cyclooxygenase (COX)-1 inhibitor, showed beneficial effects, subsequent large clin. trials, mostly using COX-2 inhibitors, failed to show any beneficial effect in AD patients with mild to severe cognitive impairment.  These combined data suggest that either an early treatment is crucial to stop the mechanisms underlying the disease before the onset of the symptoms, or that preferential COX-1 inhibition, rather than COX-2, is beneficial.  Therefore, a full understanding of the physiol., pathol., and/or neuroprotective role of COX isoforms may help to develop better therapeutic strategies for the prevention or treatment of AD.  In this study, we examd. the effect of COX-1 genetic deletion on the inflammatory response and neurodegeneration induced by β-amyloid.  β-Amyloid (Aβ1-42) was centrally injected in the lateral ventricle of COX-1-deficient (COX-1-/-) and their resp. wild-type (WT) mice.  In COX-1-/- mice, Aβ1-42-induced inflammatory response and neuronal damage were attenuated compared to WT mice, as shown by Fluoro-Jade B and nitrotyrosine staining.  These results indicate that inhibition of COX-1 activity may be valid therapeutic strategy to reduce brain inflammatory response and neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXGYQzHEe3HbVg90H21EOLACvtfcHk0lhYDPbQ9cX15A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GkurvF&md5=d8bd9f9c16066b02741122223fed1195</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.18632%2Faging.100021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Faging.100021%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DS.-H.%26aulast%3DBosetti%26aufirst%3DF.%26atitle%3DCyclooxygenase-1%2520null%2520mice%2520show%2520reduced%2520neuroinflammation%2520in%2520response%2520to%2520%25CE%25B2-amyloid%26jtitle%3DAging%26date%3D2009%26volume%3D1%26spage%3D234%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">McKee, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreras, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hossain, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oddo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFerla, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowall, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dedeoglu, A.</span><span> </span><span class="NLM_article-title">Ibuprofen reduces Aβ, hyperphosphorylated tau and memory deficits in Alzheimer mice</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1207</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">236</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1016%2Fj.brainres.2008.01.095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=18374906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvVyisL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1207&publication_year=2008&pages=225-236&author=A.+C.+McKeeauthor=I.+Carrerasauthor=L.+Hossainauthor=H.+Ryuauthor=W.+L.+Kleinauthor=S.+Oddoauthor=F.+M.+LaFerlaauthor=B.+G.+Jenkinsauthor=N.+W.+Kowallauthor=A.+Dedeoglu&title=Ibuprofen+reduces+A%CE%B2%2C+hyperphosphorylated+tau+and+memory+deficits+in+Alzheimer+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Ibuprofen reduces Aβ, hyperphosphorylated tau and memory deficits in Alzheimer mice</span></div><div class="casAuthors">McKee, Ann C.; Carreras, Isabel; Hossain, Lokman; Ryu, Hoon; Klein, William L.; Oddo, Salvatore; LaFerla, Frank M.; Jenkins, Bruce G.; Kowall, Neil W.; Dedeoglu, Alpaslan</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1207</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">225-236</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We examd. the effects of ibuprofen on cognitive deficits, Aβ and tau accumulation in young triple transgenic (3xTg-AD) mice. 3xTg-AD mice were fed ibuprofen-supplemented chow between 1 and 6 mo.  Untreated 3xTg-AD mice showed significant impairment in the ability to learn the Morris water maze (MWM) task compared to age-matched wild-type (WT) mice.  The performance of 3xTg-AD mice was significantly improved with ibuprofen treatment compared to untreated 3xTg-AD mice.  Ibuprofen-treated transgenic mice showed a significant decrease in intraneuronal oligomeric Aβ and hyperphosphorylated tau (AT8) immunoreactivity in the hippocampus.  Confocal microscopy demonstrated co-localization of conformationally altered (MC1) and early phosphorylated tau (CP-13) with oligomeric Aβ, and less co-localization of oligomeric Aβ and later forms of phosphorylated tau (AT8 and PHF-1) in untreated 3xTg-AD mice.  Our findings show that prophylactic treatment of young 3xTg-AD mice with ibuprofen reduces intraneuronal oligomeric Aβ, reduces cognitive deficits, and prevents hyperphosphorylated tau immunoreactivity.  These findings provide further support for intraneuronal Aβ as a cause of cognitive impairment, and suggest that pathol. alterations of tau are assocd. with intraneuronal oligomeric Aβ accumulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnXVz44djYCrVg90H21EOLACvtfcHk0ljIrvpaDAJ9QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvVyisL4%253D&md5=320a00cceb84e799f7ccc37224e02f2b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2008.01.095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2008.01.095%26sid%3Dliteratum%253Aachs%26aulast%3DMcKee%26aufirst%3DA.%2BC.%26aulast%3DCarreras%26aufirst%3DI.%26aulast%3DHossain%26aufirst%3DL.%26aulast%3DRyu%26aufirst%3DH.%26aulast%3DKlein%26aufirst%3DW.%2BL.%26aulast%3DOddo%26aufirst%3DS.%26aulast%3DLaFerla%26aufirst%3DF.%2BM.%26aulast%3DJenkins%26aufirst%3DB.%2BG.%26aulast%3DKowall%26aufirst%3DN.%2BW.%26aulast%3DDedeoglu%26aufirst%3DA.%26atitle%3DIbuprofen%2520reduces%2520A%25CE%25B2%252C%2520hyperphosphorylated%2520tau%2520and%2520memory%2520deficits%2520in%2520Alzheimer%2520mice%26jtitle%3DBrain%2520Res.%26date%3D2008%26volume%3D1207%26spage%3D225%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Nomura, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blankman, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinsey, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcondes, M. C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation</span> <span class="citation_source-journal">Science (Washington, DC, U.S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">334</span><span class="NLM_x">, </span> <span class="NLM_fpage">809</span><span class="NLM_x">–</span> <span class="NLM_lpage">813</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1126%2Fscience.1209200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=22021672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVagtrnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=2011&pages=809-813&author=D.+K.+Nomuraauthor=B.+E.+Morrisonauthor=J.+L.+Blankmanauthor=J.+Z.+Longauthor=S.+G.+Kinseyauthor=M.+C.+G.+Marcondesauthor=A.+M.+Wardauthor=Y.+K.+Hahnauthor=A.+H.+Lichtmanauthor=B.+Contiauthor=B.+F.+Cravatt&title=Endocannabinoid+Hydrolysis+Generates+Brain+Prostaglandins+That+Promote+Neuroinflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation</span></div><div class="casAuthors">Nomura, Daniel K.; Morrison, Bradley E.; Blankman, Jacqueline L.; Long, Jonathan Z.; Kinsey, Steven G.; Marcondes, Maria Cecilia G.; Ward, Anna M.; Hahn, Yun Kyung; Lichtman, Aron H.; Conti, Bruno; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">334</span>
        (<span class="NLM_cas:issue">6057</span>),
    <span class="NLM_cas:pages">809-813</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Phospholipase A2(PLA2) enzymes are considered the primary source of arachidonic acid for cyclooxygenase (COX)-mediated biosynthesis of prostaglandins.  Here, we show that a distinct pathway exists in brain, where monoacyl-glycerol lipase (MAGL) hydrolyzes the endocannabinoid 2-arachidonoylglycerol to generate a major arachidonate precursor pool for neuroinflammatory prostaglandins.  MAGL-disrupted animals show neuroprotection in a parkinsonian mouse model.  These animals are spared the hemorrhaging caused by COX inhibitors in the gut, where prostaglandins are instead regulated by cytosolic PLA2.  These findings identify MAGL as a distinct metabolic node that couples endocannabinoid to prostaglandin signaling networks in the nervous system and suggest that inhibition of this enzyme may be a new and potentially safer way to suppress the proinflammatory cascades that underlie neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPRRB-JEf2GrVg90H21EOLACvtfcHk0ljIrvpaDAJ9QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVagtrnJ&md5=17967f2d83876f57e4bc901df2e7dc68</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1126%2Fscience.1209200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1209200%26sid%3Dliteratum%253Aachs%26aulast%3DNomura%26aufirst%3DD.%2BK.%26aulast%3DMorrison%26aufirst%3DB.%2BE.%26aulast%3DBlankman%26aufirst%3DJ.%2BL.%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DKinsey%26aufirst%3DS.%2BG.%26aulast%3DMarcondes%26aufirst%3DM.%2BC.%2BG.%26aulast%3DWard%26aufirst%3DA.%2BM.%26aulast%3DHahn%26aufirst%3DY.%2BK.%26aulast%3DLichtman%26aufirst%3DA.%2BH.%26aulast%3DConti%26aufirst%3DB.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DEndocannabinoid%2520Hydrolysis%2520Generates%2520Brain%2520Prostaglandins%2520That%2520Promote%2520Neuroinflammation%26jtitle%3DScience%2520%2528Washington%252C%2520DC%252C%2520U.S.%2529%26date%3D2011%26volume%3D334%26spage%3D809%26epage%3D813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Smith, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koboldt, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muhammad, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweifel, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talley, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masferrer, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seibert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isakson, P. C.</span><span> </span><span class="NLM_article-title">Pharmacological analysis of cyclooxygenase-1 in inflammation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">13313</span><span class="NLM_x">–</span> <span class="NLM_lpage">13318</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1073%2Fpnas.95.22.13313" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=9789085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADyaK1cXntFWrsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=13313-13318&author=C.+J.+Smithauthor=Y.+Zhangauthor=C.+M.+Koboldtauthor=J.+Muhammadauthor=B.+S.+Zweifelauthor=A.+Shafferauthor=J.+J.+Talleyauthor=J.+L.+Masferrerauthor=K.+Seibertauthor=P.+C.+Isakson&title=Pharmacological+analysis+of+cyclooxygenase-1+in+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological analysis of cyclooxygenase-1 in inflammation</span></div><div class="casAuthors">Smith, Christopher J.; Zhang, Yan; Koboldt, Carol M.; Muhammad, Jerry; Zweifel, Ben S.; Shaffer, Alex; Talley, John J.; Masferrer, Jaime L.; Seibert, Karen; Isakson, Peter C.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">13313-13318</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The enzymes cyclooxygenase-1 and cyclooxygenase-2 (COX-1 and COX-2) catalyze the conversion of arachidonic acid to prostaglandin (PG) H2, the precursor of PGs and thromboxane.  These lipid mediators play important roles in inflammation and pain and in normal physiol. functions.  While there are abundant data indicating that the inducible isoform, COX-2, is important in inflammation and pain, the constitutively expressed isoform, COX-1, has also been suggested to play a role in inflammatory processes.  To address the latter question pharmacol., we used a highly selective COX-1 inhibitor, SC-560 (COX-1 IC50 = 0.009 μM; COX-2 IC50 = 6.3 μM).  SC-560 inhibited COX-1-derived platelet thromboxane B2, gastric PGE2, and dermal PGE2 prodn., indicating that it was orally active, but did not inhibit COX-2-derived PGs in the lipopolysaccharide-induced rat air pouch.  Therapeutic or prophylactic administration of SC-560 in the rat carrageenan footpad model did not affect acute inflammation or hyperalgesia at doses that markedly inhibited in vivo COX-1 activity.  By contrast, celecoxib, a selective COX-2 inhibitor, was anti-inflammatory and analgesic in this model.  Paradoxically, both SC-560 and celecoxib reduced paw PGs to equiv. levels.  Increased levels of PGs were found in the cerebrospinal fluid after carrageenan injection and were markedly reduced by celecoxib, but were not affected by SC-560.  These results suggest that, in addn. to the role of peripherally produced PGs, there is a crit., centrally mediated neurol. component to inflammatory pain that is mediated at least in part by COX-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo05VnKZU2CJrVg90H21EOLACvtfcHk0lhkon2rfksM_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXntFWrsLY%253D&md5=5b1af3003f9e099205bccf7e274401d9</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.22.13313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.22.13313%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DC.%2BJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKoboldt%26aufirst%3DC.%2BM.%26aulast%3DMuhammad%26aufirst%3DJ.%26aulast%3DZweifel%26aufirst%3DB.%2BS.%26aulast%3DShaffer%26aufirst%3DA.%26aulast%3DTalley%26aufirst%3DJ.%2BJ.%26aulast%3DMasferrer%26aufirst%3DJ.%2BL.%26aulast%3DSeibert%26aufirst%3DK.%26aulast%3DIsakson%26aufirst%3DP.%2BC.%26atitle%3DPharmacological%2520analysis%2520of%2520cyclooxygenase-1%2520in%2520inflammation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D13313%26epage%3D13318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Brenneis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofacker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zulauf, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakobsson, P.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholich, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geisslinger, G.</span><span> </span><span class="NLM_article-title">Inhibition of prostaglandin E2 synthesis by SC-560 is independent of cyclooxygenase 1 inhibition</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1352</span><span class="NLM_x">–</span> <span class="NLM_lpage">1360</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=1352-1360&author=C.+Brenneisauthor=T.+J.+Maierauthor=R.+Schmidtauthor=A.+Hofackerauthor=L.+Zulaufauthor=P.-J.+Jakobssonauthor=K.+Scholichauthor=G.+Geisslinger&title=Inhibition+of+prostaglandin+E2+synthesis+by+SC-560+is+independent+of+cyclooxygenase+1+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrenneis%26aufirst%3DC.%26aulast%3DMaier%26aufirst%3DT.%2BJ.%26aulast%3DSchmidt%26aufirst%3DR.%26aulast%3DHofacker%26aufirst%3DA.%26aulast%3DZulauf%26aufirst%3DL.%26aulast%3DJakobsson%26aufirst%3DP.-J.%26aulast%3DScholich%26aufirst%3DK.%26aulast%3DGeisslinger%26aufirst%3DG.%26atitle%3DInhibition%2520of%2520prostaglandin%2520E2%2520synthesis%2520by%2520SC-560%2520is%2520independent%2520of%2520cyclooxygenase%25201%2520inhibition%26jtitle%3DFASEB%2520J.%26date%3D2006%26volume%3D20%26spage%3D1352%26epage%3D1360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Daikoku, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tranguch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trofimova, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinulescu, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacks, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikitin, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dey, S. K.</span><span> </span><span class="NLM_article-title">Cyclooxygenase-1 Is Overexpressed in Multiple Genetically Engineered Mouse Models of Epithelial Ovarian Cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">2527</span><span class="NLM_x">–</span> <span class="NLM_lpage">2531</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=2527-2531&author=T.+Daikokuauthor=S.+Tranguchauthor=I.+N.+Trofimovaauthor=D.+M.+Dinulescuauthor=T.+Jacksauthor=A.+Y.+Nikitinauthor=D.+C.+Connollyauthor=S.+K.+Dey&title=Cyclooxygenase-1+Is+Overexpressed+in+Multiple+Genetically+Engineered+Mouse+Models+of+Epithelial+Ovarian+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDaikoku%26aufirst%3DT.%26aulast%3DTranguch%26aufirst%3DS.%26aulast%3DTrofimova%26aufirst%3DI.%2BN.%26aulast%3DDinulescu%26aufirst%3DD.%2BM.%26aulast%3DJacks%26aufirst%3DT.%26aulast%3DNikitin%26aufirst%3DA.%2BY.%26aulast%3DConnolly%26aufirst%3DD.%2BC.%26aulast%3DDey%26aufirst%3DS.%2BK.%26atitle%3DCyclooxygenase-1%2520Is%2520Overexpressed%2520in%2520Multiple%2520Genetically%2520Engineered%2520Mouse%2520Models%2520of%2520Epithelial%2520Ovarian%2520Cancer%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D2527%26epage%3D2531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Gupta Rajnish, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tejada Lovella, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong Beverly, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das Sanjoy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrow Jason, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dey Sudhansu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DuBois Raymond, N.</span><span> </span><span class="NLM_article-title">Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">906</span><span class="NLM_x">–</span> <span class="NLM_lpage">911</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=906-911&author=A.+Gupta+Rajnishauthor=V.+Tejada+Lovellaauthor=J.+Tong+Beverlyauthor=K.+Das+Sanjoyauthor=D.+Morrow+Jasonauthor=K.+Dey+Sudhansuauthor=N.+DuBois+Raymond&title=Cyclooxygenase-1+is+overexpressed+and+promotes+angiogenic+growth+factor+production+in+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%2BRajnish%26aufirst%3DA.%26aulast%3DTejada%2BLovella%26aufirst%3DV.%26aulast%3DTong%2BBeverly%26aufirst%3DJ.%26aulast%3DDas%2BSanjoy%26aufirst%3DK.%26aulast%3DMorrow%2BJason%26aufirst%3DD.%26aulast%3DDey%2BSudhansu%26aufirst%3DK.%26aulast%3DDuBois%2BRaymond%26aufirst%3DN.%26atitle%3DCyclooxygenase-1%2520is%2520overexpressed%2520and%2520promotes%2520angiogenic%2520growth%2520factor%2520production%2520in%2520ovarian%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D906%26epage%3D911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Kakuta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohsawa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tai, A.</span><span> </span><span class="NLM_article-title">Identification of urine metabolites of TFAP, a cyclooxygenase-1 inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1840</span><span class="NLM_x">–</span> <span class="NLM_lpage">1843</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1840-1843&author=H.+Kakutaauthor=R.+Fukaiauthor=X.+Zhengauthor=F.+Ohsawaauthor=T.+Bambaauthor=K.+Hirataauthor=A.+Tai&title=Identification+of+urine+metabolites+of+TFAP%2C+a+cyclooxygenase-1+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKakuta%26aufirst%3DH.%26aulast%3DFukai%26aufirst%3DR.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DOhsawa%26aufirst%3DF.%26aulast%3DBamba%26aufirst%3DT.%26aulast%3DHirata%26aufirst%3DK.%26aulast%3DTai%26aufirst%3DA.%26atitle%3DIdentification%2520of%2520urine%2520metabolites%2520of%2520TFAP%252C%2520a%2520cyclooxygenase-1%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1840%26epage%3D1843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Bhattacharyya, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecomte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgans, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. L.</span><span> </span><span class="NLM_article-title">Selective inhibition of prostaglandin endoperoxide synthase-1 (cyclooxygenase-1) by valerylsalicylic acid</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=1995&pages=19-24&author=D.+K.+Bhattacharyyaauthor=M.+Lecomteauthor=J.+Dunnauthor=D.+J.+Morgansauthor=W.+L.+Smith&title=Selective+inhibition+of+prostaglandin+endoperoxide+synthase-1+%28cyclooxygenase-1%29+by+valerylsalicylic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharyya%26aufirst%3DD.%2BK.%26aulast%3DLecomte%26aufirst%3DM.%26aulast%3DDunn%26aufirst%3DJ.%26aulast%3DMorgans%26aufirst%3DD.%2BJ.%26aulast%3DSmith%26aufirst%3DW.%2BL.%26atitle%3DSelective%2520inhibition%2520of%2520prostaglandin%2520endoperoxide%2520synthase-1%2520%2528cyclooxygenase-1%2529%2520by%2520valerylsalicylic%2520acid%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1995%26volume%3D317%26spage%3D19%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Siqueira-Junior, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Brum-Fernandes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribeiro-do-Valle, R. M.</span><span> </span><span class="NLM_article-title">Effects of valeryl salicylate, a COX-1 inhibitor, on models of acute inflammation in mice</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">443</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1016%2FS1043-6618%2803%2900188-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=12967587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntVGksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2003&pages=437-443&author=J.+M.+Siqueira-Juniorauthor=R.+R.+Petersauthor=A.+J.+de+Brum-Fernandesauthor=R.+M.+Ribeiro-do-Valle&title=Effects+of+valeryl+salicylate%2C+a+COX-1+inhibitor%2C+on+models+of+acute+inflammation+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of valeryl salicylate, a COX-1 inhibitor, on models of acute inflammation in mice</span></div><div class="casAuthors">Siqueira-Junior, Jarbas M.; Peters, Rodrigo R.; de Brum-Fernandes, Artur J.; Ribeiro-do-Valle, Rosa M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">437-443</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The effect of valeryl salicylate (VS), an inhibitor of cyclooxygenase-1 (COX-1), was evaluated in arachidonic acid or croton oil-induced ear edema and carrageenan-induced paw edema in mice.  Ear edema was induced by topical administration of arachidonic acid (2 mg per ear; 20 μl) or croton oil (1 mg per ear; 20 μl) to the inner surface of the left ear and the change in the ear's thickness was measured with a precision micrometer (Fisher, USA).  VS significantly inhibited the arachidonic acid ear edema after l h at doses of 1.5-45 μg per ear; however, only at the dose of 45 μg per ear was it able to significantly reduce the croton oil-induced edema at 6 h.  Paw edema was induced by the injection of 25 μl of 1% carrageenan into the plantar aponeurosis of the right hind paw.  The edema was evaluated at 0.5, 1, 2, 4, 24, 48 and 72 h.  Previously in our expts., we obsd. two peaks in paw edema formation: one at 2 h, in the early phase (0-4 h), and the other, occurring at 48 h after carrageenan injection, in the late phase (24-72 h).  The pre-treatment with VS significantly reduced the paw edema at 2 h, the same effect obsd. with celecoxib and indomethacin treatments.  At 24 h, VS did not inhibit edema but significantly increased it mainly at 48 h after carrageenan injection.  These results showed that VS was pharmacol. active in these models and suggest that COX-1 may participate in the early and late phases of inflammation in the models studied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1nEJ03b8y5rVg90H21EOLACvtfcHk0lg_n0besBxiFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntVGksL8%253D&md5=bfc5d0957f63200d5b4ccfaa45768140</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS1043-6618%2803%2900188-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1043-6618%252803%252900188-9%26sid%3Dliteratum%253Aachs%26aulast%3DSiqueira-Junior%26aufirst%3DJ.%2BM.%26aulast%3DPeters%26aufirst%3DR.%2BR.%26aulast%3Dde%2BBrum-Fernandes%26aufirst%3DA.%2BJ.%26aulast%3DRibeiro-do-Valle%26aufirst%3DR.%2BM.%26atitle%3DEffects%2520of%2520valeryl%2520salicylate%252C%2520a%2520COX-1%2520inhibitor%252C%2520on%2520models%2520of%2520acute%2520inflammation%2520in%2520mice%26jtitle%3DPharmacol.%2520Res.%26date%3D2003%26volume%3D48%26spage%3D437%26epage%3D443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Labayle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vielh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drouhin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pariente, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bories, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duhamel, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trousset, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attali, P.</span><span> </span><span class="NLM_article-title">Sulindac causes regression of rectal polyps in familial adenomatous polyposis</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">635</span><span class="NLM_x">–</span> <span class="NLM_lpage">639</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=1991&pages=635-639&author=D.+Labayleauthor=D.+Fischerauthor=P.+Vielhauthor=F.+Drouhinauthor=A.+Parienteauthor=C.+Boriesauthor=O.+Duhamelauthor=M.+Troussetauthor=P.+Attali&title=Sulindac+causes+regression+of+rectal+polyps+in+familial+adenomatous+polyposis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLabayle%26aufirst%3DD.%26aulast%3DFischer%26aufirst%3DD.%26aulast%3DVielh%26aufirst%3DP.%26aulast%3DDrouhin%26aufirst%3DF.%26aulast%3DPariente%26aufirst%3DA.%26aulast%3DBories%26aufirst%3DC.%26aulast%3DDuhamel%26aufirst%3DO.%26aulast%3DTrousset%26aufirst%3DM.%26aulast%3DAttali%26aufirst%3DP.%26atitle%3DSulindac%2520causes%2520regression%2520of%2520rectal%2520polyps%2520in%2520familial%2520adenomatous%2520polyposis%26jtitle%3DGastroenterology%26date%3D1991%26volume%3D101%26spage%3D635%26epage%3D639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Narisawa, T.</span><span> </span><span class="NLM_article-title">An overview on chemoprevention of colorectal cancer</span> <span class="citation_source-journal">Nihon Geka Gakkai zasshi</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">362</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1998&pages=362-367&author=T.+Narisawa&title=An+overview+on+chemoprevention+of+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNarisawa%26aufirst%3DT.%26atitle%3DAn%2520overview%2520on%2520chemoprevention%2520of%2520colorectal%2520cancer%26jtitle%3DNihon%2520Geka%2520Gakkai%2520zasshi%26date%3D1998%26volume%3D99%26spage%3D362%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Kashfi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigas, B.</span><span> </span><span class="NLM_article-title">Non-COX-2 targets and cancer: Expanding the molecular target repertoire of chemoprevention</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">969</span><span class="NLM_x">–</span> <span class="NLM_lpage">986</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=969-986&author=K.+Kashfiauthor=B.+Rigas&title=Non-COX-2+targets+and+cancer%3A+Expanding+the+molecular+target+repertoire+of+chemoprevention"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKashfi%26aufirst%3DK.%26aulast%3DRigas%26aufirst%3DB.%26atitle%3DNon-COX-2%2520targets%2520and%2520cancer%253A%2520Expanding%2520the%2520molecular%2520target%2520repertoire%2520of%2520chemoprevention%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2005%26volume%3D70%26spage%3D969%26epage%3D986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Piazza, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keeton, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tinsley, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gary, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitt, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathew, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thaiparambil, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coward, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sani, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobrath, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxuitenko, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, R. C.</span><span> </span><span class="NLM_article-title">A novel sulindac derivative that does not inhibit cyclooxygenases but potently inhibits colon tumor cell growth and induces apoptosis with antitumor activity</span> <span class="citation_source-journal">Cancer Prev. Res. (Philadelphia, PA, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">572</span><span class="NLM_x">–</span> <span class="NLM_lpage">580</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1158%2F1940-6207.CAPR-09-0001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=19470791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptVWjsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=572-580&author=G.+A.+Piazzaauthor=A.+B.+Keetonauthor=H.+N.+Tinsleyauthor=B.+D.+Garyauthor=J.+D.+Whittauthor=B.+Mathewauthor=J.+Thaiparambilauthor=L.+Cowardauthor=G.+Gormanauthor=Y.+Liauthor=B.+Saniauthor=J.+V.+Hobrathauthor=Y.+Y.+Maxuitenkoauthor=R.+C.+Reynolds&title=A+novel+sulindac+derivative+that+does+not+inhibit+cyclooxygenases+but+potently+inhibits+colon+tumor+cell+growth+and+induces+apoptosis+with+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">A novel sulindac derivative that does not inhibit cyclooxygenases but potently inhibits colon tumor cell growth and induces apoptosis with antitumor activity</span></div><div class="casAuthors">Piazza, Gary A.; Keeton, Adam B.; Tinsley, Heather N.; Gary, Bernard D.; Whitt, Jason D.; Mathew, Bini; Thaiparambil, Jose; Coward, Lori; Gorman, Gregory; Li, Yonghe; Sani, Brahma; Hobrath, Judith V.; Maxuitenko, Yulia Y.; Reynolds, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Prevention Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">572-580</span>CODEN:
                <span class="NLM_cas:coden">CPRACC</span>;
        ISSN:<span class="NLM_cas:issn">1940-6207</span>.
    
            (<span class="NLM_cas:orgname">American Association of Cancer Research</span>)
        </div><div class="casAbstract">Nonsteroidal anti-inflammatory drugs such as sulindac have shown promising antineoplastic activity, although toxicity from cyclooxygenase (COX) inhibition and the suppression of prostaglandin synthesis limits their use for chemoprevention.  Previous studies have concluded that the mechanism responsible for their antineoplastic activity may be COX independent.  To selectively design out the COX inhibitory activity of sulindac sulfide (SS), in silico modeling studies were done that revealed the crucial role of the carboxylate moiety for COX-1 and COX-2 binding.  These studies prompted the synthesis of a series of SS derivs. with carboxylate modifications that were screened for tumor cell growth and COX inhibitory activity.  A SS amide (SSA) with a N,N-dimethylethyl amine substitution was found to lack COX-1 and COX-2 inhibitory activity, yet potently inhibit the growth of human colon tumor cell lines, HT-29, SW480, and HCT116 with IC50 values of 2 to 5 μmol/L compared with 73 to 85 μmol/L for SS.  The mechanism of growth inhibition involved the suppression of DNA synthesis and apoptosis induction.  Oral administration of SSA was well-tolerated in mice and generated plasma levels that exceeded its in vitro IC50 for tumor growth inhibition.  In the human HT-29 colon tumor xenograft mouse model, SSA significantly inhibited tumor growth at a dosage of 250 mg/kg.  Combined treatment of SSA with the chemotherapeutic drug, Camptosar, caused a more sustained suppression of tumor growth compared with Camptosar treatment alone.  These results indicate that SSA has potential safety and efficacy advantages for colon cancer chemoprevention as well as utility for treating malignant disease if combined with chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcB2grJ6b-lLVg90H21EOLACvtfcHk0lh3qWVUcQHQGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptVWjsro%253D&md5=00ad59b89c15afea3e005b5994654164</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1158%2F1940-6207.CAPR-09-0001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1940-6207.CAPR-09-0001%26sid%3Dliteratum%253Aachs%26aulast%3DPiazza%26aufirst%3DG.%2BA.%26aulast%3DKeeton%26aufirst%3DA.%2BB.%26aulast%3DTinsley%26aufirst%3DH.%2BN.%26aulast%3DGary%26aufirst%3DB.%2BD.%26aulast%3DWhitt%26aufirst%3DJ.%2BD.%26aulast%3DMathew%26aufirst%3DB.%26aulast%3DThaiparambil%26aufirst%3DJ.%26aulast%3DCoward%26aufirst%3DL.%26aulast%3DGorman%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DSani%26aufirst%3DB.%26aulast%3DHobrath%26aufirst%3DJ.%2BV.%26aulast%3DMaxuitenko%26aufirst%3DY.%2BY.%26aulast%3DReynolds%26aufirst%3DR.%2BC.%26atitle%3DA%2520novel%2520sulindac%2520derivative%2520that%2520does%2520not%2520inhibit%2520cyclooxygenases%2520but%2520potently%2520inhibits%2520colon%2520tumor%2520cell%2520growth%2520and%2520induces%2520apoptosis%2520with%2520antitumor%2520activity%26jtitle%3DCancer%2520Prev.%2520Res.%2520%2528Philadelphia%252C%2520PA%252C%2520U.%2520S.%2529%26date%3D2009%26volume%3D2%26spage%3D572%26epage%3D580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Piazza, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keeton, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tinsley, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitt, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gary, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathew, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grizzle, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, R. C.</span><span> </span><span class="NLM_article-title">NSAIDs: Old drugs reveal new anticancer targets</span> <span class="citation_source-journal">Pharmaceuticals</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1652</span><span class="NLM_x">–</span> <span class="NLM_lpage">1667</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.3390%2Fph3051652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=27713322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvFelsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=1652-1667&author=G.+A.+Piazzaauthor=A.+B.+Keetonauthor=H.+N.+Tinsleyauthor=J.+D.+Whittauthor=B.+D.+Garyauthor=B.+Mathewauthor=R.+Singhauthor=W.+E.+Grizzleauthor=R.+C.+Reynolds&title=NSAIDs%3A+Old+drugs+reveal+new+anticancer+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">NSAIDs: old drugs reveal new anticancer targets</span></div><div class="casAuthors">Piazza, Gary A.; Keeton, Adam B.; Tinsley, Heather N.; Whitt, Jason D.; Gary, Bernard D.; Mathew, Bini; Singh, Raj; Grizzle, William E.; Reynolds, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceuticals</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1652-1667</span>CODEN:
                <span class="NLM_cas:coden">PHARH2</span>;
        ISSN:<span class="NLM_cas:issn">1424-8247</span>.
    
            (<span class="NLM_cas:orgname">Molecular Diversity Preservation International</span>)
        </div><div class="casAbstract">A review.  There is compelling evidence that nonsteroidal anti-inflammatory drugs (NSAIDs) and cyclooxygenase-2 selective inhibitors have antineoplastic activity, but toxicity from cyclooxygenase (COX) inhibition and the suppression of physiol. important prostaglandins limits their use for cancer chemoprevention.  Previous studies as reviewed here suggest that the mechanism for their anticancer properties does not require COX inhibition, but instead involves an off-target effect.  In support of this possibility, recent mol. modeling studies have shown that the NSAID sulindac can be chem. modified to selectively design out its COX-1 and COX-2 inhibitory activity.  Unexpectedly, certain derivs. that were synthesized based on in silico modeling displayed increased potency to inhibit tumor cell growth.  Other expts. have shown that sulindac can inhibit phosphodiesterase to increase intracellular cyclic GMP levels and that this activity is closely assocd. with its ability to selectively induce apoptosis of tumor cells.  Together, these studies suggest that COX-independent mechanisms can be targeted to develop safer and more efficacious drugs for cancer chemoprevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxtF1M2g78b7Vg90H21EOLACvtfcHk0lh3qWVUcQHQGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvFelsLo%253D&md5=1a70d862216322503c407bcda895af54</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.3390%2Fph3051652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph3051652%26sid%3Dliteratum%253Aachs%26aulast%3DPiazza%26aufirst%3DG.%2BA.%26aulast%3DKeeton%26aufirst%3DA.%2BB.%26aulast%3DTinsley%26aufirst%3DH.%2BN.%26aulast%3DWhitt%26aufirst%3DJ.%2BD.%26aulast%3DGary%26aufirst%3DB.%2BD.%26aulast%3DMathew%26aufirst%3DB.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DGrizzle%26aufirst%3DW.%2BE.%26aulast%3DReynolds%26aufirst%3DR.%2BC.%26atitle%3DNSAIDs%253A%2520Old%2520drugs%2520reveal%2520new%2520anticancer%2520targets%26jtitle%3DPharmaceuticals%26date%3D2010%26volume%3D3%26spage%3D1652%26epage%3D1667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kingsley, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eling, T. E.</span><span> </span><span class="NLM_article-title">The role of NAG-1/GDF15 in the inhibition of intestinal polyps in APC/Min mice by sulindac</span> <span class="citation_source-journal">Cancer Prev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1158%2F1940-6207.CAPR-10-0196" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=21205743" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvVyqu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=150-160&author=X.+Wangauthor=P.+J.+Kingsleyauthor=L.+J.+Marnettauthor=T.+E.+Eling&title=The+role+of+NAG-1%2FGDF15+in+the+inhibition+of+intestinal+polyps+in+APC%2FMin+mice+by+sulindac"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The role of NAG-1/GDF15 in the inhibition of intestinal polyps in APC/Min mice by sulindac</span></div><div class="casAuthors">Wang, Xingya; Kingsley, Philip J.; Marnett, Larry J.; Eling, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Prevention Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">150-160</span>CODEN:
                <span class="NLM_cas:coden">CPRACC</span>;
        ISSN:<span class="NLM_cas:issn">1940-6207</span>.
    
            (<span class="NLM_cas:orgname">American Association of Cancer Research</span>)
        </div><div class="casAbstract">The antitumor effects of nonsteroidal anti-inflammatory drugs (NSAID) are assumed to be due to the inhibition of COX activity, but COX-independent mechanisms may also play an important role.  NSAID-activated gene (NAG-1/GDF15) is induced by NSAIDs and has antitumorigenic activities.  To det. the contribution of COX-2 inhibition and NAG-1/GDF15 expression to the prevention of colon carcinogenesis by NSAIDs, we evaluated several sulindac derivs. [des-Me (DM)-sulindac sulfide and its prodrug DM-sulindac] that do not inhibit COX-2 activity.  Sulindac sulfide and DM-sulindac induced the expression of NAG-1/GDF15 in HCT116 cells as detd. by quant. real-time PCR and Western blot.  We fed APC/Min mice with 320 ppm of sulindac and doses of DM-sulindac.  Only sulindac significantly inhibited tumor formation in APC/Min mice.  To det. the pharmacokinetic properties of sulindac and DM-sulindac in vivo, wild-type C57/B6 mice were fed with sulindac and DM-sulindac at 80, 160, and 320 ppm.  High-performance liq. chromatog. anal. revealed that the conversion of DM-sulindac to DM-sulindac sulfide (active form) was less efficient than the conversion of sulindac to sulindac sulfide (active form) in the mice.  Lower levels of DM-sulindac sulfide accumulated in intestinal and colon tissues in comparison with sulindac sulfide.  In addn., NAG-1/GDF15 was induced in the liver of sulindac-fed mice but not in the DM-sulindac-fed mice.  Collectively, our results suggest that the tumor-inhibitory effects of sulindac in APC/Min mice may be due to, in part, NAG-1/GDF15 induction in the liver.  Our study also suggests that pharmacol. properties should be carefully evaluated when developing drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc3g61w2WVP7Vg90H21EOLACvtfcHk0lhKUdJS4OzXYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvVyqu70%253D&md5=c37c6fdd5b85adeec9fa1fbbfee239fc</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1158%2F1940-6207.CAPR-10-0196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1940-6207.CAPR-10-0196%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DKingsley%26aufirst%3DP.%2BJ.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26aulast%3DEling%26aufirst%3DT.%2BE.%26atitle%3DThe%2520role%2520of%2520NAG-1%252FGDF15%2520in%2520the%2520inhibition%2520of%2520intestinal%2520polyps%2520in%2520APC%252FMin%2520mice%2520by%2520sulindac%26jtitle%3DCancer%2520Prev.%2520Res.%26date%3D2011%26volume%3D4%26spage%3D150%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Steinbrink, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pergola, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buehring, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metzner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haefner, A.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisniewska, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geisslinger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinhilber, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, T. J.</span><span> </span><span class="NLM_article-title">Sulindac sulfide suppresses 5-lipoxygenase at clinically relevant concentrations</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">797</span><span class="NLM_x">–</span> <span class="NLM_lpage">806</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1007%2Fs00018-009-0206-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=20091083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFCktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2010&pages=797-806&author=S.+D.+Steinbrinkauthor=C.+Pergolaauthor=U.+Buehringauthor=S.+Georgeauthor=J.+Metznerauthor=A.+S.+Fischerauthor=A.-K.+Haefnerauthor=J.+M.+Wisniewskaauthor=G.+Geisslingerauthor=O.+Werzauthor=D.+Steinhilberauthor=T.+J.+Maier&title=Sulindac+sulfide+suppresses+5-lipoxygenase+at+clinically+relevant+concentrations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Sulindac sulfide suppresses 5-lipoxygenase at clinically relevant concentrations</span></div><div class="casAuthors">Steinbrink, Svenja D.; Pergola, Carlo; Buehring, Ulrike; George, Sven; Metzner, Julia; Fischer, Astrid S.; Haefner, Ann-Kathrin; Wisniewska, Joanna M.; Geisslinger, Gerd; Werz, Oliver; Steinhilber, Dieter; Maier, Thorsten J.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">797-806</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">Sulindac is a non-selective inhibitor of cyclooxygenases (COX) used to treat inflammation and pain.  Addnl., non-COX targets may account for the drug's chemo-preventive efficacy against colorectal cancer and reduced gastrointestinal toxicity.  Here, we demonstrate that the pharmacol. active metabolite of sulindac, sulindac sulfide (SSi), targets 5-lipoxygenase (5-LO), the key enzyme in the biosynthesis of proinflammatory leukotrienes (LTs).  SSi inhibited 5-LO in ionophore A23187- and LPS/fMLP-stimulated human polymorphonuclear leukocytes (IC50 ≈ 8-10 μM).  Importantly, SSi efficiently suppressed 5-LO in human whole blood at clin. relevant plasma levels (IC50 = 18.7 μM).  SSi was 5-LO-selective as no inhibition of related lipoxygenases (12-LO, 15-LO) was obsd.  The sulindac prodrug and the other metabolite, sulindac sulfone (SSo), failed to inhibit 5-LO.  Mechanistic anal. demonstrated that SSi directly suppresses 5-LO with an IC50 of 20 μM.  Together, these findings may provide a novel mol. basis to explain the COX-independent pharmacol. effects of sulindac under therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_1rbhAeAUS7Vg90H21EOLACvtfcHk0lhKUdJS4OzXYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFCktrg%253D&md5=0e96cb8e0836592b6539818ed45836fb</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1007%2Fs00018-009-0206-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-009-0206-0%26sid%3Dliteratum%253Aachs%26aulast%3DSteinbrink%26aufirst%3DS.%2BD.%26aulast%3DPergola%26aufirst%3DC.%26aulast%3DBuehring%26aufirst%3DU.%26aulast%3DGeorge%26aufirst%3DS.%26aulast%3DMetzner%26aufirst%3DJ.%26aulast%3DFischer%26aufirst%3DA.%2BS.%26aulast%3DHaefner%26aufirst%3DA.-K.%26aulast%3DWisniewska%26aufirst%3DJ.%2BM.%26aulast%3DGeisslinger%26aufirst%3DG.%26aulast%3DWerz%26aufirst%3DO.%26aulast%3DSteinhilber%26aufirst%3DD.%26aulast%3DMaier%26aufirst%3DT.%2BJ.%26atitle%3DSulindac%2520sulfide%2520suppresses%25205-lipoxygenase%2520at%2520clinically%2520relevant%2520concentrations%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2010%26volume%3D67%26spage%3D797%26epage%3D806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Etienne, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resnick, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brot, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissbach, H.</span><span> </span><span class="NLM_article-title">Reduction of Sulindac to its active metabolite, sulindac sulfide: Assay and role of the methionine sulfoxide reductase system</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">312</span><span class="NLM_x">, </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1010</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=2003&pages=1005-1010&author=F.+Etienneauthor=L.+Resnickauthor=D.+Sagherauthor=N.+Brotauthor=H.+Weissbach&title=Reduction+of+Sulindac+to+its+active+metabolite%2C+sulindac+sulfide%3A+Assay+and+role+of+the+methionine+sulfoxide+reductase+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEtienne%26aufirst%3DF.%26aulast%3DResnick%26aufirst%3DL.%26aulast%3DSagher%26aufirst%3DD.%26aulast%3DBrot%26aufirst%3DN.%26aulast%3DWeissbach%26aufirst%3DH.%26atitle%3DReduction%2520of%2520Sulindac%2520to%2520its%2520active%2520metabolite%252C%2520sulindac%2520sulfide%253A%2520Assay%2520and%2520role%2520of%2520the%2520methionine%2520sulfoxide%2520reductase%2520system%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D312%26spage%3D1005%26epage%3D1010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Walters, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blobaum, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kingsley, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felts, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulikowski, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span> </span><span class="NLM_article-title">The influence of double bond geometry in the inhibition of cyclooxygenases by sulindac derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3271</span><span class="NLM_x">–</span> <span class="NLM_lpage">3274</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1016%2Fj.bmcl.2009.04.078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=19427206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1eksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3271-3274&author=M.+J.+Waltersauthor=A.+L.+Blobaumauthor=P.+J.+Kingsleyauthor=A.+S.+Feltsauthor=G.+A.+Sulikowskiauthor=L.+J.+Marnett&title=The+influence+of+double+bond+geometry+in+the+inhibition+of+cyclooxygenases+by+sulindac+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of double bond geometry in the inhibition of cyclooxygenases by sulindac derivatives</span></div><div class="casAuthors">Walters, Matthew J.; Blobaum, Anna L.; Kingsley, Philip J.; Felts, Andrew S.; Sulikowski, Gary A.; Marnett, Lawrence J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3271-3274</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sulindac sulfide is a benzylidene-indene that is a potent, time-dependent inhibitor of cyclooxygenases-1 and -2.  Removal of the 2'-Me group from the indene ring dramatically reduces time-dependent inhibition of both enzymes but also changes the geometry of the benzylidene double bond from Z to E.  Herein, we explore the importance of double bond geometry on cyclooxygenase inhibition.  The Z-isomer of 2'-des-Me sulindac sulfide was synthesized by redn. of a bromoindene precursor or by photoisomerization of the E-isomer.  The Z-isomer inhibited both cyclooxygenases, but with diminished potency compared to sulindac sulfide.  Thus, although the 2'-Me group is a major determinant of time-dependent cyclooxygenase inhibition, the geometry of the benzylidene double bond plays a role as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp80eAOq5v4t7Vg90H21EOLACvtfcHk0lgTpu_GQFMf8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1eksbo%253D&md5=acafed9a0f333240af3d5026a7a2f44d</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.04.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.04.078%26sid%3Dliteratum%253Aachs%26aulast%3DWalters%26aufirst%3DM.%2BJ.%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DKingsley%26aufirst%3DP.%2BJ.%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DSulikowski%26aufirst%3DG.%2BA.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26atitle%3DThe%2520influence%2520of%2520double%2520bond%2520geometry%2520in%2520the%2520inhibition%2520of%2520cyclooxygenases%2520by%2520sulindac%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3271%26epage%3D3274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Prusakiewicz, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felts, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackenzie, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span> </span><span class="NLM_article-title">Molecular Basis of the Time-Dependent Inhibition of Cyclooxygenases by Indomethacin</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">15439</span><span class="NLM_x">–</span> <span class="NLM_lpage">15445</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi048534q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpslylu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=15439-15445&author=J.+J.+Prusakiewiczauthor=A.+S.+Feltsauthor=B.+S.+Mackenzieauthor=L.+J.+Marnett&title=Molecular+Basis+of+the+Time-Dependent+Inhibition+of+Cyclooxygenases+by+Indomethacin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Basis of the Time-Dependent Inhibition of Cyclooxygenases by Indomethacin</span></div><div class="casAuthors">Prusakiewicz, Jeffery J.; Felts, Andrew S.; Mackenzie, Bonnie S.; Marnett, Lawrence J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">15439-15445</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclooxygenases (COXs) are the therapeutic targets of nonsteroidal antiinflammatory drugs.  Indomethacin (INDO) was one of the first nonsteroidal antiinflammatory drugs to be characterized as a time-dependent, functionally irreversible inhibitor, but the mol. basis of this phenomenon is uncertain.  In the crystal structure of INDO bound to COX-2, a small hydrophobic pocket was identified that surrounds the 2'-Me group of INDO.  The pocket is formed by the residues Ala-527, Val-349, Ser-530, and Leu-531.  The contribution of this pocket to inhibition was evaluated by altering its vol. by mutagenesis of Val-349.  The V349A mutation expanded the pocket and increased the potency of INDO, whereas the V349L mutation reduced the size of the pocket and decreased the potency of INDO.  Particularly striking was the reversibility of INDO inhibition of the V349L mutant.  The 2'-des-Me analog of INDO (DM-INDO) was synthesized and tested against wild-type COX-1 and COX-2, as well as the Val-349 mutants.  DM-INDO bound to all enzymes tested, but only inhibited wt mCOX-2 and the V349I enzyme.  Without the 2'-Me group anchoring DM-INDO in the active site, the compd. was readily competed off of the enzyme by arachidonic acid.  The kinetics of inhibition were comparable to the kinetics of binding as evaluated by fluorescence quenching.  These results highlight binding of the 2'-Me of INDO in the hydrophobic pocket as an important determinant of its time-dependent inhibition of COX enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs4oP-iuyS2rVg90H21EOLACvtfcHk0lhNGaYP9pMbDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpslylu7c%253D&md5=deab66bc03cd196ff48be40deaf53be8</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fbi048534q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi048534q%26sid%3Dliteratum%253Aachs%26aulast%3DPrusakiewicz%26aufirst%3DJ.%2BJ.%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DMackenzie%26aufirst%3DB.%2BS.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26atitle%3DMolecular%2520Basis%2520of%2520the%2520Time-Dependent%2520Inhibition%2520of%2520Cyclooxygenases%2520by%2520Indomethacin%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D15439%26epage%3D15445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Alcalde, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesquida, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigola, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Perez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merce, R.</span><span> </span><span class="NLM_article-title">Indene-based scaffolds. Design and synthesis of novel serotonin 5-HT6 receptor ligands</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">3795</span><span class="NLM_x">–</span> <span class="NLM_lpage">3810</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1039%2Fb808641a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=18843410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1WkurzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=3795-3810&author=E.+Alcaldeauthor=N.+Mesquidaauthor=J.+Frigolaauthor=S.+Lopez-Perezauthor=R.+Merce&title=Indene-based+scaffolds.+Design+and+synthesis+of+novel+serotonin+5-HT6+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Indene-based scaffolds. Design and synthesis of novel serotonin 5-HT6 receptor ligands</span></div><div class="casAuthors">Alcalde, Ermitas; Mesquida, Neus; Frigola, Jordi; Lopez-Perez, Sara; Merce, Ramon</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3795-3810</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A series of novel indene derivs. designed by a scaffold selection gave access to several examples of (Z)-arylmethylideneindenes and indenylsulfonamides that acted as serotonin 5-HT6 receptor ligands.  Different synthetic multistep routes could be applied to these target compds., each with their own complexity and limitations.  A reasonable route involved the (3-indenyl)acetic acids as the key intermediates, and two alternatives were also examd.  The first protocol used was a two-step sequence employing a modified Horner-Wadsworth-Emmons reaction, but better results were obtained with a procedure based on the condensation of indanones with the lithium salt of Et acetate, followed immediately by dehydration with acid and hydrolysis/isomerization under basic catalysis.  (3-Indenyl)acetic acids were transformed to their amides, which were effectively reduced to indenylsulfonamides using an optimized procedure with AlH3-NMe2Et.  The binding at the 5-HT6 receptor was with moderate affinity (Ki = 216.5 nM) for the (Z)-benzylideneindenylsulfonamide I [X = CHPh] and enhanced affinity for the simple indenylsulfonamide counterpart I [X = H2] (Ki = 50.6 nM).  Selected indenylsulfonamides were then tested, showing Ki values as low as 20.2 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs8GKoWzV8dbVg90H21EOLACvtfcHk0lhNGaYP9pMbDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1WkurzF&md5=55ade62b271fd31d89780817bf884178</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1039%2Fb808641a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb808641a%26sid%3Dliteratum%253Aachs%26aulast%3DAlcalde%26aufirst%3DE.%26aulast%3DMesquida%26aufirst%3DN.%26aulast%3DFrigola%26aufirst%3DJ.%26aulast%3DLopez-Perez%26aufirst%3DS.%26aulast%3DMerce%26aufirst%3DR.%26atitle%3DIndene-based%2520scaffolds.%2520Design%2520and%2520synthesis%2520of%2520novel%2520serotonin%25205-HT6%2520receptor%2520ligands%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2008%26volume%3D6%26spage%3D3795%26epage%3D3810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Felts, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moth, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lybrand, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannenberg, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subbaramaiah, K.</span><span> </span><span class="NLM_article-title">Sulindac Derivatives That Activate the Peroxisome Proliferator-activated Receptor gamma but Lack Cyclooxygenase Inhibition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4911</span><span class="NLM_x">–</span> <span class="NLM_lpage">4919</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm700969c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4911-4919&author=A.+S.+Feltsauthor=B.+S.+Siegelauthor=S.+M.+Youngauthor=C.+W.+Mothauthor=T.+P.+Lybrandauthor=A.+J.+Dannenbergauthor=L.+J.+Marnettauthor=K.+Subbaramaiah&title=Sulindac+Derivatives+That+Activate+the+Peroxisome+Proliferator-activated+Receptor+gamma+but+Lack+Cyclooxygenase+Inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm700969c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm700969c%26sid%3Dliteratum%253Aachs%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DSiegel%26aufirst%3DB.%2BS.%26aulast%3DYoung%26aufirst%3DS.%2BM.%26aulast%3DMoth%26aufirst%3DC.%2BW.%26aulast%3DLybrand%26aufirst%3DT.%2BP.%26aulast%3DDannenberg%26aufirst%3DA.%2BJ.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26aulast%3DSubbaramaiah%26aufirst%3DK.%26atitle%3DSulindac%2520Derivatives%2520That%2520Activate%2520the%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520gamma%2520but%2520Lack%2520Cyclooxygenase%2520Inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4911%26epage%3D4919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Musser, J. H.; Kreft, A. F.,  III; Failli, A. A.; Demerson, C. A.; Shah, U. S.; Nelson, J. A.</span><span> </span><span class="NLM_article-title">Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazolealkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase</span>. 93-29199 5420289, 19930310,<span class="NLM_x"> </span><span class="NLM_year">1995</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&author=J.+H.+Musser&author=A.+F.+Kreft&author=A.+A.+Failli&author=C.+A.+Demerson&author=U.+S.+Shah&author=J.+A.+Nelson&title=Substituted+indole-%2C+indene-%2C+pyranoindole-+and+tetrahydrocarbazolealkanoic+acid+derivatives+as+inhibitors+of+PLA2+and+lipoxygenase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DMusser%26aufirst%3DJ.%2BH.%26atitle%3DSubstituted%2520indole-%252C%2520indene-%252C%2520pyranoindole-%2520and%2520tetrahydrocarbazolealkanoic%2520acid%2520derivatives%2520as%2520inhibitors%2520of%2520PLA2%2520and%2520lipoxygenase%26date%3D1995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Musso, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochran, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selph, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigdon, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orr, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Styles, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, W. R.</span><span> </span><span class="NLM_article-title">Indanylidenes. 1. Design and Synthesis of (E)-2-(4,6-Difluoro-1-indanylidene)acetamide, a Potent, Centrally Acting Muscle Relaxant with Antiinflammatory and Analgesic Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020067s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=399-408&author=D.+L.+Mussoauthor=F.+R.+Cochranauthor=J.+L.+Kelleyauthor=E.+W.+McLeanauthor=J.+L.+Selphauthor=G.+C.+Rigdonauthor=G.+F.+Orrauthor=R.+G.+Davisauthor=B.+R.+Cooperauthor=V.+L.+Stylesauthor=J.+B.+Thompsonauthor=W.+R.+Hall&title=Indanylidenes.+1.+Design+and+Synthesis+of+%28E%29-2-%284%2C6-Difluoro-1-indanylidene%29acetamide%2C+a+Potent%2C+Centrally+Acting+Muscle+Relaxant+with+Antiinflammatory+and+Analgesic+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm020067s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020067s%26sid%3Dliteratum%253Aachs%26aulast%3DMusso%26aufirst%3DD.%2BL.%26aulast%3DCochran%26aufirst%3DF.%2BR.%26aulast%3DKelley%26aufirst%3DJ.%2BL.%26aulast%3DMcLean%26aufirst%3DE.%2BW.%26aulast%3DSelph%26aufirst%3DJ.%2BL.%26aulast%3DRigdon%26aufirst%3DG.%2BC.%26aulast%3DOrr%26aufirst%3DG.%2BF.%26aulast%3DDavis%26aufirst%3DR.%2BG.%26aulast%3DCooper%26aufirst%3DB.%2BR.%26aulast%3DStyles%26aufirst%3DV.%2BL.%26aulast%3DThompson%26aufirst%3DJ.%2BB.%26aulast%3DHall%26aufirst%3DW.%2BR.%26atitle%3DIndanylidenes.%25201.%2520Design%2520and%2520Synthesis%2520of%2520%2528E%2529-2-%25284%252C6-Difluoro-1-indanylidene%2529acetamide%252C%2520a%2520Potent%252C%2520Centrally%2520Acting%2520Muscle%2520Relaxant%2520with%2520Antiinflammatory%2520and%2520Analgesic%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D399%26epage%3D408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Romeiro Nelilma, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leite Ramon, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lima Lidia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardozo Suzana, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Miranda Ana, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraga Carlos, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreiro Eliezer, J.</span><span> </span><span class="NLM_article-title">Synthesis, pharmacological evaluation and docking studies of new sulindac analogues</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1959</span><span class="NLM_x">–</span> <span class="NLM_lpage">1971</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=1959-1971&author=C.+Romeiro+Nelilmaauthor=D.+F.+Leite+Ramonauthor=M.+Lima+Lidiaauthor=V.+S.+Cardozo+Suzanaauthor=L.+P.+de+Miranda+Anaauthor=A.+M.+Fraga+Carlosauthor=J.+Barreiro+Eliezer&title=Synthesis%2C+pharmacological+evaluation+and+docking+studies+of+new+sulindac+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRomeiro%2BNelilma%26aufirst%3DC.%26aulast%3DLeite%2BRamon%26aufirst%3DD.%2BF.%26aulast%3DLima%2BLidia%26aufirst%3DM.%26aulast%3DCardozo%2BSuzana%26aufirst%3DV.%2BS.%26aulast%3Dde%2BMiranda%2BAna%26aufirst%3DL.%2BP.%26aulast%3DFraga%2BCarlos%26aufirst%3DA.%2BM.%26aulast%3DBarreiro%2BEliezer%26aufirst%3DJ.%26atitle%3DSynthesis%252C%2520pharmacological%2520evaluation%2520and%2520docking%2520studies%2520of%2520new%2520sulindac%2520analogues%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D1959%26epage%3D1971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Jung, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neupert, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geisslinger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senter, P. D.</span><span> </span><span class="NLM_article-title">Synthesis and activity of fluorinated derivatives of sulindac sulphide and sulindac Sulphone</span> <span class="citation_source-journal">Pharm. Pharmacol. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1211%2F146080800128735926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktVGjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=217-221&author=M.+Jungauthor=A.+F.+Wahlauthor=W.+Neupertauthor=G.+Geisslingerauthor=P.+D.+Senter&title=Synthesis+and+activity+of+fluorinated+derivatives+of+sulindac+sulphide+and+sulindac+Sulphone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and activity of fluorinated derivatives of sulindac sulphide and sulindac sulphone</span></div><div class="casAuthors">Jung, Manfred; Wahl, Alan F.; Neupert, Werner; Geisslinger, Gerd; Senter, Peter D.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacy and Pharmacology Communications</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">217-221</span>CODEN:
                <span class="NLM_cas:coden">PPCOFN</span>;
        ISSN:<span class="NLM_cas:issn">1460-8081</span>.
    
            (<span class="NLM_cas:orgname">Royal Pharmaceutical Society of Great Britain</span>)
        </div><div class="casAbstract">The synthesis of fluorinated derivs. I (R = SCH2F, SO2CH2F) of the sulfide and sulfone metabolites of sulindac I (R = SMe; SO2Me), a non-steroidal anti-inflammatory agent with chemopreventative activity, is reported.  The key step in the synthesis is a Pummerer-rearrangement of the parent sulindac sulfoxide using (diethylamino)sulfur trifluoride as an activating agent and as a source of the fluoride nucleophile to give I (R = SCH2F, SO2CH2F).  Sulindac sulfide is 2.5 times more potent as a COX-1 inhibitor compared with its fluorinated counterpart I (R = SCH2F).  The sulfones were inactive as COX-1 inhibitors, and none of the compds. inhibited COX-2 concns. up to 0.1 mM.  Cytotoxicity assays showed that I (R = SCH2F, SO2CH2F) were as cytotoxic as sulindac sulfide and sulindac sulfone on 3719 colorectal carcinoma cell lines.  Compd. I (R = SO2CH2F) was the most potent compd. on RCA cells with an IC50 of 95 μM (sulindac sulfide 140 μM, sulindac sulfone 175 μM).  Fluorinated sulindac derivs. warrant further investigation since we have shown that cytotoxic activity can be retained or even increased independently from COX-inhibitory properties.  This could help minimize the undesired side-effects assocd. with chronic sulindac administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq88wVgpuci57Vg90H21EOLACvtfcHk0lhBqJZmIORKTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktVGjt7s%253D&md5=d2b81df4d8f908ccea477bece00ce0da</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1211%2F146080800128735926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252F146080800128735926%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DM.%26aulast%3DWahl%26aufirst%3DA.%2BF.%26aulast%3DNeupert%26aufirst%3DW.%26aulast%3DGeisslinger%26aufirst%3DG.%26aulast%3DSenter%26aufirst%3DP.%2BD.%26atitle%3DSynthesis%2520and%2520activity%2520of%2520fluorinated%2520derivatives%2520of%2520sulindac%2520sulphide%2520and%2520sulindac%2520Sulphone%26jtitle%3DPharm.%2520Pharmacol.%2520Commun.%26date%3D2000%26volume%3D6%26spage%3D217%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Felts, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stafford, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kingsley, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouzer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Washington, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subbaramaiah, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannenberg, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span> </span><span class="NLM_article-title">Desmethyl Derivatives of Indomethacin and Sulindac as Probes for Cyclooxygenase-Dependent Biology</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">479</span><span class="NLM_x">–</span> <span class="NLM_lpage">483</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb700077z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=479-483&author=A.+S.+Feltsauthor=C.+Jiauthor=J.+B.+Staffordauthor=B.+C.+Crewsauthor=P.+J.+Kingsleyauthor=C.+A.+Rouzerauthor=M.+K.+Washingtonauthor=K.+Subbaramaiahauthor=B.+S.+Siegelauthor=S.+M.+Youngauthor=A.+J.+Dannenbergauthor=L.+J.+Marnett&title=Desmethyl+Derivatives+of+Indomethacin+and+Sulindac+as+Probes+for+Cyclooxygenase-Dependent+Biology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fcb700077z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb700077z%26sid%3Dliteratum%253Aachs%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DJi%26aufirst%3DC.%26aulast%3DStafford%26aufirst%3DJ.%2BB.%26aulast%3DCrews%26aufirst%3DB.%2BC.%26aulast%3DKingsley%26aufirst%3DP.%2BJ.%26aulast%3DRouzer%26aufirst%3DC.%2BA.%26aulast%3DWashington%26aufirst%3DM.%2BK.%26aulast%3DSubbaramaiah%26aufirst%3DK.%26aulast%3DSiegel%26aufirst%3DB.%2BS.%26aulast%3DYoung%26aufirst%3DS.%2BM.%26aulast%3DDannenberg%26aufirst%3DA.%2BJ.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26atitle%3DDesmethyl%2520Derivatives%2520of%2520Indomethacin%2520and%2520Sulindac%2520as%2520Probes%2520for%2520Cyclooxygenase-Dependent%2520Biology%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2007%26volume%3D2%26spage%3D479%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Broyles, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, B. K.</span><span> </span><span class="NLM_article-title">Factors affecting the selection of products from a photochemically generated singlet biradical</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1757</span><span class="NLM_x">–</span> <span class="NLM_lpage">1767</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2005&pages=1757-1767&author=D.+A.+Broylesauthor=B.+K.+Carpenter&title=Factors+affecting+the+selection+of+products+from+a+photochemically+generated+singlet+biradical"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBroyles%26aufirst%3DD.%2BA.%26aulast%3DCarpenter%26aufirst%3DB.%2BK.%26atitle%3DFactors%2520affecting%2520the%2520selection%2520of%2520products%2520from%2520a%2520photochemically%2520generated%2520singlet%2520biradical%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2005%26volume%3D3%26spage%3D1757%26epage%3D1767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Brewster, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chittenden, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinder, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skeels, M.</span><span> </span><span class="NLM_article-title">Structure of the indene-3-acetic acids. II. Reformatskii reactions of 6-(benzyloxy)-, 5,6-dimethoxy-, and 6-methoxy-1-indanones</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_fpage">941</span><span class="NLM_x">–</span> <span class="NLM_lpage">943</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1972&pages=941-943&author=K.+Brewsterauthor=R.+A.+Chittendenauthor=R.+M.+Pinderauthor=M.+Skeels&title=Structure+of+the+indene-3-acetic+acids.+II.+Reformatskii+reactions+of+6-%28benzyloxy%29-%2C+5%2C6-dimethoxy-%2C+and+6-methoxy-1-indanones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrewster%26aufirst%3DK.%26aulast%3DChittenden%26aufirst%3DR.%2BA.%26aulast%3DPinder%26aufirst%3DR.%2BM.%26aulast%3DSkeels%26aufirst%3DM.%26atitle%3DStructure%2520of%2520the%2520indene-3-acetic%2520acids.%2520II.%2520Reformatskii%2520reactions%2520of%25206-%2528benzyloxy%2529-%252C%25205%252C6-dimethoxy-%252C%2520and%25206-methoxy-1-indanones%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1972%26spage%3D941%26epage%3D943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Peerboom, R. A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Koning, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nibbering, N. M. M.</span><span> </span><span class="NLM_article-title">On the stabilization of carbanions by adjacent phenyl, cyano, methoxycarbonyl, and nitro groups in the gas phase</span> <span class="citation_source-journal">J. Am. Soc. Mass Spectrom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span></span><div class="citationLinks">[<a href="/doi/10.1016/1044-0305%2894%2985029-1" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1994&pages=159-168&author=R.+A.+L.+Peerboomauthor=L.+J.+de+Koningauthor=N.+M.+M.+Nibbering&title=On+the+stabilization+of+carbanions+by+adjacent+phenyl%2C+cyano%2C+methoxycarbonyl%2C+and+nitro+groups+in+the+gas+phase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2F1044-0305%2894%2985029-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F1044-0305%252894%252985029-1%26sid%3Dliteratum%253Aachs%26aulast%3DPeerboom%26aufirst%3DR.%2BA.%2BL.%26aulast%3Dde%2BKoning%26aufirst%3DL.%2BJ.%26aulast%3DNibbering%26aufirst%3DN.%2BM.%2BM.%26atitle%3DOn%2520the%2520stabilization%2520of%2520carbanions%2520by%2520adjacent%2520phenyl%252C%2520cyano%252C%2520methoxycarbonyl%252C%2520and%2520nitro%2520groups%2520in%2520the%2520gas%2520phase%26jtitle%3DJ.%2520Am.%2520Soc.%2520Mass%2520Spectrom.%26date%3D1994%26volume%3D5%26spage%3D159%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Peretto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radaelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zandi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raveglia, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dondio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontanella, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigogno, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccardi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biscaioli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchetti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puccini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catinella, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rondelli, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cenacchi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolzoni, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caruso, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villetti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Facchinetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Giudice, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span> </span><span class="NLM_article-title">Synthesis and biological activity of flurbiprofen analogues as selective inhibitors of beta -amyloid1–42 secretion</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5705</span><span class="NLM_x">–</span> <span class="NLM_lpage">5720</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0502541" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5705-5720&author=I.+Perettoauthor=S.+Radaelliauthor=C.+Pariniauthor=M.+Zandiauthor=L.+F.+Ravegliaauthor=G.+Dondioauthor=L.+Fontanellaauthor=P.+Misianoauthor=C.+Bigognoauthor=A.+Rizziauthor=B.+Riccardiauthor=M.+Biscaioliauthor=S.+Marchettiauthor=P.+Pucciniauthor=S.+Catinellaauthor=I.+Rondelliauthor=V.+Cenacchiauthor=P.+T.+Bolzoniauthor=P.+Carusoauthor=G.+Villettiauthor=F.+Facchinettiauthor=E.+Del+Giudiceauthor=N.+Morettoauthor=B.+P.+Imbimbo&title=Synthesis+and+biological+activity+of+flurbiprofen+analogues+as+selective+inhibitors+of+beta+-amyloid1%E2%80%9342+secretion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm0502541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0502541%26sid%3Dliteratum%253Aachs%26aulast%3DPeretto%26aufirst%3DI.%26aulast%3DRadaelli%26aufirst%3DS.%26aulast%3DParini%26aufirst%3DC.%26aulast%3DZandi%26aufirst%3DM.%26aulast%3DRaveglia%26aufirst%3DL.%2BF.%26aulast%3DDondio%26aufirst%3DG.%26aulast%3DFontanella%26aufirst%3DL.%26aulast%3DMisiano%26aufirst%3DP.%26aulast%3DBigogno%26aufirst%3DC.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DRiccardi%26aufirst%3DB.%26aulast%3DBiscaioli%26aufirst%3DM.%26aulast%3DMarchetti%26aufirst%3DS.%26aulast%3DPuccini%26aufirst%3DP.%26aulast%3DCatinella%26aufirst%3DS.%26aulast%3DRondelli%26aufirst%3DI.%26aulast%3DCenacchi%26aufirst%3DV.%26aulast%3DBolzoni%26aufirst%3DP.%2BT.%26aulast%3DCaruso%26aufirst%3DP.%26aulast%3DVilletti%26aufirst%3DG.%26aulast%3DFacchinetti%26aufirst%3DF.%26aulast%3DDel%2BGiudice%26aufirst%3DE.%26aulast%3DMoretto%26aufirst%3DN.%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520flurbiprofen%2520analogues%2520as%2520selective%2520inhibitors%2520of%2520beta%2520-amyloid1%25E2%2580%259342%2520secretion%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5705%26epage%3D5720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Barreca, G.; Cannata, V.</span><span> </span><span class="NLM_article-title">Stereoselective isomerization process for the preparation of cis-5-fluoro-2-methyl-1-[4-(methylthio)benzyliden]inden-3-acetic acid</span>. 2000-677842 6355836, 20001003,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=G.+Barreca&author=V.+Cannata&title=Stereoselective+isomerization+process+for+the+preparation+of+cis-5-fluoro-2-methyl-1-%5B4-%28methylthio%29benzyliden%5Dinden-3-acetic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DBarreca%26aufirst%3DG.%26atitle%3DStereoselective%2520isomerization%2520process%2520for%2520the%2520preparation%2520of%2520cis-5-fluoro-2-methyl-1-%255B4-%2528methylthio%2529benzyliden%255Dinden-3-acetic%2520acid%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Liedtke, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keck, P. R. W. E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeberle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, S. A.</span><span> </span><span class="NLM_article-title">Arylpyrrolizines as Inhibitors of Microsomal Prostaglandin E2 Synthase-1 (mPGES-1) or as Dual Inhibitors of mPGES-1 and 5-Lipoxygenase (5-LOX)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4968</span><span class="NLM_x">–</span> <span class="NLM_lpage">4972</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900481c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4968-4972&author=A.+J.+Liedtkeauthor=P.+R.+W.+E.+F.+Keckauthor=F.+Lehmannauthor=A.+Koeberleauthor=O.+Werzauthor=S.+A.+Laufer&title=Arylpyrrolizines+as+Inhibitors+of+Microsomal+Prostaglandin+E2+Synthase-1+%28mPGES-1%29+or+as+Dual+Inhibitors+of+mPGES-1+and+5-Lipoxygenase+%285-LOX%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjm900481c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900481c%26sid%3Dliteratum%253Aachs%26aulast%3DLiedtke%26aufirst%3DA.%2BJ.%26aulast%3DKeck%26aufirst%3DP.%2BR.%2BW.%2BE.%2BF.%26aulast%3DLehmann%26aufirst%3DF.%26aulast%3DKoeberle%26aufirst%3DA.%26aulast%3DWerz%26aufirst%3DO.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DArylpyrrolizines%2520as%2520Inhibitors%2520of%2520Microsomal%2520Prostaglandin%2520E2%2520Synthase-1%2520%2528mPGES-1%2529%2520or%2520as%2520Dual%2520Inhibitors%2520of%2520mPGES-1%2520and%25205-Lipoxygenase%2520%25285-LOX%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4968%26epage%3D4972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arruda, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baccei, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorrain, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodanovich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stock, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span> </span><span class="NLM_article-title">5-Lipoxygenase-Activating Protein Inhibitors: Development of 3-[3-<i>tert</i>-Butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1<i>H</i>-indol-2-yl]-2,2-dimethylpropionic Acid (AM103)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5803</span><span class="NLM_x">–</span> <span class="NLM_lpage">5815</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900945d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5803-5815&author=J.+H.+Hutchinsonauthor=Y.+Liauthor=J.+M.+Arrudaauthor=C.+Bacceiauthor=G.+Bainauthor=C.+Chapmanauthor=L.+Correaauthor=J.+Darlingtonauthor=C.+D.+Kingauthor=C.+Leeauthor=D.+Lorrainauthor=P.+Prodanovichauthor=H.+Rongauthor=A.+Santiniauthor=N.+Stockauthor=P.+Prasitauthor=J.+F.+Evans&title=5-Lipoxygenase-Activating+Protein+Inhibitors%3A+Development+of+3-%5B3-tert-Butylsulfanyl-1-%5B4-%286-methoxy-pyridin-3-yl%29-benzyl%5D-5-%28pyridin-2-ylmethoxy%29-1H-indol-2-yl%5D-2%2C2-dimethylpropionic+Acid+%28AM103%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm900945d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900945d%26sid%3Dliteratum%253Aachs%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DArruda%26aufirst%3DJ.%2BM.%26aulast%3DBaccei%26aufirst%3DC.%26aulast%3DBain%26aufirst%3DG.%26aulast%3DChapman%26aufirst%3DC.%26aulast%3DCorrea%26aufirst%3DL.%26aulast%3DDarlington%26aufirst%3DJ.%26aulast%3DKing%26aufirst%3DC.%2BD.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DLorrain%26aufirst%3DD.%26aulast%3DProdanovich%26aufirst%3DP.%26aulast%3DRong%26aufirst%3DH.%26aulast%3DSantini%26aufirst%3DA.%26aulast%3DStock%26aufirst%3DN.%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26atitle%3D5-Lipoxygenase-Activating%2520Protein%2520Inhibitors%253A%2520Development%2520of%25203-%255B3-tert-Butylsulfanyl-1-%255B4-%25286-methoxy-pyridin-3-yl%2529-benzyl%255D-5-%2528pyridin-2-ylmethoxy%2529-1H-indol-2-yl%255D-2%252C2-dimethylpropionic%2520Acid%2520%2528AM103%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5803%26epage%3D5815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Bundgaard, H.; Nielsen, N. M.</span><span> </span><span class="NLM_article-title">Ester prodrug derivatives of carboxylic acid drugs</span>. 1987-DK104 8801615, 19870825,<span class="NLM_x"> </span><span class="NLM_year">1988</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1988&author=H.+Bundgaard&author=N.+M.+Nielsen&title=Ester+prodrug+derivatives+of+carboxylic+acid+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DBundgaard%26aufirst%3DH.%26atitle%3DEster%2520prodrug%2520derivatives%2520of%2520carboxylic%2520acid%2520drugs%26date%3D1988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Stock, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrigley, J. D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearman, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peachey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St-Jacques, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span> </span><span class="NLM_article-title">The geminal dimethyl analogue of Flurbiprofen as a novel Abeta 42 inhibitor and potential Alzheimer's disease modifying agent</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2219</span><span class="NLM_x">–</span> <span class="NLM_lpage">2223</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2219-2223&author=N.+Stockauthor=B.+Munozauthor=J.+D.+J.+Wrigleyauthor=M.+S.+Shearmanauthor=D.+Beherauthor=J.+Peacheyauthor=T.+L.+Williamsonauthor=G.+Bainauthor=W.+Chenauthor=X.+Jiangauthor=R.+St-Jacquesauthor=P.+Prasit&title=The+geminal+dimethyl+analogue+of+Flurbiprofen+as+a+novel+Abeta+42+inhibitor+and+potential+Alzheimer%27s+disease+modifying+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStock%26aufirst%3DN.%26aulast%3DMunoz%26aufirst%3DB.%26aulast%3DWrigley%26aufirst%3DJ.%2BD.%2BJ.%26aulast%3DShearman%26aufirst%3DM.%2BS.%26aulast%3DBeher%26aufirst%3DD.%26aulast%3DPeachey%26aufirst%3DJ.%26aulast%3DWilliamson%26aufirst%3DT.%2BL.%26aulast%3DBain%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DSt-Jacques%26aufirst%3DR.%26aulast%3DPrasit%26aufirst%3DP.%26atitle%3DThe%2520geminal%2520dimethyl%2520analogue%2520of%2520Flurbiprofen%2520as%2520a%2520novel%2520Abeta%252042%2520inhibitor%2520and%2520potential%2520Alzheimer%2527s%2520disease%2520modifying%2520agent%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2219%26epage%3D2223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Hutchinson, D. K.; Bellettini, J. R.; Betebenner, D. A.; Bishop, R. D.; Borchardt, T. B.; Bosse, T. D.; Cink, R. D.; Flentge, C. A.; Gates, B. D.; Green, B. E.; Hinman, M. M.; Huang, P. P.; Klein, L. L.; Krueger, A. C.; Larson, D. P.; Leanna, M. R.; Liu, D.; Madigan, D. L.; McDaniel, K. F.; Randolph, J. T.; Rockway, T. W.; Rosenberg, T. A.; Stewart, K. D.; Stoll, V. S.; Wagner, R.; Yeung, M. C.</span><span> </span><span class="NLM_article-title">Preparation of fused thiadiazinediones, particularly dioxothiadiazinylnaphthalenones, as antiviral agents for the treatment of infections involving RNA-containing viral species such as hepatitis B and C and HIV</span>. 2004-925072 20050107364, 20040824,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=D.+K.+Hutchinson&author=J.+R.+Bellettini&author=D.+A.+Betebenner&author=R.+D.+Bishop&author=T.+B.+Borchardt&author=T.+D.+Bosse&author=R.+D.+Cink&author=C.+A.+Flentge&author=B.+D.+Gates&author=B.+E.+Green&author=M.+M.+Hinman&author=P.+P.+Huang&author=L.+L.+Klein&author=A.+C.+Krueger&author=D.+P.+Larson&author=M.+R.+Leanna&author=D.+Liu&author=D.+L.+Madigan&author=K.+F.+McDaniel&author=J.+T.+Randolph&author=T.+W.+Rockway&author=T.+A.+Rosenberg&author=K.+D.+Stewart&author=V.+S.+Stoll&author=R.+Wagner&author=M.+C.+Yeung&title=Preparation+of+fused+thiadiazinediones%2C+particularly+dioxothiadiazinylnaphthalenones%2C+as+antiviral+agents+for+the+treatment+of+infections+involving+RNA-containing+viral+species+such+as+hepatitis+B+and+C+and+HIV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DHutchinson%26aufirst%3DD.%2BK.%26atitle%3DPreparation%2520of%2520fused%2520thiadiazinediones%252C%2520particularly%2520dioxothiadiazinylnaphthalenones%252C%2520as%2520antiviral%2520agents%2520for%2520the%2520treatment%2520of%2520infections%2520involving%2520RNA-containing%2520viral%2520species%2520such%2520as%2520hepatitis%2520B%2520and%2520C%2520and%2520HIV%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Allegretti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesta, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bizzarri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Bitondo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cioccio, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galliera, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zampella, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Bello, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Locati, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantucci, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colotta, F.</span><span> </span><span class="NLM_article-title">2-Arylpropionic CXC Chemokine Receptor 1 (CXCR1) Ligands as Novel Noncompetitive CXCL8 Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4312</span><span class="NLM_x">–</span> <span class="NLM_lpage">4331</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049082i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4312-4331&author=M.+Allegrettiauthor=R.+Bertiniauthor=M.+C.+Cestaauthor=C.+Bizzarriauthor=R.+Di+Bitondoauthor=V.+Di+Cioccioauthor=E.+Gallieraauthor=V.+Berdiniauthor=A.+Topaiauthor=G.+Zampellaauthor=V.+Russoauthor=N.+Di+Belloauthor=G.+Nanoauthor=L.+Nicoliniauthor=M.+Locatiauthor=P.+Fantucciauthor=S.+Florioauthor=F.+Colotta&title=2-Arylpropionic+CXC+Chemokine+Receptor+1+%28CXCR1%29+Ligands+as+Novel+Noncompetitive+CXCL8+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fjm049082i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049082i%26sid%3Dliteratum%253Aachs%26aulast%3DAllegretti%26aufirst%3DM.%26aulast%3DBertini%26aufirst%3DR.%26aulast%3DCesta%26aufirst%3DM.%2BC.%26aulast%3DBizzarri%26aufirst%3DC.%26aulast%3DDi%2BBitondo%26aufirst%3DR.%26aulast%3DDi%2BCioccio%26aufirst%3DV.%26aulast%3DGalliera%26aufirst%3DE.%26aulast%3DBerdini%26aufirst%3DV.%26aulast%3DTopai%26aufirst%3DA.%26aulast%3DZampella%26aufirst%3DG.%26aulast%3DRusso%26aufirst%3DV.%26aulast%3DDi%2BBello%26aufirst%3DN.%26aulast%3DNano%26aufirst%3DG.%26aulast%3DNicolini%26aufirst%3DL.%26aulast%3DLocati%26aufirst%3DM.%26aulast%3DFantucci%26aufirst%3DP.%26aulast%3DFlorio%26aufirst%3DS.%26aulast%3DColotta%26aufirst%3DF.%26atitle%3D2-Arylpropionic%2520CXC%2520Chemokine%2520Receptor%25201%2520%2528CXCR1%2529%2520Ligands%2520as%2520Novel%2520Noncompetitive%2520CXCL8%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4312%26epage%3D4331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Halder, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satyam, A.</span><span> </span><span class="NLM_article-title">Accidental discovery of a 'longer-range' vinylogous Pummerer-type lactonization: Formation of sulindac sulfide lactone from sulindac</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1179</span><span class="NLM_x">–</span> <span class="NLM_lpage">1182</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=1179-1182&author=S.+Halderauthor=A.+Satyam&title=Accidental+discovery+of+a+%27longer-range%27+vinylogous+Pummerer-type+lactonization%3A+Formation+of+sulindac+sulfide+lactone+from+sulindac"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHalder%26aufirst%3DS.%26aulast%3DSatyam%26aufirst%3DA.%26atitle%3DAccidental%2520discovery%2520of%2520a%2520%2527longer-range%2527%2520vinylogous%2520Pummerer-type%2520lactonization%253A%2520Formation%2520of%2520sulindac%2520sulfide%2520lactone%2520from%2520sulindac%26jtitle%3DTetrahedron%2520Lett.%26date%3D2011%26volume%3D52%26spage%3D1179%26epage%3D1182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Barreiro, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lima, M. E. F.</span><span> </span><span class="NLM_article-title">The synthesis and anti-inflammatory properties of a new sulindac analog synthesized from natural safrole</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">1219</span><span class="NLM_x">–</span> <span class="NLM_lpage">1222</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1992&pages=1219-1222&author=E.+J.+Barreiroauthor=M.+E.+F.+Lima&title=The+synthesis+and+anti-inflammatory+properties+of+a+new+sulindac+analog+synthesized+from+natural+safrole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarreiro%26aufirst%3DE.%2BJ.%26aulast%3DLima%26aufirst%3DM.%2BE.%2BF.%26atitle%3DThe%2520synthesis%2520and%2520anti-inflammatory%2520properties%2520of%2520a%2520new%2520sulindac%2520analog%2520synthesized%2520from%2520natural%2520safrole%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1992%26volume%3D81%26spage%3D1219%26epage%3D1222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Piazza, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahm, A. L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krutzsch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paranka, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brendel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burt, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alberts, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pamukcu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahnen, D. J.</span><span> </span><span class="NLM_article-title">Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">3110</span><span class="NLM_x">–</span> <span class="NLM_lpage">3116</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=7606732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADyaK2MXmvVyitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1995&pages=3110-3116&author=G.+A.+Piazzaauthor=A.+L.+K.+Rahmauthor=M.+Krutzschauthor=G.+Sperlauthor=N.+S.+Parankaauthor=P.+H.+Grossauthor=K.+Brendelauthor=R.+W.+Burtauthor=D.+S.+Albertsauthor=R.+Pamukcuauthor=D.+J.+Ahnen&title=Antineoplastic+drugs+sulindac+sulfide+and+sulfone+inhibit+cell+growth+by+inducing+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis</span></div><div class="casAuthors">Piazza, Gary A.; Rahm, Alanna L. Kulchak; Krutzsch, Mary; Sperl, Gerhard; Paranka, Nancy Shipp; Gross, Paul H.; Brendel, Klaus; Burt, Randall W.; Alberts, David S.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3110-16</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The nonsteroidal anti-inflammatory drug sulindac is known to inhibit chem. carcinogenesis in rodent models and cause regression of adenomas in patients with adenomatous polyposis coli.  Sulindac is a prodrug that is metabolized to a pharmacol. active sulfide deriv. that potently inhibits prostaglandin synthesis.  Recent studies, however, have shown that a sulfone deriv. of sulindac, which essentially lacks prostaglandin synthesis inhibitory activity, also inhibits chem. carcinogenesis, suggesting that redn. of prostaglandin levels is not necessary for the antineoplastic activity of this class of drugs.  Both sulindac sulfide and the sulfone inhibit the growth of cultured tumor cells, although the cellular mechanism(s) responsible for the antineoplastic activity of sulindac derivs. is unknown.  In this study, we investigated the effects of sulindac sulfide and sulfone on the proliferation, differentiation, and apoptosis of HT-29 human colon carcinoma cells.  Sulindac sulfide and sulfone significantly reduced cell no. in both preconfluent and confluent cultures of HT-29 cells with the sulfide showing approx. 4-fold greater potency.  In addn. to HT-29 cells, both drugs inhibited the growth of a variety of tumor cell lines derived from other tissues, as well as normal epithelial cells and fibroblasts.  Neither sulindac sulfide nor sulfone inhibited cell proliferation under conditions where the drugs were growth inhibitory.  Only under specific conditions involving mitogenic stimulation did sulindac sulfide and sulfone cause cell cycle arrest.  Neither sulindac sulfide nor the sulfone induced differentiation of HT-29 cells, but both drugs strongly induced apoptosis.  The apoptotic response to sulindac sulfide and sulfone was both time- and dose-dependent and involved a mechanism independent of their inhibitory effect on cell cycle progression.  These data suggest that apoptosis is responsible for the cell growth inhibitory activity of sulindac sulfide and sulfone and represents a potential mechanism for the antineoplastic activity of these drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpi5QYDEP4PerVg90H21EOLACvtfcHk0lj2CUK15TebQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmvVyitL4%253D&md5=a1e1280ab269b6badcc8ec2da9fe0f9f</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPiazza%26aufirst%3DG.%2BA.%26aulast%3DRahm%26aufirst%3DA.%2BL.%2BK.%26aulast%3DKrutzsch%26aufirst%3DM.%26aulast%3DSperl%26aufirst%3DG.%26aulast%3DParanka%26aufirst%3DN.%2BS.%26aulast%3DGross%26aufirst%3DP.%2BH.%26aulast%3DBrendel%26aufirst%3DK.%26aulast%3DBurt%26aufirst%3DR.%2BW.%26aulast%3DAlberts%26aufirst%3DD.%2BS.%26aulast%3DPamukcu%26aufirst%3DR.%26aulast%3DAhnen%26aufirst%3DD.%2BJ.%26atitle%3DAntineoplastic%2520drugs%2520sulindac%2520sulfide%2520and%2520sulfone%2520inhibit%2520cell%2520growth%2520by%2520inducing%2520apoptosis%26jtitle%3DCancer%2520Res.%26date%3D1995%26volume%3D55%26spage%3D3110%26epage%3D3116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Williams, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrow, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DuBois, R. N.</span><span> </span><span class="NLM_article-title">Sulindac sulfide, but not sulindac sulfone, inhibits colorectal cancer growth</span> <span class="citation_source-journal">Neoplasia (New York)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">170</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1038%2Fsj.neo.7900024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=10933052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADyaK1MXmslGgu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1999&pages=170-176&author=C.+S.+Williamsauthor=A.+P.+Goldmanauthor=H.+Shengauthor=J.+D.+Morrowauthor=R.+N.+DuBois&title=Sulindac+sulfide%2C+but+not+sulindac+sulfone%2C+inhibits+colorectal+cancer+growth"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Sulindac sulfide, but not sulindac sulfone, inhibits colorectal cancer growth</span></div><div class="casAuthors">Williams, Christopher S.; Goldman, Angela P.; Sheng, Hongmiao; Morrow, Jason D.; DuBois, Raymond N.</div><div class="citationInfo"><span class="NLM_cas:title">Neoplasia (New York)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">170-176</span>CODEN:
                <span class="NLM_cas:coden">NEOPFL</span>;
        ISSN:<span class="NLM_cas:issn">1522-8002</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">Both sulindac sulfide and sulindac sulfone treatment of colorectal cancer HCA-7 cells inhibited PGE2 prodn.  Both sulindac sulfide and sulfone inhibited HCA-7 and HCT-116 cell growth in vitro.  Sulindac sulfone had no effect on the growth of either HCA-7 or HCT-116 xenografts in nude mice, whereas the sulfide deriv. inhibited HCA-7 growth in vivo.  Both sulindac sulfide and sulfone inhibited colon carcinoma cell growth and prostaglandin prodn. in vitro, but sulindac sulfone had no effect on the growth of colon cancer cell xenografts in nude mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1d72bC0_XHLVg90H21EOLACvtfcHk0lgVf8xKGzDxew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmslGgu7o%253D&md5=c8aab090b466c3e64b6206d8344675e2</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1038%2Fsj.neo.7900024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.neo.7900024%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DC.%2BS.%26aulast%3DGoldman%26aufirst%3DA.%2BP.%26aulast%3DSheng%26aufirst%3DH.%26aulast%3DMorrow%26aufirst%3DJ.%2BD.%26aulast%3DDuBois%26aufirst%3DR.%2BN.%26atitle%3DSulindac%2520sulfide%252C%2520but%2520not%2520sulindac%2520sulfone%252C%2520inhibits%2520colorectal%2520cancer%2520growth%26jtitle%3DNeoplasia%2520%2528New%2520York%2529%26date%3D1999%26volume%3D1%26spage%3D170%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Richter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberger, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furstenberger, G.</span><span> </span><span class="NLM_article-title">Marian, B. Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors</span> <span class="citation_source-journal">Carcinogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2001&pages=17-25&author=M.+Richterauthor=M.+Weissauthor=I.+Weinbergerauthor=G.+Furstenberger&title=Marian%2C+B.+Growth+inhibition+and+induction+of+apoptosis+in+colorectal+tumor+cells+by+cyclooxygenase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichter%26aufirst%3DM.%26aulast%3DWeiss%26aufirst%3DM.%26aulast%3DWeinberger%26aufirst%3DI.%26aulast%3DFurstenberger%26aufirst%3DG.%26atitle%3DMarian%252C%2520B.%2520Growth%2520inhibition%2520and%2520induction%2520of%2520apoptosis%2520in%2520colorectal%2520tumor%2520cells%2520by%2520cyclooxygenase%2520inhibitors%26jtitle%3DCarcinogenesis%26date%3D2001%26volume%3D22%26spage%3D17%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Tegeder, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeilschifter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geisslinger, G.</span><span> </span><span class="NLM_article-title">Cyclooxygenase-independent actions of cyclooxygenase inhibitors</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2057</span><span class="NLM_x">–</span> <span class="NLM_lpage">2072</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2001&pages=2057-2072&author=I.+Tegederauthor=J.+Pfeilschifterauthor=G.+Geisslinger&title=Cyclooxygenase-independent+actions+of+cyclooxygenase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTegeder%26aufirst%3DI.%26aulast%3DPfeilschifter%26aufirst%3DJ.%26aulast%3DGeisslinger%26aufirst%3DG.%26atitle%3DCyclooxygenase-independent%2520actions%2520of%2520cyclooxygenase%2520inhibitors%26jtitle%3DFASEB%2520J.%26date%3D2001%26volume%3D15%26spage%3D2057%26epage%3D2072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Kundu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulton, A. M.</span><span> </span><span class="NLM_article-title">Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">2343</span><span class="NLM_x">–</span> <span class="NLM_lpage">2346</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=2343-2346&author=N.+Kunduauthor=A.+M.+Fulton&title=Selective+cyclooxygenase+%28COX%29-1+or+COX-2+inhibitors+control+metastatic+disease+in+a+murine+model+of+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKundu%26aufirst%3DN.%26aulast%3DFulton%26aufirst%3DA.%2BM.%26atitle%3DSelective%2520cyclooxygenase%2520%2528COX%2529-1%2520or%2520COX-2%2520inhibitors%2520control%2520metastatic%2520disease%2520in%2520a%2520murine%2520model%2520of%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D2343%26epage%3D2346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fei, S.</span><span> </span><span class="NLM_article-title">Non-steroidal anti-inflammatory drugs (NSAIDs) inhibiting the proliferation of human colorectal cancer cells</span> <span class="citation_source-journal">Nanjing Yike Daxue Xuebao</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">–</span> <span class="NLM_lpage">927</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Kjt77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=923-927&author=G.+Chenauthor=S.+Fei&title=Non-steroidal+anti-inflammatory+drugs+%28NSAIDs%29+inhibiting+the+proliferation+of+human+colorectal+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Non-steroidal anti-inflammatory drugs (NSAIDs) inhibiting the proliferation of human colorectal cancer cells</span></div><div class="casAuthors">Chen, Guangxia; Fei, Sujuan</div><div class="citationInfo"><span class="NLM_cas:title">Nanjing Yike Daxue Xuebao</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">923-927</span>CODEN:
                <span class="NLM_cas:coden">NYDXFS</span>;
        ISSN:<span class="NLM_cas:issn">1007-4368</span>.
    
            (<span class="NLM_cas:orgname">Nanjing Yike Daxue Xuebao Bianjibu</span>)
        </div><div class="casAbstract">The mechanism that selective cyclooxygenase-2 (COX-2) inhibitor Nimesulide and non-selective COX-2 inhibitor sulindac inhibited human colorectal cancer cells proliferation was studied.  MTT assay and flow cytometry (FCM) were used to det. the influence of Nimesulide and Sulindac on the proliferation and apoptosis of colorectal cancer cells.  Prostaglandin E2 (PGE2) was examd. in the culture supernatant by RIA.  Nimesulide and Sulindac inhibited proliferation of colorectal cancer cells in a dose- and time-dependent manner and significantly increased the proportion of cells in the G0/G1 phase and decreased the proportion of cells in the S phase (P<0.05).  Both drugs reduced the release of PGE2 (P<0.05).  Nimesulide and Sulindac can inhibit proliferation and induce apoptosis in colorectal cancer cell lines, through inhibiting COX-2 activity and PGE2 synthesis and blocking the progression of cell cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3_pDvVVKELrVg90H21EOLACvtfcHk0lh22FsuxAtmUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Kjt77E&md5=132f6a45dae116efbb1f096495eaa25d</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DG.%26aulast%3DFei%26aufirst%3DS.%26atitle%3DNon-steroidal%2520anti-inflammatory%2520drugs%2520%2528NSAIDs%2529%2520inhibiting%2520the%2520proliferation%2520of%2520human%2520colorectal%2520cancer%2520cells%26jtitle%3DNanjing%2520Yike%2520Daxue%2520Xuebao%26date%3D2005%26volume%3D25%26spage%3D923%26epage%3D927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Daikoku, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tranguch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrow, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orsulic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DuBois, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dey, S. K.</span><span> </span><span class="NLM_article-title">Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">3735</span><span class="NLM_x">–</span> <span class="NLM_lpage">3744</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=3735-3744&author=T.+Daikokuauthor=D.+Wangauthor=S.+Tranguchauthor=J.+D.+Morrowauthor=S.+Orsulicauthor=R.+N.+DuBoisauthor=S.+K.+Dey&title=Cyclooxygenase-1+is+a+potential+target+for+prevention+and+treatment+of+ovarian+epithelial+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDaikoku%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DTranguch%26aufirst%3DS.%26aulast%3DMorrow%26aufirst%3DJ.%2BD.%26aulast%3DOrsulic%26aufirst%3DS.%26aulast%3DDuBois%26aufirst%3DR.%2BN.%26aulast%3DDey%26aufirst%3DS.%2BK.%26atitle%3DCyclooxygenase-1%2520is%2520a%2520potential%2520target%2520for%2520prevention%2520and%2520treatment%2520of%2520ovarian%2520epithelial%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D3735%26epage%3D3744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Mitchell, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akarasereenont, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiemermann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flower, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vane, J. R.</span><span> </span><span class="NLM_article-title">Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">11693</span><span class="NLM_x">–</span> <span class="NLM_lpage">11697</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1993&pages=11693-11697&author=J.+A.+Mitchellauthor=P.+Akarasereenontauthor=C.+Thiemermannauthor=R.+J.+Flowerauthor=J.+R.+Vane&title=Selectivity+of+nonsteroidal+antiinflammatory+drugs+as+inhibitors+of+constitutive+and+inducible+cyclooxygenase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMitchell%26aufirst%3DJ.%2BA.%26aulast%3DAkarasereenont%26aufirst%3DP.%26aulast%3DThiemermann%26aufirst%3DC.%26aulast%3DFlower%26aufirst%3DR.%2BJ.%26aulast%3DVane%26aufirst%3DJ.%2BR.%26atitle%3DSelectivity%2520of%2520nonsteroidal%2520antiinflammatory%2520drugs%2520as%2520inhibitors%2520of%2520constitutive%2520and%2520inducible%2520cyclooxygenase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1993%26volume%3D90%26spage%3D11693%26epage%3D11697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Gierse, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rangwala, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koboldt, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seibert, K.</span><span> </span><span class="NLM_article-title">A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">15810</span><span class="NLM_x">–</span> <span class="NLM_lpage">15814</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1074%2Fjbc.271.26.15810" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=8663121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADyaK28XjvFWhsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=15810-15814&author=J.+K.+Gierseauthor=J.+J.+McDonaldauthor=S.+D.+Hauserauthor=S.+H.+Rangwalaauthor=C.+M.+Koboldtauthor=K.+Seibert&title=A+single+amino+acid+difference+between+cyclooxygenase-1+%28COX-1%29+and+-2+%28COX-2%29+reverses+the+selectivity+of+COX-2+specific+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors</span></div><div class="casAuthors">Gierse, James K.; McDonald, Joseph J.; Hauser, Scott D.; Rangwala, Shaukat H.; Koboldt, Carol M.; Seibert, Karen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">15810-15814</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nonsteroidal anti-inflammatory drugs (NSAIDs) currently available for clin. use inhibit both cyclooxygenase (COX) COX-1 and COX-2.  This suggests that clin. useful NSAIDs inhibit pro-inflammatory prostaglandins (PGs) drived from the activity of COX-2, as well as PGs in tissues like the stomach and kidney (via COX-1).  A new class of compds. has recently been developed (SC-58125) that have a high degree of selectivity for the inducible form of cyxlooxygenase (COX-2) over the constitutive form (COX-1).  This unique class of compds. exhibit a time-dependent irreversible inhibition of COX-2, while reversibly inhibiting COX-1.  The mol. basis of this selectivity was probed by site-directed mutagenesis of the active site of COX-2.  The sequence differences in the active site were detd. by amino acid replacement of the COX-2 sequences based on the known crystal structure of COX-1, which revealed a single amino acid difference in the active site (valine 509 to isoleucine) and a series of differences at the mouth of the active site.  Mutants with the single amino acid substitution in the active site and a combination of three changes in the mouth of the active site were made in human COX-2, expressed in insect cells, and purified.  The single amino acid change of valine 509 to isoleucine confers selectivity of COX-2 inhibitors in the class of SC-58125 and others of the same class (SC-236, NS-398), while commonly used NSAIDs such as indomethacin showed no change in selectivity.  Substitutions of COX-1 sequences in COX-2 at the mouth of the active site of COX-2 did not change the selectivity of SC-58125.  This indicates that the single amino acid substitution of isoleucine at position 509 for a valine is sufficient to confer COX-2 selectivity in this example of a diaryl-heterocycle COX inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpNB6pOGzOBbVg90H21EOLACvtfcHk0lgQQX8jypHekA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjvFWhsb0%253D&md5=3f792bef54b24c7b4e22375665a60c09</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.26.15810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.26.15810%26sid%3Dliteratum%253Aachs%26aulast%3DGierse%26aufirst%3DJ.%2BK.%26aulast%3DMcDonald%26aufirst%3DJ.%2BJ.%26aulast%3DHauser%26aufirst%3DS.%2BD.%26aulast%3DRangwala%26aufirst%3DS.%2BH.%26aulast%3DKoboldt%26aufirst%3DC.%2BM.%26aulast%3DSeibert%26aufirst%3DK.%26atitle%3DA%2520single%2520amino%2520acid%2520difference%2520between%2520cyclooxygenase-1%2520%2528COX-1%2529%2520and%2520-2%2520%2528COX-2%2529%2520reverses%2520the%2520selectivity%2520of%2520COX-2%2520specific%2520inhibitors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D15810%26epage%3D15814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">De Leval, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delarge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neven, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masereel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirotte, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henrotin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dogne, J. M.</span><span> </span><span class="NLM_article-title">Evaluation of classical NSAIDs and COX-2 selective inhibitors on purified ovine enzymes and human whole blood</span> <span class="citation_source-journal">Prostaglandins, Leukotrienes Essent. Fatty Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1054%2Fplef.2001.0262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=11418014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD3MXot12gt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2001&pages=211-216&author=X.+De+Levalauthor=J.+Delargeauthor=P.+Develauthor=P.+Nevenauthor=C.+Michauxauthor=B.+Masereelauthor=B.+Pirotteauthor=J.+L.+Davidauthor=Y.+Henrotinauthor=J.+M.+Dogne&title=Evaluation+of+classical+NSAIDs+and+COX-2+selective+inhibitors+on+purified+ovine+enzymes+and+human+whole+blood"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of classical NSAIDs and COX-2 selective inhibitors on purified ovine enzymes and human whole blood</span></div><div class="casAuthors">De Leval, X.; Delarge, J.; Devel, P.; Neven, P.; Michaux, C.; Masereel, B.; Pirotte, B.; David, J.-L.; Henrotin, Y.; Dogne, J.-M.</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins, Leukotrienes and Essential Fatty Acids</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">4&5</span>),
    <span class="NLM_cas:pages">211-216</span>CODEN:
                <span class="NLM_cas:coden">PLEAEU</span>;
        ISSN:<span class="NLM_cas:issn">0952-3278</span>.
    
            (<span class="NLM_cas:orgname">Churchill Livingstone</span>)
        </div><div class="casAbstract">Cyclooxygenase is the key enzyme in the biosynthesis of prostanoids, biol. active substances involved in several physiol. processes and also in pathol. conditions such as inflammation.  It has been well known for 10 yr that this enzyme exists under two forms: a constitutive (COX-1) and an inducible form (COX-2).  Both enzymes are sensitive to inhibition by conventional non-steroidal anti-inflammatory drugs (NSAIDs).  Observations were made that COX-1 was mainly involved in homeostatic processes, while the COX-2 expression was assocd. with pathol. conditions leading to the development of COX-2 selective inhibitors.  Several methods have been reported for the evaluation of the COX-1 and COX-2 inhibitory potency and selectivity of conventional or COX-2 selective NSAIDs.  In this study, we evaluated the COXs inhibitory profile of both conventional NSAIDs and COX-2 selective inhibitors using two different in vitro methods: the first test was performed using purified enzymes while the second method consisted of a whole blood assay.  The results obtained with ref. drugs in these two assays will be discussed and compared in this article.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-bhhZ5bycM7Vg90H21EOLACvtfcHk0liK9SQ5yjJqxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXot12gt7c%253D&md5=31cdabcaeac5bbe776505dd04a5474d3</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1054%2Fplef.2001.0262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1054%252Fplef.2001.0262%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLeval%26aufirst%3DX.%26aulast%3DDelarge%26aufirst%3DJ.%26aulast%3DDevel%26aufirst%3DP.%26aulast%3DNeven%26aufirst%3DP.%26aulast%3DMichaux%26aufirst%3DC.%26aulast%3DMasereel%26aufirst%3DB.%26aulast%3DPirotte%26aufirst%3DB.%26aulast%3DDavid%26aufirst%3DJ.%2BL.%26aulast%3DHenrotin%26aufirst%3DY.%26aulast%3DDogne%26aufirst%3DJ.%2BM.%26atitle%3DEvaluation%2520of%2520classical%2520NSAIDs%2520and%2520COX-2%2520selective%2520inhibitors%2520on%2520purified%2520ovine%2520enzymes%2520and%2520human%2520whole%2520blood%26jtitle%3DProstaglandins%252C%2520Leukotrienes%2520Essent.%2520Fatty%2520Acids%26date%3D2001%26volume%3D64%26spage%3D211%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Kitamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchiya, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakabayashi, K.</span><span> </span><span class="NLM_article-title">Inhibitory effects of mofezolac, a cyclooxygenase-1 selective inhibitor, on intestinal carcinogenesis</span> <span class="citation_source-journal">Carcinogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1463</span><span class="NLM_x">–</span> <span class="NLM_lpage">1466</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=1463-1466&author=T.+Kitamuraauthor=T.+Kawamoriauthor=N.+Uchiyaauthor=M.+Itohauthor=T.+Nodaauthor=M.+Matsuuraauthor=T.+Sugimuraauthor=K.+Wakabayashi&title=Inhibitory+effects+of+mofezolac%2C+a+cyclooxygenase-1+selective+inhibitor%2C+on+intestinal+carcinogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKitamura%26aufirst%3DT.%26aulast%3DKawamori%26aufirst%3DT.%26aulast%3DUchiya%26aufirst%3DN.%26aulast%3DItoh%26aufirst%3DM.%26aulast%3DNoda%26aufirst%3DT.%26aulast%3DMatsuura%26aufirst%3DM.%26aulast%3DSugimura%26aufirst%3DT.%26aulast%3DWakabayashi%26aufirst%3DK.%26atitle%3DInhibitory%2520effects%2520of%2520mofezolac%252C%2520a%2520cyclooxygenase-1%2520selective%2520inhibitor%252C%2520on%2520intestinal%2520carcinogenesis%26jtitle%3DCarcinogenesis%26date%3D2002%26volume%3D23%26spage%3D1463%26epage%3D1466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Kino, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kojima, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishizuka, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, S.</span><span> </span><span class="NLM_article-title">Prostaglandin E2 production in ovarian cancer cell lines is regulated by cyclooxygenase-1, not cyclooxygenase-2</span> <span class="citation_source-journal">Prostaglandins, Leukotrienes Essent. Fatty Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">111</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1016%2Fj.plefa.2005.04.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=15963707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsVCmu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2005&pages=103-111&author=Y.+Kinoauthor=F.+Kojimaauthor=K.+Kiguchiauthor=R.+Igarashiauthor=B.+Ishizukaauthor=S.+Kawai&title=Prostaglandin+E2+production+in+ovarian+cancer+cell+lines+is+regulated+by+cyclooxygenase-1%2C+not+cyclooxygenase-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Prostaglandin E2 production in ovarian cancer cell lines is regulated by cyclooxygenase-1, not cyclooxygenase-2</span></div><div class="casAuthors">Kino, Yuko; Kojima, Fumiaki; Kiguchi, Kazushige; Igarashi, Rie; Ishizuka, Bunpei; Kawai, Shinichi</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins, Leukotrienes and Essential Fatty Acids</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">103-111</span>CODEN:
                <span class="NLM_cas:coden">PLEAEU</span>;
        ISSN:<span class="NLM_cas:issn">0952-3278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The significance of cyclooxygenase-2 (COX-2) expression in ovarian cancer has been discussed.  In this study, we found increased expression of COX-1 mRNA and protein in three out of 10 ovarian cancer cell lines.  Prostaglandin E2 (PGE2) prodn. was elevated in these three cell lines, but not in other seven cell lines.  COX-2 protein was not detected in any of the cell lines.  Cytosolic prostaglandin E synthase (cPGES) mRNA and protein were detected in all 10 cell lines.  Membrane-assocd. PGES-1 (mPGES-1) was detected in some of the ovarian cell lines, but its presence did not correspond with PGE2 prodn.  In contrast, mPGES-2 mRNA and protein were detected in all 10 cell lines.  A nonselective COX inhibitor (indometacin) and a selective COX-1 inhibitor (SC-560) strongly inhibited PGE2 prodn. by the three cell lines, while selective COX-2 inhibitors (NS-398 and rofecoxib) did not inhibit PGE2 prodn.  In addn., increased expression of COX-1, not COX-2 protein was obsd. in the mass of ovarian cancer tissues from 22 patients when compared with that in normal tissue.  These findings suggest that COX-1 might be a major enzyme regulating PGE2 prodn. in ovarian cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobkZxwB_T2ZrVg90H21EOLACvtfcHk0lgImhrav4PCfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsVCmu7Y%253D&md5=e58979120d56380e3188174603eca947</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.plefa.2005.04.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.plefa.2005.04.014%26sid%3Dliteratum%253Aachs%26aulast%3DKino%26aufirst%3DY.%26aulast%3DKojima%26aufirst%3DF.%26aulast%3DKiguchi%26aufirst%3DK.%26aulast%3DIgarashi%26aufirst%3DR.%26aulast%3DIshizuka%26aufirst%3DB.%26aulast%3DKawai%26aufirst%3DS.%26atitle%3DProstaglandin%2520E2%2520production%2520in%2520ovarian%2520cancer%2520cell%2520lines%2520is%2520regulated%2520by%2520cyclooxygenase-1%252C%2520not%2520cyclooxygenase-2%26jtitle%3DProstaglandins%252C%2520Leukotrienes%2520Essent.%2520Fatty%2520Acids%26date%3D2005%26volume%3D73%26spage%3D103%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, R.-j.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Z.-y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuo, G.-c.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.-h.</span><span> </span><span class="NLM_article-title">Effects of a cyclooxygenase-1-selective inhibitor in a mouse model of ovarian cancer, administered alone or in combination with ibuprofen, a nonselective cyclooxygenase inhibitor</span> <span class="citation_source-journal">Med. Oncol. (Totowa, NJ, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">170</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1007%2Fs12032-008-9104-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVKitrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2009&pages=170-177&author=W.+Liauthor=R.-j.+Xuauthor=Z.-y.+Linauthor=G.-c.+Zhuoauthor=H.-h.+Zhang&title=Effects+of+a+cyclooxygenase-1-selective+inhibitor+in+a+mouse+model+of+ovarian+cancer%2C+administered+alone+or+in+combination+with+ibuprofen%2C+a+nonselective+cyclooxygenase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of a cyclooxygenase-1-selective inhibitor in a mouse model of ovarian cancer, administered alone or in combination with ibuprofen, a nonselective cyclooxygenase inhibitor</span></div><div class="casAuthors">Li, Wei; Xu, Ru-jun; Lin, Zhen-yun; Zhuo, Guang-chao; Zhang, Hong-he</div><div class="citationInfo"><span class="NLM_cas:title">Medical Oncology (Totowa, NJ, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">170-177</span>CODEN:
                <span class="NLM_cas:coden">MONCEZ</span>;
        ISSN:<span class="NLM_cas:issn">1357-0560</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Nonsteroidal anti-inflammatory drugs (NSAIDs) are known to be potent inhibitors of the cyclooxygenases.  The present study was designed to investigate the effects of a cyclooxygenase (COX)-1 inhibitor, SC-560, administered alone or in combination with ibuprofen on the growth inhibition of s.c. human ovarian SKOV-3 carcinoma and on angiogenesis.  The effects of SC-560 and ibuprofen on tumor growth inhibition have been examd. in mouse ovarian cancer models.  Angiogenesis of both COX inhibitors was measured by reverse-transcription polymerase chain reaction (RT-PCR) and immunohistochem.  Prostaglandin E2 (PGE2) levels in tumor tissues of mice were also detd. by ELISA.  The inhibitory rates in SC-560 group alone and in combination with ibuprofen group were 21.21% and 41.55%, resp.  In combination therapy with SC-560 and ibuprofen, tumor vols. were significantly reduced compared with that of control group (P < 0.05).  In treatment groups, both COX inhibitors significantly reduced intratumor PGE2 levels (all P < 0.01).  Microvessel d. (MVD) in tumor tissues were significantly decreased from 80.90 ± 5.14 in vehicle-treated to 40.70 ± 10.45 and 38.90 ± 8.41 in SC-560 group alone and combination ibuprofen therapy (all P < 0.01).  Ibuprofen was similar to the cyclooxygenase-1-selective inhibitor SC-560 in its ability to suppress the values of MVD of tumor tissues.  SC-560 administered alone or in combination with ibuprofen inhibited the COX-assocd. up-regulation of VEGF.  These studies demonstrate synergism between two COX inhibitors and that antiangiogenic therapy can be used to inhibit ovarian cancer growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqch_S7n4FMArVg90H21EOLACvtfcHk0lgImhrav4PCfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVKitrw%253D&md5=3b1c823db4da99657aa792b69d75bd1e</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1007%2Fs12032-008-9104-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12032-008-9104-9%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DR.-j.%26aulast%3DLin%26aufirst%3DZ.-y.%26aulast%3DZhuo%26aufirst%3DG.-c.%26aulast%3DZhang%26aufirst%3DH.-h.%26atitle%3DEffects%2520of%2520a%2520cyclooxygenase-1-selective%2520inhibitor%2520in%2520a%2520mouse%2520model%2520of%2520ovarian%2520cancer%252C%2520administered%2520alone%2520or%2520in%2520combination%2520with%2520ibuprofen%252C%2520a%2520nonselective%2520cyclooxygenase%2520inhibitor%26jtitle%3DMed.%2520Oncol.%2520%2528Totowa%252C%2520NJ%252C%2520U.%2520S.%2529%26date%3D2009%26volume%3D26%26spage%3D170%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Picot, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loll, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garavito, R. M.</span><span> </span><span class="NLM_article-title">The x-ray crystal structure of the membrane protein prostaglandin H2 synthase-1</span> <span class="citation_source-journal">Nature (London, United Kingdom)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">367</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">249</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1038%2F367243a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=8121489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADyaK2cXht1ynurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=1994&pages=243-249&author=D.+Picotauthor=P.+J.+Lollauthor=R.+M.+Garavito&title=The+x-ray+crystal+structure+of+the+membrane+protein+prostaglandin+H2+synthase-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">The x-ray crystal structure of the membrane protein prostaglandin H2 synthase-1</span></div><div class="casAuthors">Picot, Daniel; Loll, Patrick J.; Garavito, R. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">6460</span>),
    <span class="NLM_cas:pages">243-9</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The 3-dimensional structure of prostaglandin H2 synthase (prostaglandin endoperoxide synthase) isoenzyme 1, an integral membrane protein, complexed with the nonsteroidal antiinflammatory drug (NSAID), flurbiprofen, was detd. at 3.5 Å resoln. by x-ray crystallog.  The bifunctional enzyme comprised 3 independent folding units: an EGF domain, a membrane-binding motif, and an enzymic domain.  Two adjacent, but spatially distinct active sites were found for its heme-dependent prostaglandin hydroperoxide peroxidase and arachidonate cyclooxygenase activities.  The cyclooxygenase active site was created by a long, hydrophobic channel that was the site of NSAID binding.  The conformation of the membrane-binding motif strongly suggested that the enzyme integrates into only 1 leaflet of the lipid bilayer and is thus a monotopic membrane protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUBT9bqeSToLVg90H21EOLACvtfcHk0ljJsigz8zY4Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXht1ynurs%253D&md5=fde1c71b1fb7bd686abbde10e5121234</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1038%2F367243a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F367243a0%26sid%3Dliteratum%253Aachs%26aulast%3DPicot%26aufirst%3DD.%26aulast%3DLoll%26aufirst%3DP.%2BJ.%26aulast%3DGaravito%26aufirst%3DR.%2BM.%26atitle%3DThe%2520x-ray%2520crystal%2520structure%2520of%2520the%2520membrane%2520protein%2520prostaglandin%2520H2%2520synthase-1%26jtitle%3DNature%2520%2528London%252C%2520United%2520Kingdom%2529%26date%3D1994%26volume%3D367%26spage%3D243%26epage%3D249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Harman, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turman, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozak, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garavito, R. M.</span><span> </span><span class="NLM_article-title">Structural Basis of Enantioselective Inhibition of Cyclooxygenase-1 by S-alpha -Substituted Indomethacin Ethanolamides</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">28096</span><span class="NLM_x">–</span> <span class="NLM_lpage">28105</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=28096-28105&author=C.+A.+Harmanauthor=M.+V.+Turmanauthor=K.+R.+Kozakauthor=L.+J.+Marnettauthor=W.+L.+Smithauthor=R.+M.+Garavito&title=Structural+Basis+of+Enantioselective+Inhibition+of+Cyclooxygenase-1+by+S-alpha+-Substituted+Indomethacin+Ethanolamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarman%26aufirst%3DC.%2BA.%26aulast%3DTurman%26aufirst%3DM.%2BV.%26aulast%3DKozak%26aufirst%3DK.%2BR.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26aulast%3DSmith%26aufirst%3DW.%2BL.%26aulast%3DGaravito%26aufirst%3DR.%2BM.%26atitle%3DStructural%2520Basis%2520of%2520Enantioselective%2520Inhibition%2520of%2520Cyclooxygenase-1%2520by%2520S-alpha%2520-Substituted%2520Indomethacin%2520Ethanolamides%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D28096%26epage%3D28105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Perissutti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Severino, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roviezzo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sautebin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santagada, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caliendo, G.</span><span> </span><span class="NLM_article-title">Synthesis of 2-Methyl-3-indolylacetic Derivatives as Anti-Inflammatory Agents That Inhibit Preferentially Cyclooxygenase 1 without Gastric Damage</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7774</span><span class="NLM_x">–</span> <span class="NLM_lpage">7780</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0608199" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7774-7780&author=E.+Perissuttiauthor=F.+Fiorinoauthor=C.+Rennerauthor=B.+Severinoauthor=F.+Roviezzoauthor=L.+Sautebinauthor=A.+Rossiauthor=G.+Cirinoauthor=V.+Santagadaauthor=G.+Caliendo&title=Synthesis+of+2-Methyl-3-indolylacetic+Derivatives+as+Anti-Inflammatory+Agents+That+Inhibit+Preferentially+Cyclooxygenase+1+without+Gastric+Damage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Fjm0608199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0608199%26sid%3Dliteratum%253Aachs%26aulast%3DPerissutti%26aufirst%3DE.%26aulast%3DFiorino%26aufirst%3DF.%26aulast%3DRenner%26aufirst%3DC.%26aulast%3DSeverino%26aufirst%3DB.%26aulast%3DRoviezzo%26aufirst%3DF.%26aulast%3DSautebin%26aufirst%3DL.%26aulast%3DRossi%26aufirst%3DA.%26aulast%3DCirino%26aufirst%3DG.%26aulast%3DSantagada%26aufirst%3DV.%26aulast%3DCaliendo%26aufirst%3DG.%26atitle%3DSynthesis%2520of%25202-Methyl-3-indolylacetic%2520Derivatives%2520as%2520Anti-Inflammatory%2520Agents%2520That%2520Inhibit%2520Preferentially%2520Cyclooxygenase%25201%2520without%2520Gastric%2520Damage%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7774%26epage%3D7780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Bikzhanova, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toulokhonova, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gately, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, R.</span><span> </span><span class="NLM_article-title">Novel silicon-containing drugs derived from the indomethacin scaffold: Synthesis, characterization and evaluation of biological activity</span> <span class="citation_source-journal">Silicon Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1007%2Fs11201-006-9008-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlGktbvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=209-217&author=G.+A.+Bikzhanovaauthor=I.+S.+Toulokhonovaauthor=S.+Gatelyauthor=R.+West&title=Novel+silicon-containing+drugs+derived+from+the+indomethacin+scaffold%3A+Synthesis%2C+characterization+and+evaluation+of+biological+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Novel silicon-containing drugs derived from the indomethacin scaffold: Synthesis, characterization and evaluation of biological activity</span></div><div class="casAuthors">Bikzhanova, Galina A.; Toulokhonova, Irina S.; Gately, Stephen; West, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Silicon Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3/4</span>),
    <span class="NLM_cas:pages">209-217</span>CODEN:
                <span class="NLM_cas:coden">SCIHB4</span>;
        ISSN:<span class="NLM_cas:issn">1569-0660</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Synthesis, spectroscopic characterization and in vitro pharmacol. and cancer cell growth inhibitory activity studies of new Si-contg. compds. based on the indomethacin scaffold are now reported.  Amidation of the indomethacin carboxylate group using amino-functional silanes, R12SiR(CH2)nNH2 (R1 = Me, R = Me, Ph; R1 = R = OEt, n = 1, 3) generated novel lipophilic derivs. of indomethacin I.  The pharmacol. activity of these derivs. tested against human recombinant cyclooxygenase-1 and 2 demonstrated that the Si-contg. derivs. are cyclooxygenase-2 (COX-2) selective.  The Si-contg. amides of indomethacin demonstrated in vitro growth inhibitory activity against human MiaPaCa-2 pancreatic carcinoma cells at low μM concns.  I (n = 3, R1 = R = Me and n = 1, R1 = Me, R = Ph) exhibited the most potent in vitro antiproliferative activity, with IC50 <6.0 μM, compared to unmodified indomethacin having an IC50100 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoraWf5eDSF17Vg90H21EOLACvtfcHk0lhbERPYJKk8og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlGktbvP&md5=1eb0ca53f2176ad72f8e62cdd9460628</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1007%2Fs11201-006-9008-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11201-006-9008-5%26sid%3Dliteratum%253Aachs%26aulast%3DBikzhanova%26aufirst%3DG.%2BA.%26aulast%3DToulokhonova%26aufirst%3DI.%2BS.%26aulast%3DGately%26aufirst%3DS.%26aulast%3DWest%26aufirst%3DR.%26atitle%3DNovel%2520silicon-containing%2520drugs%2520derived%2520from%2520the%2520indomethacin%2520scaffold%253A%2520Synthesis%252C%2520characterization%2520and%2520evaluation%2520of%2520biological%2520activity%26jtitle%3DSilicon%2520Chem.%26date%3D2007%26volume%3D3%26spage%3D209%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Boltze, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brendler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Opitz, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raddatz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidel, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vollbrecht, D.</span><span> </span><span class="NLM_article-title">Chemical structure and antiinflammatory activity in the group of substituted indole-3-acetic acids</span> <span class="citation_source-journal">Arzneim.-Forsch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1314</span><span class="NLM_x">–</span> <span class="NLM_lpage">1325</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=7191301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADyaL3MXktVKqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1980&pages=1314-1325&author=K.+H.+Boltzeauthor=O.+Brendlerauthor=H.+Jacobiauthor=W.+Opitzauthor=S.+Raddatzauthor=P.+R.+Seidelauthor=D.+Vollbrecht&title=Chemical+structure+and+antiinflammatory+activity+in+the+group+of+substituted+indole-3-acetic+acids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical structure and antiinflammatory activity in the group of substituted indole-3-acetic acids</span></div><div class="casAuthors">Boltze, K. H.; Brendler, O.; Jacobi, H.; Opitz, W.; Raddatz, S.; Seidel, P. R.; Vollbrecht, D.</div><div class="citationInfo"><span class="NLM_cas:title">Arzneimittel-Forschung</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">8A</span>),
    <span class="NLM_cas:pages">1314-25</span>CODEN:
                <span class="NLM_cas:coden">ARZNAD</span>;
        ISSN:<span class="NLM_cas:issn">0004-4172</span>.
    </div><div class="casAbstract">About 110 potential antiinflammatory compds. were prepd. by systematically modifying indometacin (I; R = H) by modifying the α-methylene group, derivatizing the CO2H group, substituting the 4-ClC6H4CO moiety by ether aryl groups, introducing other substituents into the indole ring, and fusing other heterocycles to the indole ring.  Of all these compds., acemetacin (I; R = CH2CO2H) showed ∼2 times the activity of I (R = H) in the kaolin-induced rat paw edema test.  Further modification of acemetacin did not improve its activity.  Apparently substitution of the indole nucleus and the acetoxyacetic acid side chain are responsible for the high activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohHPTw9VSPxbVg90H21EOLACvtfcHk0lhbERPYJKk8og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXktVKqt7c%253D&md5=d9425d40a234ff5569a8e33d3a2c3039</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoltze%26aufirst%3DK.%2BH.%26aulast%3DBrendler%26aufirst%3DO.%26aulast%3DJacobi%26aufirst%3DH.%26aulast%3DOpitz%26aufirst%3DW.%26aulast%3DRaddatz%26aufirst%3DS.%26aulast%3DSeidel%26aufirst%3DP.%2BR.%26aulast%3DVollbrecht%26aufirst%3DD.%26atitle%3DChemical%2520structure%2520and%2520antiinflammatory%2520activity%2520in%2520the%2520group%2520of%2520substituted%2520indole-3-acetic%2520acids%26jtitle%3DArzneim.-Forsch.%26date%3D1980%26volume%3D30%26spage%3D1314%26epage%3D1325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 43 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Carol A. Rouzer, <span class="NLM_string-name hlFld-ContribAuthor">Lawrence J. Marnett</span>. </span><span class="cited-content_cbyCitation_article-title">Structural and Chemical Biology of the Interaction of Cyclooxygenase with Substrates and Non-Steroidal Anti-Inflammatory Drugs. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2020,</strong> <em>120 </em>
                                    (15)
                                     , 7592-7641. <a href="https://doi.org/10.1021/acs.chemrev.0c00215" title="DOI URL">https://doi.org/10.1021/acs.chemrev.0c00215</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.0c00215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.0c00215%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DStructural%252Band%252BChemical%252BBiology%252Bof%252Bthe%252BInteraction%252Bof%252BCyclooxygenase%252Bwith%252BSubstrates%252Band%252BNon-Steroidal%252BAnti-Inflammatory%252BDrugs%26aulast%3DRouzer%26aufirst%3DCarol%2BA.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D25032020%26date%3D01072020%26volume%3D120%26issue%3D15%26spage%3D7592%26epage%3D7641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jeyun Jo, Myeonggyo Jeong, Ji-Su Ahn, Jinia Akter, Hyung-Sik Kim, Young-Ger Suh, <span class="NLM_string-name hlFld-ContribAuthor">Hwayoung Yun</span>. </span><span class="cited-content_cbyCitation_article-title">Total Synthesis of Anmindenol A and Its Application to the Design, Synthesis, and Biological Evaluation of Derivatives Thereof. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (17)
                                     , 10953-10961. <a href="https://doi.org/10.1021/acs.joc.9b01564" title="DOI URL">https://doi.org/10.1021/acs.joc.9b01564</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b01564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b01564%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DTotal%252BSynthesis%252Bof%252BAnmindenol%252BA%252Band%252BIts%252BApplication%252Bto%252Bthe%252BDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BDerivatives%252BThereof%26aulast%3DJo%26aufirst%3DJeyun%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D12062019%26date%3D12082019%26date%3D30072019%26volume%3D84%26issue%3D17%26spage%3D10953%26epage%3D10961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jan Hošek, Veronika Leláková, Pavel Bobál, Hana Pížová, Markéta Gazdová, Milan Malaník, Karolina Jakubczyk, Ondřej Veselý, Přemysl Landa, Veronika Temml, Daniela Schuster, Vilailak Prachyawarakorn, Phanruethai Pailee, Gang Ren, Filip Zpurný, Michal Oravec, <span class="NLM_string-name hlFld-ContribAuthor">Karel Šmejkal</span>. </span><span class="cited-content_cbyCitation_article-title">Prenylated Stilbenoids Affect Inflammation by Inhibiting the NF-κB/AP-1 Signaling Pathway and Cyclooxygenases and Lipoxygenase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Natural Products</span><span> <strong>2019,</strong> <em>82 </em>
                                    (7)
                                     , 1839-1848. <a href="https://doi.org/10.1021/acs.jnatprod.9b00081" title="DOI URL">https://doi.org/10.1021/acs.jnatprod.9b00081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jnatprod.9b00081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jnatprod.9b00081%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Natural%2520Products%26atitle%3DPrenylated%252BStilbenoids%252BAffect%252BInflammation%252Bby%252BInhibiting%252Bthe%252BNF-%2525CE%2525BAB%25252FAP-1%252BSignaling%252BPathway%252Band%252BCyclooxygenases%252Band%252BLipoxygenase%26aulast%3DHo%25C5%25A1ek%26aufirst%3DJan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D27012019%26date%3D03072019%26volume%3D82%26issue%3D7%26spage%3D1839%26epage%3D1848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Antonia Rinaldi, Vittoria Langé, Enrique Gómez-Bengoa, Giovanna Zanella, Dina Scarpi, <span class="NLM_string-name hlFld-ContribAuthor">Ernesto G. Occhiato</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Indenes by Tandem Gold(I)-Catalyzed Claisen Rearrangement/Hydroarylation Reaction of Propargyl Vinyl Ethers. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (10)
                                     , 6298-6311. <a href="https://doi.org/10.1021/acs.joc.9b00646" title="DOI URL">https://doi.org/10.1021/acs.joc.9b00646</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b00646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b00646%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BIndenes%252Bby%252BTandem%252BGold%252528I%252529-Catalyzed%252BClaisen%252BRearrangement%25252FHydroarylation%252BReaction%252Bof%252BPropargyl%252BVinyl%252BEthers%26aulast%3DRinaldi%26aufirst%3DAntonia%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D06032019%26date%3D06052019%26volume%3D84%26issue%3D10%26spage%3D6298%26epage%3D6311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Bharatkumar Chaudhary, Prashant Auti, Suchita Dattatray Shinde, Prasanna Anjaneyulu Yakkala, Deepesh Giri, <span class="NLM_string-name hlFld-ContribAuthor">Satyasheel Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Rh(III)-Catalyzed [3 + 2] Annulation via C–H Activation: Direct Access to Trifluoromethyl-Substituted Indenamines and Aminoindanes. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (8)
                                     , 2763-2767. <a href="https://doi.org/10.1021/acs.orglett.9b00720" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b00720</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b00720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b00720%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DRh%252528III%252529-Catalyzed%252B%25255B3%252B%25252B%252B2%25255D%252BAnnulation%252Bvia%252BC%2525E2%252580%252593H%252BActivation%25253A%252BDirect%252BAccess%252Bto%252BTrifluoromethyl-Substituted%252BIndenamines%252Band%252BAminoindanes%26aulast%3DChaudhary%26aufirst%3DBharatkumar%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D26022019%26date%3D01042019%26volume%3D21%26issue%3D8%26spage%3D2763%26epage%3D2767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tao Zhang, Fan Chen, Xiao-Hong Zhang, Peng-Cheng Qian, <span class="NLM_string-name hlFld-ContribAuthor">Xing-Guo Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-Catalyzed Tandem Carbocyclization and Hetroarylation for the Synthesis of 2-(Trifluoromethyl)indenylmethyleneindoles. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (1)
                                     , 307-313. <a href="https://doi.org/10.1021/acs.joc.8b02781" title="DOI URL">https://doi.org/10.1021/acs.joc.8b02781</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b02781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b02781%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPalladium-Catalyzed%252BTandem%252BCarbocyclization%252Band%252BHetroarylation%252Bfor%252Bthe%252BSynthesis%252Bof%252B2-%252528Trifluoromethyl%252529indenylmethyleneindoles%26aulast%3DZhang%26aufirst%3DTao%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D30102018%26date%3D13122018%26date%3D07122018%26volume%3D84%26issue%3D1%26spage%3D307%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Trimurtulu Kotipalli, <span class="NLM_string-name hlFld-ContribAuthor">Duen-Ren Hou</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Indenes by a BF3·OEt2-Mediated, One-Pot Reaction of Aryl Homopropargyl Alcohols, Aldehydes, and Arenes. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (16)
                                     , 4787-4790. <a href="https://doi.org/10.1021/acs.orglett.8b01929" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b01929</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b01929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b01929%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSynthesis%252Bof%252BIndenes%252Bby%252Ba%252BBF3%2525C2%2525B7OEt2-Mediated%25252C%252BOne-Pot%252BReaction%252Bof%252BAryl%252BHomopropargyl%252BAlcohols%25252C%252BAldehydes%25252C%252Band%252BArenes%26aulast%3DKotipalli%26aufirst%3DTrimurtulu%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D20062018%26date%3D03082018%26volume%3D20%26issue%3D16%26spage%3D4787%26epage%3D4790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patricia  García-García</span>, <span class="hlFld-ContribAuthor ">Ana M.  Sanjuán</span>, <span class="hlFld-ContribAuthor ">Muhammad A.  Rashid</span>, <span class="hlFld-ContribAuthor ">Alberto  Martínez-Cuezva</span>, <span class="hlFld-ContribAuthor ">Manuel A.  Fernández-Rodríguez</span>, <span class="hlFld-ContribAuthor ">Félix  Rodríguez</span>, and <span class="hlFld-ContribAuthor ">Roberto  Sanz</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of Functionalized 1H-Indenes and Benzofulvenes through Iodocyclization of o-(Alkynyl)styrenes. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (2)
                                     , 1155-1165. <a href="https://doi.org/10.1021/acs.joc.6b02788" title="DOI URL">https://doi.org/10.1021/acs.joc.6b02788</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.6b02788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.6b02788%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BFunctionalized%252B1H-Indenes%252Band%252BBenzofulvenes%252Bthrough%252BIodocyclization%252Bof%252Bo-%252528Alkynyl%252529styrenes%26aulast%3DGarc%25C3%25ADa-Garc%25C3%25ADa%26aufirst%3DPatricia%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D21112016%26date%3D30122016%26date%3D20012017%26date%3D19122016%26volume%3D82%26issue%3D2%26spage%3D1155%26epage%3D1165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mary E.  Konkle</span>, <span class="hlFld-ContribAuthor ">Anna L.  Blobaum</span>, <span class="hlFld-ContribAuthor ">Christopher W.  Moth</span>, <span class="hlFld-ContribAuthor ">Jeffery J.  Prusakiewicz</span>, <span class="hlFld-ContribAuthor ">Shu  Xu</span>, <span class="hlFld-ContribAuthor ">Kebreab  Ghebreselasie</span>, <span class="hlFld-ContribAuthor ">Dapo  Akingbade</span>, <span class="hlFld-ContribAuthor ">Aaron T.  Jacobs</span>, <span class="hlFld-ContribAuthor ">Carol A.  Rouzer</span>, <span class="hlFld-ContribAuthor ">Terry P.  Lybrand</span>, and <span class="hlFld-ContribAuthor ">Lawrence J.  Marnett</span>  . </span><span class="cited-content_cbyCitation_article-title">Conservative Secondary Shell Substitution In Cyclooxygenase-2 Reduces Inhibition by Indomethacin Amides and Esters via Altered Enzyme Dynamics. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2016,</strong> <em>55 </em>
                                    (2)
                                     , 348-359. <a href="https://doi.org/10.1021/acs.biochem.5b01222" title="DOI URL">https://doi.org/10.1021/acs.biochem.5b01222</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biochem.5b01222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biochem.5b01222%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DConservative%252BSecondary%252BShell%252BSubstitution%252BIn%252BCyclooxygenase-2%252BReduces%252BInhibition%252Bby%252BIndomethacin%252BAmides%252Band%252BEsters%252Bvia%252BAltered%252BEnzyme%252BDynamics%26aulast%3DKonkle%26aufirst%3DMary%2BE.%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D11112015%26date%3D18122015%26date%3D31122015%26date%3D19012016%26date%3D24122015%26volume%3D55%26issue%3D2%26spage%3D348%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seetharaman  Manojveer</span> and <span class="hlFld-ContribAuthor ">Rengarajan  Balamurugan</span>  . </span><span class="cited-content_cbyCitation_article-title">In Situ Formed Acetal-Facilitated Synthesis of Substituted Indene Derivatives from o-Alkenylbenzaldehydes. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2015,</strong> <em>17 </em>
                                    (14)
                                     , 3600-3603. <a href="https://doi.org/10.1021/acs.orglett.5b01695" title="DOI URL">https://doi.org/10.1021/acs.orglett.5b01695</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.5b01695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.5b01695%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DIn%252BSitu%252BFormed%252BAcetal-Facilitated%252BSynthesis%252Bof%252BSubstituted%252BIndene%252BDerivatives%252Bfrom%252Bo-Alkenylbenzaldehydes%26aulast%3DManojveer%26aufirst%3DSeetharaman%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D10062015%26date%3D07072015%26date%3D17072015%26volume%3D17%26issue%3D14%26spage%3D3600%26epage%3D3603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Md. Jashim  Uddin</span>, <span class="hlFld-ContribAuthor ">Anna V.  Elleman</span>, <span class="hlFld-ContribAuthor ">Kebreab  Ghebreselasie</span>, <span class="hlFld-ContribAuthor ">Cristina K.  Daniel</span>, <span class="hlFld-ContribAuthor ">Brenda C.  Crews</span>, <span class="hlFld-ContribAuthor ">Kellie D.  Nance</span>, <span class="hlFld-ContribAuthor ">Tamanna  Huda</span>, and <span class="hlFld-ContribAuthor ">Lawrence J.  Marnett</span>  . </span><span class="cited-content_cbyCitation_article-title">Design of Fluorine-Containing 3,4-Diarylfuran-2(5H)-ones as Selective COX-1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>5 </em>
                                    (11)
                                     , 1254-1258. <a href="https://doi.org/10.1021/ml500344j" title="DOI URL">https://doi.org/10.1021/ml500344j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml500344j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml500344j%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Bof%252BFluorine-Containing%252B3%25252C4-Diarylfuran-2%2525285H%252529-ones%252Bas%252BSelective%252BCOX-1%252BInhibitors%26aulast%3DUddin%26aufirst%3DMd.%2BJashim%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D25082014%26date%3D12102014%26date%3D17102014%26date%3D13112014%26date%3D12102014%26volume%3D5%26issue%3D11%26spage%3D1254%26epage%3D1258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sengodagounder  Muthusamy</span> and <span class="hlFld-ContribAuthor ">Manickasamy  Sivaguru</span>  . </span><span class="cited-content_cbyCitation_article-title">Atom-Economical Access to Highly Substituted Indenes and Furan-2-ones via Tandem Reaction of Diazo Compounds and Propargyl Alcohols. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2014,</strong> <em>16 </em>
                                    (16)
                                     , 4248-4251. <a href="https://doi.org/10.1021/ol501942y" title="DOI URL">https://doi.org/10.1021/ol501942y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol501942y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol501942y%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DAtom-Economical%252BAccess%252Bto%252BHighly%252BSubstituted%252BIndenes%252Band%252BFuran-2-ones%252Bvia%252BTandem%252BReaction%252Bof%252BDiazo%252BCompounds%252Band%252BPropargyl%252BAlcohols%26aulast%3DMuthusamy%26aufirst%3DSengodagounder%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D04072014%26date%3D01082014%26date%3D15082014%26volume%3D16%26issue%3D16%26spage%3D4248%26epage%3D4251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andy J.  Liedtke</span>, <span class="hlFld-ContribAuthor ">Adegoke O.  Adeniji</span>, <span class="hlFld-ContribAuthor ">Mo  Chen</span>, <span class="hlFld-ContribAuthor ">Michael C.  Byrns</span>, <span class="hlFld-ContribAuthor ">Yi  Jin</span>, <span class="hlFld-ContribAuthor ">David W.  Christianson</span>, <span class="hlFld-ContribAuthor ">Lawrence J.  Marnett</span>, and <span class="hlFld-ContribAuthor ">Trevor M.  Penning</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of Potent and Selective Indomethacin Analogues for the Inhibition of AKR1C3 (Type 5 17β-Hydroxysteroid Dehydrogenase/Prostaglandin F Synthase) in Castrate-Resistant Prostate Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (6)
                                     , 2429-2446. <a href="https://doi.org/10.1021/jm3017656" title="DOI URL">https://doi.org/10.1021/jm3017656</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3017656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3017656%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BPotent%252Band%252BSelective%252BIndomethacin%252BAnalogues%252Bfor%252Bthe%252BInhibition%252Bof%252BAKR1C3%252B%252528Type%252B5%252B17%2525CE%2525B2-Hydroxysteroid%252BDehydrogenase%25252FProstaglandin%252BF%252BSynthase%252529%252Bin%252BCastrate-Resistant%252BProstate%252BCancer%26aulast%3DLiedtke%26aufirst%3DAndy%2BJ.%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D03122012%26date%3D13032013%26date%3D28032013%26date%3D22022013%26volume%3D56%26issue%3D6%26spage%3D2429%26epage%3D2446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bagrat A.  Shainyan</span> and <span class="hlFld-ContribAuthor ">Ljudmila L.  Tolstikova</span>  . </span><span class="cited-content_cbyCitation_article-title">Trifluoromethanesulfonamides and Related Compounds. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2013,</strong> <em>113 </em>
                                    (1)
                                     , 699-733. <a href="https://doi.org/10.1021/cr300220h" title="DOI URL">https://doi.org/10.1021/cr300220h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr300220h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr300220h%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DTrifluoromethanesulfonamides%252Band%252BRelated%252BCompounds%26aulast%3DShainyan%26aufirst%3DBagrat%2BA.%26date%3D2013%26date%3D2012%26date%3D2012%26date%3D01062012%26date%3D20112012%26date%3D09012013%26volume%3D113%26issue%3D1%26spage%3D699%26epage%3D733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Parteek  Prasher</span>, <span class="hlFld-ContribAuthor ">Mousmee  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal Chemistry of Indane and Its Analogues: A Mini Review. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (11)
                                     , 2658-2677. <a href="https://doi.org/10.1002/slct.202100177" title="DOI URL">https://doi.org/10.1002/slct.202100177</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202100177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202100177%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DMedicinal%252BChemistry%252Bof%252BIndane%252Band%252BIts%252BAnalogues%25253A%252BA%252BMini%252BReview%26aulast%3DPrasher%26aufirst%3DParteek%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D11%26spage%3D2658%26epage%3D2677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura  Lucarini</span>, <span class="hlFld-ContribAuthor ">Mariaconcetta  Durante</span>, <span class="hlFld-ContribAuthor ">Silvia  Sgambellone</span>, <span class="hlFld-ContribAuthor ">Cecilia  Lanzi</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Bigagli</span>, <span class="hlFld-ContribAuthor ">Ozlem  Akgul</span>, <span class="hlFld-ContribAuthor ">Emanuela  Masini</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Carta</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of New NSAID-CAI Hybrid Compounds in Inflammation and Lung Fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (9)
                                     , 1307. <a href="https://doi.org/10.3390/biom10091307" title="DOI URL">https://doi.org/10.3390/biom10091307</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10091307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10091307%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DEffects%252Bof%252BNew%252BNSAID-CAI%252BHybrid%252BCompounds%252Bin%252BInflammation%252Band%252BLung%252BFibrosis%26aulast%3DLucarini%26aufirst%3DLaura%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D9%26spage%3D1307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bharatkumar  Chaudhary</span>, <span class="hlFld-ContribAuthor ">Neeraj  Kulkarni</span>, <span class="hlFld-ContribAuthor ">Satyasheel  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Rhodium(
              iii
              )-catalyzed synthesis of 3-trifluoromethylindanones from
              N
              -methoxybenzamides
              via
              C–H activation and Claisen/retro-Claisen reaction. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2020,</strong> <em>7 </em>
                                    (12)
                                     , 1512-1519. <a href="https://doi.org/10.1039/D0QO00330A" title="DOI URL">https://doi.org/10.1039/D0QO00330A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QO00330A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QO00330A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DRhodium%252528%252Biii%252B%252529-catalyzed%252Bsynthesis%252Bof%252B3-trifluoromethylindanones%252Bfrom%252BN%252B-methoxybenzamides%252Bvia%252BC%2525E2%252580%252593H%252Bactivation%252Band%252BClaisen%25252Fretro-Claisen%252Breaction%26aulast%3DChaudhary%26aufirst%3DBharatkumar%26date%3D2020%26date%3D2020%26volume%3D7%26issue%3D12%26spage%3D1512%26epage%3D1519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mashooq A.  Bhat</span>, <span class="hlFld-ContribAuthor ">Mohamed A.  Al-Omar</span>, <span class="hlFld-ContribAuthor ">Nawaf A.  Alsaif</span>, <span class="hlFld-ContribAuthor ">Abdulrahman A.  Almehizia</span>, <span class="hlFld-ContribAuthor ">Ahmed M.  Naglah</span>, <span class="hlFld-ContribAuthor ">Suhail  Razak</span>, <span class="hlFld-ContribAuthor ">Azmat Ali  Khan</span>, <span class="hlFld-ContribAuthor ">Naeem Mahmood  Ashraf</span>. </span><span class="cited-content_cbyCitation_article-title">Novel sulindac derivatives: synthesis, characterisation, evaluation of antioxidant, analgesic, anti-inflammatory, ulcerogenic and COX-2 inhibition activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2020,</strong> <em>35 </em>
                                    (1)
                                     , 921-934. <a href="https://doi.org/10.1080/14756366.2020.1746783" title="DOI URL">https://doi.org/10.1080/14756366.2020.1746783</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2020.1746783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2020.1746783%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bsulindac%252Bderivatives%25253A%252Bsynthesis%25252C%252Bcharacterisation%25252C%252Bevaluation%252Bof%252Bantioxidant%25252C%252Banalgesic%25252C%252Banti-inflammatory%25252C%252Bulcerogenic%252Band%252BCOX-2%252Binhibition%252Bactivity%26aulast%3DBhat%26aufirst%3DMashooq%2BA.%26date%3D2020%26date%3D2020%26volume%3D35%26issue%3D1%26spage%3D921%26epage%3D934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonia  Rinaldi</span>, <span class="hlFld-ContribAuthor ">Dina  Scarpi</span>, <span class="hlFld-ContribAuthor ">Ernesto G.  Occhiato</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the Synthesis of Indenes. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>2019 </em>
                                    (45)
                                     , 7401-7419. <a href="https://doi.org/10.1002/ejoc.201901425" title="DOI URL">https://doi.org/10.1002/ejoc.201901425</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201901425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201901425%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BSynthesis%252Bof%252BIndenes%26aulast%3DRinaldi%26aufirst%3DAntonia%26date%3D2019%26date%3D2019%26volume%3D2019%26issue%3D45%26spage%3D7401%26epage%3D7419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luminita  Crisan</span>, <span class="hlFld-ContribAuthor ">Ana  Borota</span>, <span class="hlFld-ContribAuthor ">Alina  Bora</span>, <span class="hlFld-ContribAuthor ">Liliana  Pacureanu</span>. </span><span class="cited-content_cbyCitation_article-title">Diarylthiazole and diarylimidazole selective COX-1 inhibitor analysis through pharmacophore modeling, virtual screening, and DFT-based approaches. </span><span class="cited-content_cbyCitation_journal-name">Structural Chemistry</span><span> <strong>2019,</strong> <em>30 </em>
                                    (6)
                                     , 2311-2326. <a href="https://doi.org/10.1007/s11224-019-01414-w" title="DOI URL">https://doi.org/10.1007/s11224-019-01414-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11224-019-01414-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11224-019-01414-w%26sid%3Dliteratum%253Aachs%26jtitle%3DStructural%2520Chemistry%26atitle%3DDiarylthiazole%252Band%252Bdiarylimidazole%252Bselective%252BCOX-1%252Binhibitor%252Banalysis%252Bthrough%252Bpharmacophore%252Bmodeling%25252C%252Bvirtual%252Bscreening%25252C%252Band%252BDFT-based%252Bapproaches%26aulast%3DCrisan%26aufirst%3DLuminita%26date%3D2019%26date%3D2019%26volume%3D30%26issue%3D6%26spage%3D2311%26epage%3D2326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammad Rizki Fadhil  Pratama</span>, <span class="hlFld-ContribAuthor ">Hadi  Poerwono</span>, <span class="hlFld-ContribAuthor ">Siswandono  Siswodiharjo</span>. </span><span class="cited-content_cbyCitation_article-title">ADMET properties of novel 5-O-benzoylpinostrobin derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Basic and Clinical Physiology and Pharmacology</span><span> <strong>2019,</strong> <em>30 </em>
                                    (6)
                                     <a href="https://doi.org/10.1515/jbcpp-2019-0251" title="DOI URL">https://doi.org/10.1515/jbcpp-2019-0251</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/jbcpp-2019-0251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fjbcpp-2019-0251%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Basic%2520and%2520Clinical%2520Physiology%2520and%2520Pharmacology%26atitle%3DADMET%252Bproperties%252Bof%252Bnovel%252B5-O-benzoylpinostrobin%252Bderivatives%26aulast%3DPratama%26aufirst%3DMohammad%2BRizki%2BFadhil%26date%3D2019%26volume%3D30%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Trimurtulu  Kotipalli</span>, <span class="hlFld-ContribAuthor ">Duen‐Ren  Hou</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 3‐Bromoindenes from 4‐Alkynyl Alcohols/Sulfonamides and Aldehydes via Prins Cyclization, Ring‐Opening and Friedel‐Crafts Reactions. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>8 </em>
                                    (8)
                                     , 1561-1571. <a href="https://doi.org/10.1002/ajoc.201900292" title="DOI URL">https://doi.org/10.1002/ajoc.201900292</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.201900292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.201900292%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B3%2525E2%252580%252590Bromoindenes%252Bfrom%252B4%2525E2%252580%252590Alkynyl%252BAlcohols%25252FSulfonamides%252Band%252BAldehydes%252Bvia%252BPrins%252BCyclization%25252C%252BRing%2525E2%252580%252590Opening%252Band%252BFriedel%2525E2%252580%252590Crafts%252BReactions%26aulast%3DKotipalli%26aufirst%3DTrimurtulu%26date%3D2019%26date%3D2019%26volume%3D8%26issue%3D8%26spage%3D1561%26epage%3D1571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin‐Bao  Peng</span>, <span class="hlFld-ContribAuthor ">Fu‐Peng  Wu</span>, <span class="hlFld-ContribAuthor ">Anke  Spannenberg</span>, <span class="hlFld-ContribAuthor ">Xiao‐Feng  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium‐Catalyzed Tunable Carbonylative Synthesis of Enones and Benzofulvenes. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2019,</strong> <em>96 </em><a href="https://doi.org/10.1002/chem.201901530" title="DOI URL">https://doi.org/10.1002/chem.201901530</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201901530&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201901530%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DPalladium%2525E2%252580%252590Catalyzed%252BTunable%252BCarbonylative%252BSynthesis%252Bof%252BEnones%252Band%252BBenzofulvenes%26aulast%3DPeng%26aufirst%3DJin%25E2%2580%2590Bao%26date%3D2019%26date%3D2019%26volume%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akari  Ikeda</span>, <span class="hlFld-ContribAuthor ">Eishi  Funakoshi</span>, <span class="hlFld-ContribAuthor ">Mitsugu  Araki</span>, <span class="hlFld-ContribAuthor ">Biao  Ma</span>, <span class="hlFld-ContribAuthor ">Yukiko  Karuo</span>, <span class="hlFld-ContribAuthor ">Atsushi  Tarui</span>, <span class="hlFld-ContribAuthor ">Kazuyuki  Sato</span>, <span class="hlFld-ContribAuthor ">Yasushi  Okuno</span>, <span class="hlFld-ContribAuthor ">Kentaro  Kawai</span>, <span class="hlFld-ContribAuthor ">Masaaki  Omote</span>. </span><span class="cited-content_cbyCitation_article-title">Structural modification of indomethacin toward selective inhibition of COX-2 with a significant increase in van der Waals contributions. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (9)
                                     , 1789-1794. <a href="https://doi.org/10.1016/j.bmc.2019.03.021" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.03.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.03.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.03.021%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DStructural%252Bmodification%252Bof%252Bindomethacin%252Btoward%252Bselective%252Binhibition%252Bof%252BCOX-2%252Bwith%252Ba%252Bsignificant%252Bincrease%252Bin%252Bvan%252Bder%252BWaals%252Bcontributions%26aulast%3DIkeda%26aufirst%3DAkari%26date%3D2019%26volume%3D27%26issue%3D9%26spage%3D1789%26epage%3D1794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Zhang</span>, <span class="hlFld-ContribAuthor ">Jun‐Shu  Sun</span>, <span class="hlFld-ContribAuthor ">Ying‐Qi  Xia</span>, <span class="hlFld-ContribAuthor ">Lin  Dong</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient Synthesis of Functionalized Indene Derivatives via Rh(III)‐Catalyzed Cascade Reaction between Oxadiazoles and Allylic Alcohols. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2019,</strong> <em>361 </em>
                                    (9)
                                     , 2037-2041. <a href="https://doi.org/10.1002/adsc.201801606" title="DOI URL">https://doi.org/10.1002/adsc.201801606</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201801606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201801606%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DEfficient%252BSynthesis%252Bof%252BFunctionalized%252BIndene%252BDerivatives%252Bvia%252BRh%252528III%252529%2525E2%252580%252590Catalyzed%252BCascade%252BReaction%252Bbetween%252BOxadiazoles%252Band%252BAllylic%252BAlcohols%26aulast%3DZhang%26aufirst%3DJing%26date%3D2019%26date%3D2019%26volume%3D361%26issue%3D9%26spage%3D2037%26epage%3D2041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinhua  Li</span>, <span class="hlFld-ContribAuthor ">Huijun  Kang</span>, <span class="hlFld-ContribAuthor ">Kaiyue  Zhuo</span>, <span class="hlFld-ContribAuthor ">Qingde  Zhuo</span>, <span class="hlFld-ContribAuthor ">Hong  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu-Mei  Lin</span>, <span class="hlFld-ContribAuthor ">Haiping  Xia</span>. </span><span class="cited-content_cbyCitation_article-title">Alternation of Metal-Bridged Metallacycle Skeletons: From Ruthenapentalyne to Ruthenapentalene and Ruthenaindene Derivative. </span><span class="cited-content_cbyCitation_journal-name">Chinese Journal of Chemistry</span><span> <strong>2018,</strong> <em>36 </em>
                                    (12)
                                     , 1156-1160. <a href="https://doi.org/10.1002/cjoc.201800362" title="DOI URL">https://doi.org/10.1002/cjoc.201800362</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cjoc.201800362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcjoc.201800362%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Journal%2520of%2520Chemistry%26atitle%3DAlternation%252Bof%252BMetal-Bridged%252BMetallacycle%252BSkeletons%25253A%252BFrom%252BRuthenapentalyne%252Bto%252BRuthenapentalene%252Band%252BRuthenaindene%252BDerivative%26aulast%3DLi%26aufirst%3DJinhua%26date%3D2018%26date%3D2018%26volume%3D36%26issue%3D12%26spage%3D1156%26epage%3D1160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Danielle Cristina  Zimmermann-Franco</span>, <span class="hlFld-ContribAuthor ">Bruna  Esteves</span>, <span class="hlFld-ContribAuthor ">Leticia Moroni  Lacerda</span>, <span class="hlFld-ContribAuthor ">Isabela de Oliveira  Souza</span>, <span class="hlFld-ContribAuthor ">Juliana Alves dos  Santos</span>, <span class="hlFld-ContribAuthor ">Nícolas de Castro Campos  Pinto</span>, <span class="hlFld-ContribAuthor ">Elita  Scio</span>, <span class="hlFld-ContribAuthor ">Adilson David  da Silva</span>, <span class="hlFld-ContribAuthor ">Gilson Costa  Macedo</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro and in vivo anti-inflammatory properties of imine resveratrol analogues. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (17)
                                     , 4898-4906. <a href="https://doi.org/10.1016/j.bmc.2018.08.029" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.08.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.08.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.08.029%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DIn%252Bvitro%252Band%252Bin%252Bvivo%252Banti-inflammatory%252Bproperties%252Bof%252Bimine%252Bresveratrol%252Banalogues%26aulast%3DZimmermann-Franco%26aufirst%3DDanielle%2BCristina%26date%3D2018%26volume%3D26%26issue%3D17%26spage%3D4898%26epage%3D4906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rongnan  Yi</span>, <span class="hlFld-ContribAuthor ">Jinyang  Chen</span>, <span class="hlFld-ContribAuthor ">Xueyan  Wang</span>, <span class="hlFld-ContribAuthor ">Zhiwu  Liang</span>, <span class="hlFld-ContribAuthor ">Xinhua  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">A Rapid and Highly Efficient Method for the Synthesis of Benzofulvenes via CsOH-Catalyzed Condensation of Indene and Aldehydes. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>2018 </em>
                                    (11)
                                     , 1347-1351. <a href="https://doi.org/10.1002/ejoc.201701710" title="DOI URL">https://doi.org/10.1002/ejoc.201701710</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201701710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201701710%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DA%252BRapid%252Band%252BHighly%252BEfficient%252BMethod%252Bfor%252Bthe%252BSynthesis%252Bof%252BBenzofulvenes%252Bvia%252BCsOH-Catalyzed%252BCondensation%252Bof%252BIndene%252Band%252BAldehydes%26aulast%3DYi%26aufirst%3DRongnan%26date%3D2018%26date%3D2018%26volume%3D2018%26issue%3D11%26spage%3D1347%26epage%3D1351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi  Chang</span>, <span class="hlFld-ContribAuthor ">Wen-Hsien  Hsu</span>, <span class="hlFld-ContribAuthor ">Wen-Bin  Yang</span>, <span class="hlFld-ContribAuthor ">Thanasekaran  Jayakumar</span>, <span class="hlFld-ContribAuthor ">Tzu-Yin  Lee</span>, <span class="hlFld-ContribAuthor ">Joen-Rong  Sheu</span>, <span class="hlFld-ContribAuthor ">Wan-Jung  Lu</span>, <span class="hlFld-ContribAuthor ">Jiun-Yi  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-activity relationship of three synthesized benzimidazole-based oligosaccharides in human platelet activation. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Medicine</span><span> <strong>2017,</strong> <em>40 </em>
                                    (5)
                                     , 1520-1528. <a href="https://doi.org/10.3892/ijmm.2017.3133" title="DOI URL">https://doi.org/10.3892/ijmm.2017.3133</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/ijmm.2017.3133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fijmm.2017.3133%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Medicine%26atitle%3DStructure-activity%252Brelationship%252Bof%252Bthree%252Bsynthesized%252Bbenzimidazole-based%252Boligosaccharides%252Bin%252Bhuman%252Bplatelet%252Bactivation%26aulast%3DChang%26aufirst%3DYi%26date%3D2017%26date%3D2017%26volume%3D40%26issue%3D5%26spage%3D1520%26epage%3D1528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Swati  Singh</span>, <span class="hlFld-ContribAuthor ">Manika  Awasthi</span>, <span class="hlFld-ContribAuthor ">Veda P.  Pandey</span>, <span class="hlFld-ContribAuthor ">Upendra N.  Dwivedi</span>. </span><span class="cited-content_cbyCitation_article-title">Plant derived anti-cancerous secondary metabolites as multipronged inhibitor of COX, Topo, and aromatase: molecular modeling and dynamics simulation analyses. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2017,</strong> <em>35 </em>
                                    (14)
                                     , 3082-3097. <a href="https://doi.org/10.1080/07391102.2016.1241720" title="DOI URL">https://doi.org/10.1080/07391102.2016.1241720</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2016.1241720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2016.1241720%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DPlant%252Bderived%252Banti-cancerous%252Bsecondary%252Bmetabolites%252Bas%252Bmultipronged%252Binhibitor%252Bof%252BCOX%25252C%252BTopo%25252C%252Band%252Baromatase%25253A%252Bmolecular%252Bmodeling%252Band%252Bdynamics%252Bsimulation%252Banalyses%26aulast%3DSingh%26aufirst%3DSwati%26date%3D2017%26date%3D2016%26volume%3D35%26issue%3D14%26spage%3D3082%26epage%3D3097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">André L.  Lourenço</span>, <span class="hlFld-ContribAuthor ">Raquel R.S.  Salvador</span>, <span class="hlFld-ContribAuthor ">Leonardo A.  Silva</span>, <span class="hlFld-ContribAuthor ">Max S.  Saito</span>, <span class="hlFld-ContribAuthor ">Juliana F.R.  Mello</span>, <span class="hlFld-ContribAuthor ">Lúcio M.  Cabral</span>, <span class="hlFld-ContribAuthor ">Carlos R.  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Maria A.F.  Vera</span>, <span class="hlFld-ContribAuthor ">Estela M.F.  Muri</span>, <span class="hlFld-ContribAuthor ">Alessandra M.T.  de Souza</span>, <span class="hlFld-ContribAuthor ">Charles S.  Craik</span>, <span class="hlFld-ContribAuthor ">Luiza R.S.  Dias</span>, <span class="hlFld-ContribAuthor ">Helena C.  Castro</span>, <span class="hlFld-ContribAuthor ">Plínio C.  Sathler</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and mechanistic evaluation of novel N ’-benzylidene-carbohydrazide-1 H -pyrazolo[3,4 -b ]pyridine derivatives as non-anionic antiplatelet agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>135 </em>, 213-229. <a href="https://doi.org/10.1016/j.ejmech.2017.04.023" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.04.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.04.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.04.023%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bmechanistic%252Bevaluation%252Bof%252Bnovel%252BN%252B%2525E2%252580%252599-benzylidene-carbohydrazide-1%252BH%252B-pyrazolo%25255B3%25252C4%252B-b%252B%25255Dpyridine%252Bderivatives%252Bas%252Bnon-anionic%252Bantiplatelet%252Bagents%26aulast%3DLouren%25C3%25A7o%26aufirst%3DAndr%25C3%25A9%2BL.%26date%3D2017%26volume%3D135%26spage%3D213%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tohasib Yusub  Chaudhari</span>, <span class="hlFld-ContribAuthor ">Sandeep K.  Ginotra</span>, <span class="hlFld-ContribAuthor ">Vibha  Tandon</span>. </span><span class="cited-content_cbyCitation_article-title">Facile access to functionalized indenes and fused quinolines by regioselective 5-
              enolexo
              -dig Michael addition and cyclization reactions. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2017,</strong> <em>15 </em>
                                    (44)
                                     , 9319-9330. <a href="https://doi.org/10.1039/C7OB02498C" title="DOI URL">https://doi.org/10.1039/C7OB02498C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7OB02498C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7OB02498C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DFacile%252Baccess%252Bto%252Bfunctionalized%252Bindenes%252Band%252Bfused%252Bquinolines%252Bby%252Bregioselective%252B5-%252Benolexo%252B-dig%252BMichael%252Baddition%252Band%252Bcyclization%252Breactions%26aulast%3DChaudhari%26aufirst%3DTohasib%2BYusub%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D44%26spage%3D9319%26epage%3D9330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Omar  Gómez-García</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Gómez</span>, <span class="hlFld-ContribAuthor ">César  Monzón-González</span>, <span class="hlFld-ContribAuthor ">Teresa  Ramírez-Apan</span>, <span class="hlFld-ContribAuthor ">Cecilio  Álvarez-Toledano</span>. </span><span class="cited-content_cbyCitation_article-title">An Efficient Strategy for the Synthesis of 1-(Trifluoromethylsulfonamido)propan-2-yl Esters and the Evaluation of Their Cytotoxic Activity. </span><span class="cited-content_cbyCitation_journal-name">CHEMICAL & PHARMACEUTICAL BULLETIN</span><span> <strong>2017,</strong> <em>65 </em>
                                    (3)
                                     , 248-252. <a href="https://doi.org/10.1248/cpb.c16-00724" title="DOI URL">https://doi.org/10.1248/cpb.c16-00724</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/cpb.c16-00724&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fcpb.c16-00724%26sid%3Dliteratum%253Aachs%26jtitle%3DCHEMICAL%2520%2526%2520PHARMACEUTICAL%2520BULLETIN%26atitle%3DAn%252BEfficient%252BStrategy%252Bfor%252Bthe%252BSynthesis%252Bof%252B1-%252528Trifluoromethylsulfonamido%252529propan-2-yl%252BEsters%252Band%252Bthe%252BEvaluation%252Bof%252BTheir%252BCytotoxic%252BActivity%26aulast%3DG%25C3%25B3mez-Garc%25C3%25ADa%26aufirst%3DOmar%26date%3D2017%26volume%3D65%26issue%3D3%26spage%3D248%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Max Seidy  Saito</span>, <span class="hlFld-ContribAuthor ">André Luiz  Lourenço</span>, <span class="hlFld-ContribAuthor ">Luiza Rosaria Sousa  Dias</span>, <span class="hlFld-ContribAuthor ">Antônio Carlos Carreira  Freitas</span>, <span class="hlFld-ContribAuthor ">Maíra Ingrid  Vitorino</span>, <span class="hlFld-ContribAuthor ">Magaly Girão  Albuquerque</span>, <span class="hlFld-ContribAuthor ">Carlos Rangel  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Lúcio Mendes  Cabral</span>, <span class="hlFld-ContribAuthor ">Eliane Pedra  Dias</span>, <span class="hlFld-ContribAuthor ">Helena Carla  Castro</span>, <span class="hlFld-ContribAuthor ">Plínio Cunha  Satlher</span>. </span><span class="cited-content_cbyCitation_article-title">Antiplatelet pyrazolopyridines derivatives: pharmacological, biochemical and toxicological characterization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2016,</strong> <em>31 </em>
                                    (6)
                                     , 1591-1601. <a href="https://doi.org/10.3109/14756366.2016.1158712" title="DOI URL">https://doi.org/10.3109/14756366.2016.1158712</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/14756366.2016.1158712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F14756366.2016.1158712%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DAntiplatelet%252Bpyrazolopyridines%252Bderivatives%25253A%252Bpharmacological%25252C%252Bbiochemical%252Band%252Btoxicological%252Bcharacterization%26aulast%3DSaito%26aufirst%3DMax%2BSeidy%26date%3D2016%26date%3D2016%26volume%3D31%26issue%3D6%26spage%3D1591%26epage%3D1601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paola  Vitale</span>, <span class="hlFld-ContribAuthor ">Andrea  Panella</span>, <span class="hlFld-ContribAuthor ">Antonio  Scilimati</span>, <span class="hlFld-ContribAuthor ">Maria Grazia  Perrone</span>. </span><span class="cited-content_cbyCitation_article-title">COX-1 Inhibitors: Beyond Structure Toward Therapy. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2016,</strong> <em>36 </em>
                                    (4)
                                     , 641-671. <a href="https://doi.org/10.1002/med.21389" title="DOI URL">https://doi.org/10.1002/med.21389</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21389%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DCOX-1%252BInhibitors%25253A%252BBeyond%252BStructure%252BToward%252BTherapy%26aulast%3DVitale%26aufirst%3DPaola%26date%3D2016%26date%3D2016%26volume%3D36%26issue%3D4%26spage%3D641%26epage%3D671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ben  Ma</span>, <span class="hlFld-ContribAuthor ">Ziang  Wu</span>, <span class="hlFld-ContribAuthor ">Ben  Huang</span>, <span class="hlFld-ContribAuthor ">Lu  Liu</span>, <span class="hlFld-ContribAuthor ">Junliang  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Gold-catalysed facile access to indene scaffolds via sequential C–H functionalization and 5-endo-dig carbocyclization. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2016,</strong> <em>52 </em>
                                    (60)
                                     , 9351-9354. <a href="https://doi.org/10.1039/C6CC04034A" title="DOI URL">https://doi.org/10.1039/C6CC04034A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6CC04034A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6CC04034A%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DGold-catalysed%252Bfacile%252Baccess%252Bto%252Bindene%252Bscaffolds%252Bvia%252Bsequential%252BC%2525E2%252580%252593H%252Bfunctionalization%252Band%252B5-endo-dig%252Bcarbocyclization%26aulast%3DMa%26aufirst%3DBen%26date%3D2016%26date%3D2016%26volume%3D52%26issue%3D60%26spage%3D9351%26epage%3D9354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Markella  Konstantinidou</span>, <span class="hlFld-ContribAuthor ">Alice  Gkermani</span>, <span class="hlFld-ContribAuthor ">Dimitra  Hadjipavlou-Litina</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Pharmacochemistry of New Pleiotropic  Pyrrolyl Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2015,</strong> <em>20 </em>
                                    (9)
                                     , 16354-16374. <a href="https://doi.org/10.3390/molecules200916354" title="DOI URL">https://doi.org/10.3390/molecules200916354</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules200916354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules200916354%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BPharmacochemistry%252Bof%252BNew%252BPleiotropic%252BPyrrolyl%252BDerivatives%26aulast%3DKonstantinidou%26aufirst%3DMarkella%26date%3D2015%26date%3D2015%26volume%3D20%26issue%3D9%26spage%3D16354%26epage%3D16374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">André  Lourenço</span>, <span class="hlFld-ContribAuthor ">Max  Saito</span>, <span class="hlFld-ContribAuthor ">Luís  Dorneles</span>, <span class="hlFld-ContribAuthor ">Gil  Viana</span>, <span class="hlFld-ContribAuthor ">Plínio  Sathler</span>, <span class="hlFld-ContribAuthor ">Lúcia  Aguiar</span>, <span class="hlFld-ContribAuthor ">Marcelo  de Pádula</span>, <span class="hlFld-ContribAuthor ">Thaisa  Domingos</span>, <span class="hlFld-ContribAuthor ">Aline  Fraga</span>, <span class="hlFld-ContribAuthor ">Carlos  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Valeria  de Sousa</span>, <span class="hlFld-ContribAuthor ">Helena  Castro</span>, <span class="hlFld-ContribAuthor ">Lucio  Cabral</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Antiplatelet Activity of Antithrombotic  Thiourea Compounds: Biological and Structure-Activity Relationship Studies. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2015,</strong> <em>20 </em>
                                    (4)
                                     , 7174-7200. <a href="https://doi.org/10.3390/molecules20047174" title="DOI URL">https://doi.org/10.3390/molecules20047174</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules20047174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules20047174%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BAntiplatelet%252BActivity%252Bof%252BAntithrombotic%252BThiourea%252BCompounds%25253A%252BBiological%252Band%252BStructure-Activity%252BRelationship%252BStudies%26aulast%3DLouren%25C3%25A7o%26aufirst%3DAndr%25C3%25A9%26date%3D2015%26date%3D2015%26volume%3D20%26issue%3D4%26spage%3D7174%26epage%3D7200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sharad Kumar  Suthar</span>, <span class="hlFld-ContribAuthor ">Manu  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Developments in Chimeric NSAIDs as Safer Anti-Inflammatory Agents. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2015,</strong> <em>35 </em>
                                    (2)
                                     , 341-407. <a href="https://doi.org/10.1002/med.21331" title="DOI URL">https://doi.org/10.1002/med.21331</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21331&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21331%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DRecent%252BDevelopments%252Bin%252BChimeric%252BNSAIDs%252Bas%252BSafer%252BAnti-Inflammatory%252BAgents%26aulast%3DSuthar%26aufirst%3DSharad%2BKumar%26date%3D2015%26date%3D2014%26volume%3D35%26issue%3D2%26spage%3D341%26epage%3D407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sikkandarkani  Akbar</span>, <span class="hlFld-ContribAuthor ">Kannupal  Srinivasan</span>. </span><span class="cited-content_cbyCitation_article-title">Iron(
              iii
              ) halide or iodine-promoted synthesis of 3-haloindene derivatives from o-alkynylarene chalcones. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2015,</strong> <em>5 </em>
                                    (8)
                                     , 5542-5545. <a href="https://doi.org/10.1039/C4RA14935A" title="DOI URL">https://doi.org/10.1039/C4RA14935A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4RA14935A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4RA14935A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DIron%252528%252Biii%252B%252529%252Bhalide%252Bor%252Biodine-promoted%252Bsynthesis%252Bof%252B3-haloindene%252Bderivatives%252Bfrom%252Bo-alkynylarene%252Bchalcones%26aulast%3DAkbar%26aufirst%3DSikkandarkani%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D8%26spage%3D5542%26epage%3D5545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tamanna  Narsinghani</span>, <span class="hlFld-ContribAuthor ">Rajesh  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Lead Optimization on Conventional Non-Steroidal Anti-Inflammatory Drugs: An Approach to Reduce Gastrointestinal Toxicity. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2014,</strong> <em>84 </em>
                                    (1)
                                     , 1-23. <a href="https://doi.org/10.1111/cbdd.12292" title="DOI URL">https://doi.org/10.1111/cbdd.12292</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12292%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DLead%252BOptimization%252Bon%252BConventional%252BNon-Steroidal%252BAnti-Inflammatory%252BDrugs%25253A%252BAn%252BApproach%252Bto%252BReduce%252BGastrointestinal%252BToxicity%26aulast%3DNarsinghani%26aufirst%3DTamanna%26date%3D2014%26date%3D2014%26volume%3D84%26issue%3D1%26spage%3D1%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Swati  Singh</span>, <span class="hlFld-ContribAuthor ">Veda P  Pandey</span>, <span class="hlFld-ContribAuthor ">Huma  Naaz</span>, <span class="hlFld-ContribAuthor ">Priyanka  Singh</span>, <span class="hlFld-ContribAuthor ">Upendra N.  Dwivedi</span>. </span><span class="cited-content_cbyCitation_article-title">Structural modeling and simulation studies of human cyclooxygenase (COX) isozymes with selected terpenes: Implications in drug designing and development. </span><span class="cited-content_cbyCitation_journal-name">Computers in Biology and Medicine</span><span> <strong>2013,</strong> <em>43 </em>
                                    (6)
                                     , 744-750. <a href="https://doi.org/10.1016/j.compbiomed.2013.02.019" title="DOI URL">https://doi.org/10.1016/j.compbiomed.2013.02.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.compbiomed.2013.02.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.compbiomed.2013.02.019%26sid%3Dliteratum%253Aachs%26jtitle%3DComputers%2520in%2520Biology%2520and%2520Medicine%26atitle%3DStructural%252Bmodeling%252Band%252Bsimulation%252Bstudies%252Bof%252Bhuman%252Bcyclooxygenase%252B%252528COX%252529%252Bisozymes%252Bwith%252Bselected%252Bterpenes%25253A%252BImplications%252Bin%252Bdrug%252Bdesigning%252Band%252Bdevelopment%26aulast%3DSingh%26aufirst%3DSwati%26date%3D2013%26volume%3D43%26issue%3D6%26spage%3D744%26epage%3D750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ho-Lien  Huang</span>, <span class="hlFld-ContribAuthor ">Chun-Nan  Yeh</span>, <span class="hlFld-ContribAuthor ">Wei-Yuan  Lee</span>, <span class="hlFld-ContribAuthor ">Ying-Cheng  Huang</span>, <span class="hlFld-ContribAuthor ">Kang-Wei  Chang</span>, <span class="hlFld-ContribAuthor ">Kun-Ju  Lin</span>, <span class="hlFld-ContribAuthor ">Shu-Fan  Tien</span>, <span class="hlFld-ContribAuthor ">Wen-Chin  Su</span>, <span class="hlFld-ContribAuthor ">Ching-Hsiuan  Yang</span>, <span class="hlFld-ContribAuthor ">Jenn-Tzong  Chen</span>, <span class="hlFld-ContribAuthor ">Wuu-Jyh  Lin</span>, <span class="hlFld-ContribAuthor ">Shio-Shio  Fan</span>, <span class="hlFld-ContribAuthor ">Chung-Shan  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">[123I]Iodooctyl fenbufen amide as a SPECT tracer for imaging tumors that over-express COX enzymes. </span><span class="cited-content_cbyCitation_journal-name">Biomaterials</span><span> <strong>2013,</strong> <em>34 </em>
                                    (13)
                                     , 3355-3365. <a href="https://doi.org/10.1016/j.biomaterials.2013.01.050" title="DOI URL">https://doi.org/10.1016/j.biomaterials.2013.01.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biomaterials.2013.01.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biomaterials.2013.01.050%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomaterials%26atitle%3D%25255B123I%25255DIodooctyl%252Bfenbufen%252Bamide%252Bas%252Ba%252BSPECT%252Btracer%252Bfor%252Bimaging%252Btumors%252Bthat%252Bover-express%252BCOX%252Benzymes%26aulast%3DHuang%26aufirst%3DHo-Lien%26date%3D2013%26volume%3D34%26issue%3D13%26spage%3D3355%26epage%3D3365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/medium/jm-2011-01528b_0001.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201528b&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/medium/jm-2011-01528b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0003.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Upper row: the structures of sulindac (sulfoxide, <b>1a</b>), its in vivo metabolites (<b>1b</b> and <b>1c</b>), and 2′-<i>des</i>-methyl sulindac sulfide (<b>2</b>) as well as indomethacin (<b>3</b>, nonselective COX-1/-2 inhibitor). Lower row: <i>N</i>-(5-amino-2-pyridinyl)-4-(trifluoromethyl) benzamide (TFAP, <b>4</b>), SC-560 (<b>5</b>) (selective COX-1 inhibitors), celecoxib (<b>6</b>), and rofecoxib (<b>7</b>) (selective COX-2 inhibitors).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201528b&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/medium/jm-2011-01528b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0004.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Intended chemical modifications on <b>2</b> and <b>13</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201528b&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/medium/jm-2011-01528b_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Route to Multisubstituted (<i>E</i>)-2′-<i>Des</i>-methyl Sulindac Sulfide Analogues Including Procedures for Ester Cleavage and (Re)Esterification Reactions<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201528b&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) For compound <b>2</b>: ethyl bromoacetate, activated zinc dust, benzene/ether, reflux, 16 h. (b) 2 M LDA, THF, (substituted) ethyl alkanoate, −75 °C, 2 h. (c) TsOH·2H<sub>2</sub>O, CaCl<sub>2</sub>·2H<sub>2</sub>O, toluene, reflux, overnight. (d) 1 N NaOH, MeOH, 65–70 °C. (e) Potassium trimethylsilanoate (90% material), THF, microwave radiation, 90–120 °C, 15 min. (f) Water, 2–4 M HCl. (g) 1 M LiOH, THF, RT, 5–6 h. (h) Alkyl alcohol, H<sub>2</sub>SO<sub>4</sub>, reflux, overnight.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/medium/jm-2011-01528b_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of New “Biphenyl Derivatives” of 2′-<i>Des</i>-methyl Sulindac Sulfide Using Suzuki–Miyaura Coupling Reactions<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201528b&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sup>+</sup>-carbonate, DME/H<sub>2</sub>0, 90 °C, 14 h. Suzuki–Miyaura couplings were performed on submillimolar scale in a sealed glass tube under argon.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/medium/jm-2011-01528b_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of Sulfonimide Derivatives of 2′-<i>Des</i>-methyl Sulindac Sulfide<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201528b&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Syntheses were performed on a parallel synthesis apparatus using a straightforward one-pot, two-step CDI carbodiimide coupling reaction (route A).<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Alternatively, the two-step sulfonamide couplings could be accomplished with oxalyl chloride as the carboxylic acid activator, according to a disclosed procedure, as established for compound <b>21c</b> (route B).<a onclick="showRef(event, 'ref65 ref86 ref87'); return false;" href="javascript:void(0);" class="ref ref65 ref86 ref87">(65, 86, 87)</a> Reagents and conditions: (Route A): (a1) CDI/DCM, 0–5 °C, 2 h; (b1) alkyl-/arylsulfonamide, DBU, RT, overnight. (Route B): (a2) oxalyl chloride/DCM, RT, overnight; (b2) alkyl-/arylsulfonamide, 1,2-DCE, pyridine, RT, overnight.</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/medium/jm-2011-01528b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0005.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Comparison of the inhibition of ovine COX-1 by <b>15a</b> (black circle), <b>15b</b> (red triangle), and <b>2</b> (blue square).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201528b&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/medium/jm-2011-01528b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0006.jpeg" id="rightTab-GRAPHIC-d347e1324-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) Inhibition of COX-1 in ovarian cancer cells. The OVCAR-3 human ovarian epithelial cancer cell line expresses high levels of catalytically active COX-1 but no COX-2 (see Western blot above).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Whole-cell lysates from the OVCAR-3 human ovarian epithelial cancer cell lines were fractionated on a 10% PAGE and probed with polyclonal antibodies specific for COX-1 and COX-2. The control lane for the COX-1 blot is a standard solution of 0.3 μg/μL purified oCOX-1 in M-PER and Laemmli sample buffer, whereas the control lane for the COX-2 blot is a standard solution of 0.3 μg/μL purified mCOX-2 in M-PER and Laemmli sample buffer. Lower graph: Inhibition of hCOX-1 in OVCAR-3 cells (8 μM <sup>14</sup>C-AA, 30 min at 37 °C) by <i>E</i>-DMSS analogues <b>2</b> (green circle; IC<sub>50</sub>, 116 nM), <b>13a</b> (red triangle; IC<sub>50</sub>, 300 nM), and <b>21c</b> (blue square; IC<sub>50</sub>, 495 nM) in comparison with literature reference compounds <b>5</b> (brown diamond; positive control; IC<sub>50</sub>, 160 nM) and <b>6</b> (○; negative control 16% inhibition at 5 μM). (b) Inhibition of hCOX-2 in HNSCC 1483 cells by <i>E</i>-DMSS analogues <b>2</b> (blue circle, n.i. at 5 μM) and <b>13a</b> (red square, n.i. at 5 μM) in comparison with literature reference compound <b>6</b> (○; positive control; IC<sub>50</sub>, 54 nM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201528b&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/medium/jm-2011-01528b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. OVCAR-3 cell growth inhibition by <b>1a</b> (purple triangle, n.i. at 250 μM), <b>1b</b> (blue diamond; EC<sub>50</sub>, 210 μM), <b>2</b> (green circle; EC<sub>50</sub>, 223 μM), and <b>13a</b> (red square; EC<sub>50</sub>, 132 μM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201528b&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/medium/jm-2011-01528b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. SAR for selective COX-1 inhibition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201528b&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/medium/jm-2011-01528b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Derivatization and COX activity data of lead compound <b>13a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-5/jm201528b/production/images/large/jm-2011-01528b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201528b&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43648" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43648" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 87 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Blobaum, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span> </span><span class="NLM_article-title">Structural and Functional Basis of Cyclooxygenase Inhibition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1425</span><span class="NLM_x">–</span> <span class="NLM_lpage">1441</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0613166" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXisFeisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1425-1441&author=A.+L.+Blobaumauthor=L.+J.+Marnett&title=Structural+and+Functional+Basis+of+Cyclooxygenase+Inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Functional Basis of Cyclooxygenase Inhibition</span></div><div class="casAuthors">Blobaum, Anna L.; Marnett, Lawrence J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1425-1441</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This review will focus on the structural and functional basis of the inhibition of cyclooxygenase (COX) enzymes by nonselective and COX-2 selective inhibitors.  It will integrate kinetic, mechanistic, and structural information to illustrate not only the range of mols. with COX inhibitory activity but also the diversity of mechanisms by which they act.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8SMg_SRasDLVg90H21EOLACvtfcHk0liQvNM6C_0bJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXisFeisL8%253D&md5=b9de2eafa7d2b510c866245b09fba546</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Fjm0613166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0613166%26sid%3Dliteratum%253Aachs%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26atitle%3DStructural%2520and%2520Functional%2520Basis%2520of%2520Cyclooxygenase%2520Inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1425%26epage%3D1441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Vane, J. R.</span><span> </span><span class="NLM_article-title">Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs</span> <span class="citation_source-journal">Nature (London), New Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">231</span><span class="NLM_x">, </span> <span class="NLM_fpage">232</span><span class="NLM_x">–</span> <span class="NLM_lpage">235</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1038%2Fnewbio231232a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=5284360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADyaE3MXltVyjur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=231&publication_year=1971&pages=232-235&author=J.+R.+Vane&title=Inhibition+of+prostaglandin+synthesis+as+a+mechanism+of+action+for+aspirin-like+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs</span></div><div class="casAuthors">Vane, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London), New Biology</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">231</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">232-5</span>CODEN:
                <span class="NLM_cas:coden">NNBYA7</span>;
        ISSN:<span class="NLM_cas:issn">0369-4887</span>.
    </div><div class="casAbstract">Indomethacin (I) aspirin (II), and Na salicylate inhibited the generation of prostaglandin F2α (PGF2α)-like activity by guinea pig lung prepns.  Thus, on a wt. basis, I was 23-times more potent than II as an inhibitor of PGF2α, and on a molar basis 47-times more potent.  Na salicylate was less potent than II as an inhibitor of PGF2α-like activity and there was much more variation in the results.  Similar results were obtained when the activity of the samples were assayed on rat stomach strips in terms of prostaglandin E2 (PGE2).  Hydrocortisone (50 μg/ml) inhibited PGF2α and PGE2-like activity <20%; morphine (50 μg/ml) or mepyramine (50 μg/ml) had no effect.  Some of the therapeutic effects of Na salicylate and II-like drugs may be due to inhibition of the synthesis of prostaglandins.  Incubation of lung homogenates with arachidonic acid for 30 min increased PGF2α-like activity by 220-520 ng/ml and PGE2-like activity by 100-500 ng/ml.  The ID50 values for I was 0.27 μg/ml, whereas that for II was 6.3 μg/ml.  None of the drugs tested decreased the contractions of the assay tissues (rat stomach strips and colons) induced by the prostaglandins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSuOCB-VIpVrVg90H21EOLACvtfcHk0lhXyZ5yU9LY3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXltVyjur4%253D&md5=20de9e860c4f6bb6fb8b46530dd8aaa6</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnewbio231232a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnewbio231232a0%26sid%3Dliteratum%253Aachs%26aulast%3DVane%26aufirst%3DJ.%2BR.%26atitle%3DInhibition%2520of%2520prostaglandin%2520synthesis%2520as%2520a%2520mechanism%2520of%2520action%2520for%2520aspirin-like%2520drugs%26jtitle%3DNature%2520%2528London%2529%252C%2520New%2520Biol.%26date%3D1971%26volume%3D231%26spage%3D232%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Smith, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, A. L.</span><span> </span><span class="NLM_article-title">Aspirin selectively inhibits prostaglandin production in human platelets</span> <span class="citation_source-journal">Nature (London), New Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">231</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">237</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1038%2F231294a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=5284361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADyaE3MXkvFOhsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=231&publication_year=1971&pages=235-237&author=J.+B.+Smithauthor=A.+L.+Willis&title=Aspirin+selectively+inhibits+prostaglandin+production+in+human+platelets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Aspirin selectively inhibits prostaglandin production in human platelets</span></div><div class="casAuthors">Smith, J. B.; Willis, A. L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London), New Biology</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">231</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">235-7</span>CODEN:
                <span class="NLM_cas:coden">NNBYA7</span>;
        ISSN:<span class="NLM_cas:issn">0369-4887</span>.
    </div><div class="casAbstract">Aspirin (I) (0.01-10.0 μg/ml) markedly decreased the production of prostaglandins F2α and E2 by 3-14C-labeled 5-hydroxytryptamine creatinine sulfate (5-HT) treated human platelets although it had no effect on the release of 5-HT, β-N-acetyl glucosamidase, or phospholipase A1.  I (0.3 μg/ml) inhibited the production of prostaglandin by 50%.  Indomethacin (II) was ∼10-times more potent than I, whereas Na salicylate was ∼10-times less potent.  Hydrocortisone (100 μg/ml) had no effect.  I (600 mg) inhibited the production of prostaglandins in the platelet in a system in which "the release reaction" induced by thrombin (5 units/ml) was impaired.  II (50 mg) taken by 2 volunteers, and II (100 mg) taken by 1 volunteer inhibited the production of prostaglandins by 51, 64, and 83%, resp., without affecting the release of lysosomal enzymes.  No change in the production of prostaglandins was found in platelets of 1 individual given 60 mg codeine or 2 untreated controls.  The finding that the production of prostaglandins is inhibited by I, while the release of phospholipase A is unaffected, strongly suggests that one action of I on platelets is inhibition of the conversion of arachidonic acid into prostaglandins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreUmLyWeiTCLVg90H21EOLACvtfcHk0lhXyZ5yU9LY3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXkvFOhsr0%253D&md5=5aaae4920427d85d276c84d38ccaa3fa</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2F231294a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F231294a0%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DJ.%2BB.%26aulast%3DWillis%26aufirst%3DA.%2BL.%26atitle%3DAspirin%2520selectively%2520inhibits%2520prostaglandin%2520production%2520in%2520human%2520platelets%26jtitle%3DNature%2520%2528London%2529%252C%2520New%2520Biol.%26date%3D1971%26volume%3D231%26spage%3D235%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Ferreira, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moncada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vane, J. R.</span><span> </span><span class="NLM_article-title">Indomethacin and aspirin abolish prostaglandin release from the spleen</span> <span class="citation_source-journal">Nature (London), New Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">231</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1038%2F231237a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=5284362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADyaE3MXkvFOjur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=231&publication_year=1971&pages=237-239&author=S.+H.+Ferreiraauthor=S.+Moncadaauthor=J.+R.+Vane&title=Indomethacin+and+aspirin+abolish+prostaglandin+release+from+the+spleen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Indomethacin and aspirin abolish prostaglandin release from the spleen</span></div><div class="casAuthors">Ferreira, S. H.; Moncada, S.; Vane, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London), New Biology</span>
        (<span class="NLM_cas:date">1971</span>),
    <span class="NLM_cas:volume">231</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">237-9</span>CODEN:
                <span class="NLM_cas:coden">NNBYA7</span>;
        ISSN:<span class="NLM_cas:issn">0369-4887</span>.
    </div><div class="casAbstract">Adrenaline bitartrate (I) (200 ng/min or 6-10 mg/ml during 3 min) infusion into the perfusion dog spleen increased splenic perfusion pressures, contracted the spleen, and increased prostaglandin output, chiefly prostaglandin E2.  Indomethacin (II) (0.37 μg/ml) infusions into the spleen did not decrease splenic wt. or change the splenic perfusion pressure.  The increase in prostaglandin output induced by I infusion, however, was abolished.  In sep. expts., II (4 μg/ml for 15 min and 750 ng/ml for 15 min) completely abolished prostaglandin output.  In these expts., after the II infusion was stopped, there was a gradual return of prostaglandin output induced by I infusion, which reached at least 60% of the initial output within 1-3 hr and sometimes 100%.  Aspirin was much less effective as an inhibitor of prostaglandin release, i.e., at 15 μg/ml, there was 60% inhibition and at 40 μg/ml (2 expts.), there was 75 and 100% inhibition.  Na salicylate (20 and 40 μg/ml) (2 expts.) and hydrocortisone dihydrogen succinate (2 or 25 μg/ml) did not change the prostaglandin output induced by I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNurGG3-yqlLVg90H21EOLACvtfcHk0liKmHTTDZ3hlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3MXkvFOjur4%253D&md5=1651bcb0653f9d27358a46b2f96ec76a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2F231237a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F231237a0%26sid%3Dliteratum%253Aachs%26aulast%3DFerreira%26aufirst%3DS.%2BH.%26aulast%3DMoncada%26aufirst%3DS.%26aulast%3DVane%26aufirst%3DJ.%2BR.%26atitle%3DIndomethacin%2520and%2520aspirin%2520abolish%2520prostaglandin%2520release%2520from%2520the%2520spleen%26jtitle%3DNature%2520%2528London%2529%252C%2520New%2520Biol.%26date%3D1971%26volume%3D231%26spage%3D237%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Xie, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chipman, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erikson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, D. L.</span><span> </span><span class="NLM_article-title">Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">2692</span><span class="NLM_x">–</span> <span class="NLM_lpage">2696</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1073%2Fpnas.88.7.2692" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=1849272" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADyaK38XhsVyr" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1991&pages=2692-2696&author=W.+Xieauthor=J.+G.+Chipmanauthor=D.+L.+Robertsonauthor=R.+L.+Eriksonauthor=D.+L.+Simmons&title=Expression+of+a+mitogen-responsive+gene+encoding+prostaglandin+synthase+is+regulated+by+mRNA+splicing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing</span></div><div class="casAuthors">Xie, Weilin; Chipman, Jeffrey G.; Robertson, Donald L.; Erikson, R. L.; Simmons, Daniel L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2692-6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Rous sarcoma virus was shown to induce in chicken embryo fibroblasts (CEF) a 4.1-kb mRNA (designated CEF0147) encoding a 603-amino acid protein.  Anal. of the protein sequence showed that it shared 59% amino acid identity with sheep prostaglandin G/H synthase, the enzyme that catalyzes the rate-limiting steps in the prodn. of prostaglandins.  Significant differences, at both the protein and mRNA levels, existed between the src oncogene product-inducible prostaglandin synthase and the protein isolated and cloned from sheep seminal vesicle, suggesting that the src-inducible prostaglandin synthase may be a new form of the enzyme.  A distinguishing feature of src-inducible prostaglandin synthase mRNA is its low abundance in nonproliferating chicken embryo fibroblasts and its relatively high abundance in src-transformed cells.  Addnl., the majority of the src-inducible prostaglandin synthase RNA present in nonproliferating cells was found to be nonfunctional because of the presence of an unspliced intron that sepd. the signal peptide from the remainder of the protein.  Upon mitogenic stimulation, this intron was removed, resulting in the induction of fully-spliced CEF-147 mRNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX45jEf6RjKbVg90H21EOLACvtfcHk0liKmHTTDZ3hlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhsVyr&md5=ac26730b2590e4484249f49f77df868c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.88.7.2692&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.88.7.2692%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DW.%26aulast%3DChipman%26aufirst%3DJ.%2BG.%26aulast%3DRobertson%26aufirst%3DD.%2BL.%26aulast%3DErikson%26aufirst%3DR.%2BL.%26aulast%3DSimmons%26aufirst%3DD.%2BL.%26atitle%3DExpression%2520of%2520a%2520mitogen-responsive%2520gene%2520encoding%2520prostaglandin%2520synthase%2520is%2520regulated%2520by%2520mRNA%2520splicing%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1991%26volume%3D88%26spage%3D2692%26epage%3D2696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Fu, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masferrer, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seibert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Needleman, P.</span><span> </span><span class="NLM_article-title">The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">265</span><span class="NLM_x">, </span> <span class="NLM_fpage">16737</span><span class="NLM_x">–</span> <span class="NLM_lpage">16740</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=265&publication_year=1990&pages=16737-16740&author=J.+Y.+Fuauthor=J.+L.+Masferrerauthor=K.+Seibertauthor=A.+Razauthor=P.+Needleman&title=The+induction+and+suppression+of+prostaglandin+H2+synthase+%28cyclooxygenase%29+in+human+monocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DJ.%2BY.%26aulast%3DMasferrer%26aufirst%3DJ.%2BL.%26aulast%3DSeibert%26aufirst%3DK.%26aulast%3DRaz%26aufirst%3DA.%26aulast%3DNeedleman%26aufirst%3DP.%26atitle%3DThe%2520induction%2520and%2520suppression%2520of%2520prostaglandin%2520H2%2520synthase%2520%2528cyclooxygenase%2529%2520in%2520human%2520monocytes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1990%26volume%3D265%26spage%3D16737%26epage%3D16740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Kujubu, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varnum, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herschman, H. R.</span><span> </span><span class="NLM_article-title">TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">266</span><span class="NLM_x">, </span> <span class="NLM_fpage">12866</span><span class="NLM_x">–</span> <span class="NLM_lpage">12872</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1016%2FS0021-9258%2818%2998774-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=1712772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADyaK38Xhs1Ontbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1991&pages=12866-12872&author=D.+A.+Kujubuauthor=B.+S.+Fletcherauthor=B.+C.+Varnumauthor=R.+W.+Limauthor=H.+R.+Herschman&title=TIS10%2C+a+phorbol+ester+tumor+promoter-inducible+mRNA+from+Swiss+3T3+cells%2C+encodes+a+novel+prostaglandin+synthase%2Fcyclooxygenase+homologue"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homolog</span></div><div class="casAuthors">Kujubu, Dean A.; Fletcher, Bradley S.; Varnum, Brian C.; Lim, Robert W.; Herschman, Harvey R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">266</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">12866-72</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">TIS10 is a primary response gene whose cDNA was cloned as a result of its rapid, superinducible expression in Swiss 3T3 cells in response to 12-O-tetradecanoylphorbol-13-acetate.  The 5'-untranslated region of the 3.9-kilobase TIS10 message contains only 124 nucleotides, whereas the 3'-untranslated region is almost 2 kilobases in length.  Within this long 3' region, there are multiple repeats of the sequence ATTTA, a sequence often present in rapidly degraded mRNA species.  Primer extension revealed that the SIS10 cDNA begins 16 base pairs downstream of the transcription start site for the TIS10 gene.  The TIS10 cDNA encodes a predicted protein of 604 amino acids.  A computer search identified striking similarities between the predicted TIS10 protein product and the murine, sheep, and human prostaglandin synthase/cyclooxygenase proteins.  The TIS10 protein has many of the same conserved amino acids that are thought to be important for cyclooxygenase function.  TIS10 mRNA is undetectable by Northern anal. in quiescent 3T3 cells.  The TIS10 gene is rapidly and transiently induced by forskolin and serum, as well as by 12-O-tetradecanoylphorbol-13-acetate, in Swiss 3T3 cells.  These agents elicit far more dramatic changes in TIS10 mRNA levels than in cyclooxygenase mRNA levels.  The expression of the TIS10 gene appears to be highly cell type-restricted in cultured cell lines; of 12 cell lines tested under superinducing conditions, only the rodent embryonic Swiss 3T3 and Rat1 cell lines expressed TIS10 gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1PfH0Q-KhvrVg90H21EOLACvtfcHk0liRm3kAyV1XQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xhs1Ontbk%253D&md5=881e17ae78d721bfd5b59233656c820a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0021-9258%2818%2998774-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0021-9258%252818%252998774-0%26sid%3Dliteratum%253Aachs%26aulast%3DKujubu%26aufirst%3DD.%2BA.%26aulast%3DFletcher%26aufirst%3DB.%2BS.%26aulast%3DVarnum%26aufirst%3DB.%2BC.%26aulast%3DLim%26aufirst%3DR.%2BW.%26aulast%3DHerschman%26aufirst%3DH.%2BR.%26atitle%3DTIS10%252C%2520a%2520phorbol%2520ester%2520tumor%2520promoter-inducible%2520mRNA%2520from%2520Swiss%25203T3%2520cells%252C%2520encodes%2520a%2520novel%2520prostaglandin%2520synthase%252Fcyclooxygenase%2520homologue%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1991%26volume%3D266%26spage%3D12866%26epage%3D12872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Patel, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sen, D. J.</span><span> </span><span class="NLM_article-title">COX-1 and COX-2 inhibitors: Current status and future prospects over COX-3 inhibitors</span> <span class="citation_source-journal">Int. J. Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">136</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFegt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=136-145&author=C.+K.+Patelauthor=D.+J.+Sen&title=COX-1+and+COX-2+inhibitors%3A+Current+status+and+future+prospects+over+COX-3+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">COX-1 and COX-2 inhibitors: current status and future prospects over COX-3 inhibitors</span></div><div class="casAuthors">Patel, Chirag K.; Sen, Dhrubo Jyoti</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Drug Development & Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">136-145</span>CODEN:
                <span class="NLM_cas:coden">IJDDA7</span>;
        ISSN:<span class="NLM_cas:issn">0975-9344</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Drug Development & Research</span>)
        </div><div class="casAbstract">A review.  Prostaglandins are formed from arachidonic acid by the action of cyclooxygenase and subsequent downstream synthetases.  Two closely related forms of the cyclooxygenase have been identified which are now known as COX-1 and COX-2.  Both isoenzymes transform arachidonic acid to prostaglandins, but differ in their distribution and their physiol. roles.  Meanwhile, the responsible genes and their regulation have been clarified.  COX-1, the pre-dominantly constitutive form of the enzyme, is expressed throughout the body and performs a no. of homeostatic functions such as maintaining normal gastric mucosa and influencing renal blood flow and platelet aggregation.  In contrast, the inducible form is expressed in response to inflammatory and other physiol. stimuli and growth factors, and is involved in the prodn. of the prostaglandins that mediate pain and support the inflammatory process.  All the classic NSAIDs inhibit both COX-1 and COX-2 at std. anti-inflammatory doses.  Simmons also recently co-discovered COX-3 in 2002 and analyzed this new isoenzyme's relation to acetaminophen (paracetamol), arguably the most widely used analgesic drug in the world.  The clin. ramifications and knowledge of COX isoenzymes are therefore rapidly expanding and could perhaps offer significant hope for future treatments of pain, inflammation and fever.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo02JeZep06cLVg90H21EOLACvtfcHk0liRm3kAyV1XQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFegt74%253D&md5=179457dba85c2f7dee66c4048b881585</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DC.%2BK.%26aulast%3DSen%26aufirst%3DD.%2BJ.%26atitle%3DCOX-1%2520and%2520COX-2%2520inhibitors%253A%2520Current%2520status%2520and%2520future%2520prospects%2520over%2520COX-3%2520inhibitors%26jtitle%3DInt.%2520J.%2520Drug%2520Dev.%2520Res.%26date%3D2009%26volume%3D1%26spage%3D136%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Kawai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kojima, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusunoki, N.</span><span> </span><span class="NLM_article-title">Recent advances in nonsteroidal anti-inflammatory drugs</span> <span class="citation_source-journal">Allergol. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">215</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.2332%2Fallergolint.54.209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtVSjurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2005&pages=209-215&author=S.+Kawaiauthor=F.+Kojimaauthor=N.+Kusunoki&title=Recent+advances+in+nonsteroidal+anti-inflammatory+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in nonsteroidal anti-inflammatory drugs</span></div><div class="casAuthors">Kawai, Shinichi; Kojima, Fumiaki; Kusunoki, Natsuko</div><div class="citationInfo"><span class="NLM_cas:title">Allergology International</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">209-215</span>CODEN:
                <span class="NLM_cas:coden">ALINFR</span>;
        ISSN:<span class="NLM_cas:issn">1323-8930</span>.
    
            (<span class="NLM_cas:orgname">Japanese Society of Allergology</span>)
        </div><div class="casAbstract">A review.  Recent advances in basic and clin. researches of nonsteroidal anti-inflammatory drugs (NSAIDs) are reviewed.  Concerning arachidonic acid cascade, recent studies revealed that not only cyclooxygenase (COX) but also terminal enzymes such as prostaglandin E synthase are very important in the understanding of the pathogenesis of inflammation and mechanisms of action of NSAIDs.  We also found that some conventional NSAIDs and a selective COX-2 inhibitor exert pro-apoptotic effect on synovial fibroblasts and several cancer cells by COX-independent mechanisms.  Clin. indications for use of NSAIDs are broad and include the following: rheumatic diseases; painful and/or febrile conditions; and prevention from thrombotic diseases such as myocardial infarction.  In addn., recently developed selective COX-2 inhibitors have been found to be nearly as effective for the same conditions as conventional NSAIDs except with regard to the prevention of thrombosis.  The incidence of severe gastrointestinal events in patients treated with selective COX-2 inhibitors has been proven to be lower than patients treated with conventional NSAIDs.  However, there was no difference in renal complications between the two groups.  Instead, an increased incidence of myocardial infarction after administration of selective COX-2 inhibitors may occur in patients with risk factors for atherosclerotic or thrombotic complications.  Further basic and clin. studies remain to be investigated in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYpTfs6dG5F7Vg90H21EOLACvtfcHk0lijHzmFKwtqAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtVSjurk%253D&md5=4d8adbb17e2f4b40fc72b47b394417d6</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2332%2Fallergolint.54.209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2332%252Fallergolint.54.209%26sid%3Dliteratum%253Aachs%26aulast%3DKawai%26aufirst%3DS.%26aulast%3DKojima%26aufirst%3DF.%26aulast%3DKusunoki%26aufirst%3DN.%26atitle%3DRecent%2520advances%2520in%2520nonsteroidal%2520anti-inflammatory%2520drugs%26jtitle%3DAllergol.%2520Int.%26date%3D2005%26volume%3D54%26spage%3D209%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Al-Hourani, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mane, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuszynski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baracos, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kniess, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suresh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietzsch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wuest, F.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of 1,5-diaryl-substituted tetrazoles as novel selective cyclooxygenase-2 (COX-2) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1823</span><span class="NLM_x">–</span> <span class="NLM_lpage">1826</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1016%2Fj.bmcl.2011.01.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=21316237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjslKjsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1823-1826&author=B.+J.+Al-Houraniauthor=S.+K.+Sharmaauthor=J.+Y.+Maneauthor=J.+Tuszynskiauthor=V.+Baracosauthor=T.+Kniessauthor=M.+Sureshauthor=J.+Pietzschauthor=F.+Wuest&title=Synthesis+and+evaluation+of+1%2C5-diaryl-substituted+tetrazoles+as+novel+selective+cyclooxygenase-2+%28COX-2%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of 1,5-diaryl-substituted tetrazoles as novel selective cyclooxygenase-2 (COX-2) inhibitors</span></div><div class="casAuthors">Al-Hourani, Baker Jawabrah; Sharma, Sai Kiran; Mane, Jonathan Y.; Tuszynski, Jack; Baracos, Vickie; Kniess, Torsten; Suresh, Mavanur; Pietzsch, Jens; Wuest, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1823-1826</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of 1,5-diaryl-substituted tetrazole derivs. was synthesized via conversion of readily available diaryl amides into the corresponding imidoyl chlorides followed by reaction with sodium azide.  All compds. were evaluated by cyclooxygenase (COX) assays in vitro to det. COX-1 and COX-2 inhibitory potency and selectivity.  The tetrazoles showed IC50 values ranging from 0.42 to 8.1 mM for COX-1 and 2.0 to 200 μM for COX-2.  The most potent compd. (IC50 (COX-2) = 2.0 μM) was further used in mol. modeling docking studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxtjcbzE_jpbVg90H21EOLACvtfcHk0lijHzmFKwtqAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjslKjsbo%253D&md5=e12b71f9a590e8aaa717e7d7465d1087</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.01.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.01.057%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Hourani%26aufirst%3DB.%2BJ.%26aulast%3DSharma%26aufirst%3DS.%2BK.%26aulast%3DMane%26aufirst%3DJ.%2BY.%26aulast%3DTuszynski%26aufirst%3DJ.%26aulast%3DBaracos%26aufirst%3DV.%26aulast%3DKniess%26aufirst%3DT.%26aulast%3DSuresh%26aufirst%3DM.%26aulast%3DPietzsch%26aufirst%3DJ.%26aulast%3DWuest%26aufirst%3DF.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%25201%252C5-diaryl-substituted%2520tetrazoles%2520as%2520novel%2520selective%2520cyclooxygenase-2%2520%2528COX-2%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D1823%26epage%3D1826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Pairet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churchill, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trummlitz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelhardt, G.</span><span> </span><span class="NLM_article-title">Differential inhibition of cyclooxygenase-1 (COX-1) and −2 (COX-2) by NSAIDS: Consequences on anti-inflammatory activity versus gastric and renal safety</span> <span class="citation_source-journal">Inflammopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1996&pages=61-70&author=M.+Pairetauthor=L.+Churchillauthor=G.+Trummlitzauthor=G.+Engelhardt&title=Differential+inhibition+of+cyclooxygenase-1+%28COX-1%29+and+%E2%88%922+%28COX-2%29+by+NSAIDS%3A+Consequences+on+anti-inflammatory+activity+versus+gastric+and+renal+safety"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPairet%26aufirst%3DM.%26aulast%3DChurchill%26aufirst%3DL.%26aulast%3DTrummlitz%26aufirst%3DG.%26aulast%3DEngelhardt%26aufirst%3DG.%26atitle%3DDifferential%2520inhibition%2520of%2520cyclooxygenase-1%2520%2528COX-1%2529%2520and%2520%25E2%2588%25922%2520%2528COX-2%2529%2520by%2520NSAIDS%253A%2520Consequences%2520on%2520anti-inflammatory%2520activity%2520versus%2520gastric%2520and%2520renal%2520safety%26jtitle%3DInflammopharmacology%26date%3D1996%26volume%3D4%26spage%3D61%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Prasit, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span> </span><span class="NLM_article-title">Selective cyclooxygenase-2 inhibitors</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">220</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1997&pages=211-220&author=P.+Prasitauthor=D.+Riendeau&title=Selective+cyclooxygenase-2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DRiendeau%26aufirst%3DD.%26atitle%3DSelective%2520cyclooxygenase-2%2520inhibitors%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D1997%26volume%3D32%26spage%3D211%26epage%3D220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Talley, J. J.</span><span> </span><span class="NLM_article-title">Selective inhibitors of cyclooxygenase-2 (COX-2)</span> <span class="citation_source-journal">Prog. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1016%2FS0079-6468%2808%2970048-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=10818674" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADyaK1MXjvV2ntbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1999&pages=201-234&author=J.+J.+Talley&title=Selective+inhibitors+of+cyclooxygenase-2+%28COX-2%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibitors of cyclooxygenase-2 (COX-2)</span></div><div class="casAuthors">Talley, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">201-234</span>CODEN:
                <span class="NLM_cas:coden">PMDCAY</span>;
        ISSN:<span class="NLM_cas:issn">0079-6468</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review with 241 refs. on the discovery and screening of selective cyclooxygenase-2 inhibitors.  COX-2 inhibitors offer the hope of relief from arthritic diseases and pain without the complication of gastrointestinal side-effects.  In addn., COX-2 inhibitors may be useful for the treatment or prevention of certain tipes of cancer and Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmEUTyOmU-e7Vg90H21EOLACvtfcHk0lh-jH7-4LZ3kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvV2ntbg%253D&md5=ba0886ac03f8d1295c4c9b37c90c3481</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0079-6468%2808%2970048-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0079-6468%252808%252970048-1%26sid%3Dliteratum%253Aachs%26aulast%3DTalley%26aufirst%3DJ.%2BJ.%26atitle%3DSelective%2520inhibitors%2520of%2520cyclooxygenase-2%2520%2528COX-2%2529%26jtitle%3DProg.%2520Med.%2520Chem.%26date%3D1999%26volume%3D36%26spage%3D201%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Talley, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertenshaw, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graneto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koboldt, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masferrer, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogier, D. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweifel, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seibert, K.</span><span> </span><span class="NLM_article-title">4,5-Diaryloxazole inhibitors of cyclooxygenase-2 (COX-2)</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1002%2F%28SICI%291098-1128%28199905%2919%3A3%3C199%3A%3AAID-MED1%3E3.0.CO%3B2-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=10232649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADyaK1MXjtVGhur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=199-208&author=J.+J.+Talleyauthor=S.+R.+Bertenshawauthor=D.+L.+Brownauthor=J.+S.+Carterauthor=M.+J.+Granetoauthor=C.+M.+Koboldtauthor=J.+L.+Masferrerauthor=B.+H.+Normanauthor=D.+J.+Rogierauthor=B.+S.+Zweifelauthor=K.+Seibert&title=4%2C5-Diaryloxazole+inhibitors+of+cyclooxygenase-2+%28COX-2%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">4,5-Diaryloxazole inhibitors of cyclooxygenase-2 (COX-2)</span></div><div class="casAuthors">Talley, John J.; Bertenshaw, Stephen R.; Brown, David L.; Carter, Jeffery S.; Graneto, Mathew J.; Koboldt, Carol M.; Masferrer, Jaime L.; Norman, Bryan H.; Rogier, D. Joseph, Jr.; Zweifel, Ben S.; Seibert, Karen</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">199-208</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A series of methylsulfonyl or sulfonamido substituted 4,5-diaryloxazole were prepd. and evaluated for their ability to inhibit the inducible form of cyclooxygenase (COX-2) in vitro and in vivo.  Several unique substitution patterns were identified that led to potent and selective inhibitors of COX-2.  In general, 2-trifluoromethyl-4,5-diaryloxazoles substituted with a methylsulfonyl or sulfonamido group were particularly potent inhibitors.  One of the more potent compds. with a selectivity for COX-2 of about 800 fold was SC-299 (I).  I, a highly fluorescent mol., may be useful for spectroscopic studies on preferential inhibitor binding to COX-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4CDYxBCLLrLVg90H21EOLACvtfcHk0lj4fdeDfj92Bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtVGhur4%253D&md5=a6602064867f2791cf6da5d9d5025b5b</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-1128%28199905%2919%3A3%3C199%3A%3AAID-MED1%3E3.0.CO%3B2-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-1128%2528199905%252919%253A3%253C199%253A%253AAID-MED1%253E3.0.CO%253B2-7%26sid%3Dliteratum%253Aachs%26aulast%3DTalley%26aufirst%3DJ.%2BJ.%26aulast%3DBertenshaw%26aufirst%3DS.%2BR.%26aulast%3DBrown%26aufirst%3DD.%2BL.%26aulast%3DCarter%26aufirst%3DJ.%2BS.%26aulast%3DGraneto%26aufirst%3DM.%2BJ.%26aulast%3DKoboldt%26aufirst%3DC.%2BM.%26aulast%3DMasferrer%26aufirst%3DJ.%2BL.%26aulast%3DNorman%26aufirst%3DB.%2BH.%26aulast%3DRogier%26aufirst%3DD.%2BJ.%26aulast%3DZweifel%26aufirst%3DB.%2BS.%26aulast%3DSeibert%26aufirst%3DK.%26atitle%3D4%252C5-Diaryloxazole%2520inhibitors%2520of%2520cyclooxygenase-2%2520%2528COX-2%2529%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D1999%26volume%3D19%26spage%3D199%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Chan, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brideau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charleson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cromlish, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ethier, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford-Hutchinson, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrest, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gresser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kargman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Neill, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouellet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrier, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodger, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagari, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Therien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vickers, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visco, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamboni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span> </span><span class="NLM_article-title">Rofecoxib [Vioxx, MK-0966; 4-(4′-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: A potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">551</span><span class="NLM_x">–</span> <span class="NLM_lpage">560</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=10411562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADyaK1MXkvVKgu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=1999&pages=551-560&author=C.+C.+Chanauthor=S.+Boyceauthor=C.+Brideauauthor=S.+Charlesonauthor=W.+Cromlishauthor=D.+Ethierauthor=J.+Evansauthor=A.+W.+Ford-Hutchinsonauthor=M.+J.+Forrestauthor=J.+Y.+Gauthierauthor=R.+Gordonauthor=M.+Gresserauthor=J.+Guayauthor=S.+Kargmanauthor=B.+Kennedyauthor=Y.+Leblancauthor=S.+Legerauthor=J.+Manciniauthor=G.+P.+O%27Neillauthor=M.+Ouelletauthor=D.+Patrickauthor=M.+D.+Percivalauthor=H.+Perrierauthor=P.+Prasitauthor=I.+Rodgerauthor=P.+Tagariauthor=M.+Therienauthor=P.+Vickersauthor=D.+Viscoauthor=Z.+Wangauthor=J.+Webbauthor=E.+Wongauthor=L.+J.+Xuauthor=R.+N.+Youngauthor=R.+Zamboniauthor=D.+Riendeau&title=Rofecoxib+%5BVioxx%2C+MK-0966%3B+4-%284%E2%80%B2-methylsulfonylphenyl%29-3-phenyl-2-%285H%29-furanone%5D%3A+A+potent+and+orally+active+cyclooxygenase-2+inhibitor.+Pharmacological+and+biochemical+profiles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles</span></div><div class="casAuthors">Chan, C.-C.; Boyce, S.; Brideau, C.; Charleson, S.; Cromlish, W.; Ethier, D.; Evans, J.; Ford-Hutchinson, A. W.; Forrest, M. J.; Gauthier, J. Y.; Gordon, R.; Gresser, M.; Guay, J.; Kargman, S.; Kennedy, B.; Leblanc, Y.; Leger, S.; Mancini, J.; O'Neill, G. P.; Ouellet, M.; Patrick, D.; Percival, M. D.; Perrier, H.; Prasit, P.; Rodger, I.; Tagari, P.; Therien, M.; Vickers, P.; Visco, D.; Wang, Z.; Webb, J.; Wong, E.; Xu, L-J.; Young, R. N.; Zamboni, R.; Riendeau, D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">551-560</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The discoveries that cyclooxygenase (COX)-2 is an inducible form of COX involved in inflammation and that COX-1 is the major isoform responsible for the prodn. of prostaglandins (PGs) in the gastrointestinal tract have provided a rationale for the development of specific COX-2 inhibitors as a new class of anti-inflammatory agents with improved gastrointestinal tolerability.  In the present study, the preclin. pharmacol. and biochem. profiles of rofecoxib [Vioxx, also known as MK-0966, 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone], an orally active COX-2 inhibitor, are described.  Rofecoxib is a potent inhibitor of the COX-2-dependent prodn. of PGE2 in human osteosarcoma cells (IC50 = 26 ± 10 nM) and Chinese hamster ovary cells expressing human COX-2 (IC50 = 18 ± 7 nM) with a 1000-fold selectivity for the inhibition of COX-2 compared with the inhibition of COX-1 activity (IC50 > 50 μM in U937 cells and IC50 > 15 μM in Chinese hamster ovary cells expressing human COX-1).  Rofecoxib is a time-dependent inhibitor of purified human recombinant COX-2 (IC50 = 0.34 μM) but caused inhibition of purified human COX-1 in a non-time-dependent manner that could only be obsd. at a very low substrate concn. (IC50 = 26 μM at 0.1 μM arachidonic acid concn.).  In an in vitro human whole blood assay, rofecoxib selectively inhibited lipopolysaccharide-induced, COX-2-derived PGE2 synthesis with an IC50 value of 0.53 ± 0.02 μM compared with an IC50 value of 18.8 ± 0.9 μM for the inhibition of COX-1-derived thromboxane B2 synthesis after blood coagulation.  Using the ratio of the COX-1 IC50 values over the COX-2 IC50 values in the human whole blood assay, selectivity ratios for the inhibition of COX-2 of 36, 6.6, 2, 3, and 0.4 were obtained for rofecoxib, celecoxib, meloxicam, diclofenac, and indomethacin, resp.  In several in vivo rodent models, rofecoxib is a potent inhibitor of carrageenan-induced paw edema (ID50 = 1.5 mg/kg), carrageenan-induced paw hyperalgesia (ID50 = 1.0 mg/kg), lipopolysaccharide-induced pyresis (ID50 = 0.24 mg/kg), and adjuvant-induced arthritis (ID50 = 0.74 mg/kg/day).  Rofecoxib also has a protective effect on adjuvant-induced destruction of cartilage and bone structures in rats.  In a 51Cr excretion assay for detection of gastrointestinal integrity in either rats or squirrel monkeys, rofecoxib has no effect at doses up to 200 mg/kg/day for 5 days.  Rofecoxib is a novel COX-2 inhibitor with a biochem. and pharmacol. profile clearly distinct from that of current nonsteroidal anti-inflammatory drugs and represents a new therapeutic class of anti-inflammatory agents for the treatment of the symptoms of osteoarthritis and rheumatoid arthritis with improved gastrointestinal tolerability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMiRyINGaokLVg90H21EOLACvtfcHk0lgDh7DHjv0JVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkvVKgu7k%253D&md5=c5ed209578557f65d4d5c5c37eab731e</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DC.%2BC.%26aulast%3DBoyce%26aufirst%3DS.%26aulast%3DBrideau%26aufirst%3DC.%26aulast%3DCharleson%26aufirst%3DS.%26aulast%3DCromlish%26aufirst%3DW.%26aulast%3DEthier%26aufirst%3DD.%26aulast%3DEvans%26aufirst%3DJ.%26aulast%3DFord-Hutchinson%26aufirst%3DA.%2BW.%26aulast%3DForrest%26aufirst%3DM.%2BJ.%26aulast%3DGauthier%26aufirst%3DJ.%2BY.%26aulast%3DGordon%26aufirst%3DR.%26aulast%3DGresser%26aufirst%3DM.%26aulast%3DGuay%26aufirst%3DJ.%26aulast%3DKargman%26aufirst%3DS.%26aulast%3DKennedy%26aufirst%3DB.%26aulast%3DLeblanc%26aufirst%3DY.%26aulast%3DLeger%26aufirst%3DS.%26aulast%3DMancini%26aufirst%3DJ.%26aulast%3DO%2527Neill%26aufirst%3DG.%2BP.%26aulast%3DOuellet%26aufirst%3DM.%26aulast%3DPatrick%26aufirst%3DD.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DPerrier%26aufirst%3DH.%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DRodger%26aufirst%3DI.%26aulast%3DTagari%26aufirst%3DP.%26aulast%3DTherien%26aufirst%3DM.%26aulast%3DVickers%26aufirst%3DP.%26aulast%3DVisco%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWebb%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DE.%26aulast%3DXu%26aufirst%3DL.%2BJ.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DZamboni%26aufirst%3DR.%26aulast%3DRiendeau%26aufirst%3DD.%26atitle%3DRofecoxib%2520%255BVioxx%252C%2520MK-0966%253B%25204-%25284%25E2%2580%25B2-methylsulfonylphenyl%2529-3-phenyl-2-%25285H%2529-furanone%255D%253A%2520A%2520potent%2520and%2520orally%2520active%2520cyclooxygenase-2%2520inhibitor.%2520Pharmacological%2520and%2520biochemical%2520profiles%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D290%26spage%3D551%26epage%3D560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Esser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimoto, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haston, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimble, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koehler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peppard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quadros, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quintavalla, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toscano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Duzer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, P. J.</span><span> </span><span class="NLM_article-title">Preclinical pharmacology of lumiracoxib: A novel selective inhibitor of cyclooxygenase-2</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x">, </span> <span class="NLM_fpage">538</span><span class="NLM_x">–</span> <span class="NLM_lpage">550</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1038%2Fsj.bjp.0706078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=15655513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsVOmsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2005&pages=538-550&author=R.+Esserauthor=C.+Berryauthor=Z.+Duauthor=J.+Dawsonauthor=A.+Foxauthor=R.+A.+Fujimotoauthor=W.+Hastonauthor=E.+F.+Kimbleauthor=J.+Koehlerauthor=J.+Peppardauthor=E.+Quadrosauthor=J.+Quintavallaauthor=K.+Toscanoauthor=L.+Urbanauthor=J.+van+Duzerauthor=X.+Zhangauthor=S.+Zhouauthor=P.+J.+Marshall&title=Preclinical+pharmacology+of+lumiracoxib%3A+A+novel+selective+inhibitor+of+cyclooxygenase-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase-2</span></div><div class="casAuthors">Esser, Ronald; Berry, Carol; Du, Zhengming; Dawson, Janet; Fox, Alyson; Fujimoto, Roger A.; Haston, William; Kimble, Earl F.; Koehler, Julie; Peppard, Jane; Quadros, Elizabeth; Quintavalla, Joseph; Toscano, Karen; Urban, Laszlo; van Duzer, John; Zhang, Xiaoli; Zhou, Siyuan; Marshall, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">538-550</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">This manuscript presents the preclin. profile of lumiracoxib, a novel cyclooxygenase-2 (COX-2) selective inhibitor.  Lumiracoxib inhibited purified COX-1 and COX-2 with Ki values of 3 and 0.06 μM, resp.  In cellular assays, lumiracoxib had an IC50 of 0.14 μM in COX-2-expressing dermal fibroblasts, but caused no inhibition of COX-1 at concns. up to 30 μM (HEK 293 cells transfected with human COX-1).  In a human whole blood assay, IC50 values for lumiracoxib were 0.13 μM for COX-2 and 67 μM for COX-1 (COX-1/COX-2 selectivity ratio 515).  Lumiracoxib was rapidly absorbed following oral administration in rats with peak plasma levels being reached between 0.5 and 1 h.  Ex vivo, lumiracoxib inhibited COX-1-derived thromboxane B2 (TxB2) generation with an ID50 of 33 mg kg-1, whereas COX-2-derived prodn. of prostaglandin E2 (PGE2) in the lipopolysaccharide-stimulated rat air pouch was inhibited with an ID50 value of 0.24 mg kg-1.  Efficacy of lumiracoxib in rat models of hyperalgesia, edema, pyresis and arthritis was dose-dependent and similar to diclofenac.  However, consistent with its low COX-1 inhibitory activity, lumiracoxib at a dose of 100 mg kg-1 orally caused no ulcers and was significantly less ulcerogenic than diclofenac (P<0.05).  Lumiracoxib is a highly selective COX-2 inhibitor with anti-inflammatory, analgesic and antipyretic activities comparable with diclofenac, the ref. NSAID, but with much improved gastrointestinal safety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGFkSVhj6hjbVg90H21EOLACvtfcHk0lgDh7DHjv0JVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsVOmsbk%253D&md5=c56dbbee7e3bc394087d2cc450c24d47</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706078%26sid%3Dliteratum%253Aachs%26aulast%3DEsser%26aufirst%3DR.%26aulast%3DBerry%26aufirst%3DC.%26aulast%3DDu%26aufirst%3DZ.%26aulast%3DDawson%26aufirst%3DJ.%26aulast%3DFox%26aufirst%3DA.%26aulast%3DFujimoto%26aufirst%3DR.%2BA.%26aulast%3DHaston%26aufirst%3DW.%26aulast%3DKimble%26aufirst%3DE.%2BF.%26aulast%3DKoehler%26aufirst%3DJ.%26aulast%3DPeppard%26aufirst%3DJ.%26aulast%3DQuadros%26aufirst%3DE.%26aulast%3DQuintavalla%26aufirst%3DJ.%26aulast%3DToscano%26aufirst%3DK.%26aulast%3DUrban%26aufirst%3DL.%26aulast%3Dvan%2BDuzer%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DMarshall%26aufirst%3DP.%2BJ.%26atitle%3DPreclinical%2520pharmacology%2520of%2520lumiracoxib%253A%2520A%2520novel%2520selective%2520inhibitor%2520of%2520cyclooxygenase-2%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D144%26spage%3D538%26epage%3D550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Marnett, L. J.</span><span> </span><span class="NLM_article-title">The COXIB experience: A look in the rearview mirror</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1146%2Fannurev.pharmtox.011008.145638" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=18851701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisV2jsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=265-290&author=L.+J.+Marnett&title=The+COXIB+experience%3A+A+look+in+the+rearview+mirror"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The COXIB experience: a look in the rearview mirror</span></div><div class="casAuthors">Marnett, Lawrence J.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">265-290</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most widely used prescription and nonprescription drugs in the world.  The discovery of cyclooxygenase (COX) as the target of NSAIDs, the subsequent identification of two isoforms of COX (COX-1 and COX-2), and studies of their regulation and sites of expression led to the hypothesis that COX-2 is the mol. target for the anti-inflammatory and analgesic effects of NSAIDs.  A corollary was that COX-2-selective inhibitors (COXIBs) would retain the desirable effects of NSAIDs without some of their liabilities (e.g., gastrointestinal toxicity, which was ascribed to COX-1 inhibition).  The first marketed COXIBs exhibited reduced gastrointestinal side effects relative to traditional NSAIDs and were enormous com. successes.  However, clin. trials testing the hypothesis that COXIBs prevent recurrence of premalignant colon polyps uncovered adverse cardiovascular effects that are mechanism based.  This review provides an overview of the discovery, development, and difficulties of the COXIBs, a perspective on what has been learned, and speculation on the way forward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAJBE0T9Iu_7Vg90H21EOLACvtfcHk0ljIia9f9oMgiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisV2jsb4%253D&md5=5147f02bf6314c86f1f707609a9d2fa5</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.011008.145638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.011008.145638%26sid%3Dliteratum%253Aachs%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26atitle%3DThe%2520COXIB%2520experience%253A%2520A%2520look%2520in%2520the%2520rearview%2520mirror%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2009%26volume%3D49%26spage%3D265%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Rodriguez, L. A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolosa, L. B.</span><span> </span><span class="NLM_article-title">Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">498</span><span class="NLM_x">–</span> <span class="NLM_lpage">506</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2007&pages=498-506&author=L.+A.+G.+Rodriguezauthor=L.+B.+Tolosa&title=Risk+of+upper+gastrointestinal+complications+among+users+of+traditional+NSAIDs+and+COXIBs+in+the+general+population"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez%26aufirst%3DL.%2BA.%2BG.%26aulast%3DTolosa%26aufirst%3DL.%2BB.%26atitle%3DRisk%2520of%2520upper%2520gastrointestinal%2520complications%2520among%2520users%2520of%2520traditional%2520NSAIDs%2520and%2520COXIBs%2520in%2520the%2520general%2520population%26jtitle%3DGastroenterology%26date%3D2007%26volume%3D132%26spage%3D498%26epage%3D506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Hippisley-Cox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coupland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logan, R.</span><span> </span><span class="NLM_article-title">Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: Population based nested case-control analysis</span> <span class="citation_source-journal">BMJ [Br. Med. J.]</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">331</span><span class="NLM_x">, </span> <span class="NLM_fpage">1310</span><span class="NLM_x">–</span> <span class="NLM_lpage">1312</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1136%2Fbmj.331.7528.1310" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=16322018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD28XivVSmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=2005&pages=1310-1312&author=J.+Hippisley-Coxauthor=C.+Couplandauthor=R.+Logan&title=Risk+of+adverse+gastrointestinal+outcomes+in+patients+taking+cyclo-oxygenase-2+inhibitors+or+conventional+non-steroidal+anti-inflammatory+drugs%3A+Population+based+nested+case-control+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis</span></div><div class="casAuthors">Hippisley-Cox, Julia; Coupland, Carol; Logan, Richard</div><div class="citationInfo"><span class="NLM_cas:title">BMJ [British Medical Journal]</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">331</span>
        (<span class="NLM_cas:issue">7528</span>),
    <span class="NLM_cas:pages">1310-1312</span>CODEN:
                <span class="NLM_cas:coden">BMJBFE</span>;
        ISSN:<span class="NLM_cas:issn">0959-8146</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">To det. the risk of an adverse upper gastrointestinal event in patients taking different cyclo-oxygenase-2 inhibitors compared with non-selective non-steroidal anti-inflammatory drugs.  Nested case-control study.  Three hundred sixty-seven general practices contributing to the UK QRESEARCH database, spread throughout every strategic health authority and each health board in England, Wales, and Scotland.  Patients aged 25 or more with a first ever diagnosis of an adverse upper gastrointestinal event (peptic ulcer or hematemesis) between 1 August 2000 and 31 July 2004 and up to 10 controls per case matched for age, sex, calendar time, and practice.  Unadjusted and adjusted odds ratios for adverse upper gastrointestinal events assocd. with exposure to celecoxib, rofecoxib, ibuprofen, diclofenac, naproxen, other selective and non-selective non-steroidal anti-inflammatory drugs, and aspirin.  The incidence of adverse upper gastrointestinal events was 1.36 per 1000 person years (95% confidence interval 1.34 to 1.39).  We identified 9407 incident cases and 88 867 matched controls.  Increased risks of adverse gastrointestinal events were assocd. with current use of cyclo-oxygenase-2 inhibitors and with conventional non-steroidal anti-inflammatory drugs.  Risks were reduced after adjustment for confounders but remained significantly increased for naproxen (adjusted odds ratio 2.12, 95% confidence interval 1.73 to 2.58), diclofenac (1.96, 1.78 to 2.15), and rofecoxib (1.56, 1.30 to 1.87) but not for current use of celecoxib (1.11, 0.87 to 1.41).  We found clin. important interactions with current use of ulcer healing drugs that removed the increased risks for adverse gastrointestinal events for all groups of non-steroidal anti-inflammatory drugs except diclofenac, which still had an increased odds ratio (1.49, 1.26 to 1.76).  No consistent evidence was found of enhanced safety against gastrointestinal events with any of the new cyclo-oxygenase-2 inhibitors compared with non-selective non-steroidal anti-inflammatory drugs.  The use of ulcer healing drugs reduced the increased risk of adverse gastrointestinal outcomes with all groups of non-steroidal anti-inflammatory drugs, but for diclofenac the increased risk remained significant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvRWAkh6DvRrVg90H21EOLACvtfcHk0ljIia9f9oMgiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XivVSmsg%253D%253D&md5=9653ecc6041941da8de130a6eb9d498e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1136%2Fbmj.331.7528.1310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.331.7528.1310%26sid%3Dliteratum%253Aachs%26aulast%3DHippisley-Cox%26aufirst%3DJ.%26aulast%3DCoupland%26aufirst%3DC.%26aulast%3DLogan%26aufirst%3DR.%26atitle%3DRisk%2520of%2520adverse%2520gastrointestinal%2520outcomes%2520in%2520patients%2520taking%2520cyclo-oxygenase-2%2520inhibitors%2520or%2520conventional%2520non-steroidal%2520anti-inflammatory%2520drugs%253A%2520Population%2520based%2520nested%2520case-control%2520analysis%26jtitle%3DBMJ%2520%255BBr.%2520Med.%2520J.%255D%26date%3D2005%26volume%3D331%26spage%3D1310%26epage%3D1312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Ott, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nussmeier, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duke, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feneck, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alston, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snabes, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saidman, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangano, D. T.</span><span> </span><span class="NLM_article-title">Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery</span> <span class="citation_source-journal">J. Thorac. Cardiovasc. Surg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">1481</span><span class="NLM_x">–</span> <span class="NLM_lpage">1492</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=1481-1492&author=E.+Ottauthor=N.+A.+Nussmeierauthor=P.+C.+Dukeauthor=R.+O.+Feneckauthor=R.+P.+Alstonauthor=M.+C.+Snabesauthor=R.+C.+Hubbardauthor=P.+H.+Hsuauthor=L.+J.+Saidmanauthor=D.+T.+Mangano&title=Efficacy+and+safety+of+the+cyclooxygenase+2+inhibitors+parecoxib+and+valdecoxib+in+patients+undergoing+coronary+artery+bypass+surgery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOtt%26aufirst%3DE.%26aulast%3DNussmeier%26aufirst%3DN.%2BA.%26aulast%3DDuke%26aufirst%3DP.%2BC.%26aulast%3DFeneck%26aufirst%3DR.%2BO.%26aulast%3DAlston%26aufirst%3DR.%2BP.%26aulast%3DSnabes%26aufirst%3DM.%2BC.%26aulast%3DHubbard%26aufirst%3DR.%2BC.%26aulast%3DHsu%26aufirst%3DP.%2BH.%26aulast%3DSaidman%26aufirst%3DL.%2BJ.%26aulast%3DMangano%26aufirst%3DD.%2BT.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520the%2520cyclooxygenase%25202%2520inhibitors%2520parecoxib%2520and%2520valdecoxib%2520in%2520patients%2520undergoing%2520coronary%2520artery%2520bypass%2520surgery%26jtitle%3DJ.%2520Thorac.%2520Cardiovasc.%2520Surg.%26date%3D2003%26volume%3D125%26spage%3D1481%26epage%3D1492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Nussmeier, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whelton, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langford, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoeft, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parlow, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verburg, K. M.</span><span> </span><span class="NLM_article-title">Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x">, </span> <span class="NLM_fpage">1081</span><span class="NLM_x">–</span> <span class="NLM_lpage">1091</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1056%2FNEJMoa050330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=15713945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXit1Kqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2005&pages=1081-1091&author=N.+A.+Nussmeierauthor=A.+A.+Wheltonauthor=M.+T.+Brownauthor=R.+M.+Langfordauthor=A.+Hoeftauthor=J.+L.+Parlowauthor=S.+W.+Boyceauthor=K.+M.+Verburg&title=Complications+of+the+COX-2+inhibitors+parecoxib+and+valdecoxib+after+cardiac+surgery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery</span></div><div class="casAuthors">Nussmeier, Nancy A.; Whelton, Andrew A.; Brown, Mark T.; Langford, Richard M.; Hoeft, Andreas; Parlow, Joel L.; Boyce, Steven W.; Verburg, Kenneth M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1081-1091</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Valdecoxib and its i.v. prodrug parecoxib are used to treat postoperative pain but may involve risk after coronary-artery bypass grafting (CABG).  We conducted a randomized trial to assess the safety of these drugs after CABG.  In this randomized, double-blind study involving 10 days of treatment and 30 days of follow-up, 1671 patients were randomly assigned to receive i.v. parecoxib for at least 3 days, followed by oral valdecoxib through day 10; i.v. placebo followed by oral valdecoxib; or placebo for 10 days.  All patients had access to std. opioid medications.  The primary end point was the frequency of predefined adverse events, including cardiovascular events, renal failure or dysfunction, gastroduodenal ulceration, and wound-healing complications.  As compared with the group given placebo alone, both the group given parecoxib and valdecoxib and the group given placebo and valdecoxib had a higher proportion of patients with at least one confirmed adverse event (7.4 % in each of these two groups vs. 4.0 % in the placebo group; risk ratio for each comparison, 1.9; 95 % confidence interval, 1.1 to 3.2; P = 0.02 for each comparison with the placebo group).  In particular, cardiovascular events (including myocardial infarction, cardiac arrest, stroke, and pulmonary embolism) were more frequent among the patients given parecoxib and valdecoxib than among those given placebo (2.0 % vs. 0.5 %; risk ratio, 3.7; 95 % confidence interval, 1.0 to 13.5; P = 0.03).  The use of parecoxib and valdecoxib after CABG was assocd. with an increased incidence of cardiovascular events, arousing serious concern about the use of these drugs in such circumstances.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplvkMQyXQWoLVg90H21EOLACvtfcHk0liLwucLzbPiIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXit1Kqu74%253D&md5=ca20e1d0f91cc56020437883ebd4c6d7</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa050330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa050330%26sid%3Dliteratum%253Aachs%26aulast%3DNussmeier%26aufirst%3DN.%2BA.%26aulast%3DWhelton%26aufirst%3DA.%2BA.%26aulast%3DBrown%26aufirst%3DM.%2BT.%26aulast%3DLangford%26aufirst%3DR.%2BM.%26aulast%3DHoeft%26aufirst%3DA.%26aulast%3DParlow%26aufirst%3DJ.%2BL.%26aulast%3DBoyce%26aufirst%3DS.%2BW.%26aulast%3DVerburg%26aufirst%3DK.%2BM.%26atitle%3DComplications%2520of%2520the%2520COX-2%2520inhibitors%2520parecoxib%2520and%2520valdecoxib%2520after%2520cardiac%2520surgery%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D352%26spage%3D1081%26epage%3D1091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Cannon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtis, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">FitzGerald, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krum, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognese, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reicin, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bombardier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinblatt, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Heijde, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laine, L.</span><span> </span><span class="NLM_article-title">Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the multinational etoricoxib and diclofenac arthritis long-term (MEDAL) programme: A randomized comparison</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x">, </span> <span class="NLM_fpage">1771</span><span class="NLM_x">–</span> <span class="NLM_lpage">1781</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2006&pages=1771-1781&author=C.+P.+Cannonauthor=S.+P.+Curtisauthor=G.+A.+FitzGeraldauthor=H.+Krumauthor=A.+Kaurauthor=J.+A.+Bologneseauthor=A.+S.+Reicinauthor=C.+Bombardierauthor=M.+E.+Weinblattauthor=D.+van+der+Heijdeauthor=E.+Erdmannauthor=L.+Laine&title=Cardiovascular+outcomes+with+etoricoxib+and+diclofenac+in+patients+with+osteoarthritis+and+rheumatoid+arthritis+in+the+multinational+etoricoxib+and+diclofenac+arthritis+long-term+%28MEDAL%29+programme%3A+A+randomized+comparison"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCannon%26aufirst%3DC.%2BP.%26aulast%3DCurtis%26aufirst%3DS.%2BP.%26aulast%3DFitzGerald%26aufirst%3DG.%2BA.%26aulast%3DKrum%26aufirst%3DH.%26aulast%3DKaur%26aufirst%3DA.%26aulast%3DBolognese%26aufirst%3DJ.%2BA.%26aulast%3DReicin%26aufirst%3DA.%2BS.%26aulast%3DBombardier%26aufirst%3DC.%26aulast%3DWeinblatt%26aufirst%3DM.%2BE.%26aulast%3Dvan%2Bder%2BHeijde%26aufirst%3DD.%26aulast%3DErdmann%26aufirst%3DE.%26aulast%3DLaine%26aufirst%3DL.%26atitle%3DCardiovascular%2520outcomes%2520with%2520etoricoxib%2520and%2520diclofenac%2520in%2520patients%2520with%2520osteoarthritis%2520and%2520rheumatoid%2520arthritis%2520in%2520the%2520multinational%2520etoricoxib%2520and%2520diclofenac%2520arthritis%2520long-term%2520%2528MEDAL%2529%2520programme%253A%2520A%2520randomized%2520comparison%26jtitle%3DLancet%26date%3D2006%26volume%3D368%26spage%3D1771%26epage%3D1781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Blobaum, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span> </span><span class="NLM_article-title">NSAID action and the foundations for cardiovascular toxicity</span> <span class="citation_source-journal">Cardiotoxicity Non-Cardiovascular Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">285</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1002%2F9780470660379.ch8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSqs7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&pages=257-285&author=A.+L.+Blobaumauthor=L.+J.+Marnett&title=NSAID+action+and+the+foundations+for+cardiovascular+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">NSAID action and the foundations for cardiovascular toxicity</span></div><div class="casAuthors">Blobaum, Anna L.; Marnett, Lawrence J.</div><div class="citationInfo"><span class="NLM_cas:title">Cardiotoxicity of Non-Cardiovascular Drugs</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">257-285</span>CODEN:
                <span class="NLM_cas:coden">69NEAC</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review on the clin. history of non-steroidal anti-inflammatory drugs (NSAIDs) and COXIBs and the mol. foundations of their cardiovascular toxicity.  Topics discussed include history of NSAIDs, COX and NSAID action, the discovery of COX-2 and the development of COXIBs, COX-2 and arthritis trials, COX-2 and cancer, colon polyp recurrence trials, specific evidence for COX-2 derived PGI2 suppression and cardiovascular toxicity, addnl. mechanisms for cardiovascular events related to COX-2 inhibition, and COXIBs vs. NSAIDs and cardiovascular risk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeq4wqXJPBtrVg90H21EOLACvtfcHk0liLwucLzbPiIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVSqs7vP&md5=cb66f38061fe4cf6943c08af82cd428d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2F9780470660379.ch8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F9780470660379.ch8%26sid%3Dliteratum%253Aachs%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26atitle%3DNSAID%2520action%2520and%2520the%2520foundations%2520for%2520cardiovascular%2520toxicity%26jtitle%3DCardiotoxicity%2520Non-Cardiovascular%2520Drugs%26date%3D2010%26spage%3D257%26epage%3D285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Wallace, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKnight, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vergnolle, N.</span><span> </span><span class="NLM_article-title">NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">706</span><span class="NLM_x">–</span> <span class="NLM_lpage">714</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2000&pages=706-714&author=J.+L.+Wallaceauthor=W.+McKnightauthor=B.+K.+Reuterauthor=N.+Vergnolle&title=NSAID-induced+gastric+damage+in+rats%3A+requirement+for+inhibition+of+both+cyclooxygenase+1+and+2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWallace%26aufirst%3DJ.%2BL.%26aulast%3DMcKnight%26aufirst%3DW.%26aulast%3DReuter%26aufirst%3DB.%2BK.%26aulast%3DVergnolle%26aufirst%3DN.%26atitle%3DNSAID-induced%2520gastric%2520damage%2520in%2520rats%253A%2520requirement%2520for%2520inhibition%2520of%2520both%2520cyclooxygenase%25201%2520and%25202%26jtitle%3DGastroenterology%26date%3D2000%26volume%3D119%26spage%3D706%26epage%3D714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Kakuta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tai, A.</span><span> </span><span class="NLM_article-title">Cyclooxygenase-1-Selective Inhibitors Are Attractive Candidates for Analgesics That Do Not Cause Gastric Damage. Design and in Vitro/in Vivo Evaluation of a Benzamide-Type Cyclooxygenase-1 Selective Inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2400</span><span class="NLM_x">–</span> <span class="NLM_lpage">2411</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701191z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2400-2411&author=H.+Kakutaauthor=X.+Zhengauthor=H.+Odaauthor=S.+Haradaauthor=Y.+Sugimotoauthor=K.+Sasakiauthor=A.+Tai&title=Cyclooxygenase-1-Selective+Inhibitors+Are+Attractive+Candidates+for+Analgesics+That+Do+Not+Cause+Gastric+Damage.+Design+and+in+Vitro%2Fin+Vivo+Evaluation+of+a+Benzamide-Type+Cyclooxygenase-1+Selective+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm701191z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701191z%26sid%3Dliteratum%253Aachs%26aulast%3DKakuta%26aufirst%3DH.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DOda%26aufirst%3DH.%26aulast%3DHarada%26aufirst%3DS.%26aulast%3DSugimoto%26aufirst%3DY.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DTai%26aufirst%3DA.%26atitle%3DCyclooxygenase-1-Selective%2520Inhibitors%2520Are%2520Attractive%2520Candidates%2520for%2520Analgesics%2520That%2520Do%2520Not%2520Cause%2520Gastric%2520Damage.%2520Design%2520and%2520in%2520Vitro%252Fin%2520Vivo%2520Evaluation%2520of%2520a%2520Benzamide-Type%2520Cyclooxygenase-1%2520Selective%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2400%26epage%3D2411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Perrone, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scilimati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simone, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitale, P.</span><span> </span><span class="NLM_article-title">Selective COX-1 inhibition: A therapeutic target to be reconsidered</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3769</span><span class="NLM_x">–</span> <span class="NLM_lpage">3805</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.2174%2F092986710793205408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=20858219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGqu7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=3769-3805&author=M.+G.+Perroneauthor=A.+Scilimatiauthor=L.+Simoneauthor=P.+Vitale&title=Selective+COX-1+inhibition%3A+A+therapeutic+target+to+be+reconsidered"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Selective COX-1 inhibition: a therapeutic target to be reconsidered</span></div><div class="casAuthors">Perrone, M. G.; Scilimati, A.; Simone, L.; Vitale, P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">3769-3805</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Since cyclooxygenase (COX) isoenzymes discovery, many papers and reviews have been published to describe the structural bases of COX inhibition, and to debate on the therapeutic and adverse effects of worldwide clin. used nonsteroidal anti-inflammatory drugs (NSAIDs), included COX-2 selective inhibitors (well known as Coxibs).  COX-2 inhibition has been widely investigated, whereas the role of COX-1 in human pathophysiol. is mostly not yet well ascertained.  As time goes on, the cliche that the constitutively expressed isoform COX-1 is only involved in normal physiol. functions, such as platelet aggregation, gastric mucosa protection and renal electrolyte homeostasis is going to be shattered.  Low-dose aspirin, behaving as a preferential inhibitor of platelet COX-1, allowed to enlighten the role exerted by this isoenzyme in many mammalian cell types.  This review would elucidate the most recent findings on selective COX-1 inhibition and their relevance to human pathol. such as cancer, neuro-inflammation, cardioprotection, fever and pain.  It would also focus on the design and development of new highly selective COX-1 inhibitors, useful tools in pharmacol. studies aimed at gaining a deeper insight of the role of COX-1 in human health and disease.  Among the traditional NSAIDs, other then aspirin and indomethacin, only few examples of selective COX-1 inhibitors (SC-560, FR122047, mofezolac, P6 and TFAP) have been so far identified.  This review has also the scope to stimulate the development of novel drugs, which activity is COX-1 mediated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg5V9ocjssTLVg90H21EOLACvtfcHk0lh4f5QahwFrtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGqu7vI&md5=6cfc06d889d5b2234302d63c309d86b1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2174%2F092986710793205408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710793205408%26sid%3Dliteratum%253Aachs%26aulast%3DPerrone%26aufirst%3DM.%2BG.%26aulast%3DScilimati%26aufirst%3DA.%26aulast%3DSimone%26aufirst%3DL.%26aulast%3DVitale%26aufirst%3DP.%26atitle%3DSelective%2520COX-1%2520inhibition%253A%2520A%2520therapeutic%2520target%2520to%2520be%2520reconsidered%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D3769%26epage%3D3805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Aid, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosetti, F.</span><span> </span><span class="NLM_article-title">Targeting cyclooxygenases-1 and -2 in neuroinflammation: Therapeutic implications</span> <span class="citation_source-journal">Biochimie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2011&pages=46-51&author=S.+Aidauthor=F.+Bosetti&title=Targeting+cyclooxygenases-1+and+-2+in+neuroinflammation%3A+Therapeutic+implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAid%26aufirst%3DS.%26aulast%3DBosetti%26aufirst%3DF.%26atitle%3DTargeting%2520cyclooxygenases-1%2520and%2520-2%2520in%2520neuroinflammation%253A%2520Therapeutic%2520implications%26jtitle%3DBiochimie%26date%3D2011%26volume%3D93%26spage%3D46%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Simmons, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botting, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hla, T.</span><span> </span><span class="NLM_article-title">Cyclooxygenase isozymes: The biology of prostaglandin synthesis and inhibition</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">437</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2004&pages=387-437&author=D.+L.+Simmonsauthor=R.+M.+Bottingauthor=T.+Hla&title=Cyclooxygenase+isozymes%3A+The+biology+of+prostaglandin+synthesis+and+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSimmons%26aufirst%3DD.%2BL.%26aulast%3DBotting%26aufirst%3DR.%2BM.%26aulast%3DHla%26aufirst%3DT.%26atitle%3DCyclooxygenase%2520isozymes%253A%2520The%2520biology%2520of%2520prostaglandin%2520synthesis%2520and%2520inhibition%26jtitle%3DPharmacol.%2520Rev.%26date%3D2004%26volume%3D56%26spage%3D387%26epage%3D437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Teismann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tieu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, D.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, D.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunot, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vila, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson-Lewis, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Przedborski, S.</span><span> </span><span class="NLM_article-title">Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">5473</span><span class="NLM_x">–</span> <span class="NLM_lpage">5478</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=5473-5478&author=P.+Teismannauthor=K.+Tieuauthor=D.-K.+Choiauthor=D.-C.+Wuauthor=A.+Nainiauthor=S.+Hunotauthor=M.+Vilaauthor=V.+Jackson-Lewisauthor=S.+Przedborski&title=Cyclooxygenase-2+is+instrumental+in+Parkinson%27s+disease+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTeismann%26aufirst%3DP.%26aulast%3DTieu%26aufirst%3DK.%26aulast%3DChoi%26aufirst%3DD.-K.%26aulast%3DWu%26aufirst%3DD.-C.%26aulast%3DNaini%26aufirst%3DA.%26aulast%3DHunot%26aufirst%3DS.%26aulast%3DVila%26aufirst%3DM.%26aulast%3DJackson-Lewis%26aufirst%3DV.%26aulast%3DPrzedborski%26aufirst%3DS.%26atitle%3DCyclooxygenase-2%2520is%2520instrumental%2520in%2520Parkinson%2527s%2520disease%2520neurodegeneration%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2003%26volume%3D100%26spage%3D5473%26epage%3D5478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Choi, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosetti, F.</span><span> </span><span class="NLM_article-title">Cyclooxygenase-1 null mice show reduced neuroinflammation in response to β-amyloid</span> <span class="citation_source-journal">Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">234</span><span class="NLM_x">–</span> <span class="NLM_lpage">244</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.18632%2Faging.100021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=20157512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GkurvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=234-244&author=S.-H.+Choiauthor=F.+Bosetti&title=Cyclooxygenase-1+null+mice+show+reduced+neuroinflammation+in+response+to+%CE%B2-amyloid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclooxygenase-1 null mice show reduced neuroinflammation in response to β-amyloid</span></div><div class="casAuthors">Choi, Sang-Ho; Bosetti, Francesca</div><div class="citationInfo"><span class="NLM_cas:title">Aging</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">234-244</span>CODEN:
                <span class="NLM_cas:coden">AGINCN</span>;
        ISSN:<span class="NLM_cas:issn">1945-4589</span>.
    
            (<span class="NLM_cas:orgname">Impact Journals LLC</span>)
        </div><div class="casAbstract">Several independent epidemiol. studies indicate that chronic use of non-steroidal anti-inflammatory drugs can reduce the risk of developing Alzheimer's disease (AD), supporting the inflammatory cascade hypothesis.  Although the first clin. trial with indomethacin, a preferential cyclooxygenase (COX)-1 inhibitor, showed beneficial effects, subsequent large clin. trials, mostly using COX-2 inhibitors, failed to show any beneficial effect in AD patients with mild to severe cognitive impairment.  These combined data suggest that either an early treatment is crucial to stop the mechanisms underlying the disease before the onset of the symptoms, or that preferential COX-1 inhibition, rather than COX-2, is beneficial.  Therefore, a full understanding of the physiol., pathol., and/or neuroprotective role of COX isoforms may help to develop better therapeutic strategies for the prevention or treatment of AD.  In this study, we examd. the effect of COX-1 genetic deletion on the inflammatory response and neurodegeneration induced by β-amyloid.  β-Amyloid (Aβ1-42) was centrally injected in the lateral ventricle of COX-1-deficient (COX-1-/-) and their resp. wild-type (WT) mice.  In COX-1-/- mice, Aβ1-42-induced inflammatory response and neuronal damage were attenuated compared to WT mice, as shown by Fluoro-Jade B and nitrotyrosine staining.  These results indicate that inhibition of COX-1 activity may be valid therapeutic strategy to reduce brain inflammatory response and neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXGYQzHEe3HbVg90H21EOLACvtfcHk0ljX3KCmC4awHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GkurvF&md5=d8bd9f9c16066b02741122223fed1195</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.18632%2Faging.100021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Faging.100021%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DS.-H.%26aulast%3DBosetti%26aufirst%3DF.%26atitle%3DCyclooxygenase-1%2520null%2520mice%2520show%2520reduced%2520neuroinflammation%2520in%2520response%2520to%2520%25CE%25B2-amyloid%26jtitle%3DAging%26date%3D2009%26volume%3D1%26spage%3D234%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">McKee, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreras, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hossain, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oddo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFerla, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowall, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dedeoglu, A.</span><span> </span><span class="NLM_article-title">Ibuprofen reduces Aβ, hyperphosphorylated tau and memory deficits in Alzheimer mice</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1207</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">236</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1016%2Fj.brainres.2008.01.095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=18374906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvVyisL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1207&publication_year=2008&pages=225-236&author=A.+C.+McKeeauthor=I.+Carrerasauthor=L.+Hossainauthor=H.+Ryuauthor=W.+L.+Kleinauthor=S.+Oddoauthor=F.+M.+LaFerlaauthor=B.+G.+Jenkinsauthor=N.+W.+Kowallauthor=A.+Dedeoglu&title=Ibuprofen+reduces+A%CE%B2%2C+hyperphosphorylated+tau+and+memory+deficits+in+Alzheimer+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Ibuprofen reduces Aβ, hyperphosphorylated tau and memory deficits in Alzheimer mice</span></div><div class="casAuthors">McKee, Ann C.; Carreras, Isabel; Hossain, Lokman; Ryu, Hoon; Klein, William L.; Oddo, Salvatore; LaFerla, Frank M.; Jenkins, Bruce G.; Kowall, Neil W.; Dedeoglu, Alpaslan</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1207</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">225-236</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We examd. the effects of ibuprofen on cognitive deficits, Aβ and tau accumulation in young triple transgenic (3xTg-AD) mice. 3xTg-AD mice were fed ibuprofen-supplemented chow between 1 and 6 mo.  Untreated 3xTg-AD mice showed significant impairment in the ability to learn the Morris water maze (MWM) task compared to age-matched wild-type (WT) mice.  The performance of 3xTg-AD mice was significantly improved with ibuprofen treatment compared to untreated 3xTg-AD mice.  Ibuprofen-treated transgenic mice showed a significant decrease in intraneuronal oligomeric Aβ and hyperphosphorylated tau (AT8) immunoreactivity in the hippocampus.  Confocal microscopy demonstrated co-localization of conformationally altered (MC1) and early phosphorylated tau (CP-13) with oligomeric Aβ, and less co-localization of oligomeric Aβ and later forms of phosphorylated tau (AT8 and PHF-1) in untreated 3xTg-AD mice.  Our findings show that prophylactic treatment of young 3xTg-AD mice with ibuprofen reduces intraneuronal oligomeric Aβ, reduces cognitive deficits, and prevents hyperphosphorylated tau immunoreactivity.  These findings provide further support for intraneuronal Aβ as a cause of cognitive impairment, and suggest that pathol. alterations of tau are assocd. with intraneuronal oligomeric Aβ accumulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnXVz44djYCrVg90H21EOLACvtfcHk0ljGPPR5Bi_dNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvVyisL4%253D&md5=320a00cceb84e799f7ccc37224e02f2b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2008.01.095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2008.01.095%26sid%3Dliteratum%253Aachs%26aulast%3DMcKee%26aufirst%3DA.%2BC.%26aulast%3DCarreras%26aufirst%3DI.%26aulast%3DHossain%26aufirst%3DL.%26aulast%3DRyu%26aufirst%3DH.%26aulast%3DKlein%26aufirst%3DW.%2BL.%26aulast%3DOddo%26aufirst%3DS.%26aulast%3DLaFerla%26aufirst%3DF.%2BM.%26aulast%3DJenkins%26aufirst%3DB.%2BG.%26aulast%3DKowall%26aufirst%3DN.%2BW.%26aulast%3DDedeoglu%26aufirst%3DA.%26atitle%3DIbuprofen%2520reduces%2520A%25CE%25B2%252C%2520hyperphosphorylated%2520tau%2520and%2520memory%2520deficits%2520in%2520Alzheimer%2520mice%26jtitle%3DBrain%2520Res.%26date%3D2008%26volume%3D1207%26spage%3D225%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Nomura, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blankman, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinsey, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcondes, M. C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation</span> <span class="citation_source-journal">Science (Washington, DC, U.S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">334</span><span class="NLM_x">, </span> <span class="NLM_fpage">809</span><span class="NLM_x">–</span> <span class="NLM_lpage">813</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1126%2Fscience.1209200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=22021672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVagtrnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=2011&pages=809-813&author=D.+K.+Nomuraauthor=B.+E.+Morrisonauthor=J.+L.+Blankmanauthor=J.+Z.+Longauthor=S.+G.+Kinseyauthor=M.+C.+G.+Marcondesauthor=A.+M.+Wardauthor=Y.+K.+Hahnauthor=A.+H.+Lichtmanauthor=B.+Contiauthor=B.+F.+Cravatt&title=Endocannabinoid+Hydrolysis+Generates+Brain+Prostaglandins+That+Promote+Neuroinflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation</span></div><div class="casAuthors">Nomura, Daniel K.; Morrison, Bradley E.; Blankman, Jacqueline L.; Long, Jonathan Z.; Kinsey, Steven G.; Marcondes, Maria Cecilia G.; Ward, Anna M.; Hahn, Yun Kyung; Lichtman, Aron H.; Conti, Bruno; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">334</span>
        (<span class="NLM_cas:issue">6057</span>),
    <span class="NLM_cas:pages">809-813</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Phospholipase A2(PLA2) enzymes are considered the primary source of arachidonic acid for cyclooxygenase (COX)-mediated biosynthesis of prostaglandins.  Here, we show that a distinct pathway exists in brain, where monoacyl-glycerol lipase (MAGL) hydrolyzes the endocannabinoid 2-arachidonoylglycerol to generate a major arachidonate precursor pool for neuroinflammatory prostaglandins.  MAGL-disrupted animals show neuroprotection in a parkinsonian mouse model.  These animals are spared the hemorrhaging caused by COX inhibitors in the gut, where prostaglandins are instead regulated by cytosolic PLA2.  These findings identify MAGL as a distinct metabolic node that couples endocannabinoid to prostaglandin signaling networks in the nervous system and suggest that inhibition of this enzyme may be a new and potentially safer way to suppress the proinflammatory cascades that underlie neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPRRB-JEf2GrVg90H21EOLACvtfcHk0ljGPPR5Bi_dNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVagtrnJ&md5=17967f2d83876f57e4bc901df2e7dc68</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1126%2Fscience.1209200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1209200%26sid%3Dliteratum%253Aachs%26aulast%3DNomura%26aufirst%3DD.%2BK.%26aulast%3DMorrison%26aufirst%3DB.%2BE.%26aulast%3DBlankman%26aufirst%3DJ.%2BL.%26aulast%3DLong%26aufirst%3DJ.%2BZ.%26aulast%3DKinsey%26aufirst%3DS.%2BG.%26aulast%3DMarcondes%26aufirst%3DM.%2BC.%2BG.%26aulast%3DWard%26aufirst%3DA.%2BM.%26aulast%3DHahn%26aufirst%3DY.%2BK.%26aulast%3DLichtman%26aufirst%3DA.%2BH.%26aulast%3DConti%26aufirst%3DB.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DEndocannabinoid%2520Hydrolysis%2520Generates%2520Brain%2520Prostaglandins%2520That%2520Promote%2520Neuroinflammation%26jtitle%3DScience%2520%2528Washington%252C%2520DC%252C%2520U.S.%2529%26date%3D2011%26volume%3D334%26spage%3D809%26epage%3D813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Smith, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koboldt, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muhammad, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweifel, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talley, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masferrer, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seibert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isakson, P. C.</span><span> </span><span class="NLM_article-title">Pharmacological analysis of cyclooxygenase-1 in inflammation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">13313</span><span class="NLM_x">–</span> <span class="NLM_lpage">13318</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1073%2Fpnas.95.22.13313" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=9789085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADyaK1cXntFWrsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=13313-13318&author=C.+J.+Smithauthor=Y.+Zhangauthor=C.+M.+Koboldtauthor=J.+Muhammadauthor=B.+S.+Zweifelauthor=A.+Shafferauthor=J.+J.+Talleyauthor=J.+L.+Masferrerauthor=K.+Seibertauthor=P.+C.+Isakson&title=Pharmacological+analysis+of+cyclooxygenase-1+in+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological analysis of cyclooxygenase-1 in inflammation</span></div><div class="casAuthors">Smith, Christopher J.; Zhang, Yan; Koboldt, Carol M.; Muhammad, Jerry; Zweifel, Ben S.; Shaffer, Alex; Talley, John J.; Masferrer, Jaime L.; Seibert, Karen; Isakson, Peter C.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">13313-13318</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The enzymes cyclooxygenase-1 and cyclooxygenase-2 (COX-1 and COX-2) catalyze the conversion of arachidonic acid to prostaglandin (PG) H2, the precursor of PGs and thromboxane.  These lipid mediators play important roles in inflammation and pain and in normal physiol. functions.  While there are abundant data indicating that the inducible isoform, COX-2, is important in inflammation and pain, the constitutively expressed isoform, COX-1, has also been suggested to play a role in inflammatory processes.  To address the latter question pharmacol., we used a highly selective COX-1 inhibitor, SC-560 (COX-1 IC50 = 0.009 μM; COX-2 IC50 = 6.3 μM).  SC-560 inhibited COX-1-derived platelet thromboxane B2, gastric PGE2, and dermal PGE2 prodn., indicating that it was orally active, but did not inhibit COX-2-derived PGs in the lipopolysaccharide-induced rat air pouch.  Therapeutic or prophylactic administration of SC-560 in the rat carrageenan footpad model did not affect acute inflammation or hyperalgesia at doses that markedly inhibited in vivo COX-1 activity.  By contrast, celecoxib, a selective COX-2 inhibitor, was anti-inflammatory and analgesic in this model.  Paradoxically, both SC-560 and celecoxib reduced paw PGs to equiv. levels.  Increased levels of PGs were found in the cerebrospinal fluid after carrageenan injection and were markedly reduced by celecoxib, but were not affected by SC-560.  These results suggest that, in addn. to the role of peripherally produced PGs, there is a crit., centrally mediated neurol. component to inflammatory pain that is mediated at least in part by COX-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo05VnKZU2CJrVg90H21EOLACvtfcHk0lgTVxDK0cncxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXntFWrsLY%253D&md5=5b1af3003f9e099205bccf7e274401d9</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.22.13313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.22.13313%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DC.%2BJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKoboldt%26aufirst%3DC.%2BM.%26aulast%3DMuhammad%26aufirst%3DJ.%26aulast%3DZweifel%26aufirst%3DB.%2BS.%26aulast%3DShaffer%26aufirst%3DA.%26aulast%3DTalley%26aufirst%3DJ.%2BJ.%26aulast%3DMasferrer%26aufirst%3DJ.%2BL.%26aulast%3DSeibert%26aufirst%3DK.%26aulast%3DIsakson%26aufirst%3DP.%2BC.%26atitle%3DPharmacological%2520analysis%2520of%2520cyclooxygenase-1%2520in%2520inflammation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D13313%26epage%3D13318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Brenneis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofacker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zulauf, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakobsson, P.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholich, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geisslinger, G.</span><span> </span><span class="NLM_article-title">Inhibition of prostaglandin E2 synthesis by SC-560 is independent of cyclooxygenase 1 inhibition</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1352</span><span class="NLM_x">–</span> <span class="NLM_lpage">1360</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=1352-1360&author=C.+Brenneisauthor=T.+J.+Maierauthor=R.+Schmidtauthor=A.+Hofackerauthor=L.+Zulaufauthor=P.-J.+Jakobssonauthor=K.+Scholichauthor=G.+Geisslinger&title=Inhibition+of+prostaglandin+E2+synthesis+by+SC-560+is+independent+of+cyclooxygenase+1+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrenneis%26aufirst%3DC.%26aulast%3DMaier%26aufirst%3DT.%2BJ.%26aulast%3DSchmidt%26aufirst%3DR.%26aulast%3DHofacker%26aufirst%3DA.%26aulast%3DZulauf%26aufirst%3DL.%26aulast%3DJakobsson%26aufirst%3DP.-J.%26aulast%3DScholich%26aufirst%3DK.%26aulast%3DGeisslinger%26aufirst%3DG.%26atitle%3DInhibition%2520of%2520prostaglandin%2520E2%2520synthesis%2520by%2520SC-560%2520is%2520independent%2520of%2520cyclooxygenase%25201%2520inhibition%26jtitle%3DFASEB%2520J.%26date%3D2006%26volume%3D20%26spage%3D1352%26epage%3D1360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Daikoku, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tranguch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trofimova, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinulescu, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacks, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikitin, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dey, S. K.</span><span> </span><span class="NLM_article-title">Cyclooxygenase-1 Is Overexpressed in Multiple Genetically Engineered Mouse Models of Epithelial Ovarian Cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">2527</span><span class="NLM_x">–</span> <span class="NLM_lpage">2531</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=2527-2531&author=T.+Daikokuauthor=S.+Tranguchauthor=I.+N.+Trofimovaauthor=D.+M.+Dinulescuauthor=T.+Jacksauthor=A.+Y.+Nikitinauthor=D.+C.+Connollyauthor=S.+K.+Dey&title=Cyclooxygenase-1+Is+Overexpressed+in+Multiple+Genetically+Engineered+Mouse+Models+of+Epithelial+Ovarian+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDaikoku%26aufirst%3DT.%26aulast%3DTranguch%26aufirst%3DS.%26aulast%3DTrofimova%26aufirst%3DI.%2BN.%26aulast%3DDinulescu%26aufirst%3DD.%2BM.%26aulast%3DJacks%26aufirst%3DT.%26aulast%3DNikitin%26aufirst%3DA.%2BY.%26aulast%3DConnolly%26aufirst%3DD.%2BC.%26aulast%3DDey%26aufirst%3DS.%2BK.%26atitle%3DCyclooxygenase-1%2520Is%2520Overexpressed%2520in%2520Multiple%2520Genetically%2520Engineered%2520Mouse%2520Models%2520of%2520Epithelial%2520Ovarian%2520Cancer%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D2527%26epage%3D2531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Gupta Rajnish, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tejada Lovella, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong Beverly, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das Sanjoy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrow Jason, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dey Sudhansu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DuBois Raymond, N.</span><span> </span><span class="NLM_article-title">Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">906</span><span class="NLM_x">–</span> <span class="NLM_lpage">911</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=906-911&author=A.+Gupta+Rajnishauthor=V.+Tejada+Lovellaauthor=J.+Tong+Beverlyauthor=K.+Das+Sanjoyauthor=D.+Morrow+Jasonauthor=K.+Dey+Sudhansuauthor=N.+DuBois+Raymond&title=Cyclooxygenase-1+is+overexpressed+and+promotes+angiogenic+growth+factor+production+in+ovarian+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%2BRajnish%26aufirst%3DA.%26aulast%3DTejada%2BLovella%26aufirst%3DV.%26aulast%3DTong%2BBeverly%26aufirst%3DJ.%26aulast%3DDas%2BSanjoy%26aufirst%3DK.%26aulast%3DMorrow%2BJason%26aufirst%3DD.%26aulast%3DDey%2BSudhansu%26aufirst%3DK.%26aulast%3DDuBois%2BRaymond%26aufirst%3DN.%26atitle%3DCyclooxygenase-1%2520is%2520overexpressed%2520and%2520promotes%2520angiogenic%2520growth%2520factor%2520production%2520in%2520ovarian%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D906%26epage%3D911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Kakuta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohsawa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tai, A.</span><span> </span><span class="NLM_article-title">Identification of urine metabolites of TFAP, a cyclooxygenase-1 inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1840</span><span class="NLM_x">–</span> <span class="NLM_lpage">1843</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1840-1843&author=H.+Kakutaauthor=R.+Fukaiauthor=X.+Zhengauthor=F.+Ohsawaauthor=T.+Bambaauthor=K.+Hirataauthor=A.+Tai&title=Identification+of+urine+metabolites+of+TFAP%2C+a+cyclooxygenase-1+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKakuta%26aufirst%3DH.%26aulast%3DFukai%26aufirst%3DR.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DOhsawa%26aufirst%3DF.%26aulast%3DBamba%26aufirst%3DT.%26aulast%3DHirata%26aufirst%3DK.%26aulast%3DTai%26aufirst%3DA.%26atitle%3DIdentification%2520of%2520urine%2520metabolites%2520of%2520TFAP%252C%2520a%2520cyclooxygenase-1%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1840%26epage%3D1843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Bhattacharyya, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecomte, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgans, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. L.</span><span> </span><span class="NLM_article-title">Selective inhibition of prostaglandin endoperoxide synthase-1 (cyclooxygenase-1) by valerylsalicylic acid</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=1995&pages=19-24&author=D.+K.+Bhattacharyyaauthor=M.+Lecomteauthor=J.+Dunnauthor=D.+J.+Morgansauthor=W.+L.+Smith&title=Selective+inhibition+of+prostaglandin+endoperoxide+synthase-1+%28cyclooxygenase-1%29+by+valerylsalicylic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharyya%26aufirst%3DD.%2BK.%26aulast%3DLecomte%26aufirst%3DM.%26aulast%3DDunn%26aufirst%3DJ.%26aulast%3DMorgans%26aufirst%3DD.%2BJ.%26aulast%3DSmith%26aufirst%3DW.%2BL.%26atitle%3DSelective%2520inhibition%2520of%2520prostaglandin%2520endoperoxide%2520synthase-1%2520%2528cyclooxygenase-1%2529%2520by%2520valerylsalicylic%2520acid%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1995%26volume%3D317%26spage%3D19%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Siqueira-Junior, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Brum-Fernandes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribeiro-do-Valle, R. M.</span><span> </span><span class="NLM_article-title">Effects of valeryl salicylate, a COX-1 inhibitor, on models of acute inflammation in mice</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">443</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1016%2FS1043-6618%2803%2900188-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=12967587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntVGksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2003&pages=437-443&author=J.+M.+Siqueira-Juniorauthor=R.+R.+Petersauthor=A.+J.+de+Brum-Fernandesauthor=R.+M.+Ribeiro-do-Valle&title=Effects+of+valeryl+salicylate%2C+a+COX-1+inhibitor%2C+on+models+of+acute+inflammation+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of valeryl salicylate, a COX-1 inhibitor, on models of acute inflammation in mice</span></div><div class="casAuthors">Siqueira-Junior, Jarbas M.; Peters, Rodrigo R.; de Brum-Fernandes, Artur J.; Ribeiro-do-Valle, Rosa M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">437-443</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The effect of valeryl salicylate (VS), an inhibitor of cyclooxygenase-1 (COX-1), was evaluated in arachidonic acid or croton oil-induced ear edema and carrageenan-induced paw edema in mice.  Ear edema was induced by topical administration of arachidonic acid (2 mg per ear; 20 μl) or croton oil (1 mg per ear; 20 μl) to the inner surface of the left ear and the change in the ear's thickness was measured with a precision micrometer (Fisher, USA).  VS significantly inhibited the arachidonic acid ear edema after l h at doses of 1.5-45 μg per ear; however, only at the dose of 45 μg per ear was it able to significantly reduce the croton oil-induced edema at 6 h.  Paw edema was induced by the injection of 25 μl of 1% carrageenan into the plantar aponeurosis of the right hind paw.  The edema was evaluated at 0.5, 1, 2, 4, 24, 48 and 72 h.  Previously in our expts., we obsd. two peaks in paw edema formation: one at 2 h, in the early phase (0-4 h), and the other, occurring at 48 h after carrageenan injection, in the late phase (24-72 h).  The pre-treatment with VS significantly reduced the paw edema at 2 h, the same effect obsd. with celecoxib and indomethacin treatments.  At 24 h, VS did not inhibit edema but significantly increased it mainly at 48 h after carrageenan injection.  These results showed that VS was pharmacol. active in these models and suggest that COX-1 may participate in the early and late phases of inflammation in the models studied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1nEJ03b8y5rVg90H21EOLACvtfcHk0ljSMaGdIsm6Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntVGksL8%253D&md5=bfc5d0957f63200d5b4ccfaa45768140</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS1043-6618%2803%2900188-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1043-6618%252803%252900188-9%26sid%3Dliteratum%253Aachs%26aulast%3DSiqueira-Junior%26aufirst%3DJ.%2BM.%26aulast%3DPeters%26aufirst%3DR.%2BR.%26aulast%3Dde%2BBrum-Fernandes%26aufirst%3DA.%2BJ.%26aulast%3DRibeiro-do-Valle%26aufirst%3DR.%2BM.%26atitle%3DEffects%2520of%2520valeryl%2520salicylate%252C%2520a%2520COX-1%2520inhibitor%252C%2520on%2520models%2520of%2520acute%2520inflammation%2520in%2520mice%26jtitle%3DPharmacol.%2520Res.%26date%3D2003%26volume%3D48%26spage%3D437%26epage%3D443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Labayle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vielh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drouhin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pariente, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bories, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duhamel, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trousset, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attali, P.</span><span> </span><span class="NLM_article-title">Sulindac causes regression of rectal polyps in familial adenomatous polyposis</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">635</span><span class="NLM_x">–</span> <span class="NLM_lpage">639</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=1991&pages=635-639&author=D.+Labayleauthor=D.+Fischerauthor=P.+Vielhauthor=F.+Drouhinauthor=A.+Parienteauthor=C.+Boriesauthor=O.+Duhamelauthor=M.+Troussetauthor=P.+Attali&title=Sulindac+causes+regression+of+rectal+polyps+in+familial+adenomatous+polyposis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLabayle%26aufirst%3DD.%26aulast%3DFischer%26aufirst%3DD.%26aulast%3DVielh%26aufirst%3DP.%26aulast%3DDrouhin%26aufirst%3DF.%26aulast%3DPariente%26aufirst%3DA.%26aulast%3DBories%26aufirst%3DC.%26aulast%3DDuhamel%26aufirst%3DO.%26aulast%3DTrousset%26aufirst%3DM.%26aulast%3DAttali%26aufirst%3DP.%26atitle%3DSulindac%2520causes%2520regression%2520of%2520rectal%2520polyps%2520in%2520familial%2520adenomatous%2520polyposis%26jtitle%3DGastroenterology%26date%3D1991%26volume%3D101%26spage%3D635%26epage%3D639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Narisawa, T.</span><span> </span><span class="NLM_article-title">An overview on chemoprevention of colorectal cancer</span> <span class="citation_source-journal">Nihon Geka Gakkai zasshi</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">362</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1998&pages=362-367&author=T.+Narisawa&title=An+overview+on+chemoprevention+of+colorectal+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNarisawa%26aufirst%3DT.%26atitle%3DAn%2520overview%2520on%2520chemoprevention%2520of%2520colorectal%2520cancer%26jtitle%3DNihon%2520Geka%2520Gakkai%2520zasshi%26date%3D1998%26volume%3D99%26spage%3D362%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Kashfi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigas, B.</span><span> </span><span class="NLM_article-title">Non-COX-2 targets and cancer: Expanding the molecular target repertoire of chemoprevention</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">969</span><span class="NLM_x">–</span> <span class="NLM_lpage">986</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=969-986&author=K.+Kashfiauthor=B.+Rigas&title=Non-COX-2+targets+and+cancer%3A+Expanding+the+molecular+target+repertoire+of+chemoprevention"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKashfi%26aufirst%3DK.%26aulast%3DRigas%26aufirst%3DB.%26atitle%3DNon-COX-2%2520targets%2520and%2520cancer%253A%2520Expanding%2520the%2520molecular%2520target%2520repertoire%2520of%2520chemoprevention%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2005%26volume%3D70%26spage%3D969%26epage%3D986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Piazza, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keeton, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tinsley, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gary, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitt, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathew, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thaiparambil, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coward, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sani, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobrath, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxuitenko, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, R. C.</span><span> </span><span class="NLM_article-title">A novel sulindac derivative that does not inhibit cyclooxygenases but potently inhibits colon tumor cell growth and induces apoptosis with antitumor activity</span> <span class="citation_source-journal">Cancer Prev. Res. (Philadelphia, PA, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">572</span><span class="NLM_x">–</span> <span class="NLM_lpage">580</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1158%2F1940-6207.CAPR-09-0001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=19470791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptVWjsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=572-580&author=G.+A.+Piazzaauthor=A.+B.+Keetonauthor=H.+N.+Tinsleyauthor=B.+D.+Garyauthor=J.+D.+Whittauthor=B.+Mathewauthor=J.+Thaiparambilauthor=L.+Cowardauthor=G.+Gormanauthor=Y.+Liauthor=B.+Saniauthor=J.+V.+Hobrathauthor=Y.+Y.+Maxuitenkoauthor=R.+C.+Reynolds&title=A+novel+sulindac+derivative+that+does+not+inhibit+cyclooxygenases+but+potently+inhibits+colon+tumor+cell+growth+and+induces+apoptosis+with+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">A novel sulindac derivative that does not inhibit cyclooxygenases but potently inhibits colon tumor cell growth and induces apoptosis with antitumor activity</span></div><div class="casAuthors">Piazza, Gary A.; Keeton, Adam B.; Tinsley, Heather N.; Gary, Bernard D.; Whitt, Jason D.; Mathew, Bini; Thaiparambil, Jose; Coward, Lori; Gorman, Gregory; Li, Yonghe; Sani, Brahma; Hobrath, Judith V.; Maxuitenko, Yulia Y.; Reynolds, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Prevention Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">572-580</span>CODEN:
                <span class="NLM_cas:coden">CPRACC</span>;
        ISSN:<span class="NLM_cas:issn">1940-6207</span>.
    
            (<span class="NLM_cas:orgname">American Association of Cancer Research</span>)
        </div><div class="casAbstract">Nonsteroidal anti-inflammatory drugs such as sulindac have shown promising antineoplastic activity, although toxicity from cyclooxygenase (COX) inhibition and the suppression of prostaglandin synthesis limits their use for chemoprevention.  Previous studies have concluded that the mechanism responsible for their antineoplastic activity may be COX independent.  To selectively design out the COX inhibitory activity of sulindac sulfide (SS), in silico modeling studies were done that revealed the crucial role of the carboxylate moiety for COX-1 and COX-2 binding.  These studies prompted the synthesis of a series of SS derivs. with carboxylate modifications that were screened for tumor cell growth and COX inhibitory activity.  A SS amide (SSA) with a N,N-dimethylethyl amine substitution was found to lack COX-1 and COX-2 inhibitory activity, yet potently inhibit the growth of human colon tumor cell lines, HT-29, SW480, and HCT116 with IC50 values of 2 to 5 μmol/L compared with 73 to 85 μmol/L for SS.  The mechanism of growth inhibition involved the suppression of DNA synthesis and apoptosis induction.  Oral administration of SSA was well-tolerated in mice and generated plasma levels that exceeded its in vitro IC50 for tumor growth inhibition.  In the human HT-29 colon tumor xenograft mouse model, SSA significantly inhibited tumor growth at a dosage of 250 mg/kg.  Combined treatment of SSA with the chemotherapeutic drug, Camptosar, caused a more sustained suppression of tumor growth compared with Camptosar treatment alone.  These results indicate that SSA has potential safety and efficacy advantages for colon cancer chemoprevention as well as utility for treating malignant disease if combined with chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcB2grJ6b-lLVg90H21EOLACvtfcHk0ljYhgqk0PQM3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptVWjsro%253D&md5=00ad59b89c15afea3e005b5994654164</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1158%2F1940-6207.CAPR-09-0001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1940-6207.CAPR-09-0001%26sid%3Dliteratum%253Aachs%26aulast%3DPiazza%26aufirst%3DG.%2BA.%26aulast%3DKeeton%26aufirst%3DA.%2BB.%26aulast%3DTinsley%26aufirst%3DH.%2BN.%26aulast%3DGary%26aufirst%3DB.%2BD.%26aulast%3DWhitt%26aufirst%3DJ.%2BD.%26aulast%3DMathew%26aufirst%3DB.%26aulast%3DThaiparambil%26aufirst%3DJ.%26aulast%3DCoward%26aufirst%3DL.%26aulast%3DGorman%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DSani%26aufirst%3DB.%26aulast%3DHobrath%26aufirst%3DJ.%2BV.%26aulast%3DMaxuitenko%26aufirst%3DY.%2BY.%26aulast%3DReynolds%26aufirst%3DR.%2BC.%26atitle%3DA%2520novel%2520sulindac%2520derivative%2520that%2520does%2520not%2520inhibit%2520cyclooxygenases%2520but%2520potently%2520inhibits%2520colon%2520tumor%2520cell%2520growth%2520and%2520induces%2520apoptosis%2520with%2520antitumor%2520activity%26jtitle%3DCancer%2520Prev.%2520Res.%2520%2528Philadelphia%252C%2520PA%252C%2520U.%2520S.%2529%26date%3D2009%26volume%3D2%26spage%3D572%26epage%3D580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Piazza, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keeton, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tinsley, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitt, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gary, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathew, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grizzle, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, R. C.</span><span> </span><span class="NLM_article-title">NSAIDs: Old drugs reveal new anticancer targets</span> <span class="citation_source-journal">Pharmaceuticals</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1652</span><span class="NLM_x">–</span> <span class="NLM_lpage">1667</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.3390%2Fph3051652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=27713322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvFelsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=1652-1667&author=G.+A.+Piazzaauthor=A.+B.+Keetonauthor=H.+N.+Tinsleyauthor=J.+D.+Whittauthor=B.+D.+Garyauthor=B.+Mathewauthor=R.+Singhauthor=W.+E.+Grizzleauthor=R.+C.+Reynolds&title=NSAIDs%3A+Old+drugs+reveal+new+anticancer+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">NSAIDs: old drugs reveal new anticancer targets</span></div><div class="casAuthors">Piazza, Gary A.; Keeton, Adam B.; Tinsley, Heather N.; Whitt, Jason D.; Gary, Bernard D.; Mathew, Bini; Singh, Raj; Grizzle, William E.; Reynolds, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceuticals</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1652-1667</span>CODEN:
                <span class="NLM_cas:coden">PHARH2</span>;
        ISSN:<span class="NLM_cas:issn">1424-8247</span>.
    
            (<span class="NLM_cas:orgname">Molecular Diversity Preservation International</span>)
        </div><div class="casAbstract">A review.  There is compelling evidence that nonsteroidal anti-inflammatory drugs (NSAIDs) and cyclooxygenase-2 selective inhibitors have antineoplastic activity, but toxicity from cyclooxygenase (COX) inhibition and the suppression of physiol. important prostaglandins limits their use for cancer chemoprevention.  Previous studies as reviewed here suggest that the mechanism for their anticancer properties does not require COX inhibition, but instead involves an off-target effect.  In support of this possibility, recent mol. modeling studies have shown that the NSAID sulindac can be chem. modified to selectively design out its COX-1 and COX-2 inhibitory activity.  Unexpectedly, certain derivs. that were synthesized based on in silico modeling displayed increased potency to inhibit tumor cell growth.  Other expts. have shown that sulindac can inhibit phosphodiesterase to increase intracellular cyclic GMP levels and that this activity is closely assocd. with its ability to selectively induce apoptosis of tumor cells.  Together, these studies suggest that COX-independent mechanisms can be targeted to develop safer and more efficacious drugs for cancer chemoprevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxtF1M2g78b7Vg90H21EOLACvtfcHk0lhQSwSeGQ8kYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvFelsLo%253D&md5=1a70d862216322503c407bcda895af54</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.3390%2Fph3051652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph3051652%26sid%3Dliteratum%253Aachs%26aulast%3DPiazza%26aufirst%3DG.%2BA.%26aulast%3DKeeton%26aufirst%3DA.%2BB.%26aulast%3DTinsley%26aufirst%3DH.%2BN.%26aulast%3DWhitt%26aufirst%3DJ.%2BD.%26aulast%3DGary%26aufirst%3DB.%2BD.%26aulast%3DMathew%26aufirst%3DB.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DGrizzle%26aufirst%3DW.%2BE.%26aulast%3DReynolds%26aufirst%3DR.%2BC.%26atitle%3DNSAIDs%253A%2520Old%2520drugs%2520reveal%2520new%2520anticancer%2520targets%26jtitle%3DPharmaceuticals%26date%3D2010%26volume%3D3%26spage%3D1652%26epage%3D1667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kingsley, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eling, T. E.</span><span> </span><span class="NLM_article-title">The role of NAG-1/GDF15 in the inhibition of intestinal polyps in APC/Min mice by sulindac</span> <span class="citation_source-journal">Cancer Prev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1158%2F1940-6207.CAPR-10-0196" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=21205743" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvVyqu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=150-160&author=X.+Wangauthor=P.+J.+Kingsleyauthor=L.+J.+Marnettauthor=T.+E.+Eling&title=The+role+of+NAG-1%2FGDF15+in+the+inhibition+of+intestinal+polyps+in+APC%2FMin+mice+by+sulindac"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The role of NAG-1/GDF15 in the inhibition of intestinal polyps in APC/Min mice by sulindac</span></div><div class="casAuthors">Wang, Xingya; Kingsley, Philip J.; Marnett, Larry J.; Eling, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Prevention Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">150-160</span>CODEN:
                <span class="NLM_cas:coden">CPRACC</span>;
        ISSN:<span class="NLM_cas:issn">1940-6207</span>.
    
            (<span class="NLM_cas:orgname">American Association of Cancer Research</span>)
        </div><div class="casAbstract">The antitumor effects of nonsteroidal anti-inflammatory drugs (NSAID) are assumed to be due to the inhibition of COX activity, but COX-independent mechanisms may also play an important role.  NSAID-activated gene (NAG-1/GDF15) is induced by NSAIDs and has antitumorigenic activities.  To det. the contribution of COX-2 inhibition and NAG-1/GDF15 expression to the prevention of colon carcinogenesis by NSAIDs, we evaluated several sulindac derivs. [des-Me (DM)-sulindac sulfide and its prodrug DM-sulindac] that do not inhibit COX-2 activity.  Sulindac sulfide and DM-sulindac induced the expression of NAG-1/GDF15 in HCT116 cells as detd. by quant. real-time PCR and Western blot.  We fed APC/Min mice with 320 ppm of sulindac and doses of DM-sulindac.  Only sulindac significantly inhibited tumor formation in APC/Min mice.  To det. the pharmacokinetic properties of sulindac and DM-sulindac in vivo, wild-type C57/B6 mice were fed with sulindac and DM-sulindac at 80, 160, and 320 ppm.  High-performance liq. chromatog. anal. revealed that the conversion of DM-sulindac to DM-sulindac sulfide (active form) was less efficient than the conversion of sulindac to sulindac sulfide (active form) in the mice.  Lower levels of DM-sulindac sulfide accumulated in intestinal and colon tissues in comparison with sulindac sulfide.  In addn., NAG-1/GDF15 was induced in the liver of sulindac-fed mice but not in the DM-sulindac-fed mice.  Collectively, our results suggest that the tumor-inhibitory effects of sulindac in APC/Min mice may be due to, in part, NAG-1/GDF15 induction in the liver.  Our study also suggests that pharmacol. properties should be carefully evaluated when developing drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc3g61w2WVP7Vg90H21EOLACvtfcHk0lhQSwSeGQ8kYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvVyqu70%253D&md5=c37c6fdd5b85adeec9fa1fbbfee239fc</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1158%2F1940-6207.CAPR-10-0196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1940-6207.CAPR-10-0196%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DKingsley%26aufirst%3DP.%2BJ.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26aulast%3DEling%26aufirst%3DT.%2BE.%26atitle%3DThe%2520role%2520of%2520NAG-1%252FGDF15%2520in%2520the%2520inhibition%2520of%2520intestinal%2520polyps%2520in%2520APC%252FMin%2520mice%2520by%2520sulindac%26jtitle%3DCancer%2520Prev.%2520Res.%26date%3D2011%26volume%3D4%26spage%3D150%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Steinbrink, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pergola, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buehring, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metzner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haefner, A.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisniewska, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geisslinger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinhilber, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, T. J.</span><span> </span><span class="NLM_article-title">Sulindac sulfide suppresses 5-lipoxygenase at clinically relevant concentrations</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">797</span><span class="NLM_x">–</span> <span class="NLM_lpage">806</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1007%2Fs00018-009-0206-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=20091083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFCktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2010&pages=797-806&author=S.+D.+Steinbrinkauthor=C.+Pergolaauthor=U.+Buehringauthor=S.+Georgeauthor=J.+Metznerauthor=A.+S.+Fischerauthor=A.-K.+Haefnerauthor=J.+M.+Wisniewskaauthor=G.+Geisslingerauthor=O.+Werzauthor=D.+Steinhilberauthor=T.+J.+Maier&title=Sulindac+sulfide+suppresses+5-lipoxygenase+at+clinically+relevant+concentrations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Sulindac sulfide suppresses 5-lipoxygenase at clinically relevant concentrations</span></div><div class="casAuthors">Steinbrink, Svenja D.; Pergola, Carlo; Buehring, Ulrike; George, Sven; Metzner, Julia; Fischer, Astrid S.; Haefner, Ann-Kathrin; Wisniewska, Joanna M.; Geisslinger, Gerd; Werz, Oliver; Steinhilber, Dieter; Maier, Thorsten J.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">797-806</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">Sulindac is a non-selective inhibitor of cyclooxygenases (COX) used to treat inflammation and pain.  Addnl., non-COX targets may account for the drug's chemo-preventive efficacy against colorectal cancer and reduced gastrointestinal toxicity.  Here, we demonstrate that the pharmacol. active metabolite of sulindac, sulindac sulfide (SSi), targets 5-lipoxygenase (5-LO), the key enzyme in the biosynthesis of proinflammatory leukotrienes (LTs).  SSi inhibited 5-LO in ionophore A23187- and LPS/fMLP-stimulated human polymorphonuclear leukocytes (IC50 ≈ 8-10 μM).  Importantly, SSi efficiently suppressed 5-LO in human whole blood at clin. relevant plasma levels (IC50 = 18.7 μM).  SSi was 5-LO-selective as no inhibition of related lipoxygenases (12-LO, 15-LO) was obsd.  The sulindac prodrug and the other metabolite, sulindac sulfone (SSo), failed to inhibit 5-LO.  Mechanistic anal. demonstrated that SSi directly suppresses 5-LO with an IC50 of 20 μM.  Together, these findings may provide a novel mol. basis to explain the COX-independent pharmacol. effects of sulindac under therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_1rbhAeAUS7Vg90H21EOLACvtfcHk0ljHm_L3ULpJow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFCktrg%253D&md5=0e96cb8e0836592b6539818ed45836fb</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1007%2Fs00018-009-0206-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-009-0206-0%26sid%3Dliteratum%253Aachs%26aulast%3DSteinbrink%26aufirst%3DS.%2BD.%26aulast%3DPergola%26aufirst%3DC.%26aulast%3DBuehring%26aufirst%3DU.%26aulast%3DGeorge%26aufirst%3DS.%26aulast%3DMetzner%26aufirst%3DJ.%26aulast%3DFischer%26aufirst%3DA.%2BS.%26aulast%3DHaefner%26aufirst%3DA.-K.%26aulast%3DWisniewska%26aufirst%3DJ.%2BM.%26aulast%3DGeisslinger%26aufirst%3DG.%26aulast%3DWerz%26aufirst%3DO.%26aulast%3DSteinhilber%26aufirst%3DD.%26aulast%3DMaier%26aufirst%3DT.%2BJ.%26atitle%3DSulindac%2520sulfide%2520suppresses%25205-lipoxygenase%2520at%2520clinically%2520relevant%2520concentrations%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2010%26volume%3D67%26spage%3D797%26epage%3D806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Etienne, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resnick, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brot, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissbach, H.</span><span> </span><span class="NLM_article-title">Reduction of Sulindac to its active metabolite, sulindac sulfide: Assay and role of the methionine sulfoxide reductase system</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">312</span><span class="NLM_x">, </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1010</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=2003&pages=1005-1010&author=F.+Etienneauthor=L.+Resnickauthor=D.+Sagherauthor=N.+Brotauthor=H.+Weissbach&title=Reduction+of+Sulindac+to+its+active+metabolite%2C+sulindac+sulfide%3A+Assay+and+role+of+the+methionine+sulfoxide+reductase+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEtienne%26aufirst%3DF.%26aulast%3DResnick%26aufirst%3DL.%26aulast%3DSagher%26aufirst%3DD.%26aulast%3DBrot%26aufirst%3DN.%26aulast%3DWeissbach%26aufirst%3DH.%26atitle%3DReduction%2520of%2520Sulindac%2520to%2520its%2520active%2520metabolite%252C%2520sulindac%2520sulfide%253A%2520Assay%2520and%2520role%2520of%2520the%2520methionine%2520sulfoxide%2520reductase%2520system%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D312%26spage%3D1005%26epage%3D1010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Walters, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blobaum, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kingsley, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felts, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulikowski, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span> </span><span class="NLM_article-title">The influence of double bond geometry in the inhibition of cyclooxygenases by sulindac derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3271</span><span class="NLM_x">–</span> <span class="NLM_lpage">3274</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1016%2Fj.bmcl.2009.04.078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=19427206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1eksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3271-3274&author=M.+J.+Waltersauthor=A.+L.+Blobaumauthor=P.+J.+Kingsleyauthor=A.+S.+Feltsauthor=G.+A.+Sulikowskiauthor=L.+J.+Marnett&title=The+influence+of+double+bond+geometry+in+the+inhibition+of+cyclooxygenases+by+sulindac+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of double bond geometry in the inhibition of cyclooxygenases by sulindac derivatives</span></div><div class="casAuthors">Walters, Matthew J.; Blobaum, Anna L.; Kingsley, Philip J.; Felts, Andrew S.; Sulikowski, Gary A.; Marnett, Lawrence J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3271-3274</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sulindac sulfide is a benzylidene-indene that is a potent, time-dependent inhibitor of cyclooxygenases-1 and -2.  Removal of the 2'-Me group from the indene ring dramatically reduces time-dependent inhibition of both enzymes but also changes the geometry of the benzylidene double bond from Z to E.  Herein, we explore the importance of double bond geometry on cyclooxygenase inhibition.  The Z-isomer of 2'-des-Me sulindac sulfide was synthesized by redn. of a bromoindene precursor or by photoisomerization of the E-isomer.  The Z-isomer inhibited both cyclooxygenases, but with diminished potency compared to sulindac sulfide.  Thus, although the 2'-Me group is a major determinant of time-dependent cyclooxygenase inhibition, the geometry of the benzylidene double bond plays a role as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp80eAOq5v4t7Vg90H21EOLACvtfcHk0ljHm_L3ULpJow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1eksbo%253D&md5=acafed9a0f333240af3d5026a7a2f44d</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.04.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.04.078%26sid%3Dliteratum%253Aachs%26aulast%3DWalters%26aufirst%3DM.%2BJ.%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DKingsley%26aufirst%3DP.%2BJ.%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DSulikowski%26aufirst%3DG.%2BA.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26atitle%3DThe%2520influence%2520of%2520double%2520bond%2520geometry%2520in%2520the%2520inhibition%2520of%2520cyclooxygenases%2520by%2520sulindac%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3271%26epage%3D3274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Prusakiewicz, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felts, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackenzie, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span> </span><span class="NLM_article-title">Molecular Basis of the Time-Dependent Inhibition of Cyclooxygenases by Indomethacin</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">15439</span><span class="NLM_x">–</span> <span class="NLM_lpage">15445</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi048534q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpslylu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=15439-15445&author=J.+J.+Prusakiewiczauthor=A.+S.+Feltsauthor=B.+S.+Mackenzieauthor=L.+J.+Marnett&title=Molecular+Basis+of+the+Time-Dependent+Inhibition+of+Cyclooxygenases+by+Indomethacin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Basis of the Time-Dependent Inhibition of Cyclooxygenases by Indomethacin</span></div><div class="casAuthors">Prusakiewicz, Jeffery J.; Felts, Andrew S.; Mackenzie, Bonnie S.; Marnett, Lawrence J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">15439-15445</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclooxygenases (COXs) are the therapeutic targets of nonsteroidal antiinflammatory drugs.  Indomethacin (INDO) was one of the first nonsteroidal antiinflammatory drugs to be characterized as a time-dependent, functionally irreversible inhibitor, but the mol. basis of this phenomenon is uncertain.  In the crystal structure of INDO bound to COX-2, a small hydrophobic pocket was identified that surrounds the 2'-Me group of INDO.  The pocket is formed by the residues Ala-527, Val-349, Ser-530, and Leu-531.  The contribution of this pocket to inhibition was evaluated by altering its vol. by mutagenesis of Val-349.  The V349A mutation expanded the pocket and increased the potency of INDO, whereas the V349L mutation reduced the size of the pocket and decreased the potency of INDO.  Particularly striking was the reversibility of INDO inhibition of the V349L mutant.  The 2'-des-Me analog of INDO (DM-INDO) was synthesized and tested against wild-type COX-1 and COX-2, as well as the Val-349 mutants.  DM-INDO bound to all enzymes tested, but only inhibited wt mCOX-2 and the V349I enzyme.  Without the 2'-Me group anchoring DM-INDO in the active site, the compd. was readily competed off of the enzyme by arachidonic acid.  The kinetics of inhibition were comparable to the kinetics of binding as evaluated by fluorescence quenching.  These results highlight binding of the 2'-Me of INDO in the hydrophobic pocket as an important determinant of its time-dependent inhibition of COX enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs4oP-iuyS2rVg90H21EOLACvtfcHk0lhZHzLeIfHs3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpslylu7c%253D&md5=deab66bc03cd196ff48be40deaf53be8</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fbi048534q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi048534q%26sid%3Dliteratum%253Aachs%26aulast%3DPrusakiewicz%26aufirst%3DJ.%2BJ.%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DMackenzie%26aufirst%3DB.%2BS.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26atitle%3DMolecular%2520Basis%2520of%2520the%2520Time-Dependent%2520Inhibition%2520of%2520Cyclooxygenases%2520by%2520Indomethacin%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D15439%26epage%3D15445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Alcalde, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesquida, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigola, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Perez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merce, R.</span><span> </span><span class="NLM_article-title">Indene-based scaffolds. Design and synthesis of novel serotonin 5-HT6 receptor ligands</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">3795</span><span class="NLM_x">–</span> <span class="NLM_lpage">3810</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1039%2Fb808641a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=18843410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1WkurzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=3795-3810&author=E.+Alcaldeauthor=N.+Mesquidaauthor=J.+Frigolaauthor=S.+Lopez-Perezauthor=R.+Merce&title=Indene-based+scaffolds.+Design+and+synthesis+of+novel+serotonin+5-HT6+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Indene-based scaffolds. Design and synthesis of novel serotonin 5-HT6 receptor ligands</span></div><div class="casAuthors">Alcalde, Ermitas; Mesquida, Neus; Frigola, Jordi; Lopez-Perez, Sara; Merce, Ramon</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3795-3810</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A series of novel indene derivs. designed by a scaffold selection gave access to several examples of (Z)-arylmethylideneindenes and indenylsulfonamides that acted as serotonin 5-HT6 receptor ligands.  Different synthetic multistep routes could be applied to these target compds., each with their own complexity and limitations.  A reasonable route involved the (3-indenyl)acetic acids as the key intermediates, and two alternatives were also examd.  The first protocol used was a two-step sequence employing a modified Horner-Wadsworth-Emmons reaction, but better results were obtained with a procedure based on the condensation of indanones with the lithium salt of Et acetate, followed immediately by dehydration with acid and hydrolysis/isomerization under basic catalysis.  (3-Indenyl)acetic acids were transformed to their amides, which were effectively reduced to indenylsulfonamides using an optimized procedure with AlH3-NMe2Et.  The binding at the 5-HT6 receptor was with moderate affinity (Ki = 216.5 nM) for the (Z)-benzylideneindenylsulfonamide I [X = CHPh] and enhanced affinity for the simple indenylsulfonamide counterpart I [X = H2] (Ki = 50.6 nM).  Selected indenylsulfonamides were then tested, showing Ki values as low as 20.2 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs8GKoWzV8dbVg90H21EOLACvtfcHk0lhZHzLeIfHs3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1WkurzF&md5=55ade62b271fd31d89780817bf884178</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1039%2Fb808641a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb808641a%26sid%3Dliteratum%253Aachs%26aulast%3DAlcalde%26aufirst%3DE.%26aulast%3DMesquida%26aufirst%3DN.%26aulast%3DFrigola%26aufirst%3DJ.%26aulast%3DLopez-Perez%26aufirst%3DS.%26aulast%3DMerce%26aufirst%3DR.%26atitle%3DIndene-based%2520scaffolds.%2520Design%2520and%2520synthesis%2520of%2520novel%2520serotonin%25205-HT6%2520receptor%2520ligands%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2008%26volume%3D6%26spage%3D3795%26epage%3D3810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Felts, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moth, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lybrand, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannenberg, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subbaramaiah, K.</span><span> </span><span class="NLM_article-title">Sulindac Derivatives That Activate the Peroxisome Proliferator-activated Receptor gamma but Lack Cyclooxygenase Inhibition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4911</span><span class="NLM_x">–</span> <span class="NLM_lpage">4919</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm700969c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4911-4919&author=A.+S.+Feltsauthor=B.+S.+Siegelauthor=S.+M.+Youngauthor=C.+W.+Mothauthor=T.+P.+Lybrandauthor=A.+J.+Dannenbergauthor=L.+J.+Marnettauthor=K.+Subbaramaiah&title=Sulindac+Derivatives+That+Activate+the+Peroxisome+Proliferator-activated+Receptor+gamma+but+Lack+Cyclooxygenase+Inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm700969c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm700969c%26sid%3Dliteratum%253Aachs%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DSiegel%26aufirst%3DB.%2BS.%26aulast%3DYoung%26aufirst%3DS.%2BM.%26aulast%3DMoth%26aufirst%3DC.%2BW.%26aulast%3DLybrand%26aufirst%3DT.%2BP.%26aulast%3DDannenberg%26aufirst%3DA.%2BJ.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26aulast%3DSubbaramaiah%26aufirst%3DK.%26atitle%3DSulindac%2520Derivatives%2520That%2520Activate%2520the%2520Peroxisome%2520Proliferator-activated%2520Receptor%2520gamma%2520but%2520Lack%2520Cyclooxygenase%2520Inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4911%26epage%3D4919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Musser, J. H.; Kreft, A. F.,  III; Failli, A. A.; Demerson, C. A.; Shah, U. S.; Nelson, J. A.</span><span> </span><span class="NLM_article-title">Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazolealkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase</span>. 93-29199 5420289, 19930310,<span class="NLM_x"> </span><span class="NLM_year">1995</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&author=J.+H.+Musser&author=A.+F.+Kreft&author=A.+A.+Failli&author=C.+A.+Demerson&author=U.+S.+Shah&author=J.+A.+Nelson&title=Substituted+indole-%2C+indene-%2C+pyranoindole-+and+tetrahydrocarbazolealkanoic+acid+derivatives+as+inhibitors+of+PLA2+and+lipoxygenase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DMusser%26aufirst%3DJ.%2BH.%26atitle%3DSubstituted%2520indole-%252C%2520indene-%252C%2520pyranoindole-%2520and%2520tetrahydrocarbazolealkanoic%2520acid%2520derivatives%2520as%2520inhibitors%2520of%2520PLA2%2520and%2520lipoxygenase%26date%3D1995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Musso, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochran, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelley, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selph, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigdon, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orr, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Styles, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, W. R.</span><span> </span><span class="NLM_article-title">Indanylidenes. 1. Design and Synthesis of (E)-2-(4,6-Difluoro-1-indanylidene)acetamide, a Potent, Centrally Acting Muscle Relaxant with Antiinflammatory and Analgesic Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020067s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=399-408&author=D.+L.+Mussoauthor=F.+R.+Cochranauthor=J.+L.+Kelleyauthor=E.+W.+McLeanauthor=J.+L.+Selphauthor=G.+C.+Rigdonauthor=G.+F.+Orrauthor=R.+G.+Davisauthor=B.+R.+Cooperauthor=V.+L.+Stylesauthor=J.+B.+Thompsonauthor=W.+R.+Hall&title=Indanylidenes.+1.+Design+and+Synthesis+of+%28E%29-2-%284%2C6-Difluoro-1-indanylidene%29acetamide%2C+a+Potent%2C+Centrally+Acting+Muscle+Relaxant+with+Antiinflammatory+and+Analgesic+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm020067s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020067s%26sid%3Dliteratum%253Aachs%26aulast%3DMusso%26aufirst%3DD.%2BL.%26aulast%3DCochran%26aufirst%3DF.%2BR.%26aulast%3DKelley%26aufirst%3DJ.%2BL.%26aulast%3DMcLean%26aufirst%3DE.%2BW.%26aulast%3DSelph%26aufirst%3DJ.%2BL.%26aulast%3DRigdon%26aufirst%3DG.%2BC.%26aulast%3DOrr%26aufirst%3DG.%2BF.%26aulast%3DDavis%26aufirst%3DR.%2BG.%26aulast%3DCooper%26aufirst%3DB.%2BR.%26aulast%3DStyles%26aufirst%3DV.%2BL.%26aulast%3DThompson%26aufirst%3DJ.%2BB.%26aulast%3DHall%26aufirst%3DW.%2BR.%26atitle%3DIndanylidenes.%25201.%2520Design%2520and%2520Synthesis%2520of%2520%2528E%2529-2-%25284%252C6-Difluoro-1-indanylidene%2529acetamide%252C%2520a%2520Potent%252C%2520Centrally%2520Acting%2520Muscle%2520Relaxant%2520with%2520Antiinflammatory%2520and%2520Analgesic%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D399%26epage%3D408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Romeiro Nelilma, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leite Ramon, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lima Lidia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardozo Suzana, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Miranda Ana, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraga Carlos, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreiro Eliezer, J.</span><span> </span><span class="NLM_article-title">Synthesis, pharmacological evaluation and docking studies of new sulindac analogues</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1959</span><span class="NLM_x">–</span> <span class="NLM_lpage">1971</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=1959-1971&author=C.+Romeiro+Nelilmaauthor=D.+F.+Leite+Ramonauthor=M.+Lima+Lidiaauthor=V.+S.+Cardozo+Suzanaauthor=L.+P.+de+Miranda+Anaauthor=A.+M.+Fraga+Carlosauthor=J.+Barreiro+Eliezer&title=Synthesis%2C+pharmacological+evaluation+and+docking+studies+of+new+sulindac+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRomeiro%2BNelilma%26aufirst%3DC.%26aulast%3DLeite%2BRamon%26aufirst%3DD.%2BF.%26aulast%3DLima%2BLidia%26aufirst%3DM.%26aulast%3DCardozo%2BSuzana%26aufirst%3DV.%2BS.%26aulast%3Dde%2BMiranda%2BAna%26aufirst%3DL.%2BP.%26aulast%3DFraga%2BCarlos%26aufirst%3DA.%2BM.%26aulast%3DBarreiro%2BEliezer%26aufirst%3DJ.%26atitle%3DSynthesis%252C%2520pharmacological%2520evaluation%2520and%2520docking%2520studies%2520of%2520new%2520sulindac%2520analogues%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D1959%26epage%3D1971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Jung, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neupert, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geisslinger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senter, P. D.</span><span> </span><span class="NLM_article-title">Synthesis and activity of fluorinated derivatives of sulindac sulphide and sulindac Sulphone</span> <span class="citation_source-journal">Pharm. Pharmacol. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1211%2F146080800128735926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktVGjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=217-221&author=M.+Jungauthor=A.+F.+Wahlauthor=W.+Neupertauthor=G.+Geisslingerauthor=P.+D.+Senter&title=Synthesis+and+activity+of+fluorinated+derivatives+of+sulindac+sulphide+and+sulindac+Sulphone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and activity of fluorinated derivatives of sulindac sulphide and sulindac sulphone</span></div><div class="casAuthors">Jung, Manfred; Wahl, Alan F.; Neupert, Werner; Geisslinger, Gerd; Senter, Peter D.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacy and Pharmacology Communications</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">217-221</span>CODEN:
                <span class="NLM_cas:coden">PPCOFN</span>;
        ISSN:<span class="NLM_cas:issn">1460-8081</span>.
    
            (<span class="NLM_cas:orgname">Royal Pharmaceutical Society of Great Britain</span>)
        </div><div class="casAbstract">The synthesis of fluorinated derivs. I (R = SCH2F, SO2CH2F) of the sulfide and sulfone metabolites of sulindac I (R = SMe; SO2Me), a non-steroidal anti-inflammatory agent with chemopreventative activity, is reported.  The key step in the synthesis is a Pummerer-rearrangement of the parent sulindac sulfoxide using (diethylamino)sulfur trifluoride as an activating agent and as a source of the fluoride nucleophile to give I (R = SCH2F, SO2CH2F).  Sulindac sulfide is 2.5 times more potent as a COX-1 inhibitor compared with its fluorinated counterpart I (R = SCH2F).  The sulfones were inactive as COX-1 inhibitors, and none of the compds. inhibited COX-2 concns. up to 0.1 mM.  Cytotoxicity assays showed that I (R = SCH2F, SO2CH2F) were as cytotoxic as sulindac sulfide and sulindac sulfone on 3719 colorectal carcinoma cell lines.  Compd. I (R = SO2CH2F) was the most potent compd. on RCA cells with an IC50 of 95 μM (sulindac sulfide 140 μM, sulindac sulfone 175 μM).  Fluorinated sulindac derivs. warrant further investigation since we have shown that cytotoxic activity can be retained or even increased independently from COX-inhibitory properties.  This could help minimize the undesired side-effects assocd. with chronic sulindac administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq88wVgpuci57Vg90H21EOLACvtfcHk0ljJaiaBi-e55w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktVGjt7s%253D&md5=d2b81df4d8f908ccea477bece00ce0da</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1211%2F146080800128735926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252F146080800128735926%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DM.%26aulast%3DWahl%26aufirst%3DA.%2BF.%26aulast%3DNeupert%26aufirst%3DW.%26aulast%3DGeisslinger%26aufirst%3DG.%26aulast%3DSenter%26aufirst%3DP.%2BD.%26atitle%3DSynthesis%2520and%2520activity%2520of%2520fluorinated%2520derivatives%2520of%2520sulindac%2520sulphide%2520and%2520sulindac%2520Sulphone%26jtitle%3DPharm.%2520Pharmacol.%2520Commun.%26date%3D2000%26volume%3D6%26spage%3D217%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Felts, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stafford, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kingsley, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouzer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Washington, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subbaramaiah, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannenberg, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span> </span><span class="NLM_article-title">Desmethyl Derivatives of Indomethacin and Sulindac as Probes for Cyclooxygenase-Dependent Biology</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">479</span><span class="NLM_x">–</span> <span class="NLM_lpage">483</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb700077z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=479-483&author=A.+S.+Feltsauthor=C.+Jiauthor=J.+B.+Staffordauthor=B.+C.+Crewsauthor=P.+J.+Kingsleyauthor=C.+A.+Rouzerauthor=M.+K.+Washingtonauthor=K.+Subbaramaiahauthor=B.+S.+Siegelauthor=S.+M.+Youngauthor=A.+J.+Dannenbergauthor=L.+J.+Marnett&title=Desmethyl+Derivatives+of+Indomethacin+and+Sulindac+as+Probes+for+Cyclooxygenase-Dependent+Biology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fcb700077z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb700077z%26sid%3Dliteratum%253Aachs%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DJi%26aufirst%3DC.%26aulast%3DStafford%26aufirst%3DJ.%2BB.%26aulast%3DCrews%26aufirst%3DB.%2BC.%26aulast%3DKingsley%26aufirst%3DP.%2BJ.%26aulast%3DRouzer%26aufirst%3DC.%2BA.%26aulast%3DWashington%26aufirst%3DM.%2BK.%26aulast%3DSubbaramaiah%26aufirst%3DK.%26aulast%3DSiegel%26aufirst%3DB.%2BS.%26aulast%3DYoung%26aufirst%3DS.%2BM.%26aulast%3DDannenberg%26aufirst%3DA.%2BJ.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26atitle%3DDesmethyl%2520Derivatives%2520of%2520Indomethacin%2520and%2520Sulindac%2520as%2520Probes%2520for%2520Cyclooxygenase-Dependent%2520Biology%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2007%26volume%3D2%26spage%3D479%26epage%3D483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Broyles, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, B. K.</span><span> </span><span class="NLM_article-title">Factors affecting the selection of products from a photochemically generated singlet biradical</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1757</span><span class="NLM_x">–</span> <span class="NLM_lpage">1767</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2005&pages=1757-1767&author=D.+A.+Broylesauthor=B.+K.+Carpenter&title=Factors+affecting+the+selection+of+products+from+a+photochemically+generated+singlet+biradical"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBroyles%26aufirst%3DD.%2BA.%26aulast%3DCarpenter%26aufirst%3DB.%2BK.%26atitle%3DFactors%2520affecting%2520the%2520selection%2520of%2520products%2520from%2520a%2520photochemically%2520generated%2520singlet%2520biradical%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2005%26volume%3D3%26spage%3D1757%26epage%3D1767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Brewster, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chittenden, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinder, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skeels, M.</span><span> </span><span class="NLM_article-title">Structure of the indene-3-acetic acids. II. Reformatskii reactions of 6-(benzyloxy)-, 5,6-dimethoxy-, and 6-methoxy-1-indanones</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_fpage">941</span><span class="NLM_x">–</span> <span class="NLM_lpage">943</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1972&pages=941-943&author=K.+Brewsterauthor=R.+A.+Chittendenauthor=R.+M.+Pinderauthor=M.+Skeels&title=Structure+of+the+indene-3-acetic+acids.+II.+Reformatskii+reactions+of+6-%28benzyloxy%29-%2C+5%2C6-dimethoxy-%2C+and+6-methoxy-1-indanones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrewster%26aufirst%3DK.%26aulast%3DChittenden%26aufirst%3DR.%2BA.%26aulast%3DPinder%26aufirst%3DR.%2BM.%26aulast%3DSkeels%26aufirst%3DM.%26atitle%3DStructure%2520of%2520the%2520indene-3-acetic%2520acids.%2520II.%2520Reformatskii%2520reactions%2520of%25206-%2528benzyloxy%2529-%252C%25205%252C6-dimethoxy-%252C%2520and%25206-methoxy-1-indanones%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1972%26spage%3D941%26epage%3D943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Peerboom, R. A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Koning, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nibbering, N. M. M.</span><span> </span><span class="NLM_article-title">On the stabilization of carbanions by adjacent phenyl, cyano, methoxycarbonyl, and nitro groups in the gas phase</span> <span class="citation_source-journal">J. Am. Soc. Mass Spectrom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span></span><div class="citationLinks">[<a href="/doi/10.1016/1044-0305%2894%2985029-1" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1994&pages=159-168&author=R.+A.+L.+Peerboomauthor=L.+J.+de+Koningauthor=N.+M.+M.+Nibbering&title=On+the+stabilization+of+carbanions+by+adjacent+phenyl%2C+cyano%2C+methoxycarbonyl%2C+and+nitro+groups+in+the+gas+phase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2F1044-0305%2894%2985029-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F1044-0305%252894%252985029-1%26sid%3Dliteratum%253Aachs%26aulast%3DPeerboom%26aufirst%3DR.%2BA.%2BL.%26aulast%3Dde%2BKoning%26aufirst%3DL.%2BJ.%26aulast%3DNibbering%26aufirst%3DN.%2BM.%2BM.%26atitle%3DOn%2520the%2520stabilization%2520of%2520carbanions%2520by%2520adjacent%2520phenyl%252C%2520cyano%252C%2520methoxycarbonyl%252C%2520and%2520nitro%2520groups%2520in%2520the%2520gas%2520phase%26jtitle%3DJ.%2520Am.%2520Soc.%2520Mass%2520Spectrom.%26date%3D1994%26volume%3D5%26spage%3D159%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Peretto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radaelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zandi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raveglia, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dondio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontanella, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigogno, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccardi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biscaioli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchetti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puccini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catinella, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rondelli, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cenacchi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolzoni, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caruso, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villetti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Facchinetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Giudice, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moretto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span> </span><span class="NLM_article-title">Synthesis and biological activity of flurbiprofen analogues as selective inhibitors of beta -amyloid1–42 secretion</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5705</span><span class="NLM_x">–</span> <span class="NLM_lpage">5720</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0502541" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5705-5720&author=I.+Perettoauthor=S.+Radaelliauthor=C.+Pariniauthor=M.+Zandiauthor=L.+F.+Ravegliaauthor=G.+Dondioauthor=L.+Fontanellaauthor=P.+Misianoauthor=C.+Bigognoauthor=A.+Rizziauthor=B.+Riccardiauthor=M.+Biscaioliauthor=S.+Marchettiauthor=P.+Pucciniauthor=S.+Catinellaauthor=I.+Rondelliauthor=V.+Cenacchiauthor=P.+T.+Bolzoniauthor=P.+Carusoauthor=G.+Villettiauthor=F.+Facchinettiauthor=E.+Del+Giudiceauthor=N.+Morettoauthor=B.+P.+Imbimbo&title=Synthesis+and+biological+activity+of+flurbiprofen+analogues+as+selective+inhibitors+of+beta+-amyloid1%E2%80%9342+secretion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm0502541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0502541%26sid%3Dliteratum%253Aachs%26aulast%3DPeretto%26aufirst%3DI.%26aulast%3DRadaelli%26aufirst%3DS.%26aulast%3DParini%26aufirst%3DC.%26aulast%3DZandi%26aufirst%3DM.%26aulast%3DRaveglia%26aufirst%3DL.%2BF.%26aulast%3DDondio%26aufirst%3DG.%26aulast%3DFontanella%26aufirst%3DL.%26aulast%3DMisiano%26aufirst%3DP.%26aulast%3DBigogno%26aufirst%3DC.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DRiccardi%26aufirst%3DB.%26aulast%3DBiscaioli%26aufirst%3DM.%26aulast%3DMarchetti%26aufirst%3DS.%26aulast%3DPuccini%26aufirst%3DP.%26aulast%3DCatinella%26aufirst%3DS.%26aulast%3DRondelli%26aufirst%3DI.%26aulast%3DCenacchi%26aufirst%3DV.%26aulast%3DBolzoni%26aufirst%3DP.%2BT.%26aulast%3DCaruso%26aufirst%3DP.%26aulast%3DVilletti%26aufirst%3DG.%26aulast%3DFacchinetti%26aufirst%3DF.%26aulast%3DDel%2BGiudice%26aufirst%3DE.%26aulast%3DMoretto%26aufirst%3DN.%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520flurbiprofen%2520analogues%2520as%2520selective%2520inhibitors%2520of%2520beta%2520-amyloid1%25E2%2580%259342%2520secretion%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5705%26epage%3D5720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Barreca, G.; Cannata, V.</span><span> </span><span class="NLM_article-title">Stereoselective isomerization process for the preparation of cis-5-fluoro-2-methyl-1-[4-(methylthio)benzyliden]inden-3-acetic acid</span>. 2000-677842 6355836, 20001003,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=G.+Barreca&author=V.+Cannata&title=Stereoselective+isomerization+process+for+the+preparation+of+cis-5-fluoro-2-methyl-1-%5B4-%28methylthio%29benzyliden%5Dinden-3-acetic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DBarreca%26aufirst%3DG.%26atitle%3DStereoselective%2520isomerization%2520process%2520for%2520the%2520preparation%2520of%2520cis-5-fluoro-2-methyl-1-%255B4-%2528methylthio%2529benzyliden%255Dinden-3-acetic%2520acid%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Liedtke, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keck, P. R. W. E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeberle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, S. A.</span><span> </span><span class="NLM_article-title">Arylpyrrolizines as Inhibitors of Microsomal Prostaglandin E2 Synthase-1 (mPGES-1) or as Dual Inhibitors of mPGES-1 and 5-Lipoxygenase (5-LOX)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4968</span><span class="NLM_x">–</span> <span class="NLM_lpage">4972</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900481c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4968-4972&author=A.+J.+Liedtkeauthor=P.+R.+W.+E.+F.+Keckauthor=F.+Lehmannauthor=A.+Koeberleauthor=O.+Werzauthor=S.+A.+Laufer&title=Arylpyrrolizines+as+Inhibitors+of+Microsomal+Prostaglandin+E2+Synthase-1+%28mPGES-1%29+or+as+Dual+Inhibitors+of+mPGES-1+and+5-Lipoxygenase+%285-LOX%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjm900481c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900481c%26sid%3Dliteratum%253Aachs%26aulast%3DLiedtke%26aufirst%3DA.%2BJ.%26aulast%3DKeck%26aufirst%3DP.%2BR.%2BW.%2BE.%2BF.%26aulast%3DLehmann%26aufirst%3DF.%26aulast%3DKoeberle%26aufirst%3DA.%26aulast%3DWerz%26aufirst%3DO.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DArylpyrrolizines%2520as%2520Inhibitors%2520of%2520Microsomal%2520Prostaglandin%2520E2%2520Synthase-1%2520%2528mPGES-1%2529%2520or%2520as%2520Dual%2520Inhibitors%2520of%2520mPGES-1%2520and%25205-Lipoxygenase%2520%25285-LOX%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4968%26epage%3D4972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arruda, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baccei, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorrain, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodanovich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stock, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span> </span><span class="NLM_article-title">5-Lipoxygenase-Activating Protein Inhibitors: Development of 3-[3-<i>tert</i>-Butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1<i>H</i>-indol-2-yl]-2,2-dimethylpropionic Acid (AM103)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5803</span><span class="NLM_x">–</span> <span class="NLM_lpage">5815</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900945d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5803-5815&author=J.+H.+Hutchinsonauthor=Y.+Liauthor=J.+M.+Arrudaauthor=C.+Bacceiauthor=G.+Bainauthor=C.+Chapmanauthor=L.+Correaauthor=J.+Darlingtonauthor=C.+D.+Kingauthor=C.+Leeauthor=D.+Lorrainauthor=P.+Prodanovichauthor=H.+Rongauthor=A.+Santiniauthor=N.+Stockauthor=P.+Prasitauthor=J.+F.+Evans&title=5-Lipoxygenase-Activating+Protein+Inhibitors%3A+Development+of+3-%5B3-tert-Butylsulfanyl-1-%5B4-%286-methoxy-pyridin-3-yl%29-benzyl%5D-5-%28pyridin-2-ylmethoxy%29-1H-indol-2-yl%5D-2%2C2-dimethylpropionic+Acid+%28AM103%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm900945d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900945d%26sid%3Dliteratum%253Aachs%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DArruda%26aufirst%3DJ.%2BM.%26aulast%3DBaccei%26aufirst%3DC.%26aulast%3DBain%26aufirst%3DG.%26aulast%3DChapman%26aufirst%3DC.%26aulast%3DCorrea%26aufirst%3DL.%26aulast%3DDarlington%26aufirst%3DJ.%26aulast%3DKing%26aufirst%3DC.%2BD.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DLorrain%26aufirst%3DD.%26aulast%3DProdanovich%26aufirst%3DP.%26aulast%3DRong%26aufirst%3DH.%26aulast%3DSantini%26aufirst%3DA.%26aulast%3DStock%26aufirst%3DN.%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26atitle%3D5-Lipoxygenase-Activating%2520Protein%2520Inhibitors%253A%2520Development%2520of%25203-%255B3-tert-Butylsulfanyl-1-%255B4-%25286-methoxy-pyridin-3-yl%2529-benzyl%255D-5-%2528pyridin-2-ylmethoxy%2529-1H-indol-2-yl%255D-2%252C2-dimethylpropionic%2520Acid%2520%2528AM103%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5803%26epage%3D5815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Bundgaard, H.; Nielsen, N. M.</span><span> </span><span class="NLM_article-title">Ester prodrug derivatives of carboxylic acid drugs</span>. 1987-DK104 8801615, 19870825,<span class="NLM_x"> </span><span class="NLM_year">1988</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1988&author=H.+Bundgaard&author=N.+M.+Nielsen&title=Ester+prodrug+derivatives+of+carboxylic+acid+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DBundgaard%26aufirst%3DH.%26atitle%3DEster%2520prodrug%2520derivatives%2520of%2520carboxylic%2520acid%2520drugs%26date%3D1988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Stock, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrigley, J. D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shearman, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peachey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St-Jacques, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span> </span><span class="NLM_article-title">The geminal dimethyl analogue of Flurbiprofen as a novel Abeta 42 inhibitor and potential Alzheimer's disease modifying agent</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2219</span><span class="NLM_x">–</span> <span class="NLM_lpage">2223</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2219-2223&author=N.+Stockauthor=B.+Munozauthor=J.+D.+J.+Wrigleyauthor=M.+S.+Shearmanauthor=D.+Beherauthor=J.+Peacheyauthor=T.+L.+Williamsonauthor=G.+Bainauthor=W.+Chenauthor=X.+Jiangauthor=R.+St-Jacquesauthor=P.+Prasit&title=The+geminal+dimethyl+analogue+of+Flurbiprofen+as+a+novel+Abeta+42+inhibitor+and+potential+Alzheimer%27s+disease+modifying+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStock%26aufirst%3DN.%26aulast%3DMunoz%26aufirst%3DB.%26aulast%3DWrigley%26aufirst%3DJ.%2BD.%2BJ.%26aulast%3DShearman%26aufirst%3DM.%2BS.%26aulast%3DBeher%26aufirst%3DD.%26aulast%3DPeachey%26aufirst%3DJ.%26aulast%3DWilliamson%26aufirst%3DT.%2BL.%26aulast%3DBain%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DSt-Jacques%26aufirst%3DR.%26aulast%3DPrasit%26aufirst%3DP.%26atitle%3DThe%2520geminal%2520dimethyl%2520analogue%2520of%2520Flurbiprofen%2520as%2520a%2520novel%2520Abeta%252042%2520inhibitor%2520and%2520potential%2520Alzheimer%2527s%2520disease%2520modifying%2520agent%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2219%26epage%3D2223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Hutchinson, D. K.; Bellettini, J. R.; Betebenner, D. A.; Bishop, R. D.; Borchardt, T. B.; Bosse, T. D.; Cink, R. D.; Flentge, C. A.; Gates, B. D.; Green, B. E.; Hinman, M. M.; Huang, P. P.; Klein, L. L.; Krueger, A. C.; Larson, D. P.; Leanna, M. R.; Liu, D.; Madigan, D. L.; McDaniel, K. F.; Randolph, J. T.; Rockway, T. W.; Rosenberg, T. A.; Stewart, K. D.; Stoll, V. S.; Wagner, R.; Yeung, M. C.</span><span> </span><span class="NLM_article-title">Preparation of fused thiadiazinediones, particularly dioxothiadiazinylnaphthalenones, as antiviral agents for the treatment of infections involving RNA-containing viral species such as hepatitis B and C and HIV</span>. 2004-925072 20050107364, 20040824,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=D.+K.+Hutchinson&author=J.+R.+Bellettini&author=D.+A.+Betebenner&author=R.+D.+Bishop&author=T.+B.+Borchardt&author=T.+D.+Bosse&author=R.+D.+Cink&author=C.+A.+Flentge&author=B.+D.+Gates&author=B.+E.+Green&author=M.+M.+Hinman&author=P.+P.+Huang&author=L.+L.+Klein&author=A.+C.+Krueger&author=D.+P.+Larson&author=M.+R.+Leanna&author=D.+Liu&author=D.+L.+Madigan&author=K.+F.+McDaniel&author=J.+T.+Randolph&author=T.+W.+Rockway&author=T.+A.+Rosenberg&author=K.+D.+Stewart&author=V.+S.+Stoll&author=R.+Wagner&author=M.+C.+Yeung&title=Preparation+of+fused+thiadiazinediones%2C+particularly+dioxothiadiazinylnaphthalenones%2C+as+antiviral+agents+for+the+treatment+of+infections+involving+RNA-containing+viral+species+such+as+hepatitis+B+and+C+and+HIV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DHutchinson%26aufirst%3DD.%2BK.%26atitle%3DPreparation%2520of%2520fused%2520thiadiazinediones%252C%2520particularly%2520dioxothiadiazinylnaphthalenones%252C%2520as%2520antiviral%2520agents%2520for%2520the%2520treatment%2520of%2520infections%2520involving%2520RNA-containing%2520viral%2520species%2520such%2520as%2520hepatitis%2520B%2520and%2520C%2520and%2520HIV%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Allegretti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesta, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bizzarri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Bitondo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cioccio, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galliera, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berdini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Topai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zampella, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Bello, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Locati, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantucci, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Florio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colotta, F.</span><span> </span><span class="NLM_article-title">2-Arylpropionic CXC Chemokine Receptor 1 (CXCR1) Ligands as Novel Noncompetitive CXCL8 Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4312</span><span class="NLM_x">–</span> <span class="NLM_lpage">4331</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049082i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4312-4331&author=M.+Allegrettiauthor=R.+Bertiniauthor=M.+C.+Cestaauthor=C.+Bizzarriauthor=R.+Di+Bitondoauthor=V.+Di+Cioccioauthor=E.+Gallieraauthor=V.+Berdiniauthor=A.+Topaiauthor=G.+Zampellaauthor=V.+Russoauthor=N.+Di+Belloauthor=G.+Nanoauthor=L.+Nicoliniauthor=M.+Locatiauthor=P.+Fantucciauthor=S.+Florioauthor=F.+Colotta&title=2-Arylpropionic+CXC+Chemokine+Receptor+1+%28CXCR1%29+Ligands+as+Novel+Noncompetitive+CXCL8+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fjm049082i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049082i%26sid%3Dliteratum%253Aachs%26aulast%3DAllegretti%26aufirst%3DM.%26aulast%3DBertini%26aufirst%3DR.%26aulast%3DCesta%26aufirst%3DM.%2BC.%26aulast%3DBizzarri%26aufirst%3DC.%26aulast%3DDi%2BBitondo%26aufirst%3DR.%26aulast%3DDi%2BCioccio%26aufirst%3DV.%26aulast%3DGalliera%26aufirst%3DE.%26aulast%3DBerdini%26aufirst%3DV.%26aulast%3DTopai%26aufirst%3DA.%26aulast%3DZampella%26aufirst%3DG.%26aulast%3DRusso%26aufirst%3DV.%26aulast%3DDi%2BBello%26aufirst%3DN.%26aulast%3DNano%26aufirst%3DG.%26aulast%3DNicolini%26aufirst%3DL.%26aulast%3DLocati%26aufirst%3DM.%26aulast%3DFantucci%26aufirst%3DP.%26aulast%3DFlorio%26aufirst%3DS.%26aulast%3DColotta%26aufirst%3DF.%26atitle%3D2-Arylpropionic%2520CXC%2520Chemokine%2520Receptor%25201%2520%2528CXCR1%2529%2520Ligands%2520as%2520Novel%2520Noncompetitive%2520CXCL8%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4312%26epage%3D4331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Halder, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satyam, A.</span><span> </span><span class="NLM_article-title">Accidental discovery of a 'longer-range' vinylogous Pummerer-type lactonization: Formation of sulindac sulfide lactone from sulindac</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1179</span><span class="NLM_x">–</span> <span class="NLM_lpage">1182</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=1179-1182&author=S.+Halderauthor=A.+Satyam&title=Accidental+discovery+of+a+%27longer-range%27+vinylogous+Pummerer-type+lactonization%3A+Formation+of+sulindac+sulfide+lactone+from+sulindac"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHalder%26aufirst%3DS.%26aulast%3DSatyam%26aufirst%3DA.%26atitle%3DAccidental%2520discovery%2520of%2520a%2520%2527longer-range%2527%2520vinylogous%2520Pummerer-type%2520lactonization%253A%2520Formation%2520of%2520sulindac%2520sulfide%2520lactone%2520from%2520sulindac%26jtitle%3DTetrahedron%2520Lett.%26date%3D2011%26volume%3D52%26spage%3D1179%26epage%3D1182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Barreiro, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lima, M. E. F.</span><span> </span><span class="NLM_article-title">The synthesis and anti-inflammatory properties of a new sulindac analog synthesized from natural safrole</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">1219</span><span class="NLM_x">–</span> <span class="NLM_lpage">1222</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1992&pages=1219-1222&author=E.+J.+Barreiroauthor=M.+E.+F.+Lima&title=The+synthesis+and+anti-inflammatory+properties+of+a+new+sulindac+analog+synthesized+from+natural+safrole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarreiro%26aufirst%3DE.%2BJ.%26aulast%3DLima%26aufirst%3DM.%2BE.%2BF.%26atitle%3DThe%2520synthesis%2520and%2520anti-inflammatory%2520properties%2520of%2520a%2520new%2520sulindac%2520analog%2520synthesized%2520from%2520natural%2520safrole%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1992%26volume%3D81%26spage%3D1219%26epage%3D1222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Piazza, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahm, A. L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krutzsch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paranka, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brendel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burt, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alberts, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pamukcu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahnen, D. J.</span><span> </span><span class="NLM_article-title">Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">3110</span><span class="NLM_x">–</span> <span class="NLM_lpage">3116</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=7606732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADyaK2MXmvVyitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1995&pages=3110-3116&author=G.+A.+Piazzaauthor=A.+L.+K.+Rahmauthor=M.+Krutzschauthor=G.+Sperlauthor=N.+S.+Parankaauthor=P.+H.+Grossauthor=K.+Brendelauthor=R.+W.+Burtauthor=D.+S.+Albertsauthor=R.+Pamukcuauthor=D.+J.+Ahnen&title=Antineoplastic+drugs+sulindac+sulfide+and+sulfone+inhibit+cell+growth+by+inducing+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis</span></div><div class="casAuthors">Piazza, Gary A.; Rahm, Alanna L. Kulchak; Krutzsch, Mary; Sperl, Gerhard; Paranka, Nancy Shipp; Gross, Paul H.; Brendel, Klaus; Burt, Randall W.; Alberts, David S.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3110-16</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The nonsteroidal anti-inflammatory drug sulindac is known to inhibit chem. carcinogenesis in rodent models and cause regression of adenomas in patients with adenomatous polyposis coli.  Sulindac is a prodrug that is metabolized to a pharmacol. active sulfide deriv. that potently inhibits prostaglandin synthesis.  Recent studies, however, have shown that a sulfone deriv. of sulindac, which essentially lacks prostaglandin synthesis inhibitory activity, also inhibits chem. carcinogenesis, suggesting that redn. of prostaglandin levels is not necessary for the antineoplastic activity of this class of drugs.  Both sulindac sulfide and the sulfone inhibit the growth of cultured tumor cells, although the cellular mechanism(s) responsible for the antineoplastic activity of sulindac derivs. is unknown.  In this study, we investigated the effects of sulindac sulfide and sulfone on the proliferation, differentiation, and apoptosis of HT-29 human colon carcinoma cells.  Sulindac sulfide and sulfone significantly reduced cell no. in both preconfluent and confluent cultures of HT-29 cells with the sulfide showing approx. 4-fold greater potency.  In addn. to HT-29 cells, both drugs inhibited the growth of a variety of tumor cell lines derived from other tissues, as well as normal epithelial cells and fibroblasts.  Neither sulindac sulfide nor sulfone inhibited cell proliferation under conditions where the drugs were growth inhibitory.  Only under specific conditions involving mitogenic stimulation did sulindac sulfide and sulfone cause cell cycle arrest.  Neither sulindac sulfide nor the sulfone induced differentiation of HT-29 cells, but both drugs strongly induced apoptosis.  The apoptotic response to sulindac sulfide and sulfone was both time- and dose-dependent and involved a mechanism independent of their inhibitory effect on cell cycle progression.  These data suggest that apoptosis is responsible for the cell growth inhibitory activity of sulindac sulfide and sulfone and represents a potential mechanism for the antineoplastic activity of these drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpi5QYDEP4PerVg90H21EOLACvtfcHk0ljTE1d4E6GUCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmvVyitL4%253D&md5=a1e1280ab269b6badcc8ec2da9fe0f9f</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPiazza%26aufirst%3DG.%2BA.%26aulast%3DRahm%26aufirst%3DA.%2BL.%2BK.%26aulast%3DKrutzsch%26aufirst%3DM.%26aulast%3DSperl%26aufirst%3DG.%26aulast%3DParanka%26aufirst%3DN.%2BS.%26aulast%3DGross%26aufirst%3DP.%2BH.%26aulast%3DBrendel%26aufirst%3DK.%26aulast%3DBurt%26aufirst%3DR.%2BW.%26aulast%3DAlberts%26aufirst%3DD.%2BS.%26aulast%3DPamukcu%26aufirst%3DR.%26aulast%3DAhnen%26aufirst%3DD.%2BJ.%26atitle%3DAntineoplastic%2520drugs%2520sulindac%2520sulfide%2520and%2520sulfone%2520inhibit%2520cell%2520growth%2520by%2520inducing%2520apoptosis%26jtitle%3DCancer%2520Res.%26date%3D1995%26volume%3D55%26spage%3D3110%26epage%3D3116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Williams, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrow, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DuBois, R. N.</span><span> </span><span class="NLM_article-title">Sulindac sulfide, but not sulindac sulfone, inhibits colorectal cancer growth</span> <span class="citation_source-journal">Neoplasia (New York)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">170</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1038%2Fsj.neo.7900024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=10933052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADyaK1MXmslGgu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1999&pages=170-176&author=C.+S.+Williamsauthor=A.+P.+Goldmanauthor=H.+Shengauthor=J.+D.+Morrowauthor=R.+N.+DuBois&title=Sulindac+sulfide%2C+but+not+sulindac+sulfone%2C+inhibits+colorectal+cancer+growth"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Sulindac sulfide, but not sulindac sulfone, inhibits colorectal cancer growth</span></div><div class="casAuthors">Williams, Christopher S.; Goldman, Angela P.; Sheng, Hongmiao; Morrow, Jason D.; DuBois, Raymond N.</div><div class="citationInfo"><span class="NLM_cas:title">Neoplasia (New York)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">170-176</span>CODEN:
                <span class="NLM_cas:coden">NEOPFL</span>;
        ISSN:<span class="NLM_cas:issn">1522-8002</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">Both sulindac sulfide and sulindac sulfone treatment of colorectal cancer HCA-7 cells inhibited PGE2 prodn.  Both sulindac sulfide and sulfone inhibited HCA-7 and HCT-116 cell growth in vitro.  Sulindac sulfone had no effect on the growth of either HCA-7 or HCT-116 xenografts in nude mice, whereas the sulfide deriv. inhibited HCA-7 growth in vivo.  Both sulindac sulfide and sulfone inhibited colon carcinoma cell growth and prostaglandin prodn. in vitro, but sulindac sulfone had no effect on the growth of colon cancer cell xenografts in nude mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1d72bC0_XHLVg90H21EOLACvtfcHk0ljTE1d4E6GUCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmslGgu7o%253D&md5=c8aab090b466c3e64b6206d8344675e2</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1038%2Fsj.neo.7900024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.neo.7900024%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DC.%2BS.%26aulast%3DGoldman%26aufirst%3DA.%2BP.%26aulast%3DSheng%26aufirst%3DH.%26aulast%3DMorrow%26aufirst%3DJ.%2BD.%26aulast%3DDuBois%26aufirst%3DR.%2BN.%26atitle%3DSulindac%2520sulfide%252C%2520but%2520not%2520sulindac%2520sulfone%252C%2520inhibits%2520colorectal%2520cancer%2520growth%26jtitle%3DNeoplasia%2520%2528New%2520York%2529%26date%3D1999%26volume%3D1%26spage%3D170%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Richter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberger, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furstenberger, G.</span><span> </span><span class="NLM_article-title">Marian, B. Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors</span> <span class="citation_source-journal">Carcinogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2001&pages=17-25&author=M.+Richterauthor=M.+Weissauthor=I.+Weinbergerauthor=G.+Furstenberger&title=Marian%2C+B.+Growth+inhibition+and+induction+of+apoptosis+in+colorectal+tumor+cells+by+cyclooxygenase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichter%26aufirst%3DM.%26aulast%3DWeiss%26aufirst%3DM.%26aulast%3DWeinberger%26aufirst%3DI.%26aulast%3DFurstenberger%26aufirst%3DG.%26atitle%3DMarian%252C%2520B.%2520Growth%2520inhibition%2520and%2520induction%2520of%2520apoptosis%2520in%2520colorectal%2520tumor%2520cells%2520by%2520cyclooxygenase%2520inhibitors%26jtitle%3DCarcinogenesis%26date%3D2001%26volume%3D22%26spage%3D17%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Tegeder, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfeilschifter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geisslinger, G.</span><span> </span><span class="NLM_article-title">Cyclooxygenase-independent actions of cyclooxygenase inhibitors</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2057</span><span class="NLM_x">–</span> <span class="NLM_lpage">2072</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2001&pages=2057-2072&author=I.+Tegederauthor=J.+Pfeilschifterauthor=G.+Geisslinger&title=Cyclooxygenase-independent+actions+of+cyclooxygenase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTegeder%26aufirst%3DI.%26aulast%3DPfeilschifter%26aufirst%3DJ.%26aulast%3DGeisslinger%26aufirst%3DG.%26atitle%3DCyclooxygenase-independent%2520actions%2520of%2520cyclooxygenase%2520inhibitors%26jtitle%3DFASEB%2520J.%26date%3D2001%26volume%3D15%26spage%3D2057%26epage%3D2072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Kundu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulton, A. M.</span><span> </span><span class="NLM_article-title">Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">2343</span><span class="NLM_x">–</span> <span class="NLM_lpage">2346</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=2343-2346&author=N.+Kunduauthor=A.+M.+Fulton&title=Selective+cyclooxygenase+%28COX%29-1+or+COX-2+inhibitors+control+metastatic+disease+in+a+murine+model+of+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKundu%26aufirst%3DN.%26aulast%3DFulton%26aufirst%3DA.%2BM.%26atitle%3DSelective%2520cyclooxygenase%2520%2528COX%2529-1%2520or%2520COX-2%2520inhibitors%2520control%2520metastatic%2520disease%2520in%2520a%2520murine%2520model%2520of%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D2343%26epage%3D2346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fei, S.</span><span> </span><span class="NLM_article-title">Non-steroidal anti-inflammatory drugs (NSAIDs) inhibiting the proliferation of human colorectal cancer cells</span> <span class="citation_source-journal">Nanjing Yike Daxue Xuebao</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">–</span> <span class="NLM_lpage">927</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Kjt77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=923-927&author=G.+Chenauthor=S.+Fei&title=Non-steroidal+anti-inflammatory+drugs+%28NSAIDs%29+inhibiting+the+proliferation+of+human+colorectal+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Non-steroidal anti-inflammatory drugs (NSAIDs) inhibiting the proliferation of human colorectal cancer cells</span></div><div class="casAuthors">Chen, Guangxia; Fei, Sujuan</div><div class="citationInfo"><span class="NLM_cas:title">Nanjing Yike Daxue Xuebao</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">923-927</span>CODEN:
                <span class="NLM_cas:coden">NYDXFS</span>;
        ISSN:<span class="NLM_cas:issn">1007-4368</span>.
    
            (<span class="NLM_cas:orgname">Nanjing Yike Daxue Xuebao Bianjibu</span>)
        </div><div class="casAbstract">The mechanism that selective cyclooxygenase-2 (COX-2) inhibitor Nimesulide and non-selective COX-2 inhibitor sulindac inhibited human colorectal cancer cells proliferation was studied.  MTT assay and flow cytometry (FCM) were used to det. the influence of Nimesulide and Sulindac on the proliferation and apoptosis of colorectal cancer cells.  Prostaglandin E2 (PGE2) was examd. in the culture supernatant by RIA.  Nimesulide and Sulindac inhibited proliferation of colorectal cancer cells in a dose- and time-dependent manner and significantly increased the proportion of cells in the G0/G1 phase and decreased the proportion of cells in the S phase (P<0.05).  Both drugs reduced the release of PGE2 (P<0.05).  Nimesulide and Sulindac can inhibit proliferation and induce apoptosis in colorectal cancer cell lines, through inhibiting COX-2 activity and PGE2 synthesis and blocking the progression of cell cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3_pDvVVKELrVg90H21EOLACvtfcHk0li0PUw2lgH-ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Kjt77E&md5=132f6a45dae116efbb1f096495eaa25d</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DG.%26aulast%3DFei%26aufirst%3DS.%26atitle%3DNon-steroidal%2520anti-inflammatory%2520drugs%2520%2528NSAIDs%2529%2520inhibiting%2520the%2520proliferation%2520of%2520human%2520colorectal%2520cancer%2520cells%26jtitle%3DNanjing%2520Yike%2520Daxue%2520Xuebao%26date%3D2005%26volume%3D25%26spage%3D923%26epage%3D927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Daikoku, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tranguch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrow, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orsulic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DuBois, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dey, S. K.</span><span> </span><span class="NLM_article-title">Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">3735</span><span class="NLM_x">–</span> <span class="NLM_lpage">3744</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=3735-3744&author=T.+Daikokuauthor=D.+Wangauthor=S.+Tranguchauthor=J.+D.+Morrowauthor=S.+Orsulicauthor=R.+N.+DuBoisauthor=S.+K.+Dey&title=Cyclooxygenase-1+is+a+potential+target+for+prevention+and+treatment+of+ovarian+epithelial+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDaikoku%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DTranguch%26aufirst%3DS.%26aulast%3DMorrow%26aufirst%3DJ.%2BD.%26aulast%3DOrsulic%26aufirst%3DS.%26aulast%3DDuBois%26aufirst%3DR.%2BN.%26aulast%3DDey%26aufirst%3DS.%2BK.%26atitle%3DCyclooxygenase-1%2520is%2520a%2520potential%2520target%2520for%2520prevention%2520and%2520treatment%2520of%2520ovarian%2520epithelial%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D3735%26epage%3D3744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Mitchell, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akarasereenont, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiemermann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flower, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vane, J. R.</span><span> </span><span class="NLM_article-title">Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">11693</span><span class="NLM_x">–</span> <span class="NLM_lpage">11697</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1993&pages=11693-11697&author=J.+A.+Mitchellauthor=P.+Akarasereenontauthor=C.+Thiemermannauthor=R.+J.+Flowerauthor=J.+R.+Vane&title=Selectivity+of+nonsteroidal+antiinflammatory+drugs+as+inhibitors+of+constitutive+and+inducible+cyclooxygenase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMitchell%26aufirst%3DJ.%2BA.%26aulast%3DAkarasereenont%26aufirst%3DP.%26aulast%3DThiemermann%26aufirst%3DC.%26aulast%3DFlower%26aufirst%3DR.%2BJ.%26aulast%3DVane%26aufirst%3DJ.%2BR.%26atitle%3DSelectivity%2520of%2520nonsteroidal%2520antiinflammatory%2520drugs%2520as%2520inhibitors%2520of%2520constitutive%2520and%2520inducible%2520cyclooxygenase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1993%26volume%3D90%26spage%3D11693%26epage%3D11697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Gierse, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rangwala, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koboldt, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seibert, K.</span><span> </span><span class="NLM_article-title">A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">15810</span><span class="NLM_x">–</span> <span class="NLM_lpage">15814</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1074%2Fjbc.271.26.15810" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=8663121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADyaK28XjvFWhsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=15810-15814&author=J.+K.+Gierseauthor=J.+J.+McDonaldauthor=S.+D.+Hauserauthor=S.+H.+Rangwalaauthor=C.+M.+Koboldtauthor=K.+Seibert&title=A+single+amino+acid+difference+between+cyclooxygenase-1+%28COX-1%29+and+-2+%28COX-2%29+reverses+the+selectivity+of+COX-2+specific+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors</span></div><div class="casAuthors">Gierse, James K.; McDonald, Joseph J.; Hauser, Scott D.; Rangwala, Shaukat H.; Koboldt, Carol M.; Seibert, Karen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">15810-15814</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nonsteroidal anti-inflammatory drugs (NSAIDs) currently available for clin. use inhibit both cyclooxygenase (COX) COX-1 and COX-2.  This suggests that clin. useful NSAIDs inhibit pro-inflammatory prostaglandins (PGs) drived from the activity of COX-2, as well as PGs in tissues like the stomach and kidney (via COX-1).  A new class of compds. has recently been developed (SC-58125) that have a high degree of selectivity for the inducible form of cyxlooxygenase (COX-2) over the constitutive form (COX-1).  This unique class of compds. exhibit a time-dependent irreversible inhibition of COX-2, while reversibly inhibiting COX-1.  The mol. basis of this selectivity was probed by site-directed mutagenesis of the active site of COX-2.  The sequence differences in the active site were detd. by amino acid replacement of the COX-2 sequences based on the known crystal structure of COX-1, which revealed a single amino acid difference in the active site (valine 509 to isoleucine) and a series of differences at the mouth of the active site.  Mutants with the single amino acid substitution in the active site and a combination of three changes in the mouth of the active site were made in human COX-2, expressed in insect cells, and purified.  The single amino acid change of valine 509 to isoleucine confers selectivity of COX-2 inhibitors in the class of SC-58125 and others of the same class (SC-236, NS-398), while commonly used NSAIDs such as indomethacin showed no change in selectivity.  Substitutions of COX-1 sequences in COX-2 at the mouth of the active site of COX-2 did not change the selectivity of SC-58125.  This indicates that the single amino acid substitution of isoleucine at position 509 for a valine is sufficient to confer COX-2 selectivity in this example of a diaryl-heterocycle COX inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpNB6pOGzOBbVg90H21EOLACvtfcHk0lhtrmPtIL8IeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjvFWhsb0%253D&md5=3f792bef54b24c7b4e22375665a60c09</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.26.15810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.26.15810%26sid%3Dliteratum%253Aachs%26aulast%3DGierse%26aufirst%3DJ.%2BK.%26aulast%3DMcDonald%26aufirst%3DJ.%2BJ.%26aulast%3DHauser%26aufirst%3DS.%2BD.%26aulast%3DRangwala%26aufirst%3DS.%2BH.%26aulast%3DKoboldt%26aufirst%3DC.%2BM.%26aulast%3DSeibert%26aufirst%3DK.%26atitle%3DA%2520single%2520amino%2520acid%2520difference%2520between%2520cyclooxygenase-1%2520%2528COX-1%2529%2520and%2520-2%2520%2528COX-2%2529%2520reverses%2520the%2520selectivity%2520of%2520COX-2%2520specific%2520inhibitors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D15810%26epage%3D15814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">De Leval, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delarge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neven, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masereel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirotte, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henrotin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dogne, J. M.</span><span> </span><span class="NLM_article-title">Evaluation of classical NSAIDs and COX-2 selective inhibitors on purified ovine enzymes and human whole blood</span> <span class="citation_source-journal">Prostaglandins, Leukotrienes Essent. Fatty Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1054%2Fplef.2001.0262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=11418014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD3MXot12gt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2001&pages=211-216&author=X.+De+Levalauthor=J.+Delargeauthor=P.+Develauthor=P.+Nevenauthor=C.+Michauxauthor=B.+Masereelauthor=B.+Pirotteauthor=J.+L.+Davidauthor=Y.+Henrotinauthor=J.+M.+Dogne&title=Evaluation+of+classical+NSAIDs+and+COX-2+selective+inhibitors+on+purified+ovine+enzymes+and+human+whole+blood"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of classical NSAIDs and COX-2 selective inhibitors on purified ovine enzymes and human whole blood</span></div><div class="casAuthors">De Leval, X.; Delarge, J.; Devel, P.; Neven, P.; Michaux, C.; Masereel, B.; Pirotte, B.; David, J.-L.; Henrotin, Y.; Dogne, J.-M.</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins, Leukotrienes and Essential Fatty Acids</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">4&5</span>),
    <span class="NLM_cas:pages">211-216</span>CODEN:
                <span class="NLM_cas:coden">PLEAEU</span>;
        ISSN:<span class="NLM_cas:issn">0952-3278</span>.
    
            (<span class="NLM_cas:orgname">Churchill Livingstone</span>)
        </div><div class="casAbstract">Cyclooxygenase is the key enzyme in the biosynthesis of prostanoids, biol. active substances involved in several physiol. processes and also in pathol. conditions such as inflammation.  It has been well known for 10 yr that this enzyme exists under two forms: a constitutive (COX-1) and an inducible form (COX-2).  Both enzymes are sensitive to inhibition by conventional non-steroidal anti-inflammatory drugs (NSAIDs).  Observations were made that COX-1 was mainly involved in homeostatic processes, while the COX-2 expression was assocd. with pathol. conditions leading to the development of COX-2 selective inhibitors.  Several methods have been reported for the evaluation of the COX-1 and COX-2 inhibitory potency and selectivity of conventional or COX-2 selective NSAIDs.  In this study, we evaluated the COXs inhibitory profile of both conventional NSAIDs and COX-2 selective inhibitors using two different in vitro methods: the first test was performed using purified enzymes while the second method consisted of a whole blood assay.  The results obtained with ref. drugs in these two assays will be discussed and compared in this article.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-bhhZ5bycM7Vg90H21EOLACvtfcHk0lhtrmPtIL8IeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXot12gt7c%253D&md5=31cdabcaeac5bbe776505dd04a5474d3</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1054%2Fplef.2001.0262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1054%252Fplef.2001.0262%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLeval%26aufirst%3DX.%26aulast%3DDelarge%26aufirst%3DJ.%26aulast%3DDevel%26aufirst%3DP.%26aulast%3DNeven%26aufirst%3DP.%26aulast%3DMichaux%26aufirst%3DC.%26aulast%3DMasereel%26aufirst%3DB.%26aulast%3DPirotte%26aufirst%3DB.%26aulast%3DDavid%26aufirst%3DJ.%2BL.%26aulast%3DHenrotin%26aufirst%3DY.%26aulast%3DDogne%26aufirst%3DJ.%2BM.%26atitle%3DEvaluation%2520of%2520classical%2520NSAIDs%2520and%2520COX-2%2520selective%2520inhibitors%2520on%2520purified%2520ovine%2520enzymes%2520and%2520human%2520whole%2520blood%26jtitle%3DProstaglandins%252C%2520Leukotrienes%2520Essent.%2520Fatty%2520Acids%26date%3D2001%26volume%3D64%26spage%3D211%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Kitamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamori, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchiya, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakabayashi, K.</span><span> </span><span class="NLM_article-title">Inhibitory effects of mofezolac, a cyclooxygenase-1 selective inhibitor, on intestinal carcinogenesis</span> <span class="citation_source-journal">Carcinogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1463</span><span class="NLM_x">–</span> <span class="NLM_lpage">1466</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=1463-1466&author=T.+Kitamuraauthor=T.+Kawamoriauthor=N.+Uchiyaauthor=M.+Itohauthor=T.+Nodaauthor=M.+Matsuuraauthor=T.+Sugimuraauthor=K.+Wakabayashi&title=Inhibitory+effects+of+mofezolac%2C+a+cyclooxygenase-1+selective+inhibitor%2C+on+intestinal+carcinogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKitamura%26aufirst%3DT.%26aulast%3DKawamori%26aufirst%3DT.%26aulast%3DUchiya%26aufirst%3DN.%26aulast%3DItoh%26aufirst%3DM.%26aulast%3DNoda%26aufirst%3DT.%26aulast%3DMatsuura%26aufirst%3DM.%26aulast%3DSugimura%26aufirst%3DT.%26aulast%3DWakabayashi%26aufirst%3DK.%26atitle%3DInhibitory%2520effects%2520of%2520mofezolac%252C%2520a%2520cyclooxygenase-1%2520selective%2520inhibitor%252C%2520on%2520intestinal%2520carcinogenesis%26jtitle%3DCarcinogenesis%26date%3D2002%26volume%3D23%26spage%3D1463%26epage%3D1466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Kino, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kojima, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishizuka, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, S.</span><span> </span><span class="NLM_article-title">Prostaglandin E2 production in ovarian cancer cell lines is regulated by cyclooxygenase-1, not cyclooxygenase-2</span> <span class="citation_source-journal">Prostaglandins, Leukotrienes Essent. Fatty Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">111</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1016%2Fj.plefa.2005.04.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=15963707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsVCmu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2005&pages=103-111&author=Y.+Kinoauthor=F.+Kojimaauthor=K.+Kiguchiauthor=R.+Igarashiauthor=B.+Ishizukaauthor=S.+Kawai&title=Prostaglandin+E2+production+in+ovarian+cancer+cell+lines+is+regulated+by+cyclooxygenase-1%2C+not+cyclooxygenase-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Prostaglandin E2 production in ovarian cancer cell lines is regulated by cyclooxygenase-1, not cyclooxygenase-2</span></div><div class="casAuthors">Kino, Yuko; Kojima, Fumiaki; Kiguchi, Kazushige; Igarashi, Rie; Ishizuka, Bunpei; Kawai, Shinichi</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins, Leukotrienes and Essential Fatty Acids</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">103-111</span>CODEN:
                <span class="NLM_cas:coden">PLEAEU</span>;
        ISSN:<span class="NLM_cas:issn">0952-3278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The significance of cyclooxygenase-2 (COX-2) expression in ovarian cancer has been discussed.  In this study, we found increased expression of COX-1 mRNA and protein in three out of 10 ovarian cancer cell lines.  Prostaglandin E2 (PGE2) prodn. was elevated in these three cell lines, but not in other seven cell lines.  COX-2 protein was not detected in any of the cell lines.  Cytosolic prostaglandin E synthase (cPGES) mRNA and protein were detected in all 10 cell lines.  Membrane-assocd. PGES-1 (mPGES-1) was detected in some of the ovarian cell lines, but its presence did not correspond with PGE2 prodn.  In contrast, mPGES-2 mRNA and protein were detected in all 10 cell lines.  A nonselective COX inhibitor (indometacin) and a selective COX-1 inhibitor (SC-560) strongly inhibited PGE2 prodn. by the three cell lines, while selective COX-2 inhibitors (NS-398 and rofecoxib) did not inhibit PGE2 prodn.  In addn., increased expression of COX-1, not COX-2 protein was obsd. in the mass of ovarian cancer tissues from 22 patients when compared with that in normal tissue.  These findings suggest that COX-1 might be a major enzyme regulating PGE2 prodn. in ovarian cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobkZxwB_T2ZrVg90H21EOLACvtfcHk0lgw3DoSgr8Cvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsVCmu7Y%253D&md5=e58979120d56380e3188174603eca947</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.plefa.2005.04.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.plefa.2005.04.014%26sid%3Dliteratum%253Aachs%26aulast%3DKino%26aufirst%3DY.%26aulast%3DKojima%26aufirst%3DF.%26aulast%3DKiguchi%26aufirst%3DK.%26aulast%3DIgarashi%26aufirst%3DR.%26aulast%3DIshizuka%26aufirst%3DB.%26aulast%3DKawai%26aufirst%3DS.%26atitle%3DProstaglandin%2520E2%2520production%2520in%2520ovarian%2520cancer%2520cell%2520lines%2520is%2520regulated%2520by%2520cyclooxygenase-1%252C%2520not%2520cyclooxygenase-2%26jtitle%3DProstaglandins%252C%2520Leukotrienes%2520Essent.%2520Fatty%2520Acids%26date%3D2005%26volume%3D73%26spage%3D103%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, R.-j.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Z.-y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhuo, G.-c.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.-h.</span><span> </span><span class="NLM_article-title">Effects of a cyclooxygenase-1-selective inhibitor in a mouse model of ovarian cancer, administered alone or in combination with ibuprofen, a nonselective cyclooxygenase inhibitor</span> <span class="citation_source-journal">Med. Oncol. (Totowa, NJ, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">170</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1007%2Fs12032-008-9104-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVKitrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2009&pages=170-177&author=W.+Liauthor=R.-j.+Xuauthor=Z.-y.+Linauthor=G.-c.+Zhuoauthor=H.-h.+Zhang&title=Effects+of+a+cyclooxygenase-1-selective+inhibitor+in+a+mouse+model+of+ovarian+cancer%2C+administered+alone+or+in+combination+with+ibuprofen%2C+a+nonselective+cyclooxygenase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of a cyclooxygenase-1-selective inhibitor in a mouse model of ovarian cancer, administered alone or in combination with ibuprofen, a nonselective cyclooxygenase inhibitor</span></div><div class="casAuthors">Li, Wei; Xu, Ru-jun; Lin, Zhen-yun; Zhuo, Guang-chao; Zhang, Hong-he</div><div class="citationInfo"><span class="NLM_cas:title">Medical Oncology (Totowa, NJ, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">170-177</span>CODEN:
                <span class="NLM_cas:coden">MONCEZ</span>;
        ISSN:<span class="NLM_cas:issn">1357-0560</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Nonsteroidal anti-inflammatory drugs (NSAIDs) are known to be potent inhibitors of the cyclooxygenases.  The present study was designed to investigate the effects of a cyclooxygenase (COX)-1 inhibitor, SC-560, administered alone or in combination with ibuprofen on the growth inhibition of s.c. human ovarian SKOV-3 carcinoma and on angiogenesis.  The effects of SC-560 and ibuprofen on tumor growth inhibition have been examd. in mouse ovarian cancer models.  Angiogenesis of both COX inhibitors was measured by reverse-transcription polymerase chain reaction (RT-PCR) and immunohistochem.  Prostaglandin E2 (PGE2) levels in tumor tissues of mice were also detd. by ELISA.  The inhibitory rates in SC-560 group alone and in combination with ibuprofen group were 21.21% and 41.55%, resp.  In combination therapy with SC-560 and ibuprofen, tumor vols. were significantly reduced compared with that of control group (P < 0.05).  In treatment groups, both COX inhibitors significantly reduced intratumor PGE2 levels (all P < 0.01).  Microvessel d. (MVD) in tumor tissues were significantly decreased from 80.90 ± 5.14 in vehicle-treated to 40.70 ± 10.45 and 38.90 ± 8.41 in SC-560 group alone and combination ibuprofen therapy (all P < 0.01).  Ibuprofen was similar to the cyclooxygenase-1-selective inhibitor SC-560 in its ability to suppress the values of MVD of tumor tissues.  SC-560 administered alone or in combination with ibuprofen inhibited the COX-assocd. up-regulation of VEGF.  These studies demonstrate synergism between two COX inhibitors and that antiangiogenic therapy can be used to inhibit ovarian cancer growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqch_S7n4FMArVg90H21EOLACvtfcHk0liEVvoU8f2lCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVKitrw%253D&md5=3b1c823db4da99657aa792b69d75bd1e</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1007%2Fs12032-008-9104-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12032-008-9104-9%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DR.-j.%26aulast%3DLin%26aufirst%3DZ.-y.%26aulast%3DZhuo%26aufirst%3DG.-c.%26aulast%3DZhang%26aufirst%3DH.-h.%26atitle%3DEffects%2520of%2520a%2520cyclooxygenase-1-selective%2520inhibitor%2520in%2520a%2520mouse%2520model%2520of%2520ovarian%2520cancer%252C%2520administered%2520alone%2520or%2520in%2520combination%2520with%2520ibuprofen%252C%2520a%2520nonselective%2520cyclooxygenase%2520inhibitor%26jtitle%3DMed.%2520Oncol.%2520%2528Totowa%252C%2520NJ%252C%2520U.%2520S.%2529%26date%3D2009%26volume%3D26%26spage%3D170%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Picot, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loll, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garavito, R. M.</span><span> </span><span class="NLM_article-title">The x-ray crystal structure of the membrane protein prostaglandin H2 synthase-1</span> <span class="citation_source-journal">Nature (London, United Kingdom)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">367</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">249</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1038%2F367243a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=8121489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADyaK2cXht1ynurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=1994&pages=243-249&author=D.+Picotauthor=P.+J.+Lollauthor=R.+M.+Garavito&title=The+x-ray+crystal+structure+of+the+membrane+protein+prostaglandin+H2+synthase-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">The x-ray crystal structure of the membrane protein prostaglandin H2 synthase-1</span></div><div class="casAuthors">Picot, Daniel; Loll, Patrick J.; Garavito, R. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">6460</span>),
    <span class="NLM_cas:pages">243-9</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The 3-dimensional structure of prostaglandin H2 synthase (prostaglandin endoperoxide synthase) isoenzyme 1, an integral membrane protein, complexed with the nonsteroidal antiinflammatory drug (NSAID), flurbiprofen, was detd. at 3.5 Å resoln. by x-ray crystallog.  The bifunctional enzyme comprised 3 independent folding units: an EGF domain, a membrane-binding motif, and an enzymic domain.  Two adjacent, but spatially distinct active sites were found for its heme-dependent prostaglandin hydroperoxide peroxidase and arachidonate cyclooxygenase activities.  The cyclooxygenase active site was created by a long, hydrophobic channel that was the site of NSAID binding.  The conformation of the membrane-binding motif strongly suggested that the enzyme integrates into only 1 leaflet of the lipid bilayer and is thus a monotopic membrane protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUBT9bqeSToLVg90H21EOLACvtfcHk0liEVvoU8f2lCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXht1ynurs%253D&md5=fde1c71b1fb7bd686abbde10e5121234</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1038%2F367243a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F367243a0%26sid%3Dliteratum%253Aachs%26aulast%3DPicot%26aufirst%3DD.%26aulast%3DLoll%26aufirst%3DP.%2BJ.%26aulast%3DGaravito%26aufirst%3DR.%2BM.%26atitle%3DThe%2520x-ray%2520crystal%2520structure%2520of%2520the%2520membrane%2520protein%2520prostaglandin%2520H2%2520synthase-1%26jtitle%3DNature%2520%2528London%252C%2520United%2520Kingdom%2529%26date%3D1994%26volume%3D367%26spage%3D243%26epage%3D249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Harman, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turman, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozak, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garavito, R. M.</span><span> </span><span class="NLM_article-title">Structural Basis of Enantioselective Inhibition of Cyclooxygenase-1 by S-alpha -Substituted Indomethacin Ethanolamides</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">28096</span><span class="NLM_x">–</span> <span class="NLM_lpage">28105</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=28096-28105&author=C.+A.+Harmanauthor=M.+V.+Turmanauthor=K.+R.+Kozakauthor=L.+J.+Marnettauthor=W.+L.+Smithauthor=R.+M.+Garavito&title=Structural+Basis+of+Enantioselective+Inhibition+of+Cyclooxygenase-1+by+S-alpha+-Substituted+Indomethacin+Ethanolamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarman%26aufirst%3DC.%2BA.%26aulast%3DTurman%26aufirst%3DM.%2BV.%26aulast%3DKozak%26aufirst%3DK.%2BR.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26aulast%3DSmith%26aufirst%3DW.%2BL.%26aulast%3DGaravito%26aufirst%3DR.%2BM.%26atitle%3DStructural%2520Basis%2520of%2520Enantioselective%2520Inhibition%2520of%2520Cyclooxygenase-1%2520by%2520S-alpha%2520-Substituted%2520Indomethacin%2520Ethanolamides%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D28096%26epage%3D28105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Perissutti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Severino, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roviezzo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sautebin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santagada, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caliendo, G.</span><span> </span><span class="NLM_article-title">Synthesis of 2-Methyl-3-indolylacetic Derivatives as Anti-Inflammatory Agents That Inhibit Preferentially Cyclooxygenase 1 without Gastric Damage</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7774</span><span class="NLM_x">–</span> <span class="NLM_lpage">7780</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0608199" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7774-7780&author=E.+Perissuttiauthor=F.+Fiorinoauthor=C.+Rennerauthor=B.+Severinoauthor=F.+Roviezzoauthor=L.+Sautebinauthor=A.+Rossiauthor=G.+Cirinoauthor=V.+Santagadaauthor=G.+Caliendo&title=Synthesis+of+2-Methyl-3-indolylacetic+Derivatives+as+Anti-Inflammatory+Agents+That+Inhibit+Preferentially+Cyclooxygenase+1+without+Gastric+Damage"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Fjm0608199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0608199%26sid%3Dliteratum%253Aachs%26aulast%3DPerissutti%26aufirst%3DE.%26aulast%3DFiorino%26aufirst%3DF.%26aulast%3DRenner%26aufirst%3DC.%26aulast%3DSeverino%26aufirst%3DB.%26aulast%3DRoviezzo%26aufirst%3DF.%26aulast%3DSautebin%26aufirst%3DL.%26aulast%3DRossi%26aufirst%3DA.%26aulast%3DCirino%26aufirst%3DG.%26aulast%3DSantagada%26aufirst%3DV.%26aulast%3DCaliendo%26aufirst%3DG.%26atitle%3DSynthesis%2520of%25202-Methyl-3-indolylacetic%2520Derivatives%2520as%2520Anti-Inflammatory%2520Agents%2520That%2520Inhibit%2520Preferentially%2520Cyclooxygenase%25201%2520without%2520Gastric%2520Damage%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7774%26epage%3D7780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Bikzhanova, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toulokhonova, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gately, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, R.</span><span> </span><span class="NLM_article-title">Novel silicon-containing drugs derived from the indomethacin scaffold: Synthesis, characterization and evaluation of biological activity</span> <span class="citation_source-journal">Silicon Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm201528b&amp;key=10.1007%2Fs11201-006-9008-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlGktbvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=209-217&author=G.+A.+Bikzhanovaauthor=I.+S.+Toulokhonovaauthor=S.+Gatelyauthor=R.+West&title=Novel+silicon-containing+drugs+derived+from+the+indomethacin+scaffold%3A+Synthesis%2C+characterization+and+evaluation+of+biological+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Novel silicon-containing drugs derived from the indomethacin scaffold: Synthesis, characterization and evaluation of biological activity</span></div><div class="casAuthors">Bikzhanova, Galina A.; Toulokhonova, Irina S.; Gately, Stephen; West, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Silicon Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3/4</span>),
    <span class="NLM_cas:pages">209-217</span>CODEN:
                <span class="NLM_cas:coden">SCIHB4</span>;
        ISSN:<span class="NLM_cas:issn">1569-0660</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Synthesis, spectroscopic characterization and in vitro pharmacol. and cancer cell growth inhibitory activity studies of new Si-contg. compds. based on the indomethacin scaffold are now reported.  Amidation of the indomethacin carboxylate group using amino-functional silanes, R12SiR(CH2)nNH2 (R1 = Me, R = Me, Ph; R1 = R = OEt, n = 1, 3) generated novel lipophilic derivs. of indomethacin I.  The pharmacol. activity of these derivs. tested against human recombinant cyclooxygenase-1 and 2 demonstrated that the Si-contg. derivs. are cyclooxygenase-2 (COX-2) selective.  The Si-contg. amides of indomethacin demonstrated in vitro growth inhibitory activity against human MiaPaCa-2 pancreatic carcinoma cells at low μM concns.  I (n = 3, R1 = R = Me and n = 1, R1 = Me, R = Ph) exhibited the most potent in vitro antiproliferative activity, with IC50 <6.0 μM, compared to unmodified indomethacin having an IC50100 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoraWf5eDSF17Vg90H21EOLACvtfcHk0ljcS36jZl6U_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlGktbvP&md5=1eb0ca53f2176ad72f8e62cdd9460628</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1007%2Fs11201-006-9008-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11201-006-9008-5%26sid%3Dliteratum%253Aachs%26aulast%3DBikzhanova%26aufirst%3DG.%2BA.%26aulast%3DToulokhonova%26aufirst%3DI.%2BS.%26aulast%3DGately%26aufirst%3DS.%26aulast%3DWest%26aufirst%3DR.%26atitle%3DNovel%2520silicon-containing%2520drugs%2520derived%2520from%2520the%2520indomethacin%2520scaffold%253A%2520Synthesis%252C%2520characterization%2520and%2520evaluation%2520of%2520biological%2520activity%26jtitle%3DSilicon%2520Chem.%26date%3D2007%26volume%3D3%26spage%3D209%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Boltze, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brendler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Opitz, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raddatz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidel, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vollbrecht, D.</span><span> </span><span class="NLM_article-title">Chemical structure and antiinflammatory activity in the group of substituted indole-3-acetic acids</span> <span class="citation_source-journal">Arzneim.-Forsch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1314</span><span class="NLM_x">–</span> <span class="NLM_lpage">1325</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Fjm201528b&amp;key=7191301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm201528b&amp;key=1%3ACAS%3A528%3ADyaL3MXktVKqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1980&pages=1314-1325&author=K.+H.+Boltzeauthor=O.+Brendlerauthor=H.+Jacobiauthor=W.+Opitzauthor=S.+Raddatzauthor=P.+R.+Seidelauthor=D.+Vollbrecht&title=Chemical+structure+and+antiinflammatory+activity+in+the+group+of+substituted+indole-3-acetic+acids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical structure and antiinflammatory activity in the group of substituted indole-3-acetic acids</span></div><div class="casAuthors">Boltze, K. H.; Brendler, O.; Jacobi, H.; Opitz, W.; Raddatz, S.; Seidel, P. R.; Vollbrecht, D.</div><div class="citationInfo"><span class="NLM_cas:title">Arzneimittel-Forschung</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">8A</span>),
    <span class="NLM_cas:pages">1314-25</span>CODEN:
                <span class="NLM_cas:coden">ARZNAD</span>;
        ISSN:<span class="NLM_cas:issn">0004-4172</span>.
    </div><div class="casAbstract">About 110 potential antiinflammatory compds. were prepd. by systematically modifying indometacin (I; R = H) by modifying the α-methylene group, derivatizing the CO2H group, substituting the 4-ClC6H4CO moiety by ether aryl groups, introducing other substituents into the indole ring, and fusing other heterocycles to the indole ring.  Of all these compds., acemetacin (I; R = CH2CO2H) showed ∼2 times the activity of I (R = H) in the kaolin-induced rat paw edema test.  Further modification of acemetacin did not improve its activity.  Apparently substitution of the indole nucleus and the acetoxyacetic acid side chain are responsible for the high activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohHPTw9VSPxbVg90H21EOLACvtfcHk0ljcS36jZl6U_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXktVKqt7c%253D&md5=d9425d40a234ff5569a8e33d3a2c3039</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoltze%26aufirst%3DK.%2BH.%26aulast%3DBrendler%26aufirst%3DO.%26aulast%3DJacobi%26aufirst%3DH.%26aulast%3DOpitz%26aufirst%3DW.%26aulast%3DRaddatz%26aufirst%3DS.%26aulast%3DSeidel%26aufirst%3DP.%2BR.%26aulast%3DVollbrecht%26aufirst%3DD.%26atitle%3DChemical%2520structure%2520and%2520antiinflammatory%2520activity%2520in%2520the%2520group%2520of%2520substituted%2520indole-3-acetic%2520acids%26jtitle%3DArzneim.-Forsch.%26date%3D1980%26volume%3D30%26spage%3D1314%26epage%3D1325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i25"><a href="/doi/suppl/10.1021/jm201528b">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_47627"></div></div></div></div></div><hr /></hr><p class="last">Synthetic procedures, routine spectroscopic and spectrometric data, HPLC data, exemplified NMR spectra, and biochemical and biological testing methods. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm201528b/suppl_file/jm201528b_si_001.pdf">jm201528b_si_001.pdf (11.48 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm201528b&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Fjm201528b%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-5" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm201528b" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799630f1d7123f8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
